Datasets:

Me1oy

/

edtsum_ijcai-challenge

like 0

edtsum7700

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, April 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 roll-ins) treated in the OPTIMIZE PRO clinical study. The post-market, prospective, multi-center study is evaluating procedural outcomes (including pacemaker rate) associated with procedure-related techniques and post-procedure TAVR care pathways when using the self-expanding, supra-annular EvolutPRO and PRO+ TAVR systems in patients with symptomatic severe aortic stenosis. The interim data was presented virtually at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. Study investigators utilized several procedural approaches with the Evolut TAVR system in the study, including the "cusp overlap technique," which is designed to help implanters assess and achieve the target implant depth in an effort to reduce interaction with the conduction system. At 30 days, excellent safety outcomes were observed with zero death or disabling stroke and a low pacemaker rate (8.8%). Additionally, the Evolut platform showed excellent hemodynamic (blood flow) performance with low mean gradients (8.1 mm Hg) and low rates of residual total aortic regurgitation with the majority of subjects having none/trace (80.4%), and the rest mild (19.6%) at discharge. Patients also experienced an expedited discharge with a median hospital length of stay of one day. TheOPTIMIZE PRO study utilizes a TAVR care pathway to evaluate common practices and shared experiences such as conscious sedation and early mobilization. A conduction disturbance pathway evaluates efficiencies and heart team considerations for monitoring and managing patients with conduction disturbance who might be considered for a pacemaker post TAVR. "The evolution of TAVR requires that we refine aspects of the procedure and post-procedure care pathways to improve patient outcomes," said Kendra Grubb, M.D., surgical director of the Structural Heart and Valve Center at Emory Healthcare in Atlanta, and co-principal investigator in the OPTIMIZE PRO study who presented the data at the meeting. "Interim results from this study demonstrate improvements, like low pacemaker rates and next-day discharge, and are supportive of the hypothesis that the cusp overlap technique can improve patient care." The OPTIMIZE PRO study is being conducted at 46 study sites in the U.S. and Canada and up to 15 sites in Europe. The primary endpoint includes the rate of all-cause mortality or all-stroke at 30 days with secondary endpoints of discharge time, percent of patients with more than moderate aortic regurgitation, and the rate of pacemaker implant for new-onset or worsening conduction disturbance at 30 days. The study will also evaluate rehospitalization rates and discharge time at 30 days and one year. "As a leader in transcatheter valves therapies, we are committed to helping implanting centers standardize and further refine their TAVR care pathways to improve patient outcomes," said Nina Goodheart, president of the Structural Heart & Aortic business, which is part of the Cardiovascular Portfolio at Medtronic."In addition to helping us better understand the site-driven dynamics around conduction disturbance post-TAVR, the study also allows us to generate additional evidence around the Evolut PRO and PRO+ system's advanced sealing skirt and its impact on paravalvular leak." The Evolut TAVR platform, including the Evolut R, Evolut PRO and Evolut PRO+ TAVR System, is indicated for symptomatic severe aortic stenosis patients across all risk categories (extreme, high, intermediate and low) in the U.S. The Evolut PRO and PRO+ valves feature an outer tissue wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing. In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias. The company strivesto offer products and services that deliver clinical and economic value to healthcare consumers and providers around the world. About MedtronicMedtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts: Joey Lomicky Ryan Weispfenning Public Relations Investor Relations +1-763-526-2494 +1-763-505-4626 SOURCE Medtronic plc Related Links http://www.medtronic.com Answer:

Procedure-Related Techniques and Care Pathways from the OPTIMIZE PRO Clinical Study Show Promising Early Outcomes for Patients Implanted with the Medtronic Evolut TAVR System

DUBLIN, April 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced results from an interim analysis of the first 171 patients (including 71 roll-ins) treated in the OPTIMIZE PRO clinical study. The post-market, prospective, multi-center study is evaluating procedural outcomes (including pacemaker rate) associated with procedure-related techniques and post-procedure TAVR care pathways when using the self-expanding, supra-annular EvolutPRO and PRO+ TAVR systems in patients with symptomatic severe aortic stenosis. The interim data was presented virtually at the Society for Cardiovascular Angiography and Interventions (SCAI) 2021 Scientific Sessions. Study investigators utilized several procedural approaches with the Evolut TAVR system in the study, including the "cusp overlap technique," which is designed to help implanters assess and achieve the target implant depth in an effort to reduce interaction with the conduction system. At 30 days, excellent safety outcomes were observed with zero death or disabling stroke and a low pacemaker rate (8.8%). Additionally, the Evolut platform showed excellent hemodynamic (blood flow) performance with low mean gradients (8.1 mm Hg) and low rates of residual total aortic regurgitation with the majority of subjects having none/trace (80.4%), and the rest mild (19.6%) at discharge. Patients also experienced an expedited discharge with a median hospital length of stay of one day. TheOPTIMIZE PRO study utilizes a TAVR care pathway to evaluate common practices and shared experiences such as conscious sedation and early mobilization. A conduction disturbance pathway evaluates efficiencies and heart team considerations for monitoring and managing patients with conduction disturbance who might be considered for a pacemaker post TAVR. "The evolution of TAVR requires that we refine aspects of the procedure and post-procedure care pathways to improve patient outcomes," said Kendra Grubb, M.D., surgical director of the Structural Heart and Valve Center at Emory Healthcare in Atlanta, and co-principal investigator in the OPTIMIZE PRO study who presented the data at the meeting. "Interim results from this study demonstrate improvements, like low pacemaker rates and next-day discharge, and are supportive of the hypothesis that the cusp overlap technique can improve patient care." The OPTIMIZE PRO study is being conducted at 46 study sites in the U.S. and Canada and up to 15 sites in Europe. The primary endpoint includes the rate of all-cause mortality or all-stroke at 30 days with secondary endpoints of discharge time, percent of patients with more than moderate aortic regurgitation, and the rate of pacemaker implant for new-onset or worsening conduction disturbance at 30 days. The study will also evaluate rehospitalization rates and discharge time at 30 days and one year. "As a leader in transcatheter valves therapies, we are committed to helping implanting centers standardize and further refine their TAVR care pathways to improve patient outcomes," said Nina Goodheart, president of the Structural Heart & Aortic business, which is part of the Cardiovascular Portfolio at Medtronic."In addition to helping us better understand the site-driven dynamics around conduction disturbance post-TAVR, the study also allows us to generate additional evidence around the Evolut PRO and PRO+ system's advanced sealing skirt and its impact on paravalvular leak." The Evolut TAVR platform, including the Evolut R, Evolut PRO and Evolut PRO+ TAVR System, is indicated for symptomatic severe aortic stenosis patients across all risk categories (extreme, high, intermediate and low) in the U.S. The Evolut PRO and PRO+ valves feature an outer tissue wrap that adds surface area contact between the valve and the native aortic annulus to further advance valve sealing. In collaboration with leading clinicians, researchers and scientists worldwide, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular disease and cardiac arrhythmias. The company strivesto offer products and services that deliver clinical and economic value to healthcare consumers and providers around the world. About MedtronicMedtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts: Joey Lomicky Ryan Weispfenning Public Relations Investor Relations +1-763-526-2494 +1-763-505-4626 SOURCE Medtronic plc Related Links http://www.medtronic.com

edtsum7701

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PITTSBURGH, April 3, 2020 /PRNewswire/ --The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that it will hold its 2020 Annual Meeting of Shareholders solely over the web in a virtual-only format due to the public health impact of the coronavirus (COVID-19). Shareholders will not be able to attend the annual meeting in person at a physical location. The previously announced date and time of the annual meeting remain unchanged. However, previously announced dial-in and replay telephone numbers are no longer in effect. Meeting Date:Tuesday, April 28, 2020 Meeting Time:11:00 a.m. (Eastern Time) Meeting Access:www.meetingcenter.io/247992536 Shareholders as of the close of business on the record date of January 31, 2020 may vote their shares and submit questions during the virtual-only annual meeting by joining as a Shareholder, entering a control number and the password (PNC2020), and following the instructions available on the meeting website. For registered shareholders, the control number can be found on the proxy card, notice or email previously received. For street name shareholders who hold their shares through an intermediary, such as a broker or bank, a control number must be obtained in advance to vote during the meeting. To obtain a control number, street name shareholders must submit proof of their legal proxy issued by their broker or bank by sending a copy of the legal proxy, along with their name and email address, to Computershare via email at [emailprotected]. Requests for a control number must be labeled as "Legal Proxy" and be received by Computershare no later than 5:00 p.m., Eastern Time, on April 23, 2020. Street name shareholders who timely submit proof of their legal proxy will receive a confirmation email from Computershare with a control number. Shareholders who do not wish to login with a control number may join the virtual-only annual meeting as a Guest but will not have the option to vote their shares at the meeting or submit questions. A replay of the annual meeting will be available for 30 days, accessible at www.pnc.com/investoreventsor www.pnc.com/annualmeeting. The PNC Financial Services Group, Inc. is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com. CONTACTS: MEDIA:Marcey Zwiebel(412) 762-4550[emailprotected] INVESTORS: Bryan Gill (412) 768-4143 [emailprotected] SOURCE PNC Financial Services Group Answer:

The PNC Financial Services Group Announces Change From Physical Location To Virtual-Only 2020 Annual Shareholders Meeting

PITTSBURGH, April 3, 2020 /PRNewswire/ --The PNC Financial Services Group, Inc. (NYSE: PNC) announced today that it will hold its 2020 Annual Meeting of Shareholders solely over the web in a virtual-only format due to the public health impact of the coronavirus (COVID-19). Shareholders will not be able to attend the annual meeting in person at a physical location. The previously announced date and time of the annual meeting remain unchanged. However, previously announced dial-in and replay telephone numbers are no longer in effect. Meeting Date:Tuesday, April 28, 2020 Meeting Time:11:00 a.m. (Eastern Time) Meeting Access:www.meetingcenter.io/247992536 Shareholders as of the close of business on the record date of January 31, 2020 may vote their shares and submit questions during the virtual-only annual meeting by joining as a Shareholder, entering a control number and the password (PNC2020), and following the instructions available on the meeting website. For registered shareholders, the control number can be found on the proxy card, notice or email previously received. For street name shareholders who hold their shares through an intermediary, such as a broker or bank, a control number must be obtained in advance to vote during the meeting. To obtain a control number, street name shareholders must submit proof of their legal proxy issued by their broker or bank by sending a copy of the legal proxy, along with their name and email address, to Computershare via email at [emailprotected]. Requests for a control number must be labeled as "Legal Proxy" and be received by Computershare no later than 5:00 p.m., Eastern Time, on April 23, 2020. Street name shareholders who timely submit proof of their legal proxy will receive a confirmation email from Computershare with a control number. Shareholders who do not wish to login with a control number may join the virtual-only annual meeting as a Guest but will not have the option to vote their shares at the meeting or submit questions. A replay of the annual meeting will be available for 30 days, accessible at www.pnc.com/investoreventsor www.pnc.com/annualmeeting. The PNC Financial Services Group, Inc. is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com. CONTACTS: MEDIA:Marcey Zwiebel(412) 762-4550[emailprotected] INVESTORS: Bryan Gill (412) 768-4143 [emailprotected] SOURCE PNC Financial Services Group

edtsum7702

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Waste Management and Remediation Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global waste management and remediation services market as it emerges from the COVID-19 shut down. The global waste management and remediation services market is expected to grow from $504.14 billion in 2020 to $542.83 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $679.85 billion in 2025 at a CAGR of 6%. Companies Mentioned Reasons to Purchase The waste management and remediation services market consists of sales of waste management and remediation services and related goods by entities (organizations, sole traders and partnerships) that provide waste collection, treatment and disposal services, remediation services, operate materials recovery facilities, or provide septic tank pumping and related services. The waste management and remediation services market is segmented into waste collection; waste treatment and disposal; remediation services; and other waste management services. Western Europe was the largest region in the global waste management and remediation services market, accounting for 34% of the market in 2020. Asia Pacific was the second largest region accounting for 31% of the global waste management and remediation services market. Africa was the smallest region in the global waste management and remediation services market. Waste management and remediation services are increasingly using sensors for managing waste collected. A sensor is a device that detects and responds to some type of input from the physical environment. The specific input could be light, heat, motion, moisture, pressure, or any other environmental phenomena. Sensors let waste management companies know that bins are full and need to be serviced. Sensor technology can also be used to sort recyclables quickly and efficiently, thereby reducing manual work and encouraging higher recycling rates. This enables companies to have a complete visibility of containers which helps them to reduce the costs. For instance, the OnePlus Metro from OnePlus Systems is an ultrasonic trash can sensor that lets waste management companies determine if waste containers are full. Key Topics Covered: 1. Executive Summary 2. Report Structure 3. Waste Management and Remediation Services Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Waste Management and Remediation Services Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Waste Management and Remediation Services Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Waste Management and Remediation Services Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Waste Management and Remediation Services Market Trends and Strategies 8. Impact of COVID-19 on Waste Management and Remediation Services 9. Waste Management and Remediation Services Market Size and Growth 9.1. Market Size 9.2. Historic Market Growth, Value ($ Billion) 9.3. Forecast Market Growth, Value ($ Billion) 10. Waste Management and Remediation Services Market Regional Analysis 10.1. Global Waste Management and Remediation Services Market, 2020, by Region, Value ($ Billion) 10.2. Global Waste Management and Remediation Services Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region 10.3. Global Waste Management and Remediation Services Market, Growth and Market Share Comparison, by Region 11. Waste Management and Remediation Services Market Segmentation 11.1. Global Waste Management and Remediation Services Market, Segmentation by Type 11.2. Global Waste Management and Remediation Services Market, Segmentation by Application 11.3. Global Waste Management and Remediation Services Market, Segmentation by Mode 12. Waste Management and Remediation Services Market Metrics 12.1. Waste Management and Remediation Services Market Size, Percentage of GDP, 2015-2025, Global 12.2. Per Capita Average Waste Management and Remediation Services Market Expenditure, 2015-2025, Global For more information about this report visit https://www.researchandmarkets.com/r/tot32w Answer:

Global Waste Management and Remediation Services Market Report (2021 to 2030) - COVID-19 Impact and Recovery - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Waste Management and Remediation Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global waste management and remediation services market as it emerges from the COVID-19 shut down. The global waste management and remediation services market is expected to grow from $504.14 billion in 2020 to $542.83 billion in 2021 at a compound annual growth rate (CAGR) of 7.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $679.85 billion in 2025 at a CAGR of 6%. Companies Mentioned Reasons to Purchase The waste management and remediation services market consists of sales of waste management and remediation services and related goods by entities (organizations, sole traders and partnerships) that provide waste collection, treatment and disposal services, remediation services, operate materials recovery facilities, or provide septic tank pumping and related services. The waste management and remediation services market is segmented into waste collection; waste treatment and disposal; remediation services; and other waste management services. Western Europe was the largest region in the global waste management and remediation services market, accounting for 34% of the market in 2020. Asia Pacific was the second largest region accounting for 31% of the global waste management and remediation services market. Africa was the smallest region in the global waste management and remediation services market. Waste management and remediation services are increasingly using sensors for managing waste collected. A sensor is a device that detects and responds to some type of input from the physical environment. The specific input could be light, heat, motion, moisture, pressure, or any other environmental phenomena. Sensors let waste management companies know that bins are full and need to be serviced. Sensor technology can also be used to sort recyclables quickly and efficiently, thereby reducing manual work and encouraging higher recycling rates. This enables companies to have a complete visibility of containers which helps them to reduce the costs. For instance, the OnePlus Metro from OnePlus Systems is an ultrasonic trash can sensor that lets waste management companies determine if waste containers are full. Key Topics Covered: 1. Executive Summary 2. Report Structure 3. Waste Management and Remediation Services Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. Waste Management and Remediation Services Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. Waste Management and Remediation Services Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. Waste Management and Remediation Services Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. Waste Management and Remediation Services Market Trends and Strategies 8. Impact of COVID-19 on Waste Management and Remediation Services 9. Waste Management and Remediation Services Market Size and Growth 9.1. Market Size 9.2. Historic Market Growth, Value ($ Billion) 9.3. Forecast Market Growth, Value ($ Billion) 10. Waste Management and Remediation Services Market Regional Analysis 10.1. Global Waste Management and Remediation Services Market, 2020, by Region, Value ($ Billion) 10.2. Global Waste Management and Remediation Services Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region 10.3. Global Waste Management and Remediation Services Market, Growth and Market Share Comparison, by Region 11. Waste Management and Remediation Services Market Segmentation 11.1. Global Waste Management and Remediation Services Market, Segmentation by Type 11.2. Global Waste Management and Remediation Services Market, Segmentation by Application 11.3. Global Waste Management and Remediation Services Market, Segmentation by Mode 12. Waste Management and Remediation Services Market Metrics 12.1. Waste Management and Remediation Services Market Size, Percentage of GDP, 2015-2025, Global 12.2. Per Capita Average Waste Management and Remediation Services Market Expenditure, 2015-2025, Global For more information about this report visit https://www.researchandmarkets.com/r/tot32w

edtsum7703

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PORTLAND, Oregon, March 18, 2020 /PRNewswire/ --Allied Market Research published a report, titled, "Textile Dyes Marketby Dye Type (Direct, Reactive, VAT, Basic, Acid, Disperse, Solvent, Mordant, and Others), Fiber Type (Wool, Nylon, Cotton, Viscose, Silk, Acryl, Polymer, and Others), and Application (Yarn Dyeing, Garment Dyeing, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026." According to the report, the global textile dyes industry was estimated at $9.45 billion in 2018 and is expected to hit $15.5 billion by 2026, registering a CAGR of 6.3% from 20192026. Drivers, restraints and opportunities- Rise in production of textiles in developing countries to meet the increasing consumer demand, low cost of labor, and surge in population are the factors, boosting the growth of the global textile dyes industry.On the other hand, implementation of various health & environment regulations towards the use of textile dyes restrains the growth to some extent. Nevertheless, development of new processes that minimizes the water wastage is expected to usher in a number of opportunities in the near future. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5848 The disperse segment to rule the roost till 2026- Based on dye type, the disperse segment accounted for one-fourth of the global textile dyes market revenue in 2018, and is expected to retain its dominance by the end of 2026. Factors like ease of use, overall low cost, and less water requirement fuel the segment growth. The reactive segment, on the other hand, would grow at the fastest CAGR of 7.2% during 20192026, owing to its beneficial features such as bright shades, ease of application, quick-drying properties, cost-effectiveness, and others. The polyester segment to dominate during the estimated period- Based on fiber type, the polyester segment contributed to nearly half of the global textile dyes market share in 2018, and is anticipated to lead the trail by 2026. This is attributed to the numerous advantages it provides such as high strength, weather-resistant, high elasticity, and others. Simultaneously, the acrylic segment would showcase the fastest CAGR of 7.3% throughout the forecast period. Rise in demand for fibers in yarns for the manufacturing of apparel and household textiles propels the growth of the segment. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5848 Asia-Pacific, followed by Europe and North America, to remain lucrative during the study period- Based on geography, Asia-Pacific, followed by Europe and North America, garnered the major market sharein 2018, holding more than two-fifths of the global textile dyes market. The same region would also cite the fastest CAGR of 6.9% from 2019 to 2026. The growth is driven by the development in manufacturing sectors, improvement in economic conditions, and increase in population in the province. Frontrunners in the industry- Shanxi Linfen Dyeing Chemicals (Group) Co. Ltd. Archroma Colourtex,Dalian Dyestuffs & Chemicals Hangzhou Dikai Chemical Co. Ltd. Huntsman International LLC Anoky Co. Ltd. Jay Chemical Industries Ltd. Kiri Dyes and Chemicals Ltd. Xuzhou Amer International Trading Co. Ltd. Interested in Procuring this Report? visit: https://www.alliedmarketresearch.com/textile-dyes-market/purchase-options Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/library-access Avenue is a user-based library of global market report database, provides comprehensive reports pertaining to the world's largest emerging markets. It further offers e-access to all the available industry reports just in a jiffy. By offering core business insights on the varied industries, economies, and end users worldwide, Avenue ensures that the registered members get an easy as well as single gateway to their all-inclusive requirements. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Similar Reports: Digital Ink Market: Global Opportunity Analysis and Industry Forecast, 20192026 Powder Coatings Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 High Performance Ceramic Coatings Market: Global Opportunity Analysis and Industry Forecast, 20192026 Wood Coatings Market:Global Opportunity Analysis and Industry Forecast, 20202025 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact:David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975 [emailprotected] Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research Answer:

Textile Dyes Market to Garner $ 15.5 Bn, Globally, by 2026 at 6.3 % CAGR: Allied Market Research Increase in production of textiles in developing countries to meet the increasing consumer demand, low cost of labor, and rise in population drive the growth of the global textile dyes industry

PORTLAND, Oregon, March 18, 2020 /PRNewswire/ --Allied Market Research published a report, titled, "Textile Dyes Marketby Dye Type (Direct, Reactive, VAT, Basic, Acid, Disperse, Solvent, Mordant, and Others), Fiber Type (Wool, Nylon, Cotton, Viscose, Silk, Acryl, Polymer, and Others), and Application (Yarn Dyeing, Garment Dyeing, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2026." According to the report, the global textile dyes industry was estimated at $9.45 billion in 2018 and is expected to hit $15.5 billion by 2026, registering a CAGR of 6.3% from 20192026. Drivers, restraints and opportunities- Rise in production of textiles in developing countries to meet the increasing consumer demand, low cost of labor, and surge in population are the factors, boosting the growth of the global textile dyes industry.On the other hand, implementation of various health & environment regulations towards the use of textile dyes restrains the growth to some extent. Nevertheless, development of new processes that minimizes the water wastage is expected to usher in a number of opportunities in the near future. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5848 The disperse segment to rule the roost till 2026- Based on dye type, the disperse segment accounted for one-fourth of the global textile dyes market revenue in 2018, and is expected to retain its dominance by the end of 2026. Factors like ease of use, overall low cost, and less water requirement fuel the segment growth. The reactive segment, on the other hand, would grow at the fastest CAGR of 7.2% during 20192026, owing to its beneficial features such as bright shades, ease of application, quick-drying properties, cost-effectiveness, and others. The polyester segment to dominate during the estimated period- Based on fiber type, the polyester segment contributed to nearly half of the global textile dyes market share in 2018, and is anticipated to lead the trail by 2026. This is attributed to the numerous advantages it provides such as high strength, weather-resistant, high elasticity, and others. Simultaneously, the acrylic segment would showcase the fastest CAGR of 7.3% throughout the forecast period. Rise in demand for fibers in yarns for the manufacturing of apparel and household textiles propels the growth of the segment. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5848 Asia-Pacific, followed by Europe and North America, to remain lucrative during the study period- Based on geography, Asia-Pacific, followed by Europe and North America, garnered the major market sharein 2018, holding more than two-fifths of the global textile dyes market. The same region would also cite the fastest CAGR of 6.9% from 2019 to 2026. The growth is driven by the development in manufacturing sectors, improvement in economic conditions, and increase in population in the province. Frontrunners in the industry- Shanxi Linfen Dyeing Chemicals (Group) Co. Ltd. Archroma Colourtex,Dalian Dyestuffs & Chemicals Hangzhou Dikai Chemical Co. Ltd. Huntsman International LLC Anoky Co. Ltd. Jay Chemical Industries Ltd. Kiri Dyes and Chemicals Ltd. Xuzhou Amer International Trading Co. Ltd. Interested in Procuring this Report? visit: https://www.alliedmarketresearch.com/textile-dyes-market/purchase-options Access AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/library-access Avenue is a user-based library of global market report database, provides comprehensive reports pertaining to the world's largest emerging markets. It further offers e-access to all the available industry reports just in a jiffy. By offering core business insights on the varied industries, economies, and end users worldwide, Avenue ensures that the registered members get an easy as well as single gateway to their all-inclusive requirements. Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter Similar Reports: Digital Ink Market: Global Opportunity Analysis and Industry Forecast, 20192026 Powder Coatings Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 High Performance Ceramic Coatings Market: Global Opportunity Analysis and Industry Forecast, 20192026 Wood Coatings Market:Global Opportunity Analysis and Industry Forecast, 20202025 About Us Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. Contact:David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):1-800-792-5285, 1-503-894-6022, 1-503-446-1141UK:+44-845-528-1300Hong Kong:+852-301-84916India (Pune):+91-20-66346060Fax:+1(855)550-5975 [emailprotected] Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research SOURCE Allied Market Research

edtsum7704

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ABU DHABI, United Arab Emirates & LONDON--(BUSINESS WIRE)--The Global Institute for Disease Elimination (GLIDE), a new Abu Dhabi-based global health Institute focused on eliminating infectious diseases of poverty, has launched The Falcon Awards for Disease Elimination, in a drive to discover and implement innovative approaches to disease elimination. Founded in 2019 by His Highness Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi, and the Bill & Melinda Gates Foundation, GLIDE identifies the latest scientific, cultural, and global health knowledge and puts it into action with partners through programmes to advance disease elimination. The Falcon Awards, which open for submissions online on 4th May 2021, invites Non-Governmental Organisations (NGOs), philanthropic foundations, coalitions or networks of Civil Society Organisations (CSOs), academic or research institutions, Public-Private Partnerships (PPP), and public or private sector institutions in endemic countries to submit proposals that aim to accelerate the elimination of one or more of GLIDEs four focus diseases: malaria, polio, lymphatic filariasis, and onchocerciasis. GLIDE is particularly seeking proposals which address cross-border, cross-disease, cross-programme, or cross-sector approaches to disease elimination. Submissions should focus on the implementation of innovative ideas and established research which has a high potential to be catalytic, transformational, or genuinely novel in approach, or on operational research with prospects to provide solutions to existing disease elimination challenges. Simon Bland, Chief Executive Officer of GLIDE, commented: At GLIDE, we firmly believe in an integrated and collaborative approach to tackling infectious diseases of poverty. The Falcon Awards for Disease Elimination will help advance and amplify these efforts. Five winners will be announced later this year following a thorough evaluation by a jury panel comprised of esteemed global health experts. Each winner will receive a sum of up to USD200,000 to fund and implement their unique solutions to disease elimination. For more information on The Falcon Awards and how to enter, please visit: https://glideae.org/awards [ENDS] Notes for editors: The Falcon Awards - key dates: About GLIDE GLIDE is a new global health Institute, rooted in Abu Dhabi, focused on accelerating the elimination of four preventable diseases of poverty: currently malaria, polio, lymphatic filariasis, and river blindness, by 2030 and beyond. Founded in 2019 as the result of a collaboration between His Highness Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi, and the Bill & Melinda Gates Foundation, GLIDE identifies the latest scientific, cultural, and global health knowledge and puts it into action with its partners through programmes, funding, and skills development to support local health care systems and advance global thinking. For more information, please visit: https://glideae.org/ Answer:

GLIDE Launches Inaugural Awards for Disease Elimination - New Abu Dhabi-based global health Institute launches its first disease elimination awards - 5 awards of up to USD200,000 each

ABU DHABI, United Arab Emirates & LONDON--(BUSINESS WIRE)--The Global Institute for Disease Elimination (GLIDE), a new Abu Dhabi-based global health Institute focused on eliminating infectious diseases of poverty, has launched The Falcon Awards for Disease Elimination, in a drive to discover and implement innovative approaches to disease elimination. Founded in 2019 by His Highness Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi, and the Bill & Melinda Gates Foundation, GLIDE identifies the latest scientific, cultural, and global health knowledge and puts it into action with partners through programmes to advance disease elimination. The Falcon Awards, which open for submissions online on 4th May 2021, invites Non-Governmental Organisations (NGOs), philanthropic foundations, coalitions or networks of Civil Society Organisations (CSOs), academic or research institutions, Public-Private Partnerships (PPP), and public or private sector institutions in endemic countries to submit proposals that aim to accelerate the elimination of one or more of GLIDEs four focus diseases: malaria, polio, lymphatic filariasis, and onchocerciasis. GLIDE is particularly seeking proposals which address cross-border, cross-disease, cross-programme, or cross-sector approaches to disease elimination. Submissions should focus on the implementation of innovative ideas and established research which has a high potential to be catalytic, transformational, or genuinely novel in approach, or on operational research with prospects to provide solutions to existing disease elimination challenges. Simon Bland, Chief Executive Officer of GLIDE, commented: At GLIDE, we firmly believe in an integrated and collaborative approach to tackling infectious diseases of poverty. The Falcon Awards for Disease Elimination will help advance and amplify these efforts. Five winners will be announced later this year following a thorough evaluation by a jury panel comprised of esteemed global health experts. Each winner will receive a sum of up to USD200,000 to fund and implement their unique solutions to disease elimination. For more information on The Falcon Awards and how to enter, please visit: https://glideae.org/awards [ENDS] Notes for editors: The Falcon Awards - key dates: About GLIDE GLIDE is a new global health Institute, rooted in Abu Dhabi, focused on accelerating the elimination of four preventable diseases of poverty: currently malaria, polio, lymphatic filariasis, and river blindness, by 2030 and beyond. Founded in 2019 as the result of a collaboration between His Highness Sheikh Mohamed bin Zayed, Crown Prince of Abu Dhabi, and the Bill & Melinda Gates Foundation, GLIDE identifies the latest scientific, cultural, and global health knowledge and puts it into action with its partners through programmes, funding, and skills development to support local health care systems and advance global thinking. For more information, please visit: https://glideae.org/

edtsum7705

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEWPORT BEACH, Calif.--(BUSINESS WIRE)--DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (DPW, or the Company), announced that its power electronics business, Coolisys Technologies Corp. (Coolisys), has established a program targeting both national and regional fast-food franchisees to install the ACECool electric vehicle (EV) chargers as a part of a revenue sharing program. The program initially will be funded from the Companys recent capital raising activities. The program is expected to be launched in California, Nevada and Canada. While the Company is excited about Coolisys new franchise program, there is no assurance that the program will be successful. The Company expects that the program will allow franchise owners and operators to install the ACECool EV chargers and share in the net revenue from advertising and network usage. This same program is anticipated to be a model for other strategic industry-focused and geo-focused networks. Coolisys expects to launch its program with a national fast-food network franchisee that forms a part of a network with over 1,000 locations. Coolisys expects to announce other network partners in the first quarter of 2021. Global EV sales rose a dramatic 65% from 2017 to 2018, for a total of 2.1 million vehicles, with sales figures steady through 2019. The subsequent outbreak of the coronavirus pandemic, however, resulted in a 25% decline in EV purchases during the first quarter of 2020. Despite these setbacks, EV demand is again expected to rise according to a study by Bloomberg New Energy Finance, which sees improved batteries, more readily available charging infrastructure, new markets and price parity with internal combustion engine vehicles as the major growth drivers. The study estimates that EVs will comprise 10% of global passenger vehicle sales by 2025, rising to 28% in 2030 and 58% in 2040. In terms of expanding the current infrastructure to support EV deployment, McKinsey reported that by 2030 more the $30 billion will need to be spent on the rollout of EV chargers and, that by 2030, the US market for services to support the charging of EV fleets could be worth $15 billion. Amos Kohn, President and CEO of Coolisys, said, The opportunities for Coolisys in the burgeoning EV marketplace are anticipated to drive our sales growth over the next 60 months and beyond. We look forward to the potential changes coming from increased demand for EVs and the recent trends related to government support of the electrification of transport. I believe we are well positioned to leverage these opportunities as a 50+ year old company experienced and capable of creating innovative and highly-efficient power systems and solutions. For more information on DPW Holdings and its subsidiaries, the Company recommends that stockholders, investors and any other interested parties read the Companys public filings and press releases available under the Investor Relations section at www.DPWHoldings.com or available at www.sec.gov. About Coolisys Technologies Corp. Coolisys and its portfolio companies and divisions are primarily engaged in the design and manufacture of innovative, feature-rich, and top-quality power products for mission-critical applications in the harshest environments and life-saving, life sustaining applications across diverse markets including defense/aerospace, medical/healthcare, industrial, telecommunications, and automotive. Coolisys headquarters are located at 1635 South Main Street, Milpitas, CA 95035; www.Coolisys.com. About DPW Holdings, Inc. DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, and textiles. In addition, the Company extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPWs headquarters are located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com. Forward-Looking Statements This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as believes, plans, anticipates, projects, estimates, expects, intends, strategy, future, opportunity, may, will, should, could, potential, or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Companys business and financial results are included in the Companys filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Companys Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Companys website at www.DPWHoldings.com. Answer:

DPW Holdings Coolisys Power Electronics Business to Test ACECool EV Chargers Targeting National Fast-Food Franchise Networks

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--DPW Holdings, Inc. (NYSE American: DPW) a diversified holding company (DPW, or the Company), announced that its power electronics business, Coolisys Technologies Corp. (Coolisys), has established a program targeting both national and regional fast-food franchisees to install the ACECool electric vehicle (EV) chargers as a part of a revenue sharing program. The program initially will be funded from the Companys recent capital raising activities. The program is expected to be launched in California, Nevada and Canada. While the Company is excited about Coolisys new franchise program, there is no assurance that the program will be successful. The Company expects that the program will allow franchise owners and operators to install the ACECool EV chargers and share in the net revenue from advertising and network usage. This same program is anticipated to be a model for other strategic industry-focused and geo-focused networks. Coolisys expects to launch its program with a national fast-food network franchisee that forms a part of a network with over 1,000 locations. Coolisys expects to announce other network partners in the first quarter of 2021. Global EV sales rose a dramatic 65% from 2017 to 2018, for a total of 2.1 million vehicles, with sales figures steady through 2019. The subsequent outbreak of the coronavirus pandemic, however, resulted in a 25% decline in EV purchases during the first quarter of 2020. Despite these setbacks, EV demand is again expected to rise according to a study by Bloomberg New Energy Finance, which sees improved batteries, more readily available charging infrastructure, new markets and price parity with internal combustion engine vehicles as the major growth drivers. The study estimates that EVs will comprise 10% of global passenger vehicle sales by 2025, rising to 28% in 2030 and 58% in 2040. In terms of expanding the current infrastructure to support EV deployment, McKinsey reported that by 2030 more the $30 billion will need to be spent on the rollout of EV chargers and, that by 2030, the US market for services to support the charging of EV fleets could be worth $15 billion. Amos Kohn, President and CEO of Coolisys, said, The opportunities for Coolisys in the burgeoning EV marketplace are anticipated to drive our sales growth over the next 60 months and beyond. We look forward to the potential changes coming from increased demand for EVs and the recent trends related to government support of the electrification of transport. I believe we are well positioned to leverage these opportunities as a 50+ year old company experienced and capable of creating innovative and highly-efficient power systems and solutions. For more information on DPW Holdings and its subsidiaries, the Company recommends that stockholders, investors and any other interested parties read the Companys public filings and press releases available under the Investor Relations section at www.DPWHoldings.com or available at www.sec.gov. About Coolisys Technologies Corp. Coolisys and its portfolio companies and divisions are primarily engaged in the design and manufacture of innovative, feature-rich, and top-quality power products for mission-critical applications in the harshest environments and life-saving, life sustaining applications across diverse markets including defense/aerospace, medical/healthcare, industrial, telecommunications, and automotive. Coolisys headquarters are located at 1635 South Main Street, Milpitas, CA 95035; www.Coolisys.com. About DPW Holdings, Inc. DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, and textiles. In addition, the Company extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPWs headquarters are located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com. Forward-Looking Statements This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as believes, plans, anticipates, projects, estimates, expects, intends, strategy, future, opportunity, may, will, should, could, potential, or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Companys business and financial results are included in the Companys filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Companys Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Companys website at www.DPWHoldings.com.

edtsum7706

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SHANGHAI, Feb. 19, 2021 /PRNewswire/ -- "The Covid-19 pandemic has hadsignificant effects on education development in China. The Covid-19 outbreak is a crisis, but it triggers the educators in China to think about what we can learn from our current educational circumstances so as to make sufficient preparations for the future. Therefore, there has been a growing emphasis onSTEAM in China, because it isan approach to learning that uses Science, Technology, Engineering, Arts and Mathematics as access points for guiding studentshow to think critically and evaluate information, and how to apply knowledge, research and skills to solvethe problem. Enhancing such skills lies at the heart of STEAM education," Ricky Ye said, Founder & CEO of DFRobot, a Chinese open source hardware and STEAM education provider. Ricky Ye, CEO of DFRobot Ricky Ye illustrates four kinds of prevalentSTEAM teachingpractices to show current STEAM educational environment in China. PBL Project-based learning is an ideal way to master STEAM skills for students. Projects help students master useful skills, keep learning fun, and allow students to direct the course of their own education.A successful example of PBL is the bird protection for Gaoligongshan Nature Reserve, in the western Yunnan Province of China. The bird protection project is divided into three parts: the first part is for students to go to bird nature reserves to select the bird they want to observe and design an artificial nest for birds they are interested in; the second part is to learn 3D design concept and 3D printer operation and make the artificial nests after returning to school; finally, students go back to the bird nature reserve and put the artificial nest into the nature. During this project, students experience the process of finding problem, collecting data, analyzing information, discussing ideas and finally coming up with the solutions. This example is a good combination of PBL with STEAM. Students become the scientists, mathematicians, engineers, artists and technological engineers during the project. Although PBL has gradually become an attractive point in STEAM education, it is actually facing great challenges at the moment in China.Most of PBL is happening in private schools by now. Public school is slower to adopt the innovation. And, some schools were in lack of experienced teachers.It will takea long time to seethe widespread of PBL adoption in China. But, other countries in the world are also experiencing this long PBL journey. STEAM education in Makerspace In China, two factors stimulate the development of STEAM education. One is amultitude of makerspaces have sprung upin 2015. In 2015, the China Premier, Li Keqiang, decreed that makerspaces would be a part of China's economicdevelopment plan. This was followed by the government funding of hundreds of makerspaces across China. The other reason is China's Economic Maturity. As Chinese economy first started to grow rapidly in the 1970s, when it required the graduates to have the ability associated with low-cost labour, for example the ability to follow instructions. By now, as China's economy matures, Chinese companies need to focus much more on creation and innovation to make a living. The Chinese education system is criticized for not being able to provide the skills required by this innovation-led economy.[1]Makerspaces is designed for hands-on, collaborative, creative work, precisely required by China's economy today.In the years from 2015 to 2020, many public and private schools opened school makerspaces where students could build, innovate and explore the complexity of systems as a cross-subject learner, propelled by government or companies sponsored makerspaces. Wenzhou High School, located in Wenzhou, in the southeastern Zhejiang Province in China, is the first public school to set up makerspace in 2013. In the school makerspace, it includes spaces for maker and STEAM activities and equipped with 3D printers, audio-visual equipment, hands tools and other storage carts can be filled with age-appropriate materials. It takes Arduino as the main implementation platform and is also equipped with Raspberry Pi computers for students to turn their ideas into the real and tangible objects. Wenzhou High School makerspace also gains the support from DFRobot, which donates 3D printers and STEAM educational kits. In addition, many universities are setting up their own makerspaces in China. At present, the i.Center, based at Tsinghua University in China, which is the world largest makerspace at 16,000 square meters. STEAM Competitions for Kids STEAM competitionlike kid codinghasbeen gaining attention in recent years in China. Engaging young kids in competitions is a sure way to get them excited to learn. Here kids find a community and pick up skills such as critical thinking, creativity and problem-solving.In March 2019, the Ministry of Education of China announced the "Key Points of Education Informatization and Network Security Work in 2019", proposing to promote the establishment of courses related to artificial intelligence in primary and secondary schools, and to gradually promote programming education.The future national competition is about artificial intelligence, and coding is the basic skill at the AI era.With encouraging governmental policies,capitalsbegan to flood into the market for kid coding education. Currently, Scratch, Makecode and Mind+ are the three popular programming languages in Chinafrom iiMedia Research. Scratch Makecode Mind+ Developed by MIT Media Block-based visual programming language Used worldwide Produced by Microsoft A visual language programming MakeCode programs can be authored in Blocks, Static TypeScript or Static Python. Launched by DFRobot, China, in 2013 Allows kids to build a program by dragging and snapping coding blocks. Supports a wide range of hardware including Arduino, micro:bit or even a series of ESP32-based educational microcontrollers Hands-on Remote Learning Due to a nationwide epidemic control mechanism, China was the first country to mandate school closures. 270 million Chinese students are restricted to their homes. STEAM education is forced to transform from offline to online andhas become a fantastic way for students to continue their education whilst having fun at home.Although the Covid-19 pandemic has had a negative effect on education development in China, STEAM education still attracts large-scale investment because of its interdisciplinary learning, problem-solving and real-life assessment. 2020 China STEAM Education-Related Enterprise Financing Situation (Partial) from iiMedia Research Company Financing Round Sum Date Codemao Series D Funding CNY 1.3 billion Nov.20, 2020 Bell Series C Funding CNY 120 million May.5, 2020 DFRobot Series B Funding Tens of millions of CNY Jan.3, 2020 About the future STEAM development in China, Ricky Ye points out, "STEAM education in China has developed rapidly and future market growth will depend on how quickly it gains broad acceptance, which is related to the integration with national curriculum, changes in teachers and parents' teaching methods and investment. High-quality STEAM education is high-quality project-based learning. Thereisstillalong wayto localize it intoChina'seducational environment but the future is bright." Reference: [1]Quote from British Council: Made-in-China-Makerspaces-and-the-search-for-mass-innovation SOURCE DFRobot Answer:

DFRobot CEO Thoughts about COVID-19 Impact on STEAM Development in China

SHANGHAI, Feb. 19, 2021 /PRNewswire/ -- "The Covid-19 pandemic has hadsignificant effects on education development in China. The Covid-19 outbreak is a crisis, but it triggers the educators in China to think about what we can learn from our current educational circumstances so as to make sufficient preparations for the future. Therefore, there has been a growing emphasis onSTEAM in China, because it isan approach to learning that uses Science, Technology, Engineering, Arts and Mathematics as access points for guiding studentshow to think critically and evaluate information, and how to apply knowledge, research and skills to solvethe problem. Enhancing such skills lies at the heart of STEAM education," Ricky Ye said, Founder & CEO of DFRobot, a Chinese open source hardware and STEAM education provider. Ricky Ye, CEO of DFRobot Ricky Ye illustrates four kinds of prevalentSTEAM teachingpractices to show current STEAM educational environment in China. PBL Project-based learning is an ideal way to master STEAM skills for students. Projects help students master useful skills, keep learning fun, and allow students to direct the course of their own education.A successful example of PBL is the bird protection for Gaoligongshan Nature Reserve, in the western Yunnan Province of China. The bird protection project is divided into three parts: the first part is for students to go to bird nature reserves to select the bird they want to observe and design an artificial nest for birds they are interested in; the second part is to learn 3D design concept and 3D printer operation and make the artificial nests after returning to school; finally, students go back to the bird nature reserve and put the artificial nest into the nature. During this project, students experience the process of finding problem, collecting data, analyzing information, discussing ideas and finally coming up with the solutions. This example is a good combination of PBL with STEAM. Students become the scientists, mathematicians, engineers, artists and technological engineers during the project. Although PBL has gradually become an attractive point in STEAM education, it is actually facing great challenges at the moment in China.Most of PBL is happening in private schools by now. Public school is slower to adopt the innovation. And, some schools were in lack of experienced teachers.It will takea long time to seethe widespread of PBL adoption in China. But, other countries in the world are also experiencing this long PBL journey. STEAM education in Makerspace In China, two factors stimulate the development of STEAM education. One is amultitude of makerspaces have sprung upin 2015. In 2015, the China Premier, Li Keqiang, decreed that makerspaces would be a part of China's economicdevelopment plan. This was followed by the government funding of hundreds of makerspaces across China. The other reason is China's Economic Maturity. As Chinese economy first started to grow rapidly in the 1970s, when it required the graduates to have the ability associated with low-cost labour, for example the ability to follow instructions. By now, as China's economy matures, Chinese companies need to focus much more on creation and innovation to make a living. The Chinese education system is criticized for not being able to provide the skills required by this innovation-led economy.[1]Makerspaces is designed for hands-on, collaborative, creative work, precisely required by China's economy today.In the years from 2015 to 2020, many public and private schools opened school makerspaces where students could build, innovate and explore the complexity of systems as a cross-subject learner, propelled by government or companies sponsored makerspaces. Wenzhou High School, located in Wenzhou, in the southeastern Zhejiang Province in China, is the first public school to set up makerspace in 2013. In the school makerspace, it includes spaces for maker and STEAM activities and equipped with 3D printers, audio-visual equipment, hands tools and other storage carts can be filled with age-appropriate materials. It takes Arduino as the main implementation platform and is also equipped with Raspberry Pi computers for students to turn their ideas into the real and tangible objects. Wenzhou High School makerspace also gains the support from DFRobot, which donates 3D printers and STEAM educational kits. In addition, many universities are setting up their own makerspaces in China. At present, the i.Center, based at Tsinghua University in China, which is the world largest makerspace at 16,000 square meters. STEAM Competitions for Kids STEAM competitionlike kid codinghasbeen gaining attention in recent years in China. Engaging young kids in competitions is a sure way to get them excited to learn. Here kids find a community and pick up skills such as critical thinking, creativity and problem-solving.In March 2019, the Ministry of Education of China announced the "Key Points of Education Informatization and Network Security Work in 2019", proposing to promote the establishment of courses related to artificial intelligence in primary and secondary schools, and to gradually promote programming education.The future national competition is about artificial intelligence, and coding is the basic skill at the AI era.With encouraging governmental policies,capitalsbegan to flood into the market for kid coding education. Currently, Scratch, Makecode and Mind+ are the three popular programming languages in Chinafrom iiMedia Research. Scratch Makecode Mind+ Developed by MIT Media Block-based visual programming language Used worldwide Produced by Microsoft A visual language programming MakeCode programs can be authored in Blocks, Static TypeScript or Static Python. Launched by DFRobot, China, in 2013 Allows kids to build a program by dragging and snapping coding blocks. Supports a wide range of hardware including Arduino, micro:bit or even a series of ESP32-based educational microcontrollers Hands-on Remote Learning Due to a nationwide epidemic control mechanism, China was the first country to mandate school closures. 270 million Chinese students are restricted to their homes. STEAM education is forced to transform from offline to online andhas become a fantastic way for students to continue their education whilst having fun at home.Although the Covid-19 pandemic has had a negative effect on education development in China, STEAM education still attracts large-scale investment because of its interdisciplinary learning, problem-solving and real-life assessment. 2020 China STEAM Education-Related Enterprise Financing Situation (Partial) from iiMedia Research Company Financing Round Sum Date Codemao Series D Funding CNY 1.3 billion Nov.20, 2020 Bell Series C Funding CNY 120 million May.5, 2020 DFRobot Series B Funding Tens of millions of CNY Jan.3, 2020 About the future STEAM development in China, Ricky Ye points out, "STEAM education in China has developed rapidly and future market growth will depend on how quickly it gains broad acceptance, which is related to the integration with national curriculum, changes in teachers and parents' teaching methods and investment. High-quality STEAM education is high-quality project-based learning. Thereisstillalong wayto localize it intoChina'seducational environment but the future is bright." Reference: [1]Quote from British Council: Made-in-China-Makerspaces-and-the-search-for-mass-innovation SOURCE DFRobot

edtsum7707

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the Compensation Committee of Xeris Board of Directors granted non-qualified stock options for an aggregate of 18,000 shares, and restricted stock units for an aggregate of 70,200 shares, of its common stock to 11 new employee(s) under Xeris Inducement Equity Plan. Xeris Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual's entering into employment with Xeris or one of its subsidiaries, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The non-qualified stock options will vest over a period of four years, either 25% on the first anniversary of the grant with the remaining 75% vesting in thirty-six equal monthly installments thereafter, or 36% on 18 months after the grant date with the remaining 64% vesting in ten equal quarterly installments thereafter, and are subject to the employees continued employment with Xeris or one of its subsidiaries. The restricted stock units will vest over a period of four years in equal annual installments, and are subject to the employees continued employment with Xeris or one of its subsidiaries. All equity awards are subject to the terms and conditions of Xeris Inducement Equity Plan and forms of award agreements covering the grants. About Xeris Pharmaceuticals, Inc. Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world. With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial product, Gvoke. Its proprietary XeriSol and XeriJect formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system. Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram. Answer:

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the Compensation Committee of Xeris Board of Directors granted non-qualified stock options for an aggregate of 18,000 shares, and restricted stock units for an aggregate of 70,200 shares, of its common stock to 11 new employee(s) under Xeris Inducement Equity Plan. Xeris Inducement Equity Plan is used exclusively for the grant of equity awards to individuals who were not previously employed by Xeris or one of its subsidiaries as an inducement material to such individual's entering into employment with Xeris or one of its subsidiaries, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules. The non-qualified stock options will vest over a period of four years, either 25% on the first anniversary of the grant with the remaining 75% vesting in thirty-six equal monthly installments thereafter, or 36% on 18 months after the grant date with the remaining 64% vesting in ten equal quarterly installments thereafter, and are subject to the employees continued employment with Xeris or one of its subsidiaries. The restricted stock units will vest over a period of four years in equal annual installments, and are subject to the employees continued employment with Xeris or one of its subsidiaries. All equity awards are subject to the terms and conditions of Xeris Inducement Equity Plan and forms of award agreements covering the grants. About Xeris Pharmaceuticals, Inc. Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world. With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial product, Gvoke. Its proprietary XeriSol and XeriJect formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system. Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram.

edtsum7708

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DALLAS, April 22, 2020 /PRNewswire/ --On the 50th anniversary of Earth Day, Jacobs (NYSE:J) released a Climate Action Plan that outlines the commitments the company is making to help abate the climate crisis. Jacobs' Climate Action Plan commits to help solve the climate crisis by achieving and maintaining 100% renewable energy, net zero carbon for the company's operations and business travel in 2020 and carbon negative for its operations and business travel by 2030. "Today, we reveal a plan that sets us apart capturing the shared passion, pride and drive of our people as we work to preserve our planet for future generations," said Jacobs Chair and CEO Steve Demetriou. "From the way we operate our business, to the work we perform with clients and other organizations, Jacobs' Climate Action Plan details how we will continue to make a positive environmental, societal and economic difference for businesses, governments and communities around the world." The Climate Action Plan commitments and supporting delivery plans build on the foundations of Jacobs' PlanBeyondTM strategy, which was launched in early 2019 to set out sustainability priorities across the business and how the company is helping sustain the planet for future generations. The Climate Action Plan also commits us to set an ambitious, science-based target for carbon reductions across both our operations and supply chain emissions by 2030. Jacobs' biggest opportunity to affect climate change is through the work performed for clients from the world's largest infrastructure projects to mission-critical outcomes and cutting-edge manufacturing Jacobs is driven by its customers' most complex problems. The company was recently recognized by Environmental Business International (EBI) with six business achievement awards for leadership and outstanding performance in its corporate, environmental and climate change work in 2019. By challenging what is expected, Jacobs can better design in resilience to the projected climate change effects and discover a new way forward. While the COVID-19 pandemic has already made a profound impact on humanity and the global economy, it has shown communities, governments and citizens that it is possible for the world to unite together around a common cause. If people solve for climate change with the same sense of community and urgency, with everyone looking for new ways to commute, communicate and work, there is hope that the climate crisis can be slowed, and ultimately, curbed. Jacobs is doing its part to stay ahead and create these kinds of new standards the future needs. To see how Jacobs is working together with clients, communities and other partnerships to address climate change for a brighter tomorrow, visit jacobs.com/climate-action-plan to learn more. At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With $13 billion in revenue and a talent force of more than 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector. Visitjacobs.comand connect with Jacobs on Facebook, Instagram,LinkedInand Twitter. Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic and the related reaction of governments on global and regional market conditions and the company's business. For a description of some additional factors that may occur that could cause actual results to differ from our forward-looking statements, see our Annual Report on Form 10-K for the year ended September 27, 2019, and in particular the discussions contained under Item 1 - Business; Item 1A - Risk Factors; Item 3 - Legal Proceedings; and Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations, as well as the company's other filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law. For press/media inquiries:Kerrie Sparks214.583.8433 SOURCE Jacobs Related Links http://www.jacobs.com Answer:

Jacobs Will be Net Zero Carbon in 2020 and Carbon Negative by 2030 Jacobs launches Climate Action Plan on the 50th Anniversary of Earth Day

DALLAS, April 22, 2020 /PRNewswire/ --On the 50th anniversary of Earth Day, Jacobs (NYSE:J) released a Climate Action Plan that outlines the commitments the company is making to help abate the climate crisis. Jacobs' Climate Action Plan commits to help solve the climate crisis by achieving and maintaining 100% renewable energy, net zero carbon for the company's operations and business travel in 2020 and carbon negative for its operations and business travel by 2030. "Today, we reveal a plan that sets us apart capturing the shared passion, pride and drive of our people as we work to preserve our planet for future generations," said Jacobs Chair and CEO Steve Demetriou. "From the way we operate our business, to the work we perform with clients and other organizations, Jacobs' Climate Action Plan details how we will continue to make a positive environmental, societal and economic difference for businesses, governments and communities around the world." The Climate Action Plan commitments and supporting delivery plans build on the foundations of Jacobs' PlanBeyondTM strategy, which was launched in early 2019 to set out sustainability priorities across the business and how the company is helping sustain the planet for future generations. The Climate Action Plan also commits us to set an ambitious, science-based target for carbon reductions across both our operations and supply chain emissions by 2030. Jacobs' biggest opportunity to affect climate change is through the work performed for clients from the world's largest infrastructure projects to mission-critical outcomes and cutting-edge manufacturing Jacobs is driven by its customers' most complex problems. The company was recently recognized by Environmental Business International (EBI) with six business achievement awards for leadership and outstanding performance in its corporate, environmental and climate change work in 2019. By challenging what is expected, Jacobs can better design in resilience to the projected climate change effects and discover a new way forward. While the COVID-19 pandemic has already made a profound impact on humanity and the global economy, it has shown communities, governments and citizens that it is possible for the world to unite together around a common cause. If people solve for climate change with the same sense of community and urgency, with everyone looking for new ways to commute, communicate and work, there is hope that the climate crisis can be slowed, and ultimately, curbed. Jacobs is doing its part to stay ahead and create these kinds of new standards the future needs. To see how Jacobs is working together with clients, communities and other partnerships to address climate change for a brighter tomorrow, visit jacobs.com/climate-action-plan to learn more. At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With $13 billion in revenue and a talent force of more than 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector. Visitjacobs.comand connect with Jacobs on Facebook, Instagram,LinkedInand Twitter. Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic and the related reaction of governments on global and regional market conditions and the company's business. For a description of some additional factors that may occur that could cause actual results to differ from our forward-looking statements, see our Annual Report on Form 10-K for the year ended September 27, 2019, and in particular the discussions contained under Item 1 - Business; Item 1A - Risk Factors; Item 3 - Legal Proceedings; and Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations, as well as the company's other filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law. For press/media inquiries:Kerrie Sparks214.583.8433 SOURCE Jacobs Related Links http://www.jacobs.com

edtsum7709

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 27 November 2020 COMPANY ANNOUNCEMENT Immediate Release 27 November 2020 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 01 - Xtrackers Physical Gold ETC 302 23,500 25 Nov 2020 27 Nov 2020 GB00B5840F36 Following the issue of the ETC Securities described above, the total number DB ETC plc ETC Securities in issue in relation to these Series will be: Series 01 - Xtrackers Physical Gold ETC 6,372,490 Issuer Name LEI DB ETC plc 549300SNVSPBXF55RX28 Enquiries to: [email protected] DB ETC plc Answer:

Issuance of Securities

LONDON--(BUSINESS WIRE)-- DB ETC PLC Dated: 27 November 2020 COMPANY ANNOUNCEMENT Immediate Release 27 November 2020 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 01 - Xtrackers Physical Gold ETC 302 23,500 25 Nov 2020 27 Nov 2020 GB00B5840F36 Following the issue of the ETC Securities described above, the total number DB ETC plc ETC Securities in issue in relation to these Series will be: Series 01 - Xtrackers Physical Gold ETC 6,372,490 Issuer Name LEI DB ETC plc 549300SNVSPBXF55RX28 Enquiries to: [email protected] DB ETC plc

edtsum7710

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Dec. 3, 2020 /PRNewswire/ --iVoice Communications, a global Media and Public Relations Agency, today announced Roberto Girotti as the new Senior Consultant for Latin America as part of its current expansion to further help customers navigate the Hispanic Market in the United States, Latin America, and Spain. Roberto Girotti - Senior Consultant Latin America - iVoice Communications Roberto joins the Marketing and Business Development team at iVoice Communications from Delta Air Lines, where hehelped increase Delta's position and brand presence exponentially across Latin America for the past nine years.Prior to his time with Delta, hewas Director of Product Development and Director of Sales and Marketing for Latin America and the Caribbean forContinental AirlinesandUnited Airlines.Roberto holds an MBA in Marketing as well as a Master's in Clinical Psychology. Having lived in several countries, he is fluentin English, Spanish and Portuguese. "We are pleased to welcome another experienced and talented professional to our firm," said Adriana Aristizabal, CEO, and founder of iVoice Communications and recently awarded by HOLA Magazine as one of the Top 100 Latina Powerhouse 2020 in the United States. "Roberto's lengthy experience growing the presence of brands in Latin America will be a valuable asset in helping our customers thrive during these challenging times." "We're ready to provide effective solutions to our clients, one of our principal strategies is to focus on supporting the tech & entertainment, E-commerce, transportation and tourism industry, among other commercial industries, with public relations and marketing strategies that aim to attract the Hispanic Market, maximize visibility, and increase brand awareness," said Aristizabal. Please see the following link for further information www.ivoice.agency CONTACT: Chris Marino [emailprotected] (631) 365-9053 SOURCE iVoice Communications Answer:

iVoice Communications Welcomes Roberto Girotti As Senior Consultant For Latin America Roberto Girotti is an experienced executive with over 35+ years of proven leadership in the Airline Industry across Latin America & the Caribbean

NEW YORK, Dec. 3, 2020 /PRNewswire/ --iVoice Communications, a global Media and Public Relations Agency, today announced Roberto Girotti as the new Senior Consultant for Latin America as part of its current expansion to further help customers navigate the Hispanic Market in the United States, Latin America, and Spain. Roberto Girotti - Senior Consultant Latin America - iVoice Communications Roberto joins the Marketing and Business Development team at iVoice Communications from Delta Air Lines, where hehelped increase Delta's position and brand presence exponentially across Latin America for the past nine years.Prior to his time with Delta, hewas Director of Product Development and Director of Sales and Marketing for Latin America and the Caribbean forContinental AirlinesandUnited Airlines.Roberto holds an MBA in Marketing as well as a Master's in Clinical Psychology. Having lived in several countries, he is fluentin English, Spanish and Portuguese. "We are pleased to welcome another experienced and talented professional to our firm," said Adriana Aristizabal, CEO, and founder of iVoice Communications and recently awarded by HOLA Magazine as one of the Top 100 Latina Powerhouse 2020 in the United States. "Roberto's lengthy experience growing the presence of brands in Latin America will be a valuable asset in helping our customers thrive during these challenging times." "We're ready to provide effective solutions to our clients, one of our principal strategies is to focus on supporting the tech & entertainment, E-commerce, transportation and tourism industry, among other commercial industries, with public relations and marketing strategies that aim to attract the Hispanic Market, maximize visibility, and increase brand awareness," said Aristizabal. Please see the following link for further information www.ivoice.agency CONTACT: Chris Marino [emailprotected] (631) 365-9053 SOURCE iVoice Communications

edtsum7711

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--tZERO, a leader in blockchain innovation and liquidity for digital assets, announced today its CEO, Saum Noursalehi, and management team will host an update and Q&A session on Wednesday, March 10, 2021, at 4pm ET. The team will provide a brief overview and update on the company and participate in a Q&A discussion during the live event. Interested parties can register for the live webcast here and are encouraged to submit questions to [email protected] ahead of the event. A recording of the event will be available on www.tzero.com shortly after the event has ended. tZERO is a technology firm with the goal of democratizing access to private capital markets. tZERO is a subsidiary of Medici Ventures, the blockchain-focused, wholly owned subsidiary of Overstock.com, Inc. (NASDAQ:OSTK). Investor Notice Investors should note that trading securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, no assurance of liquidity, which could impact the price and ability to sell, and possible loss of principal invested. Further, an investment in single security could mean lack of diversification and, consequently, higher risk. Potential investors are urged to consult a professional adviser regarding any economic, tax, legal or other consequences of trading any securities as described herein. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of its affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as may, should, expects, anticipates, contemplates, estimates, believes, plans, projected, predicts, potential, or hopes or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZEROs ability to keep pace with new technology and changing market needs; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. About tZERO tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and trade on a regulated alternative trading system. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. For more information on tZERO, please visit https://www.tzero.com/. tZERO is not a registered broker-dealer, funding portal, underwriter, investment bank, investment adviser or investment manager, and is not providing brokerage, investment banking or underwriting services, recommendations or investment advice to any person, and does not provide any brokerage services. tZERO takes no part in the negotiation or execution of secondary market transactions for the purchase or sale of securities and at no time has possession of investor funds or securities in connection with such transactions. Answer:

tZERO to Host a Company Update and Q&A Session on March 10, 2021

NEW YORK--(BUSINESS WIRE)--tZERO, a leader in blockchain innovation and liquidity for digital assets, announced today its CEO, Saum Noursalehi, and management team will host an update and Q&A session on Wednesday, March 10, 2021, at 4pm ET. The team will provide a brief overview and update on the company and participate in a Q&A discussion during the live event. Interested parties can register for the live webcast here and are encouraged to submit questions to [email protected] ahead of the event. A recording of the event will be available on www.tzero.com shortly after the event has ended. tZERO is a technology firm with the goal of democratizing access to private capital markets. tZERO is a subsidiary of Medici Ventures, the blockchain-focused, wholly owned subsidiary of Overstock.com, Inc. (NASDAQ:OSTK). Investor Notice Investors should note that trading securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, no assurance of liquidity, which could impact the price and ability to sell, and possible loss of principal invested. Further, an investment in single security could mean lack of diversification and, consequently, higher risk. Potential investors are urged to consult a professional adviser regarding any economic, tax, legal or other consequences of trading any securities as described herein. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of its affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as may, should, expects, anticipates, contemplates, estimates, believes, plans, projected, predicts, potential, or hopes or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZEROs ability to keep pace with new technology and changing market needs; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. About tZERO tZERO Group, Inc. and its broker-dealer subsidiaries (tZERO) provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and trade on a regulated alternative trading system. tZERO democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. For more information on tZERO, please visit https://www.tzero.com/. tZERO is not a registered broker-dealer, funding portal, underwriter, investment bank, investment adviser or investment manager, and is not providing brokerage, investment banking or underwriting services, recommendations or investment advice to any person, and does not provide any brokerage services. tZERO takes no part in the negotiation or execution of secondary market transactions for the purchase or sale of securities and at no time has possession of investor funds or securities in connection with such transactions.

edtsum7712

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WALTHAM, Mass., Aug. 3, 2020 /PRNewswire/ --Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:00 p.m. ET. A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticalsis a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the MeninMLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visitwww.syndax.comor follow the Company onTwitterandLinkedIn. Syndax Contacts Investor ContactMelissa ForstArgot Partners[emailprotected]Tel 212.600.1902 Media ContactTed Held[emailprotected] Tel 212.798.9842 SNDX-G SOURCE Syndax Pharmaceuticals, Inc. Related Links http://www.syndax.com Answer:

Syndax Announces Participation in BTIG Virtual Biotechnology Conference

WALTHAM, Mass., Aug. 3, 2020 /PRNewswire/ --Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:00 p.m. ET. A live webcast of the fireside chat can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticalsis a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the MeninMLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visitwww.syndax.comor follow the Company onTwitterandLinkedIn. Syndax Contacts Investor ContactMelissa ForstArgot Partners[emailprotected]Tel 212.600.1902 Media ContactTed Held[emailprotected] Tel 212.798.9842 SNDX-G SOURCE Syndax Pharmaceuticals, Inc. Related Links http://www.syndax.com

edtsum7713

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Oct. 14, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Eaton Vance Corp. ("EV" or the "Company") (EV) relating to its proposed acquisition by Morgan Stanley ("MS"). Under the terms of the agreement, EV shareholders have the option to receive (i)$28.25in cash and 0.5833 of a share of MS common stock (the "Mixed Consideration"); or, subject to a proration and adjustment mechanism, (ii) an amount of all cash; or (iii) a number of shares of Morgan Stanley common stock. The implied per-share value of the Mixed Consideration is approximately$56.66. The investigation focuses on whether Eaton Vance Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company. Click here for more information:https://www.monteverdelaw.com/case/eaton-vance-corpIt is free and there is no cost or obligation to you. About Monteverde & Associates PC We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered money for shareholders in 6 mergers & acquisitions class action cases. If you own common stock in Eaton Vance Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [emailprotected] or by telephone at (212) 971-1341. Contact:Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4405New York, NY 10118United States of America[emailprotected]Tel: (212) 971-1341 Attorney Advertising. (C) 2020 Monteverde & Associates PC.The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC Related Links http://www.monteverdelaw.com Answer:

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Eaton Vance Corp. - EV

NEW YORK, Oct. 14, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Eaton Vance Corp. ("EV" or the "Company") (EV) relating to its proposed acquisition by Morgan Stanley ("MS"). Under the terms of the agreement, EV shareholders have the option to receive (i)$28.25in cash and 0.5833 of a share of MS common stock (the "Mixed Consideration"); or, subject to a proration and adjustment mechanism, (ii) an amount of all cash; or (iii) a number of shares of Morgan Stanley common stock. The implied per-share value of the Mixed Consideration is approximately$56.66. The investigation focuses on whether Eaton Vance Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company. Click here for more information:https://www.monteverdelaw.com/case/eaton-vance-corpIt is free and there is no cost or obligation to you. About Monteverde & Associates PC We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered money for shareholders in 6 mergers & acquisitions class action cases. If you own common stock in Eaton Vance Corp. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [emailprotected] or by telephone at (212) 971-1341. Contact:Juan E. Monteverde, Esq.MONTEVERDE & ASSOCIATES PCThe Empire State Building350 Fifth Ave. Suite 4405New York, NY 10118United States of America[emailprotected]Tel: (212) 971-1341 Attorney Advertising. (C) 2020 Monteverde & Associates PC.The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC Related Links http://www.monteverdelaw.com

edtsum7714

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN RAMON, Calif., Dec. 10, 2020 /PRNewswire/ -- The largest-ever retrospective study of its kind has found very low complication rates in children who wear soft contact lenses, similar to rates in adults.1 The newly-published outcomes offer eye care professionals (ECPs) valuable real-world information to better counsel parents and caregivers as they consider proven myopia management options to help slow myopia progression. Adverse Event Rates in The Retrospective Cohort Study of Safety of Paediatric Soft Contact Lens Wear: the ReCSS Studywill appear in the January 2021 issue of Ophthalmic & Physiological Optics, the peer reviewed journal of the UK College of Optometrists. It is now available in pre-press form via open access. Widely-respected independent researcher Robin Chalmers, OD, FAAO, served as principal investigator, co-authoring the paper with CooperVision scientists John McNally, OD, FAAO, and Paul Chamberlain, BSc(Hons), and Lisa Keay, PhD, Head of the School of Optometry and Vision Science for UNSW Sydney. The work was initiated to support CooperVision's regulatory submissions of MiSight 1 day contact lenses, which are currently available in 26 countries with more expected in 2021. ReCSS measured the rate of adverse events (AE) in children who were prescribed soft contact lenses before they turned 13 years old to establish wearing safety among that age group. The review documented AE details from clinical practice charts and clinical trial data of nearly 1,000 children and observed 2,713 years of wear across 4,611 visits. Compared to AE results derived exclusively from clinical trials, these data are likely to be more generalizable to real world experiences as myopia control soft contact lenses are prescribed more widely to young patients. Clinical records from office visits with potential AEs were independently reviewed by an adjudication panel to determine a consensus diagnosis. The current findings are very similar to but slightly lower than rates reported in previous studies of similar age groups, possibly attributed to the higher proportion of daily disposable lenses in the current study. The study found the annualized incidence rate of inflammatory events was less than 1 percent per year of wear. The majority of events were conjunctivitis or foreign body abrasions, reflective of this young population. The authors note that ReCSS study found a lower rate of microbial keratitis (7.4/10,000 yearsofwear) with a tighter confidence interval than other pediatric postmarket studies, offering reassurance to clinicians and parents of children regarding the safety of myopia control soft contact lenses. That rate is comparable to established rates of microbial keratitis in adults.2,3,4 "ReCSS is the most extensive compilation of 'real-world' data supporting safety of soft contact lens wear in children, complementing the effectiveness research from our groundbreaking, multi-year MiSight 1 day clinical study," said McNally, who serves as CooperVision's Senior Director of Clinical Research. "Practitioners will appreciate the fact that the study included a range of eyecare practice types and locations and a variety of soft contact lens brands, modalities and designs. Parents should be even more confident in embracing the benefits of a soft contact lens-based approach to myopia management by knowing that the study evaluated the safety of contact lenses in children of the same age range as their own." About CooperVision CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world's leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com. About CooperCompanies CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com. Media Contact Mike McDougall, APR, Fellow PRSA, McDougall Communications[emailprotected]or +1-585-434-2150 1 Chalmers, RL, McNally, JJ, Chamberlain, P, & Keay, L. Adverse event rates in the retrospective cohort study of safety of paediatric soft contact lens wear: the ReCSS study. Ophthalmic Physiol Opt. 2020. https://doi.org/10.1111/opo.12753 2 Poggio EC, Glynn RJ, Schein OD et al. The incidence of ulcerative keratitis among users of dailywear and extendedwear soft contact lenses. N Engl J Med 1989; 321: 779783. 3 Stapleton F, Keay L, Edwards Ket al. The incidence of contact lens related microbial keratitis. Ophthalmology2008; 115: 16551662. 4 Schein OD, McNally JJ, Katz Jet al. The Incidence Of Microbial Keratitis among wearers of a 30day silicone hydrogel extendedwear contact lens. Ophthalmology2005; 112: 21722179. SOURCE CooperVision Answer:

Largest-Ever Study on Children's Soft Contact Lens Wear Safety Shows Very Low Complication Rates Extensive Retrospective Review Offers Real-World Data for Myopia Management in Children

SAN RAMON, Calif., Dec. 10, 2020 /PRNewswire/ -- The largest-ever retrospective study of its kind has found very low complication rates in children who wear soft contact lenses, similar to rates in adults.1 The newly-published outcomes offer eye care professionals (ECPs) valuable real-world information to better counsel parents and caregivers as they consider proven myopia management options to help slow myopia progression. Adverse Event Rates in The Retrospective Cohort Study of Safety of Paediatric Soft Contact Lens Wear: the ReCSS Studywill appear in the January 2021 issue of Ophthalmic & Physiological Optics, the peer reviewed journal of the UK College of Optometrists. It is now available in pre-press form via open access. Widely-respected independent researcher Robin Chalmers, OD, FAAO, served as principal investigator, co-authoring the paper with CooperVision scientists John McNally, OD, FAAO, and Paul Chamberlain, BSc(Hons), and Lisa Keay, PhD, Head of the School of Optometry and Vision Science for UNSW Sydney. The work was initiated to support CooperVision's regulatory submissions of MiSight 1 day contact lenses, which are currently available in 26 countries with more expected in 2021. ReCSS measured the rate of adverse events (AE) in children who were prescribed soft contact lenses before they turned 13 years old to establish wearing safety among that age group. The review documented AE details from clinical practice charts and clinical trial data of nearly 1,000 children and observed 2,713 years of wear across 4,611 visits. Compared to AE results derived exclusively from clinical trials, these data are likely to be more generalizable to real world experiences as myopia control soft contact lenses are prescribed more widely to young patients. Clinical records from office visits with potential AEs were independently reviewed by an adjudication panel to determine a consensus diagnosis. The current findings are very similar to but slightly lower than rates reported in previous studies of similar age groups, possibly attributed to the higher proportion of daily disposable lenses in the current study. The study found the annualized incidence rate of inflammatory events was less than 1 percent per year of wear. The majority of events were conjunctivitis or foreign body abrasions, reflective of this young population. The authors note that ReCSS study found a lower rate of microbial keratitis (7.4/10,000 yearsofwear) with a tighter confidence interval than other pediatric postmarket studies, offering reassurance to clinicians and parents of children regarding the safety of myopia control soft contact lenses. That rate is comparable to established rates of microbial keratitis in adults.2,3,4 "ReCSS is the most extensive compilation of 'real-world' data supporting safety of soft contact lens wear in children, complementing the effectiveness research from our groundbreaking, multi-year MiSight 1 day clinical study," said McNally, who serves as CooperVision's Senior Director of Clinical Research. "Practitioners will appreciate the fact that the study included a range of eyecare practice types and locations and a variety of soft contact lens brands, modalities and designs. Parents should be even more confident in embracing the benefits of a soft contact lens-based approach to myopia management by knowing that the study evaluated the safety of contact lenses in children of the same age range as their own." About CooperVision CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world's leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com. About CooperCompanies CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com. Media Contact Mike McDougall, APR, Fellow PRSA, McDougall Communications[emailprotected]or +1-585-434-2150 1 Chalmers, RL, McNally, JJ, Chamberlain, P, & Keay, L. Adverse event rates in the retrospective cohort study of safety of paediatric soft contact lens wear: the ReCSS study. Ophthalmic Physiol Opt. 2020. https://doi.org/10.1111/opo.12753 2 Poggio EC, Glynn RJ, Schein OD et al. The incidence of ulcerative keratitis among users of dailywear and extendedwear soft contact lenses. N Engl J Med 1989; 321: 779783. 3 Stapleton F, Keay L, Edwards Ket al. The incidence of contact lens related microbial keratitis. Ophthalmology2008; 115: 16551662. 4 Schein OD, McNally JJ, Katz Jet al. The Incidence Of Microbial Keratitis among wearers of a 30day silicone hydrogel extendedwear contact lens. Ophthalmology2005; 112: 21722179. SOURCE CooperVision

edtsum7715

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that Keith Barry has joined the firm as a Managing Director and Head of Medical Technology, a new practice within the Healthcare Group. He is based in San Francisco. Mr. Barry joins from Wells Fargo Securities, where he was a Managing Director in the Healthcare Group focusing on the medical devices, life science tools, and diagnostics sectors. Prior to Wells Fargo, he spent a decade at Citigroup, where he was a Managing Director in the Global Healthcare Group advising on a broad range of M&A assignments, capital-raising transactions, and private placements for medical devices, life science tools, and diagnostics clients. Previous experience also includes roles in UBS and Salomon Smith Barneys healthcare groups. With more than two decades of experience advising clients in the medical devices, life science tools, and diagnostics sectors, Keith is an outstanding addition to our Healthcare Group, said Mark Francis, Managing Director and Global Head of Houlihan Lokeys Healthcare Group. We are excited to expand into the medical technology sector and further grow what is already one of the largest healthcare groups in financial services. Our corporate and financial sponsor clients that are considering or have investments in the medical technology sector will benefit tremendously from Keiths insights, experience, and expertise, and we are delighted that he has joined the firm. Houlihan Lokeys unique culture, market leadership in mid-cap M&A, outstanding reputation for client service and superior results, and a comprehensive service offering presented an attractive value proposition for me, and Im excited to launch a new practice for Houlihan Lokey, said Mr. Barry. I look forward to partnering with my colleagues across the firm to help clients take advantage of both the market opportunities that exist in the medical devices, life science tools, and diagnostics sectors and the broad range of products and services Houlihan Lokey provides to help them grow and thrive. Also joining the Healthcare Group as a Vice President in San Francisco is Allan Burton, who will cover medical technology. Mr. Burton spent nearly a decade at Wells Fargo Securities, where he was most recently a Vice President in the Healthcare Investment Banking Group. Like Keith, Allan embodies the same client focus and dedication to outstanding results that are integral elements of the firms culture, and the fact that they already have a strong partnership will be immensely additive to the launch and success of this new practice. Im delighted that Allan has joined Keith to establish our expansion into the medical technology sector, said Mr. Francis. Mr. Barry holds a B.A. in Finance and Computer Applications from the University of Notre Dame. Mr. Burton holds a B.S. in Finance from Wake Forest University. Houlihan Lokeys Healthcare Group is among the largest of its kind in investment banking, with more than 40 financial professionals located in New York, Dallas, Chicago, and San Francisco. In 2019, the Healthcare Group was ranked as the No. 1 M&A advisor for all U.S. healthcare transactions, based on data from Refinitiv (formerly known as Thomson Reuters). About Houlihan Lokey Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firms commitment to client success across its advisory services. Houlihan Lokey is the No. 1 M&A advisor for the past five consecutive years in the U.S., the No. 1 global restructuring advisor for the past six consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 20 years, all based on number of transactions and according to data provided by Refinitiv (formerly Thomson Reuters). Answer:

Houlihan Lokey Hires Industry Veteran to Lead New Practice in Healthcare Keith Barry Joins as Managing Director and Head of Medical Technology Coverage; Allan Burton Joins as a Vice President to Support Firms Expanded Coverage Effort

SAN FRANCISCO--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced that Keith Barry has joined the firm as a Managing Director and Head of Medical Technology, a new practice within the Healthcare Group. He is based in San Francisco. Mr. Barry joins from Wells Fargo Securities, where he was a Managing Director in the Healthcare Group focusing on the medical devices, life science tools, and diagnostics sectors. Prior to Wells Fargo, he spent a decade at Citigroup, where he was a Managing Director in the Global Healthcare Group advising on a broad range of M&A assignments, capital-raising transactions, and private placements for medical devices, life science tools, and diagnostics clients. Previous experience also includes roles in UBS and Salomon Smith Barneys healthcare groups. With more than two decades of experience advising clients in the medical devices, life science tools, and diagnostics sectors, Keith is an outstanding addition to our Healthcare Group, said Mark Francis, Managing Director and Global Head of Houlihan Lokeys Healthcare Group. We are excited to expand into the medical technology sector and further grow what is already one of the largest healthcare groups in financial services. Our corporate and financial sponsor clients that are considering or have investments in the medical technology sector will benefit tremendously from Keiths insights, experience, and expertise, and we are delighted that he has joined the firm. Houlihan Lokeys unique culture, market leadership in mid-cap M&A, outstanding reputation for client service and superior results, and a comprehensive service offering presented an attractive value proposition for me, and Im excited to launch a new practice for Houlihan Lokey, said Mr. Barry. I look forward to partnering with my colleagues across the firm to help clients take advantage of both the market opportunities that exist in the medical devices, life science tools, and diagnostics sectors and the broad range of products and services Houlihan Lokey provides to help them grow and thrive. Also joining the Healthcare Group as a Vice President in San Francisco is Allan Burton, who will cover medical technology. Mr. Burton spent nearly a decade at Wells Fargo Securities, where he was most recently a Vice President in the Healthcare Investment Banking Group. Like Keith, Allan embodies the same client focus and dedication to outstanding results that are integral elements of the firms culture, and the fact that they already have a strong partnership will be immensely additive to the launch and success of this new practice. Im delighted that Allan has joined Keith to establish our expansion into the medical technology sector, said Mr. Francis. Mr. Barry holds a B.A. in Finance and Computer Applications from the University of Notre Dame. Mr. Burton holds a B.S. in Finance from Wake Forest University. Houlihan Lokeys Healthcare Group is among the largest of its kind in investment banking, with more than 40 financial professionals located in New York, Dallas, Chicago, and San Francisco. In 2019, the Healthcare Group was ranked as the No. 1 M&A advisor for all U.S. healthcare transactions, based on data from Refinitiv (formerly known as Thomson Reuters). About Houlihan Lokey Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and valuation. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firms commitment to client success across its advisory services. Houlihan Lokey is the No. 1 M&A advisor for the past five consecutive years in the U.S., the No. 1 global restructuring advisor for the past six consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 20 years, all based on number of transactions and according to data provided by Refinitiv (formerly Thomson Reuters).

edtsum7716

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, Nov. 16, 2020 /PRNewswire/ -- The "Energy Drinks Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Energy Drinks Market size was valued at $57.4 billion in 2020 and is poised to grow at a CAGR of 7.0% percentage during the forecast period 2020-2025. Energy drinks are beverages that contain stimulant compounds such as taurine, caffeine, vitamins, glucuronolactone, proprietary blends, herbal extracts, and amino acids, which boost physical stamina and mental alertness. Energy drinks help to avoid dehydration during exercise. Initially, introduced under dietary supplements, but owing to characteristics to provide consumers with sustained energy and reduce physical and mental fatigue, they came under energy drink. Owing to the increasing income, rising sports activities and urbanization are the major reasons for market growth. An Enhanced network of convenience stores, supermarkets, and online channel is set to contribute, to the growth of the energy drinks market for the forecast period (2020-2025).Key Takeaways Geographically, North America's Energy Drinks market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high demand. Energy drinks from being a niche product have transformed into one of the fastest-growing products in the drinks market. This is set to grow the market. Based on the age group, adults contributed to the highest market share in 2019, and the teenagers segment is set to grow for the forecast period 2020-2025. By Source - Segment AnalysisThe global Energy Drinks Market based on source has organic and Non-organic segments. The non-organic segment registers for the highest market share in 2019, and is set to continue for the forecast period (2020-2025). The organic segment is set to emerge owing to the growing consumer trend towards the importance of organic food and beverages in their dietary habits. This has positively influenced the segment demand in the industry. The organic and natural energy drinks market is set to increase in Europe and Asia-Pacific owing to increasing stringent regulations in the region.By Distribution Channel - Segment AnalysisThe Distribution Channel segment of Energy Drinks Market has offline and online segments. The offline segment Energy drinks dominated the global industry in the year 2020, owing to the well-established marketing channels and long-term collaborations with the sellers. Besides, easy to approach the consumers was the additional factor for the offline segment.The online segment is set to witness the highest CAGR growth with 6.4% over the forecast period 2020-2025, owing to shifting consumer preference towards direct selling and collaborations with supermarkets and other online retailers. The online segment is predominant by bulk discounts and additional investments for advertisements and promotions, which is poised to increase the market in the forecast period (2020-2025).By Geography - Segment AnalysisThe global Energy Drinks Market by geography had the dominant share in North America accounting for 43% of the market share in terms of revenue in 2019. North America has emerged as the key consumer of Energy Drinks products and estimated to remain the same in the forecast period 2020-2025. Asia-Pacific is a growing market for energy drinks, owing to the change in demographics and increasing disposable income. On the other hand, Europe is an emerging market, which is poised to grow at a healthy rate, owing to the combined increase in consumer adoption rate in the region and marketing efforts of the key players.Drivers - Energy Drinks Market Consumer-Oriented Advertisements The demand for Energy Drinks is driving forward owing to the increase in the consumer-oriented advertisements. Besides, the strategic adoption of companies for promoting their product through cross-promotional tactics such as integrating their product through sports events or advertising their product in connection with popular music icons are acting as drivers for supporting the growth of the energy drinks market.Challenges - Energy Drinks Market The Fluctuation of Raw Material Increasing government regulations in many countries, rising commodity prices, exchange rate fluctuations, and increasing electricity costs, have contributed to increased prices for these beverage categories, which is a challenge for companies in the industry.Energy Drinks Industry outlook:Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Energy Drinks Market. Key companies of this market are Heinz, GSK, Goldwin Healthcare, Power Horse, Nourish Co., Taisho Pharmaceutical Co Ltd., Monster Energy, Red Bull, PepsiCo, Coca-Cola, and others.Acquisitions/Product Launches: In June 2018, Vita Coco owner All Market Inc. acquired energy drink brand Runa. This acquisition is beneficial in providing eight flavours which rich in nutrients like flavonoids and polyphemols. In April 2019, Coca-Cola launched its first energy drink at United Kingdom region, which is beneficial in providing direct competition with top market leaders. The drink consist of caffeine from naturally derived sources guarana extracts and B vitamins and aim at young age groups. For more information about this report visit https://www.researchandmarkets.com/r/e0weuz Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Energy Drinks Markets Report 2020-2025 Featuring Key Players - Heinz, GSK, Goldwin Healthcare, Power Horse, Nourish, Taisho Pharmaceutical, Monster Energy, Red Bull, PepsiCo, Coca-Cola

DUBLIN, Nov. 16, 2020 /PRNewswire/ -- The "Energy Drinks Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Energy Drinks Market size was valued at $57.4 billion in 2020 and is poised to grow at a CAGR of 7.0% percentage during the forecast period 2020-2025. Energy drinks are beverages that contain stimulant compounds such as taurine, caffeine, vitamins, glucuronolactone, proprietary blends, herbal extracts, and amino acids, which boost physical stamina and mental alertness. Energy drinks help to avoid dehydration during exercise. Initially, introduced under dietary supplements, but owing to characteristics to provide consumers with sustained energy and reduce physical and mental fatigue, they came under energy drink. Owing to the increasing income, rising sports activities and urbanization are the major reasons for market growth. An Enhanced network of convenience stores, supermarkets, and online channel is set to contribute, to the growth of the energy drinks market for the forecast period (2020-2025).Key Takeaways Geographically, North America's Energy Drinks market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high demand. Energy drinks from being a niche product have transformed into one of the fastest-growing products in the drinks market. This is set to grow the market. Based on the age group, adults contributed to the highest market share in 2019, and the teenagers segment is set to grow for the forecast period 2020-2025. By Source - Segment AnalysisThe global Energy Drinks Market based on source has organic and Non-organic segments. The non-organic segment registers for the highest market share in 2019, and is set to continue for the forecast period (2020-2025). The organic segment is set to emerge owing to the growing consumer trend towards the importance of organic food and beverages in their dietary habits. This has positively influenced the segment demand in the industry. The organic and natural energy drinks market is set to increase in Europe and Asia-Pacific owing to increasing stringent regulations in the region.By Distribution Channel - Segment AnalysisThe Distribution Channel segment of Energy Drinks Market has offline and online segments. The offline segment Energy drinks dominated the global industry in the year 2020, owing to the well-established marketing channels and long-term collaborations with the sellers. Besides, easy to approach the consumers was the additional factor for the offline segment.The online segment is set to witness the highest CAGR growth with 6.4% over the forecast period 2020-2025, owing to shifting consumer preference towards direct selling and collaborations with supermarkets and other online retailers. The online segment is predominant by bulk discounts and additional investments for advertisements and promotions, which is poised to increase the market in the forecast period (2020-2025).By Geography - Segment AnalysisThe global Energy Drinks Market by geography had the dominant share in North America accounting for 43% of the market share in terms of revenue in 2019. North America has emerged as the key consumer of Energy Drinks products and estimated to remain the same in the forecast period 2020-2025. Asia-Pacific is a growing market for energy drinks, owing to the change in demographics and increasing disposable income. On the other hand, Europe is an emerging market, which is poised to grow at a healthy rate, owing to the combined increase in consumer adoption rate in the region and marketing efforts of the key players.Drivers - Energy Drinks Market Consumer-Oriented Advertisements The demand for Energy Drinks is driving forward owing to the increase in the consumer-oriented advertisements. Besides, the strategic adoption of companies for promoting their product through cross-promotional tactics such as integrating their product through sports events or advertising their product in connection with popular music icons are acting as drivers for supporting the growth of the energy drinks market.Challenges - Energy Drinks Market The Fluctuation of Raw Material Increasing government regulations in many countries, rising commodity prices, exchange rate fluctuations, and increasing electricity costs, have contributed to increased prices for these beverage categories, which is a challenge for companies in the industry.Energy Drinks Industry outlook:Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Energy Drinks Market. Key companies of this market are Heinz, GSK, Goldwin Healthcare, Power Horse, Nourish Co., Taisho Pharmaceutical Co Ltd., Monster Energy, Red Bull, PepsiCo, Coca-Cola, and others.Acquisitions/Product Launches: In June 2018, Vita Coco owner All Market Inc. acquired energy drink brand Runa. This acquisition is beneficial in providing eight flavours which rich in nutrients like flavonoids and polyphemols. In April 2019, Coca-Cola launched its first energy drink at United Kingdom region, which is beneficial in providing direct competition with top market leaders. The drink consist of caffeine from naturally derived sources guarana extracts and B vitamins and aim at young age groups. For more information about this report visit https://www.researchandmarkets.com/r/e0weuz Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum7717

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PARIS--(BUSINESS WIRE)--Regulatory News: Conformment larticle 5 du Rglement europen n 596/2014 (Rglement MAR Market Abuse Regulation), les informations dtailles sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Dclaration des transactions sur actions propres ralises du 20 novembre au 26 novembre 2020 Nom de l'metteur Code identifiant de l'metteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondr moyen journalier d'acquisition Code identifiant march TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 12,746 24.2186 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 744 24.3121 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 473 24.1702 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 5,088 24.3475 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 7,673 24.2039 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 873 24.1352 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 546 24.1000 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 5,409 24.2243 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 7,278 24.0487 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 850 24.0702 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 634 24.0467 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 5,369 24.0317 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 7,056 24.0058 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 1,218 24.0282 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 622 24.0310 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 4,932 24.0073 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 7,114 23.8064 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 1,043 23.7232 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 394 23.7462 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 4,891 23.7397 BATE TOTAL 74,953 24.0737 Answer:

Tikehau Capital : Dclaration des transactions sur actions propres ralises du 20 novembre au 26 novembre 2020

PARIS--(BUSINESS WIRE)--Regulatory News: Conformment larticle 5 du Rglement europen n 596/2014 (Rglement MAR Market Abuse Regulation), les informations dtailles sont disponibles sur le site de Tikehau Capital (Paris:TKO) : https://www.tikehaucapital.com/fr/shareholders/regulatory-information Dclaration des transactions sur actions propres ralises du 20 novembre au 26 novembre 2020 Nom de l'metteur Code identifiant de l'metteur (code LEI) Jour de la transaction Code identifiant de l'instrument financier Volume total journalier (en nombre de titres) Prix pondr moyen journalier d'acquisition Code identifiant march TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 12,746 24.2186 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 744 24.3121 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 473 24.1702 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 20/11/2020 FR0013230612 5,088 24.3475 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 7,673 24.2039 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 873 24.1352 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 546 24.1000 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 23/11/2020 FR0013230612 5,409 24.2243 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 7,278 24.0487 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 850 24.0702 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 634 24.0467 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 24/11/2020 FR0013230612 5,369 24.0317 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 7,056 24.0058 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 1,218 24.0282 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 622 24.0310 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 25/11/2020 FR0013230612 4,932 24.0073 BATE TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 7,114 23.8064 XPAR TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 1,043 23.7232 CHIX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 394 23.7462 TRQX TIKEHAU CAPITAL 969500BY8TEU16U3SJ94 26/11/2020 FR0013230612 4,891 23.7397 BATE TOTAL 74,953 24.0737

edtsum7718

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: CHICAGO, Feb. 19, 2021 /PRNewswire/ -- According to the new market research report "Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to 2025", published by MarketsandMarkets, the global Point Of Care Diagnostics Market size is estimated to be USD 29.5 billion in 2020 and projected to reach USD 50.6 billion by 2025, at a CAGR of 11.4%. Browse in-depth TOC on "Point of Care/Rapid Diagnostics Market"187 Tables 53 Figures 240 Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The point of care diagnostics market includes major Tier I and II suppliers like the point-of-care diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Johnson & Johnson (US), Danaher Corporation (US), Chembio Diagnostics (US), Quidel Corporation. These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for point of care diagnostics from key end-users has increased rapidly amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have long erm increase in the growth for the point of care diagnostics market in 2020. Along with this, increase in prevalence of different types of infectious diseases, easy access of POC products through online platforms, and growing awaness about the low turnout time of diagnosis using rapid point of care test in turn will boost demnd for POC devices in the coming years. Demand for glucose monitoring products for home use result in the segment occupying the high share of the point of care diagnostics market Glucose monitoring products owes a good market share in point of care diagnostics market. The large share of this segment is attributed to factors such as the increase in the availability of glucose motioring devices increase in the prevalence of diabetes couples with growing collaborations among players for develop advance PoC deviceas and rapus shift towards the adoption of home helathacare products. Asia Pacific likely to emerge as the fastest growing point of care diagnostics market, globally Geographically, the emerging Asian countries, such as China, India, South Korea, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 18.8% from 2020 to 2025. initiatives by the government,rising awareness about selftesting products, and increase in collaborations among key players in the point-of-care diagnostics market in the region. increasing number of hospitals in India and China; and rapid expansion of healthcare infrastructures,and increase in thenumber of research centers are driving the growth of the APAC point of care diagnostics market. Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185 Prominent players in this market Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Becton Dickinson and Company (US), Abbott Laboratories (US), Quidel Diagnostics (US), and Chembio Diagnostics (US). Other prominent players operating in this market are EKF Diagnostics (UK), Trinity Biotech (Ireland), and Fluxergy (France). Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=106829185 Browse Adjacent Markets: Medical Device Market ResearchReports & Consulting Browse Related Reports: Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/cardiac-marker-market-64885447.html In-Vitro Diagnostics Marketby Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact:Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected]Research Insight: https://www.marketsandmarkets.com/ResearchInsight/point-of-care-diagnostic-market.aspVisit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/point-of-care-diagnostic.asp SOURCE MarketsandMarkets Answer:

Point of Care Diagnostics Market worth $50.6 billion by 2025 - Exclusive Report by MarketsandMarkets

CHICAGO, Feb. 19, 2021 /PRNewswire/ -- According to the new market research report "Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to 2025", published by MarketsandMarkets, the global Point Of Care Diagnostics Market size is estimated to be USD 29.5 billion in 2020 and projected to reach USD 50.6 billion by 2025, at a CAGR of 11.4%. Browse in-depth TOC on "Point of Care/Rapid Diagnostics Market"187 Tables 53 Figures 240 Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The point of care diagnostics market includes major Tier I and II suppliers like the point-of-care diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Becton, Dickinson and Company (US), Johnson & Johnson (US), Danaher Corporation (US), Chembio Diagnostics (US), Quidel Corporation. These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for point of care diagnostics from key end-users has increased rapidly amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have long erm increase in the growth for the point of care diagnostics market in 2020. Along with this, increase in prevalence of different types of infectious diseases, easy access of POC products through online platforms, and growing awaness about the low turnout time of diagnosis using rapid point of care test in turn will boost demnd for POC devices in the coming years. Demand for glucose monitoring products for home use result in the segment occupying the high share of the point of care diagnostics market Glucose monitoring products owes a good market share in point of care diagnostics market. The large share of this segment is attributed to factors such as the increase in the availability of glucose motioring devices increase in the prevalence of diabetes couples with growing collaborations among players for develop advance PoC deviceas and rapus shift towards the adoption of home helathacare products. Asia Pacific likely to emerge as the fastest growing point of care diagnostics market, globally Geographically, the emerging Asian countries, such as China, India, South Korea, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 18.8% from 2020 to 2025. initiatives by the government,rising awareness about selftesting products, and increase in collaborations among key players in the point-of-care diagnostics market in the region. increasing number of hospitals in India and China; and rapid expansion of healthcare infrastructures,and increase in thenumber of research centers are driving the growth of the APAC point of care diagnostics market. Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=106829185 Prominent players in this market Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Becton Dickinson and Company (US), Abbott Laboratories (US), Quidel Diagnostics (US), and Chembio Diagnostics (US). Other prominent players operating in this market are EKF Diagnostics (UK), Trinity Biotech (Ireland), and Fluxergy (France). Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=106829185 Browse Adjacent Markets: Medical Device Market ResearchReports & Consulting Browse Related Reports: Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) - Global Forecasts to 2025 https://www.marketsandmarkets.com/Market-Reports/cardiac-marker-market-64885447.html In-Vitro Diagnostics Marketby Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact:Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected]Research Insight: https://www.marketsandmarkets.com/ResearchInsight/point-of-care-diagnostic-market.aspVisit Our Web Site: https://www.marketsandmarkets.com Content Source: https://www.marketsandmarkets.com/PressReleases/point-of-care-diagnostic.asp SOURCE MarketsandMarkets

edtsum7719

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Global High Performance Computing (HPC) Chipset Market By Chip Type (Graphic Processing Unit (GPU), Central Processing Unit (CPU), Field Programmable Gate Array (FPGA) and Application Specific Integrated Circuit (ASIC)), By Region, Industry Analysis and F" report has been added to ResearchAndMarkets.com's offering. The Global High Performance Computing (HPC) Chipset Market size is expected to reach $12.7 billion by 2026, rising at a market growth of 20.8% CAGR during the forecast period. High-performance computing (HPC) can perform complicated calculations at high speeds and possesses the ability to process large datasets. The method of aggregating computing power is termed as high-performance computing. This technology offers much superior performance than traditional desktop computers or workstations to address big issues in engineering, business, or science. The global high-performance computing market is expected to be driven by many factors such as growing investments in artificial intelligence (AI), engineering, and the Industrial Internet of Things (IIoT), which requires electronic design automation (EDA). Moreover, various hardware providers are consistently investing in creating solutions that enhance these capabilities, which in turn, expected to augment the growth of the HPC chipset market over the upcoming years. The requirement to maintain consistent quality, combined with the increasing demand for short product development cycles (PLCs), is not possible to manage in real-time without using suitable tools & advanced technologies. The outbreak of the COVID-19 pandemic is expected to considerably impact the global HPC market. The growth of the market has hampered as numerous new ventures & projects across the world have been stopped. In addition, end-use industries are confronting with significant challenges due to this pandemic, which may decline the growth of the HPC chipset market. Majorly, manufacturing units & supply chains are disrupted across the world and hence, there is only a temporary impact of the COVID-19 pandemic on the HPC chipset market. Companies Profiled Unique Offerings from the Publisher Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Global High Performance Computing (HPC) Chipset Market by Chip Type 3.1 Global Graphic Processing Unit (GPU) High Performance Computing (HPC) Chipset Market by Region 3.2 Global Central Processing Unit (CPU) High Performance Computing (HPC) Chipset Market by Region 3.3 Global Field Programmable Gate Array (FPGA) High Performance Computing (HPC) Chipset Market by Region 3.4 Global Application Specific Integrated Circuit (ASIC) High Performance Computing (HPC) Chipset Market by Region Chapter 4. Global High Performance Computing (HPC) Chipset Market by Region 4.1 North America High Performance Computing (HPC) Chipset Market 4.2 Europe High Performance Computing (HPC) Chipset Market 4.3 Asia Pacific High Performance Computing (HPC) Chipset Market 4.4 LAMEA High Performance Computing (HPC) Chipset Market Chapter 5. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/9zvci6 Answer:

Outlook on the High Performance Computing (HPC) Chipset Global Market to 2026 - Key Industry Analysis and Forecasts - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global High Performance Computing (HPC) Chipset Market By Chip Type (Graphic Processing Unit (GPU), Central Processing Unit (CPU), Field Programmable Gate Array (FPGA) and Application Specific Integrated Circuit (ASIC)), By Region, Industry Analysis and F" report has been added to ResearchAndMarkets.com's offering. The Global High Performance Computing (HPC) Chipset Market size is expected to reach $12.7 billion by 2026, rising at a market growth of 20.8% CAGR during the forecast period. High-performance computing (HPC) can perform complicated calculations at high speeds and possesses the ability to process large datasets. The method of aggregating computing power is termed as high-performance computing. This technology offers much superior performance than traditional desktop computers or workstations to address big issues in engineering, business, or science. The global high-performance computing market is expected to be driven by many factors such as growing investments in artificial intelligence (AI), engineering, and the Industrial Internet of Things (IIoT), which requires electronic design automation (EDA). Moreover, various hardware providers are consistently investing in creating solutions that enhance these capabilities, which in turn, expected to augment the growth of the HPC chipset market over the upcoming years. The requirement to maintain consistent quality, combined with the increasing demand for short product development cycles (PLCs), is not possible to manage in real-time without using suitable tools & advanced technologies. The outbreak of the COVID-19 pandemic is expected to considerably impact the global HPC market. The growth of the market has hampered as numerous new ventures & projects across the world have been stopped. In addition, end-use industries are confronting with significant challenges due to this pandemic, which may decline the growth of the HPC chipset market. Majorly, manufacturing units & supply chains are disrupted across the world and hence, there is only a temporary impact of the COVID-19 pandemic on the HPC chipset market. Companies Profiled Unique Offerings from the Publisher Key Topics Covered: Chapter 1. Market Scope & Methodology Chapter 2. Market Overview 2.1 Introduction 2.1.1 Overview 2.1.2 Market Composition and Scenario 2.2 Key Factors Impacting the Market 2.2.1 Market Drivers 2.2.2 Market Restraints Chapter 3. Global High Performance Computing (HPC) Chipset Market by Chip Type 3.1 Global Graphic Processing Unit (GPU) High Performance Computing (HPC) Chipset Market by Region 3.2 Global Central Processing Unit (CPU) High Performance Computing (HPC) Chipset Market by Region 3.3 Global Field Programmable Gate Array (FPGA) High Performance Computing (HPC) Chipset Market by Region 3.4 Global Application Specific Integrated Circuit (ASIC) High Performance Computing (HPC) Chipset Market by Region Chapter 4. Global High Performance Computing (HPC) Chipset Market by Region 4.1 North America High Performance Computing (HPC) Chipset Market 4.2 Europe High Performance Computing (HPC) Chipset Market 4.3 Asia Pacific High Performance Computing (HPC) Chipset Market 4.4 LAMEA High Performance Computing (HPC) Chipset Market Chapter 5. Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/9zvci6

edtsum7720

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ALPHARETTA, Ga.--(BUSINESS WIRE)--Neenah, Inc. (NYSE: NP) today announced that it has joined CEO Action for Diversity & Inclusion, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace. One of nearly 2,000 CEOs that have come together for CEO Action for Diversity & Inclusion, Julie Schertell, is committing herself and Neenah to advance diversity and inclusion efforts in the company and in the communities where Neenah employees live and work. The CEO Action for Diversity and Inclusion commitment is driven by a realization that addressing diversity and inclusion is not a competitive issue, but a societal issue that CEOs can play a critical role in addressing. Companies from 85 industries have signed on, giving the signatory group additional unique perspectives on how to develop comfortable environments for employees to thrive. A diverse and inclusive workforce facilitates community, increases awareness and builds empathy, said Julie Schertell, CEO and President Neenah, Inc. It also drives innovation and creativity, as employees feel accepted and welcomed to bring their whole selves to work every day, along with their unique perspectives and experiences. All of this leads to greater value, growth and opportunities for our employees, our company, communities and shareholders. In recent months, Neenah has taken actions to address and advance diversity and inclusion, with ongoing efforts to formalize and launch a multi-dimensional, global, diversity, equity and inclusion platform, as part of the corporate employee engagement strategy. Joining the CEO Action for Diversity & Inclusion is a key component of the companys commitment and strategy to cultivate a respectful and equitable culture at Neenah. Theres no question about it, diversity and inclusivity make each of us better individually, but also collectively, as an organization. The originality of thoughts and ideas that come from varied backgrounds, ethnicities, races and cultures help drive greater knowledge and positively transforms our workplace and our world, said Schertell. I am excited to partner alongside other progressive organizations to take meaningful steps to address and advance such a critically-important societal issue. About Neenah, Inc. Neenah is committed to manufacturing growth for its customers, end users, shareholders and employees. With manufacturing facilities in the North America, Europe, the United Kingdom and Malaysia, we are a leading global manufacturer of specialty materials serving customers across six continents, with headquarters in Alpharetta, GA. We are focused on growing in filtration media, specialty coatings, custom-engineered materials and premium packaging. Our materials are found in a variety of products used every day, such as transportation and water filters, release liners, premium packaging of spirits, technology and beauty products, industrial labels, tapes and abrasives and digital printing for high-end apparel. To learn more, please visit www.neenah.com. Answer:

Neenah, Inc. Joins CEO Action for Diversity & Inclusion

ALPHARETTA, Ga.--(BUSINESS WIRE)--Neenah, Inc. (NYSE: NP) today announced that it has joined CEO Action for Diversity & Inclusion, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace. One of nearly 2,000 CEOs that have come together for CEO Action for Diversity & Inclusion, Julie Schertell, is committing herself and Neenah to advance diversity and inclusion efforts in the company and in the communities where Neenah employees live and work. The CEO Action for Diversity and Inclusion commitment is driven by a realization that addressing diversity and inclusion is not a competitive issue, but a societal issue that CEOs can play a critical role in addressing. Companies from 85 industries have signed on, giving the signatory group additional unique perspectives on how to develop comfortable environments for employees to thrive. A diverse and inclusive workforce facilitates community, increases awareness and builds empathy, said Julie Schertell, CEO and President Neenah, Inc. It also drives innovation and creativity, as employees feel accepted and welcomed to bring their whole selves to work every day, along with their unique perspectives and experiences. All of this leads to greater value, growth and opportunities for our employees, our company, communities and shareholders. In recent months, Neenah has taken actions to address and advance diversity and inclusion, with ongoing efforts to formalize and launch a multi-dimensional, global, diversity, equity and inclusion platform, as part of the corporate employee engagement strategy. Joining the CEO Action for Diversity & Inclusion is a key component of the companys commitment and strategy to cultivate a respectful and equitable culture at Neenah. Theres no question about it, diversity and inclusivity make each of us better individually, but also collectively, as an organization. The originality of thoughts and ideas that come from varied backgrounds, ethnicities, races and cultures help drive greater knowledge and positively transforms our workplace and our world, said Schertell. I am excited to partner alongside other progressive organizations to take meaningful steps to address and advance such a critically-important societal issue. About Neenah, Inc. Neenah is committed to manufacturing growth for its customers, end users, shareholders and employees. With manufacturing facilities in the North America, Europe, the United Kingdom and Malaysia, we are a leading global manufacturer of specialty materials serving customers across six continents, with headquarters in Alpharetta, GA. We are focused on growing in filtration media, specialty coatings, custom-engineered materials and premium packaging. Our materials are found in a variety of products used every day, such as transportation and water filters, release liners, premium packaging of spirits, technology and beauty products, industrial labels, tapes and abrasives and digital printing for high-end apparel. To learn more, please visit www.neenah.com.

edtsum7721

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LYON, France--(BUSINESS WIRE)--Regulatory News: CLASQUIN (Paris:ALCLA): H1 Q2 Q1 H1 2020 H1 2019 Change at current scope & exch. rates Change (lfl)** Change at current scope & exch. rates Change at current scope & exch. rates CONSOLIDATED (unaudited) Number of shipments 115,272 132,090 -12.7% -18.3% -22.0% -2.9% Sales (m) * 181.4 154.0 +17.8% +8.7% +22.4% +13.2% Gross profit (m) 36.1 36.1 -0.1% -7.4% -1.9% +1.9% * Note: Sales is not a relevant indicator for assessing activity in our business, because it is greatly impacted by changing sea and air freight rates, fuel surcharges, exchange rates (especially versus the $), etc. Changes in number of shipments, volumes shipped andin terms of the Groups financesgross profit are relevant indicators. ** lfl (like-for-like): excluding Cargolution acquisition on 1 October 2019 & at constant exchange rate. MARKET REVIEW According to WTO estimates, international trade shrank 18-19% in Q2 following a 3% decline in Q1. Measures adopted in response to the health crisis led to an unprecedented fall in production and consumption besides disrupting global logistics chains. Global sea freight market volumes fell 15-20% in Q2, while air freight volumes fell 25-30%. This decline reached a low point in April. Following the end of lockdown in most countries, trade gradually resumed in May and June but failed to regain 2019 levels. Sea freight services gradually returned to normal towards the end of Q2. Air freight services continue to be highly disrupted, as most long haul passenger flights, which normally carry around 75% of air freight, have not yet resumed. Against this backdrop, sea freight volumes shipped by the Group proved particularly resilient in Q2: TEU volumes up 4.2% & number of shipments down 7.2% (down 0.6% and 11.5% respectively excluding the October 2019 Cargolution acquisition). Air freight in Q2 was the most impacted sector, as expected: air freight tonnage down 21.0% and number of shipments down 40.4% (down 23.6% and 45.1% respectively excluding Cargolution acquisition). Roll-on/roll-off (RORO)* operations run by Group subsidiary LCI Clasquin also saw a sharp decline in business (number of shipments down 35.2%) with North Africa. * Combined road + sea transport (trailers or trucks loaded on ships) The strong resilience seen in Q2 Group gross profit was due to the Cargolution acquisition (Canada) on 01/10/19 and the robust performance achieved in the air freight business (up 10.3% at constant consolidation scope). Against a backdrop of chaos in which the standard offering had disappeared, the competence, creativity and commitment of our people enabled us to offer innovative custom solutions to Group clients by handling exceptional air freight shipments (chartering planes, etc.), in particular from Asia; this included protective and medical equipment required to tackle the COVID pandemic. Using a state-of-the-art information system that links the entire network together on a 24/7 basis, continuity of business was assured and our staff were able to adapt to the unprecedented market conditions by building solutions to deal with the major disruption to international logistics chains, in consultation with clients and suppliers. Furthermore, the diversity of the Groups business activities (air and sea freight, RORO, customs, logistics, etc.), the broad range of client sectors served (luxury goods, electronics, industry, retail, etc.) and the Groups global footprint helped it to withstand the crisis more strongly than the market. Once again, these results confirm the strength of the Groups fundamentals: BREAKDOWN BY BUSINESS LINE NUMBER OF SHIPMENTS current scope and exchange rates GROSS PROFIT (m) current scope and exchange rates H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 Sea freight 53,692 55,806 -3.8% -7.2% 16.1 15.9 +0.7% -5.3% Air freight 30,588 41,155 -25.7% -40.4% 12.8 11.5 +10.5% +19.6% RORO* 18,072 23,354 -22.6% -35.2% 3.3 4.4 -24.1% -37.9% Other 12,920 11,775 +9.7% -4.8% 2.9 3.2 -10.3% -14.0% TOTAL FORWARDING & LOGISTICS 115,272 132,090 -12.7% -22.0% 35.0 35.1 -0.2% -1.3% Log System 1.5 1.5 -1.8% -20.6% Consolidation entries -0.4 -0.5 NS NS TOTAL CONSOLIDATED 36.1 36.1 -0.1% -1.9% * Roll-on/Roll-off VOLUMES H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 Q1 2020/ Q1 2019 Sea freight 103,087 TEUs* 100,098 TEUs* +3.0% +4.2% +1.7% Air freight 25,503 T** 29,165 T** -12.6% -21.0% -2.8% * Twenty-foot equivalent units ** Tons Q2 2020 HIGHLIGHTS The main highlight of the second quarter was the continuation of the measures taken towards the end of Q1 to deal with the health crisis and its consequences. As announced in the press releases dated 21 and 30 April 2020, the Group rolled out a plan focused on four areas: All of these measures allowed the Group to maintain its human capital and expertise intact while remaining poised to bounce back when the time comes. 2020 OUTLOOK Market The uncertainty surrounding the health situation means that it is still difficult to accurately assess the depth or duration of the crisis. As a guideline, while in April the WTO forecast a 13-32% decline in international goods trade for 2020, in June it revised its forecast to around 10-15%. CLASQUIN The Group expects to post 2020 business volumes in line with the aforementioned market forecasts. UPCOMING EVENTS (publication after-market closure) CLAQUIN is an air and sea freight forwarding and overseas logistics specialist. The Group designs and manages the entire overseas transport and logistics chain, organising and coordinating the flow of client shipments between France and the rest of the world, and more specifically to and from Asia-Pacific, North America, Maghreb and Sub Saharan Africa. Its shares are listed on EURONEXT GROWTH, ISIN FR0004152882, Reuters ALCLA.PA, Bloomberg ALCLA FP. For more information, see www.clasquin.com. CLASQUIN confirms its eligibility for the share savings plan for MSCs (medium-sized companies) in accordance with Article D221-113-5 of the French Monetary and Financial Code established by decree number 2014-283 of 4 March 2014 and with Article L221-32-2 of the French Monetary and Financial Code, which set the conditions for eligibility (less than 5,000 employees and annual sales of less than 1,500m or balance sheet total of less than 2,000m). CLASQUIN is listed on the Enternext PEA-PME 150 index. LEI: 9695004FF6FA43KC4764 Answer:

CLASQUIN : Q2 2020 BUSINESS VOLUMES EXCEED EXPECTATIONS EXCELLENT GROSS PROFIT AMID A CHALLENGING ENVIRONMENT

LYON, France--(BUSINESS WIRE)--Regulatory News: CLASQUIN (Paris:ALCLA): H1 Q2 Q1 H1 2020 H1 2019 Change at current scope & exch. rates Change (lfl)** Change at current scope & exch. rates Change at current scope & exch. rates CONSOLIDATED (unaudited) Number of shipments 115,272 132,090 -12.7% -18.3% -22.0% -2.9% Sales (m) * 181.4 154.0 +17.8% +8.7% +22.4% +13.2% Gross profit (m) 36.1 36.1 -0.1% -7.4% -1.9% +1.9% * Note: Sales is not a relevant indicator for assessing activity in our business, because it is greatly impacted by changing sea and air freight rates, fuel surcharges, exchange rates (especially versus the $), etc. Changes in number of shipments, volumes shipped andin terms of the Groups financesgross profit are relevant indicators. ** lfl (like-for-like): excluding Cargolution acquisition on 1 October 2019 & at constant exchange rate. MARKET REVIEW According to WTO estimates, international trade shrank 18-19% in Q2 following a 3% decline in Q1. Measures adopted in response to the health crisis led to an unprecedented fall in production and consumption besides disrupting global logistics chains. Global sea freight market volumes fell 15-20% in Q2, while air freight volumes fell 25-30%. This decline reached a low point in April. Following the end of lockdown in most countries, trade gradually resumed in May and June but failed to regain 2019 levels. Sea freight services gradually returned to normal towards the end of Q2. Air freight services continue to be highly disrupted, as most long haul passenger flights, which normally carry around 75% of air freight, have not yet resumed. Against this backdrop, sea freight volumes shipped by the Group proved particularly resilient in Q2: TEU volumes up 4.2% & number of shipments down 7.2% (down 0.6% and 11.5% respectively excluding the October 2019 Cargolution acquisition). Air freight in Q2 was the most impacted sector, as expected: air freight tonnage down 21.0% and number of shipments down 40.4% (down 23.6% and 45.1% respectively excluding Cargolution acquisition). Roll-on/roll-off (RORO)* operations run by Group subsidiary LCI Clasquin also saw a sharp decline in business (number of shipments down 35.2%) with North Africa. * Combined road + sea transport (trailers or trucks loaded on ships) The strong resilience seen in Q2 Group gross profit was due to the Cargolution acquisition (Canada) on 01/10/19 and the robust performance achieved in the air freight business (up 10.3% at constant consolidation scope). Against a backdrop of chaos in which the standard offering had disappeared, the competence, creativity and commitment of our people enabled us to offer innovative custom solutions to Group clients by handling exceptional air freight shipments (chartering planes, etc.), in particular from Asia; this included protective and medical equipment required to tackle the COVID pandemic. Using a state-of-the-art information system that links the entire network together on a 24/7 basis, continuity of business was assured and our staff were able to adapt to the unprecedented market conditions by building solutions to deal with the major disruption to international logistics chains, in consultation with clients and suppliers. Furthermore, the diversity of the Groups business activities (air and sea freight, RORO, customs, logistics, etc.), the broad range of client sectors served (luxury goods, electronics, industry, retail, etc.) and the Groups global footprint helped it to withstand the crisis more strongly than the market. Once again, these results confirm the strength of the Groups fundamentals: BREAKDOWN BY BUSINESS LINE NUMBER OF SHIPMENTS current scope and exchange rates GROSS PROFIT (m) current scope and exchange rates H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 Sea freight 53,692 55,806 -3.8% -7.2% 16.1 15.9 +0.7% -5.3% Air freight 30,588 41,155 -25.7% -40.4% 12.8 11.5 +10.5% +19.6% RORO* 18,072 23,354 -22.6% -35.2% 3.3 4.4 -24.1% -37.9% Other 12,920 11,775 +9.7% -4.8% 2.9 3.2 -10.3% -14.0% TOTAL FORWARDING & LOGISTICS 115,272 132,090 -12.7% -22.0% 35.0 35.1 -0.2% -1.3% Log System 1.5 1.5 -1.8% -20.6% Consolidation entries -0.4 -0.5 NS NS TOTAL CONSOLIDATED 36.1 36.1 -0.1% -1.9% * Roll-on/Roll-off VOLUMES H1 2020 H1 2019 H1 2020/ H1 2019 Q2 2020/ Q2 2019 Q1 2020/ Q1 2019 Sea freight 103,087 TEUs* 100,098 TEUs* +3.0% +4.2% +1.7% Air freight 25,503 T** 29,165 T** -12.6% -21.0% -2.8% * Twenty-foot equivalent units ** Tons Q2 2020 HIGHLIGHTS The main highlight of the second quarter was the continuation of the measures taken towards the end of Q1 to deal with the health crisis and its consequences. As announced in the press releases dated 21 and 30 April 2020, the Group rolled out a plan focused on four areas: All of these measures allowed the Group to maintain its human capital and expertise intact while remaining poised to bounce back when the time comes. 2020 OUTLOOK Market The uncertainty surrounding the health situation means that it is still difficult to accurately assess the depth or duration of the crisis. As a guideline, while in April the WTO forecast a 13-32% decline in international goods trade for 2020, in June it revised its forecast to around 10-15%. CLASQUIN The Group expects to post 2020 business volumes in line with the aforementioned market forecasts. UPCOMING EVENTS (publication after-market closure) CLAQUIN is an air and sea freight forwarding and overseas logistics specialist. The Group designs and manages the entire overseas transport and logistics chain, organising and coordinating the flow of client shipments between France and the rest of the world, and more specifically to and from Asia-Pacific, North America, Maghreb and Sub Saharan Africa. Its shares are listed on EURONEXT GROWTH, ISIN FR0004152882, Reuters ALCLA.PA, Bloomberg ALCLA FP. For more information, see www.clasquin.com. CLASQUIN confirms its eligibility for the share savings plan for MSCs (medium-sized companies) in accordance with Article D221-113-5 of the French Monetary and Financial Code established by decree number 2014-283 of 4 March 2014 and with Article L221-32-2 of the French Monetary and Financial Code, which set the conditions for eligibility (less than 5,000 employees and annual sales of less than 1,500m or balance sheet total of less than 2,000m). CLASQUIN is listed on the Enternext PEA-PME 150 index. LEI: 9695004FF6FA43KC4764

edtsum7722

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WALTHAM, Mass., March 24, 2020 /PRNewswire/ -- Brainshark, Inc., the industry's only data-driven sales readiness platform, today announced mobile app offline support for customers. With these new capabilities, Brainshark Mobile App users can maximize their productivity anytime, anywhere interacting with sales readiness content even when they're not connected to the internet. "With our new mobile app offline support, reps entering low- or no-connectivity areas can stay productive, use their time efficiently and effectively, and be prepared to maximize every buyer interaction," said Greg Keshian, chief product officer, Brainshark. "We are excited to more fully support an important set of mobile use cases enabling reps to complete learning tasks, brush up on selling materials and present information from their mobile devices, without Wi-Fi or other internet connectivity. Now their productivity doesn't stop just because their internet connection did." Customers can take advantage of these capabilities using the Brainshark Mobile App, available for free in the App Store or Google Play. Users can: Select Brainshark content, courses and presentations to download for offline access. Interact with the readiness content on their smartphones and tablets while offline e.g., watching presentations, viewing/completing courses, taking quizzes and assessments, etc. Have their viewing data, course progress and quiz responses/scores automatically synced back and reflected in their profile, once they've reconnected to the internet. Swipe to delete content when finished. (This does not impact data synchronization.) Brainshark's award-winning sales readiness platform helps organizations maximize sales effectiveness, with solutions forcontent authoring,onboarding and training,coaching and practice,readiness scorecardsand more. With the Brainshark Mobile App, reps can achieve sales mastery on-the-go accessing training materials, reviewing just-in-time learning resources and engaging in video-based coaching challenges. Now with support for mobile offline views, the app gives users even more flexibility in the way they prepare for meetings and engage with clients. To learn more about Brainshark and how companies use its technology to prepare their salespeople for success wherever, whenever and however they're working please visit www.brainshark.com/success. About Brainshark Brainshark's data-driven sales readiness platform provides the tools to prepare client-facing teams with the knowledge and skills they need to perform at the highest level. With best-of-breed solutions for training and coaching, as well as cutting-edge insights into sales performance, customers can ensure their sales reps are always ready to make the most of any selling situation. With Brainshark, companies can: enable sales teams with on-demandtrainingthat accelerates onboarding and keeps reps up-to-speed; validate readiness with salescoachingand practice that ensure reps master key messages; empower teams with dynamiccontentthat can be created quickly, updated easily and accessed anywhere; and use powerfulscorecardsto visualize sales performance trends and make real connections from improved readiness to increased revenue. Thousands of customers including more than half of the Fortune 100 rely on Brainshark to close performance gaps and get better results from their sales enablement initiatives. Learn more atwww.brainshark.com. Media Contact:Lauren BoutwellEmail: [emailprotected] Phone: 781.370.8295 SOURCE Brainshark, Inc. Related Links https://www.brainshark.com Answer:

Brainshark Helps Mobile Sales Reps Stay Productive, With Offline Access to Readiness Content With Brainshark's Mobile App, Reps in Low-Connectivity Areas Now Have Instant, Intuitive Access to Courses and Content for Offline Viewing - with Data Synced Back to Brainshark Once Reps Are Online

WALTHAM, Mass., March 24, 2020 /PRNewswire/ -- Brainshark, Inc., the industry's only data-driven sales readiness platform, today announced mobile app offline support for customers. With these new capabilities, Brainshark Mobile App users can maximize their productivity anytime, anywhere interacting with sales readiness content even when they're not connected to the internet. "With our new mobile app offline support, reps entering low- or no-connectivity areas can stay productive, use their time efficiently and effectively, and be prepared to maximize every buyer interaction," said Greg Keshian, chief product officer, Brainshark. "We are excited to more fully support an important set of mobile use cases enabling reps to complete learning tasks, brush up on selling materials and present information from their mobile devices, without Wi-Fi or other internet connectivity. Now their productivity doesn't stop just because their internet connection did." Customers can take advantage of these capabilities using the Brainshark Mobile App, available for free in the App Store or Google Play. Users can: Select Brainshark content, courses and presentations to download for offline access. Interact with the readiness content on their smartphones and tablets while offline e.g., watching presentations, viewing/completing courses, taking quizzes and assessments, etc. Have their viewing data, course progress and quiz responses/scores automatically synced back and reflected in their profile, once they've reconnected to the internet. Swipe to delete content when finished. (This does not impact data synchronization.) Brainshark's award-winning sales readiness platform helps organizations maximize sales effectiveness, with solutions forcontent authoring,onboarding and training,coaching and practice,readiness scorecardsand more. With the Brainshark Mobile App, reps can achieve sales mastery on-the-go accessing training materials, reviewing just-in-time learning resources and engaging in video-based coaching challenges. Now with support for mobile offline views, the app gives users even more flexibility in the way they prepare for meetings and engage with clients. To learn more about Brainshark and how companies use its technology to prepare their salespeople for success wherever, whenever and however they're working please visit www.brainshark.com/success. About Brainshark Brainshark's data-driven sales readiness platform provides the tools to prepare client-facing teams with the knowledge and skills they need to perform at the highest level. With best-of-breed solutions for training and coaching, as well as cutting-edge insights into sales performance, customers can ensure their sales reps are always ready to make the most of any selling situation. With Brainshark, companies can: enable sales teams with on-demandtrainingthat accelerates onboarding and keeps reps up-to-speed; validate readiness with salescoachingand practice that ensure reps master key messages; empower teams with dynamiccontentthat can be created quickly, updated easily and accessed anywhere; and use powerfulscorecardsto visualize sales performance trends and make real connections from improved readiness to increased revenue. Thousands of customers including more than half of the Fortune 100 rely on Brainshark to close performance gaps and get better results from their sales enablement initiatives. Learn more atwww.brainshark.com. Media Contact:Lauren BoutwellEmail: [emailprotected] Phone: 781.370.8295 SOURCE Brainshark, Inc. Related Links https://www.brainshark.com

edtsum7723

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BOSTON, March 22, 2021 /PRNewswire/ --The two-year expansion of Affordable Care Act coverage, contained in the $1.9 trillion COVID-19 relief bill, may be the high water mark for healthcare reform under the Biden administration. Beyond this provision, legislative changes in Washington won't have a dramatic impact on the U.S. healthcare industry, according to a new report from L.E.K. Consulting, the global management consulting firm. The bill increases ACA subsidies and would lower payments for the nearly 14 million Americans currently enrolled in the program. The legislation also expands Medicaid coverage for pregnant women and provides Medicaid expansion incentives to states that have not yet expanded the program. The provisions are due to expire in two years which all but guarantees they will be campaign issues during the 2022 midterm elections. Other healthcare measures will be limited. Democratic control of the Senate increases the likelihood of legislative action on healthcare. But the narrow Democratic majority in Congress makes it unlikely that the major reforms that were flagship issues for the Biden campaign an ACA public option and the extension of Medicare eligibility to age 60 will be enacted, according to a new report from global management consulting firm L.E.K. Consulting. Narrower initiatives with bipartisan support, however, may be enacted, and a dozen executive orders related to healthcare have already been signed by President Biden. Chief among those with bipartisan support are some limited forms of drug pricing reform. While these policy initiatives won't be large-scale, they will nevertheless pose challenges and spark opportunities, and may require quick action from participants across the healthcare value chain. Those are among the predictions in Election 2020: The Biden Administration, U.S. Healthcare and the Next 4 Years, the third in a series of healthcare industry election impact reports from L.E.K. Consulting. "The slim Democratic majority effectively rules out major reforms," said Wiley Bell, Managing Director at L.E.K. Consulting and a report author. "The healthcare industry should instead prepare for more incremental changes of a kind that can generate at least some Republican support." Congress has given ACA more financial support but probably won't go beyond The L.E.K. report states that the Biden campaign's flagship proposal most likely to win in Congress was an expansion of ACA financial support along the lines of the measures included in COVID-19 relief. Biden's farther-reaching proposals are unlikely to be realized. The campaign had called for lowering the Medicare eligibility age to 60 a measure that would shift 80% of Americans aged 60-65 into Medicare, lowering their total cost of care by $100 billion and the creation of an ACA public option. The ACA public option was to extend coverage free to low-income individuals not eligible for Medicaid because their states chose not to expand, and at an affordable price to other Americans. While these proposals are theoretically on the table, the obstacles are daunting: There is no margin for even one Democratic Senator to defect, Republicans are expected to filibuster major reform legislation, and they are expected to challenge it under Senate rules if Democrats try to use the budget reconciliation process to avoid the filibuster. "The combination of the narrowest possible Democratic Senate majority and effective use by Republicans of Senate rules effectively takes most major Biden reforms off the table," Bell said. Limited coverage expansion and drug-price reductions may be on the table Other healthcare measures more likely to be enacted include: Expanded access to Medicare and Medicaid and ACA coverage. The Administration's executive order on the ACA, which predated the latest COVID-19 relief package, got attention mainly because it introduced a COVID-specific special open-enrollment period. But the order also lays the groundwork for a reversal of Trump administration policies; the reversals would increase access to federal health programs. Prescription drug pricing reductions. There are several proposals on the table, and only the narrowest are likely to get the needed level of bipartisan support. A cap on drug price increases at the current level of inflation is seen as an easy win. Also possible is a reform that would allow Medicare to negotiate with drug manufacturers though it's not clear the measure can pass with a simple majority. Less likely are a switch to pricing based on international price references which the industry opposes and value-based drug pricing, which is hard to implement due to the complexity of the models. The administration may create a panel to investigate value-based drug pricing for Medicare and Medicaid. Increased access to telehealth. Any measures that come forward will have broad bipartisan support. Support for value-based innovation. There is bipartisan support for value-based payment reform expect progress on this front as well. Although changes are incremental, stakeholders should act to take advantage Healthcare industry players should, according to the report, take steps to stay ahead and take advantage of the likely direction of health policy over the next four years: Providers: Accelerate efforts to shift care to lower-cost settings and to manage patients system-wide in order to offset reimbursement changes. Expanded access to telehealth should also be on the boards. Payers: Step up programs to steer members to lower-cost care sites, while doubling down on care management capabilities for Medicare Advantage and managed Medicaid. Supply chain participants: Develop warehousing and shopping capabilities to distribute COVID and future vaccines and expand the use of high-profile generics to counter drug pricing reform. Pharmacies: Look for opportunities for greater generic drug reimbursement and double down on investment in providing additional healthcare services, such as clinics and vaccinations. MedTech players: Get ahead on telehealth by identifying priority therapeutic areas for remote monitoring solutions and offer providers digital patient engagement tools. Biopharma: Plan to upgrade value-demonstration capabilities, prepare P&Ls for flat pricing, prepare teams for government negotiation, and explore investment in infectious disease treatments. Healthcare IT: Partner with providers to develop telehealth offerings and communicate the value proposition of healthcare IT in supporting price transparency and outcomes tracking. "While there won't be earthshattering changes in the healthcare landscape as there might have been with a bigger Democratic margin changes are coming," Bell said. "Industry participants should look carefully at the implications of these incremental reforms and be ready to seize opportunities." About L.E.K. ConsultingL.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries including the largest private and public-sector organizations, private equity firms, and emerging entrepreneurial businesses. Founded in 1983, L.E.K. employs more than 1,600 professionals across the Americas, Asia-Pacific and Europe. For more information, go towww.lek.com. Media contact:Michael-Jon RomanoAllison+Partners[emailprotected] SOURCE L.E.K. Consulting Related Links http://lek.com Answer:

ACA Expansion in COVID Relief Bill May Be High Water Mark for Biden Healthcare Reform L.E.K. Consulting Report States that Public Option and Medicare Expansion within the ACA are Unlikely Due to Slim Democratic Majority and Smaller Bipartisan Reforms May Challenge Healthcare Industry

BOSTON, March 22, 2021 /PRNewswire/ --The two-year expansion of Affordable Care Act coverage, contained in the $1.9 trillion COVID-19 relief bill, may be the high water mark for healthcare reform under the Biden administration. Beyond this provision, legislative changes in Washington won't have a dramatic impact on the U.S. healthcare industry, according to a new report from L.E.K. Consulting, the global management consulting firm. The bill increases ACA subsidies and would lower payments for the nearly 14 million Americans currently enrolled in the program. The legislation also expands Medicaid coverage for pregnant women and provides Medicaid expansion incentives to states that have not yet expanded the program. The provisions are due to expire in two years which all but guarantees they will be campaign issues during the 2022 midterm elections. Other healthcare measures will be limited. Democratic control of the Senate increases the likelihood of legislative action on healthcare. But the narrow Democratic majority in Congress makes it unlikely that the major reforms that were flagship issues for the Biden campaign an ACA public option and the extension of Medicare eligibility to age 60 will be enacted, according to a new report from global management consulting firm L.E.K. Consulting. Narrower initiatives with bipartisan support, however, may be enacted, and a dozen executive orders related to healthcare have already been signed by President Biden. Chief among those with bipartisan support are some limited forms of drug pricing reform. While these policy initiatives won't be large-scale, they will nevertheless pose challenges and spark opportunities, and may require quick action from participants across the healthcare value chain. Those are among the predictions in Election 2020: The Biden Administration, U.S. Healthcare and the Next 4 Years, the third in a series of healthcare industry election impact reports from L.E.K. Consulting. "The slim Democratic majority effectively rules out major reforms," said Wiley Bell, Managing Director at L.E.K. Consulting and a report author. "The healthcare industry should instead prepare for more incremental changes of a kind that can generate at least some Republican support." Congress has given ACA more financial support but probably won't go beyond The L.E.K. report states that the Biden campaign's flagship proposal most likely to win in Congress was an expansion of ACA financial support along the lines of the measures included in COVID-19 relief. Biden's farther-reaching proposals are unlikely to be realized. The campaign had called for lowering the Medicare eligibility age to 60 a measure that would shift 80% of Americans aged 60-65 into Medicare, lowering their total cost of care by $100 billion and the creation of an ACA public option. The ACA public option was to extend coverage free to low-income individuals not eligible for Medicaid because their states chose not to expand, and at an affordable price to other Americans. While these proposals are theoretically on the table, the obstacles are daunting: There is no margin for even one Democratic Senator to defect, Republicans are expected to filibuster major reform legislation, and they are expected to challenge it under Senate rules if Democrats try to use the budget reconciliation process to avoid the filibuster. "The combination of the narrowest possible Democratic Senate majority and effective use by Republicans of Senate rules effectively takes most major Biden reforms off the table," Bell said. Limited coverage expansion and drug-price reductions may be on the table Other healthcare measures more likely to be enacted include: Expanded access to Medicare and Medicaid and ACA coverage. The Administration's executive order on the ACA, which predated the latest COVID-19 relief package, got attention mainly because it introduced a COVID-specific special open-enrollment period. But the order also lays the groundwork for a reversal of Trump administration policies; the reversals would increase access to federal health programs. Prescription drug pricing reductions. There are several proposals on the table, and only the narrowest are likely to get the needed level of bipartisan support. A cap on drug price increases at the current level of inflation is seen as an easy win. Also possible is a reform that would allow Medicare to negotiate with drug manufacturers though it's not clear the measure can pass with a simple majority. Less likely are a switch to pricing based on international price references which the industry opposes and value-based drug pricing, which is hard to implement due to the complexity of the models. The administration may create a panel to investigate value-based drug pricing for Medicare and Medicaid. Increased access to telehealth. Any measures that come forward will have broad bipartisan support. Support for value-based innovation. There is bipartisan support for value-based payment reform expect progress on this front as well. Although changes are incremental, stakeholders should act to take advantage Healthcare industry players should, according to the report, take steps to stay ahead and take advantage of the likely direction of health policy over the next four years: Providers: Accelerate efforts to shift care to lower-cost settings and to manage patients system-wide in order to offset reimbursement changes. Expanded access to telehealth should also be on the boards. Payers: Step up programs to steer members to lower-cost care sites, while doubling down on care management capabilities for Medicare Advantage and managed Medicaid. Supply chain participants: Develop warehousing and shopping capabilities to distribute COVID and future vaccines and expand the use of high-profile generics to counter drug pricing reform. Pharmacies: Look for opportunities for greater generic drug reimbursement and double down on investment in providing additional healthcare services, such as clinics and vaccinations. MedTech players: Get ahead on telehealth by identifying priority therapeutic areas for remote monitoring solutions and offer providers digital patient engagement tools. Biopharma: Plan to upgrade value-demonstration capabilities, prepare P&Ls for flat pricing, prepare teams for government negotiation, and explore investment in infectious disease treatments. Healthcare IT: Partner with providers to develop telehealth offerings and communicate the value proposition of healthcare IT in supporting price transparency and outcomes tracking. "While there won't be earthshattering changes in the healthcare landscape as there might have been with a bigger Democratic margin changes are coming," Bell said. "Industry participants should look carefully at the implications of these incremental reforms and be ready to seize opportunities." About L.E.K. ConsultingL.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries including the largest private and public-sector organizations, private equity firms, and emerging entrepreneurial businesses. Founded in 1983, L.E.K. employs more than 1,600 professionals across the Americas, Asia-Pacific and Europe. For more information, go towww.lek.com. Media contact:Michael-Jon RomanoAllison+Partners[emailprotected] SOURCE L.E.K. Consulting Related Links http://lek.com

edtsum7724

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PHILADELPHIA--(BUSINESS WIRE)--Independence Realty Trust, Inc. (NYSE: IRT) (IRT) announced that today IRTs board of directors declared a quarterly dividend of $0.12 per share of IRT common stock, payable on October 23, 2020 to stockholders of record at the close of business on October 2, 2020. About Independence Realty Trust, Inc. Independence Realty Trust (NYSE: IRT) is a real estate investment trust that owns and operates multifamily apartment properties across non-gateway U.S. markets, including Atlanta, Louisville, Memphis, and Raleigh. IRTs investment strategy is focused on gaining scale within key amenity rich submarkets that offer good school districts, high-quality retail and major employment centers. IRT aims to provide stockholders attractive risk-adjusted returns through diligent portfolio management, strong operational performance, and a consistent return on capital through distributions and capital appreciation. More information may be found on the Companys website www.irtliving.com. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as will, strategy, expects, seeks, believes, potential, or other similar words. These forward-looking statements include, without limitation, our expectations with respect to capital allocations, including as to the timing and amount of future dividends. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. These forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally not within our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Risks and uncertainties that might cause our actual results and/or future dividends to differ materially from those expressed or implied by forward-looking statements include, but are not limited to: risks related to the impact of COVID-19 and other potential future outbreaks of infectious diseases on our financial condition, results of operations, cash flows and performance and those of our residents as well as on the economy and real estate and financial markets; changes in market demand for rental apartment homes and pricing pressures, including from competitors, that could limit our ability to lease units or increase rents or that could lead to declines in occupancy and rent levels; uncertainty and volatility in capital and credit markets, including changes that reduce availability, and increase costs, of capital; inability of tenants to meet their rent and other lease obligations and charge-offs in excess of our allowance for bad debt; legislative restrictions that may delay or limit collections of past due rents; risks endemic to real estate and the real estate industry generally; the effects of natural and other disasters; delays in completing, and cost overruns incurred in connection with, our value add initiatives and failure to achieve projected rent increases and occupancy levels on account of the initiatives; unexpected costs of REIT qualification compliance; costs and disruptions as the result of a cybersecurity incident or other technology disruption; and share price fluctuations. Please refer to the documents filed by us with the SEC, including specifically the Risk Factors sections of our Form 10-K for the year ended December 31, 2019 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and our other filings with the SEC, which identify additional factors that could cause actual results to differ from those contained in forward-looking statements. We undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law. In addition, the declaration of dividends on our common stock is subject to the discretion of our Board of Directors and depends upon a broad range of factors, including our results of operations, financial condition, capital requirements, the annual distribution requirements under the REIT provisions of the Internal Revenue Code of 1986, as amended, applicable legal requirements and such other factors as our Board of Directors may from time to time deem relevant. For these reasons, as well as others, there can be no assurance that dividends in the future will be equal or similar to the expected amount of the quarterly dividend described in this press release. Answer:

Independence Realty Trust Announces Third Quarter 2020 Dividend

PHILADELPHIA--(BUSINESS WIRE)--Independence Realty Trust, Inc. (NYSE: IRT) (IRT) announced that today IRTs board of directors declared a quarterly dividend of $0.12 per share of IRT common stock, payable on October 23, 2020 to stockholders of record at the close of business on October 2, 2020. About Independence Realty Trust, Inc. Independence Realty Trust (NYSE: IRT) is a real estate investment trust that owns and operates multifamily apartment properties across non-gateway U.S. markets, including Atlanta, Louisville, Memphis, and Raleigh. IRTs investment strategy is focused on gaining scale within key amenity rich submarkets that offer good school districts, high-quality retail and major employment centers. IRT aims to provide stockholders attractive risk-adjusted returns through diligent portfolio management, strong operational performance, and a consistent return on capital through distributions and capital appreciation. More information may be found on the Companys website www.irtliving.com. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as will, strategy, expects, seeks, believes, potential, or other similar words. These forward-looking statements include, without limitation, our expectations with respect to capital allocations, including as to the timing and amount of future dividends. Because such statements include risks, uncertainties and contingencies, actual results may differ materially from the expectations, intentions, beliefs, plans or predictions of the future expressed or implied by such forward-looking statements. These forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally not within our control. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Risks and uncertainties that might cause our actual results and/or future dividends to differ materially from those expressed or implied by forward-looking statements include, but are not limited to: risks related to the impact of COVID-19 and other potential future outbreaks of infectious diseases on our financial condition, results of operations, cash flows and performance and those of our residents as well as on the economy and real estate and financial markets; changes in market demand for rental apartment homes and pricing pressures, including from competitors, that could limit our ability to lease units or increase rents or that could lead to declines in occupancy and rent levels; uncertainty and volatility in capital and credit markets, including changes that reduce availability, and increase costs, of capital; inability of tenants to meet their rent and other lease obligations and charge-offs in excess of our allowance for bad debt; legislative restrictions that may delay or limit collections of past due rents; risks endemic to real estate and the real estate industry generally; the effects of natural and other disasters; delays in completing, and cost overruns incurred in connection with, our value add initiatives and failure to achieve projected rent increases and occupancy levels on account of the initiatives; unexpected costs of REIT qualification compliance; costs and disruptions as the result of a cybersecurity incident or other technology disruption; and share price fluctuations. Please refer to the documents filed by us with the SEC, including specifically the Risk Factors sections of our Form 10-K for the year ended December 31, 2019 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, and our other filings with the SEC, which identify additional factors that could cause actual results to differ from those contained in forward-looking statements. We undertake no obligation to update these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as may be required by law. In addition, the declaration of dividends on our common stock is subject to the discretion of our Board of Directors and depends upon a broad range of factors, including our results of operations, financial condition, capital requirements, the annual distribution requirements under the REIT provisions of the Internal Revenue Code of 1986, as amended, applicable legal requirements and such other factors as our Board of Directors may from time to time deem relevant. For these reasons, as well as others, there can be no assurance that dividends in the future will be equal or similar to the expected amount of the quarterly dividend described in this press release.

edtsum7725

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: AKRON, Ohio, March 31, 2021 /PRNewswire/ --The Goodyear Tire & Rubber Company (NASDAQ: GT)today announced that it has commenced a public offering of $1 billion aggregate principal amount of 10- and 12-year senior notes. The notes will be senior unsecured obligations of the company. Issuance and sale of the notes is subject to market and other customary closing conditions. Goodyear intends to use the net proceeds from this offering, together with its current cash and cash equivalents, to redeem in full its outstanding $1 billion 5.125% senior notes due 2023 following, and subject to, the completion of this offering, at a redemption price equal to par plus accrued and unpaid interest to the redemption date. Citigroup Global Markets Inc.; Barclays Capital Inc.; BNP Paribas Securities Corp.; BofA Securities, Inc.; Credit Agricole Securities (USA) Inc.; Deutsche Bank Securities Inc.; Fifth Third Securities, Inc.; Goldman Sachs & Co. LLC; J.P. Morgan Securities LLC; MUFG Securities Americas Inc.; PNC Capital Markets LLC; SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC are acting as the joint-bookrunning managers for the offering. BBVA Securities Inc.; BMO Capital Markets Corp.; Capital One Securities, Inc.; Citizens Capital Markets, Inc.; Huntington Securities, Inc.; KeyBanc Capital Markets Inc. and Regions Securities LLC are acting as co-managers for the offering. The offering will be made under an effective shelf registration statement that was filed with the U.S. Securities and Exchange Commission on May 13, 2020. The offering of the notes may be made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from: Citigroup Global Markets Inc. The Goodyear Tire & Rubber Company c/o Broadridge Financial Solutions Investor Relations Department 1155 Long Island Avenue 200 Innovation Way Edgewood, NY 11717 Akron, OH 44316 Attention: Prospectus Department Telephone: 330-796-3751 Telephone: 1-800-831-9146 Email: [emailprotected] This news release shall not constitute a notice of redemption under the optional redemption provisions of the indenture governing the 5.125% senior notes due 2023. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Goodyear is one of the world's largest tire companies. It employs about 62,000 people and manufactures its products in 46 facilities in 21 countries around the world. Its two Innovation Centers in Akron, Ohio, and Colmar-Berg, Luxembourg, strive to develop state-of-the-art products and services that set the technology and performance standard for the industry. Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. There are a variety of factors, many of which are beyond our control, that affect our operations, performance, business strategy and results and could cause our actual results and experience to differ materially from the assumptions, expectations and objectives expressed in any forward-looking statements. These factors include, but are not limited to: the impact on us of the COVID-19 pandemic; our success in completing our pending acquisition of Cooper Tire & Rubber Company, and our ability to achieve the expected benefits of such acquisition; our ability to implement successfully our strategic initiatives; actions and initiatives taken by both current and potential competitors; deteriorating economic conditions or an inability to access capital markets; increases in the prices paid for raw materials and energy; a labor strike, work stoppage or other similar event; foreign currency translation and transaction risks; work stoppages, financial difficulties or supply disruptions at our suppliers or customers; the adequacy of our capital expenditures; our failure to comply with a material covenant in our debt obligations; potential adverse consequences of litigation involving the company; as well as the effects of more general factors such as changes in general market, economic or political conditions or in legislation, regulation or public policy. Additional factors are discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. In addition, any forward-looking statements represent our estimates only as of today and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change. SOURCE The Goodyear Tire & Rubber Company Related Links http://www.goodyear.com Answer:

Goodyear Announces Offering Of Senior Notes

AKRON, Ohio, March 31, 2021 /PRNewswire/ --The Goodyear Tire & Rubber Company (NASDAQ: GT)today announced that it has commenced a public offering of $1 billion aggregate principal amount of 10- and 12-year senior notes. The notes will be senior unsecured obligations of the company. Issuance and sale of the notes is subject to market and other customary closing conditions. Goodyear intends to use the net proceeds from this offering, together with its current cash and cash equivalents, to redeem in full its outstanding $1 billion 5.125% senior notes due 2023 following, and subject to, the completion of this offering, at a redemption price equal to par plus accrued and unpaid interest to the redemption date. Citigroup Global Markets Inc.; Barclays Capital Inc.; BNP Paribas Securities Corp.; BofA Securities, Inc.; Credit Agricole Securities (USA) Inc.; Deutsche Bank Securities Inc.; Fifth Third Securities, Inc.; Goldman Sachs & Co. LLC; J.P. Morgan Securities LLC; MUFG Securities Americas Inc.; PNC Capital Markets LLC; SMBC Nikko Securities America, Inc. and Wells Fargo Securities, LLC are acting as the joint-bookrunning managers for the offering. BBVA Securities Inc.; BMO Capital Markets Corp.; Capital One Securities, Inc.; Citizens Capital Markets, Inc.; Huntington Securities, Inc.; KeyBanc Capital Markets Inc. and Regions Securities LLC are acting as co-managers for the offering. The offering will be made under an effective shelf registration statement that was filed with the U.S. Securities and Exchange Commission on May 13, 2020. The offering of the notes may be made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from: Citigroup Global Markets Inc. The Goodyear Tire & Rubber Company c/o Broadridge Financial Solutions Investor Relations Department 1155 Long Island Avenue 200 Innovation Way Edgewood, NY 11717 Akron, OH 44316 Attention: Prospectus Department Telephone: 330-796-3751 Telephone: 1-800-831-9146 Email: [emailprotected] This news release shall not constitute a notice of redemption under the optional redemption provisions of the indenture governing the 5.125% senior notes due 2023. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Goodyear is one of the world's largest tire companies. It employs about 62,000 people and manufactures its products in 46 facilities in 21 countries around the world. Its two Innovation Centers in Akron, Ohio, and Colmar-Berg, Luxembourg, strive to develop state-of-the-art products and services that set the technology and performance standard for the industry. Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. There are a variety of factors, many of which are beyond our control, that affect our operations, performance, business strategy and results and could cause our actual results and experience to differ materially from the assumptions, expectations and objectives expressed in any forward-looking statements. These factors include, but are not limited to: the impact on us of the COVID-19 pandemic; our success in completing our pending acquisition of Cooper Tire & Rubber Company, and our ability to achieve the expected benefits of such acquisition; our ability to implement successfully our strategic initiatives; actions and initiatives taken by both current and potential competitors; deteriorating economic conditions or an inability to access capital markets; increases in the prices paid for raw materials and energy; a labor strike, work stoppage or other similar event; foreign currency translation and transaction risks; work stoppages, financial difficulties or supply disruptions at our suppliers or customers; the adequacy of our capital expenditures; our failure to comply with a material covenant in our debt obligations; potential adverse consequences of litigation involving the company; as well as the effects of more general factors such as changes in general market, economic or political conditions or in legislation, regulation or public policy. Additional factors are discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. In addition, any forward-looking statements represent our estimates only as of today and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change. SOURCE The Goodyear Tire & Rubber Company Related Links http://www.goodyear.com

edtsum7726

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Global Sheet Metal Processing Equipment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the sheet metal processing equipment market and it is poised to grow by $5.57 billion during 2021-2025 progressing at a CAGR of 10% during the forecast period. The report on sheet metal processing equipment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising industrial automation globally, growing demand for CNC machines and growth of construction industry in many countries. The sheet metal processing equipment market analysis includes application segment and geographical landscapes. This study identifies the increasing penetration of industry 4.0 as one of the prime reasons driving the sheet metal processing equipment market growth during the next few years. Also, emergence of friction-stir welding technology and rising popularity of all-electric vehicles influencing demand for sheet metal processing equipment will lead to sizable demand in the market. Companies Mentioned The report on sheet metal processing equipment market covers the following areas: The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth. Key Topics Covered: 1. Executive Summary 2. Market Landscape 3. Market Sizing 4. Five Forces Analysis 5. Market Segmentation by Application 6. Customer landscape 7. Geographic Landscape 8. Vendor Landscape 9. Vendor Analysis 10. Appendix For more information about this report visit https://www.researchandmarkets.com/r/ovcf3y Answer:

Worldwide Sheet Metal Processing Equipment Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Sheet Metal Processing Equipment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The publisher has been monitoring the sheet metal processing equipment market and it is poised to grow by $5.57 billion during 2021-2025 progressing at a CAGR of 10% during the forecast period. The report on sheet metal processing equipment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising industrial automation globally, growing demand for CNC machines and growth of construction industry in many countries. The sheet metal processing equipment market analysis includes application segment and geographical landscapes. This study identifies the increasing penetration of industry 4.0 as one of the prime reasons driving the sheet metal processing equipment market growth during the next few years. Also, emergence of friction-stir welding technology and rising popularity of all-electric vehicles influencing demand for sheet metal processing equipment will lead to sizable demand in the market. Companies Mentioned The report on sheet metal processing equipment market covers the following areas: The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth. Key Topics Covered: 1. Executive Summary 2. Market Landscape 3. Market Sizing 4. Five Forces Analysis 5. Market Segmentation by Application 6. Customer landscape 7. Geographic Landscape 8. Vendor Landscape 9. Vendor Analysis 10. Appendix For more information about this report visit https://www.researchandmarkets.com/r/ovcf3y

edtsum7727

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--The physiotherapy market is poised to grow by USD 3.21 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The report on the physiotherapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing number of healthcare providers. The physiotherapy market analysis includes the treatment process segment and geographic landscape. This study identifies the growing use of portable physiotherapy equipment in sports as one of the prime reasons driving the physiotherapy market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The Physiotherapy Market covers the following areas: Physiotherapy Market Sizing Physiotherapy Market Forecast Physiotherapy Market Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Treatment Process Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Answer:

Global Physiotherapy Market- Featuring Accord Medical Products Pvt. Ltd.,BTL Group, Colfax Corp., Among Others

LONDON--(BUSINESS WIRE)--The physiotherapy market is poised to grow by USD 3.21 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis The report on the physiotherapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing number of healthcare providers. The physiotherapy market analysis includes the treatment process segment and geographic landscape. This study identifies the growing use of portable physiotherapy equipment in sports as one of the prime reasons driving the physiotherapy market growth during the next few years. This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The Physiotherapy Market covers the following areas: Physiotherapy Market Sizing Physiotherapy Market Forecast Physiotherapy Market Analysis Companies Mentioned Key Topics Covered: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Treatment Process Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

edtsum7728

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the closing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $3.50 per share, including the full exercise of the underwriters option to purchase an additional 2,400,000 shares. The gross proceeds to PhaseBio from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $64.4 million. Cowen, Stifel and William Blair acted as joint book-running managers for the offering. Needham & Company acted as lead manager for the offering. The offering was made pursuant to a shelf registration statement, including a base prospectus, filed by PhaseBio that was declared effective by the Securities and Exchange Commission (SEC) on January 8, 2020. The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. An electronic copy of the final prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC and is available on the SECs website at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Attn: Prospectus Department, by telephone at (833) 297-2926, or by email at [email protected]; Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at +1 (415) 364-2720 or by email at [email protected]; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: 1-800-621-0687, or by email: [email protected]. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. Answer:

PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the closing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $3.50 per share, including the full exercise of the underwriters option to purchase an additional 2,400,000 shares. The gross proceeds to PhaseBio from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $64.4 million. Cowen, Stifel and William Blair acted as joint book-running managers for the offering. Needham & Company acted as lead manager for the offering. The offering was made pursuant to a shelf registration statement, including a base prospectus, filed by PhaseBio that was declared effective by the Securities and Exchange Commission (SEC) on January 8, 2020. The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. An electronic copy of the final prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC and is available on the SECs website at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Attn: Prospectus Department, by telephone at (833) 297-2926, or by email at [email protected]; Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at +1 (415) 364-2720 or by email at [email protected]; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: 1-800-621-0687, or by email: [email protected]. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

edtsum7729

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WASHINGTON, Aug. 27, 2020 /PRNewswire/ --American Automakers FCA US LLC, Ford Motor Company and General Motors issued a new report, the American Automakers 2020 State of the U.S. Automotive Industry, illustrating how vital these three American companies are to the U.S. economy, by driving growth in both manufacturing and job creation. As policymakers consider additional measures to support the U.S. economic recovery from the impact of the COVID-19 pandemic, the data in this report shows why American Automakers are critical to this effort. "American Automakers FCA US, Ford, and General Motors are pivotal in driving growth in the U.S. manufacturing sector and will be essential to the recovery of America's economy in the months ahead," said Governor Matt Blunt, president of AAPC, the trade association representing American Automakers FCA US LLC, Ford Motor Company and General Motors Company. "The 2020 State of the U.S. Automotive Industry report highlights the many crucial contributions American Automakers make to our nation's economy. These unique contributions are especially important as policymakers consider steps to recover from the negative economic impact of the coronavirus on the U.S. economy." See below for key statistics from the American Automakers 2020 State of the U.S. Automotive Industry report detailing FCA US LLC, Ford Motor Company and General Motors impact on the U.S. economy: Production, Sales, and Exports Operate 3 out of 5 U.S. auto assembly plants. Produced 5.8 million vehicles in 2018, representing 75% of their U.S. sales. Exported nearly 1 million American-made vehicles last year, serving more than 100 foreign markets. Investment Invested more than $34 billion in U.S. assembly, engine and transmission plants, R&D labs, headquarters, and other facilities (2013-2018). Jobs Accounted for 238,000 U.S. workers at 260 assembly plants, manufacturing facilities, research labs, distribution centers, and other facilities, located in 31 states. Research and Development Spent approximately $20 billion in R&D in 2018. For more information on findings and to view the full reportclick here. The American Automotive Policy Council (AAPC) represents American Automakers FCA US LLC, Ford Motor Company and General Motors Company. AAPC is a Washington, D.C. association representing the common public policy interests of its member companies. Contact:[emailprotected] SOURCE American Automotive Policy Council Answer:

Report Shows American Automakers Will Be An Engine for Economic Recovery

WASHINGTON, Aug. 27, 2020 /PRNewswire/ --American Automakers FCA US LLC, Ford Motor Company and General Motors issued a new report, the American Automakers 2020 State of the U.S. Automotive Industry, illustrating how vital these three American companies are to the U.S. economy, by driving growth in both manufacturing and job creation. As policymakers consider additional measures to support the U.S. economic recovery from the impact of the COVID-19 pandemic, the data in this report shows why American Automakers are critical to this effort. "American Automakers FCA US, Ford, and General Motors are pivotal in driving growth in the U.S. manufacturing sector and will be essential to the recovery of America's economy in the months ahead," said Governor Matt Blunt, president of AAPC, the trade association representing American Automakers FCA US LLC, Ford Motor Company and General Motors Company. "The 2020 State of the U.S. Automotive Industry report highlights the many crucial contributions American Automakers make to our nation's economy. These unique contributions are especially important as policymakers consider steps to recover from the negative economic impact of the coronavirus on the U.S. economy." See below for key statistics from the American Automakers 2020 State of the U.S. Automotive Industry report detailing FCA US LLC, Ford Motor Company and General Motors impact on the U.S. economy: Production, Sales, and Exports Operate 3 out of 5 U.S. auto assembly plants. Produced 5.8 million vehicles in 2018, representing 75% of their U.S. sales. Exported nearly 1 million American-made vehicles last year, serving more than 100 foreign markets. Investment Invested more than $34 billion in U.S. assembly, engine and transmission plants, R&D labs, headquarters, and other facilities (2013-2018). Jobs Accounted for 238,000 U.S. workers at 260 assembly plants, manufacturing facilities, research labs, distribution centers, and other facilities, located in 31 states. Research and Development Spent approximately $20 billion in R&D in 2018. For more information on findings and to view the full reportclick here. The American Automotive Policy Council (AAPC) represents American Automakers FCA US LLC, Ford Motor Company and General Motors Company. AAPC is a Washington, D.C. association representing the common public policy interests of its member companies. Contact:[emailprotected] SOURCE American Automotive Policy Council

edtsum7730

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, Aug. 20, 2020 /PRNewswire/ -- The "Froth Flotation Chemicals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 284-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Froth Flotation Chemicals Market to Reach $2.2 Billion by 2027Amid the COVID-19 crisis, the global market for Froth Flotation Chemicals estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027. Collectors, one of the segments analyzed in the report, is projected to record a 2.8% CAGR and reach US$773.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frothers segment is readjusted to a revised 2.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $498.1 Million, While China is Forecast to Grow at 4.5% CAGRThe Froth Flotation Chemicals market in the U.S. is estimated at US$498.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$429.9 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.Modifiers Segment to Record 2% CAGRIn the global Modifiers segment, USA, Canada, Japan, China and Europe will drive the 1.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$289.8 Million in the year 2020 will reach a projected size of US$324.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$293.4 Million by the year 2027, while Latin America will expand at a 2.7% CAGR through the analysis period. Competitors identified in this market include, among others: Air Products and Chemicals, Inc. Akzo Nobel NV ArrMaz Products LP Ashland, Inc. BASF SE Cheminova A/S Chevron Phillips Chemical Company LLC Clariant AG CP Kelco Cytec Solvay Group DowDuPont, Inc. Huntsman International LLC Kemira Oyj Nasaco International Ltd. Orica Ltd. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Froth Flotation Chemicals Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/4s3lnm Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Froth Flotation Chemicals Industry (2020 to 2027) - Market Trajectory & Analytics

DUBLIN, Aug. 20, 2020 /PRNewswire/ -- The "Froth Flotation Chemicals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to the 6th edition of this report. The 284-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Froth Flotation Chemicals Market to Reach $2.2 Billion by 2027Amid the COVID-19 crisis, the global market for Froth Flotation Chemicals estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027. Collectors, one of the segments analyzed in the report, is projected to record a 2.8% CAGR and reach US$773.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frothers segment is readjusted to a revised 2.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $498.1 Million, While China is Forecast to Grow at 4.5% CAGRThe Froth Flotation Chemicals market in the U.S. is estimated at US$498.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$429.9 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.Modifiers Segment to Record 2% CAGRIn the global Modifiers segment, USA, Canada, Japan, China and Europe will drive the 1.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$289.8 Million in the year 2020 will reach a projected size of US$324.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$293.4 Million by the year 2027, while Latin America will expand at a 2.7% CAGR through the analysis period. Competitors identified in this market include, among others: Air Products and Chemicals, Inc. Akzo Nobel NV ArrMaz Products LP Ashland, Inc. BASF SE Cheminova A/S Chevron Phillips Chemical Company LLC Clariant AG CP Kelco Cytec Solvay Group DowDuPont, Inc. Huntsman International LLC Kemira Oyj Nasaco International Ltd. Orica Ltd. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Froth Flotation Chemicals Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVEIII. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/4s3lnm Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum7731

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BOSTON--(BUSINESS WIRE)--Kyruus today announced findings from a new survey of 1,000 people examining the impact of the COVID-19 pandemic on patient access experiences and preferences. The findings, published in the Patient Access Preferences Report: The Pandemic's Lasting Impact, revealed that over 50% of respondents delayed some sort of care during the pandemic and, as people resume care in the coming months, the majority will seek a hybrid of virtual and in-person options. The full findings indicate that the pandemic has permanently elevated consumer prioritization of convenience and flexibility in both care access and delivery. As the pandemic took hold, healthcare organizations quickly expanded their digitally-enabled access and delivery options, offering patients new ways to obtain care, such as virtual visits, alongside greater self-service capabilities like online scheduling. Patients embraced these options and the survey results signal that their experiences have led to a lasting mindset shift around access suggesting that organizations that continue offering flexibility around booking and obtaining care will be in the best position to attract and retain patients. Notable findings include: As healthcare organizations envision what patient access will look like as we continually navigate through the pandemic, they are thoughtfully considering which adjustments to retain long term, said Erin Jospe, MD, Chief Medical Officer at Kyruus. This research underscores the importance of coupling clinical and consumer perspectives to maximize how much of the pandemic-driven innovation remains permanently. Kyruus conducted the survey of 1,000 people, spanning ages 18 to 65-plus, through Wakefield Research in March 2021. Download the Patient Access Preferences Report at: kyruus.com/patient-access-post-pandemic-report About Kyruus Kyruus helps healthcare organizations connect people with the right care across their key access points. The companys industry-defining provider search and scheduling platform enables leading health systems, hospitals, and medical groups nationwide spanning more than 300,000 providers to attract and retain patients with a modern and consistent access experience. Robust provider data management forms the foundation of the platform, helping people find the right providers and care settings for their needs based on rich, system-wide information. To extend its impact on care navigation, Kyruus acquired HealthSparq in 2021 to bridge payer and provider access channels like never before. For more on why A Better Match Means Better Care, visit www.kyruus.com. Answer:

COVID-19 Impact Survey Shows Surge in Consumer Demand for Digital Care Navigation and Delivery Post-Pandemic Kyruus Research Reveals New Opportunities for Healthcare Organizations to Differentiate Themselves as Care Demand Rebounds

BOSTON--(BUSINESS WIRE)--Kyruus today announced findings from a new survey of 1,000 people examining the impact of the COVID-19 pandemic on patient access experiences and preferences. The findings, published in the Patient Access Preferences Report: The Pandemic's Lasting Impact, revealed that over 50% of respondents delayed some sort of care during the pandemic and, as people resume care in the coming months, the majority will seek a hybrid of virtual and in-person options. The full findings indicate that the pandemic has permanently elevated consumer prioritization of convenience and flexibility in both care access and delivery. As the pandemic took hold, healthcare organizations quickly expanded their digitally-enabled access and delivery options, offering patients new ways to obtain care, such as virtual visits, alongside greater self-service capabilities like online scheduling. Patients embraced these options and the survey results signal that their experiences have led to a lasting mindset shift around access suggesting that organizations that continue offering flexibility around booking and obtaining care will be in the best position to attract and retain patients. Notable findings include: As healthcare organizations envision what patient access will look like as we continually navigate through the pandemic, they are thoughtfully considering which adjustments to retain long term, said Erin Jospe, MD, Chief Medical Officer at Kyruus. This research underscores the importance of coupling clinical and consumer perspectives to maximize how much of the pandemic-driven innovation remains permanently. Kyruus conducted the survey of 1,000 people, spanning ages 18 to 65-plus, through Wakefield Research in March 2021. Download the Patient Access Preferences Report at: kyruus.com/patient-access-post-pandemic-report About Kyruus Kyruus helps healthcare organizations connect people with the right care across their key access points. The companys industry-defining provider search and scheduling platform enables leading health systems, hospitals, and medical groups nationwide spanning more than 300,000 providers to attract and retain patients with a modern and consistent access experience. Robust provider data management forms the foundation of the platform, helping people find the right providers and care settings for their needs based on rich, system-wide information. To extend its impact on care navigation, Kyruus acquired HealthSparq in 2021 to bridge payer and provider access channels like never before. For more on why A Better Match Means Better Care, visit www.kyruus.com.

edtsum7732

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DENVER, Feb. 25, 2021 /PRNewswire/ -- CMG Capital began construction on Momentum at First Creek, a $50 million multifamily rental project in Denver. The company partnered with Massimino Development on the property located at 56th Avenue & Telluride Road within the high-growth corridor of the Denver International Airport.The Momentum project is the second CMG Capital and Massimino Development partnership in Colorado. The two companies broke ground on Farm Haus Apartments in Longmont in August 2019. (PRNewsfoto/CMG Capital) The development offers an astonishing array of amenities featuring a 7,750 square foot clubhouse with an impressive resort-style lobby and 24-hour state-of-the-art fitness center, a coffee bar, co-working offices, expansive lounge areas, a game room and indoor/outdoor kitchens, along with a dog wash. The property will offer the most robust outdoor amenity program in the market including a resort style pool, oversized spa, two water features, pool cabanas and a pool pavilion featuring two outdoor televisions. Fire pits, al fresco dining areas, a BBQ pavilion outfitted with gas grills and a pizza oven make for awesome meals. Televisions, outdoor game areas, a bocce ball court, dog park, playground and walking path complete the outdoor amenities. "There is nothing like this property in the sub-market," said Shawn Chemtov, CEO of CMG Capital. "The amenities are unparalleled and we believe that there is a pent-up demand for this type of development."Momentum at First Creek will offer 200 one, two, and three-bedroom luxury apartments encompassing six residential buildings on almost eight acres. Apartments include designer kitchens featuring stainless steel appliances, quartz countertops and large islands. They offer oversized private balconies, full-size washers and dryers and faux wood plank flooring. Master suites feature spacious walk-in closets, double vanities, oversized tubs, and nine-foot ceilings.Units range in size from 620 square feet to 1,412 square feet. Rents will start at $1,395 and units will be available in April 2022.Chemtov is a limited partner in Connect at First Creek, a 150-unit multi-family development directly adjacent to Momentum developed by Massimino Development. Connect at First Creek's property leaseup began at the peak of the pandemic and is currently stabilized, averaging 18 units per month during lease-up.SOURCE CMG Capital Answer:

CMG Capital Breaks Ground On $50M Denver Apartments Partnered with Massimino Development on Amenity-Filled Project

DENVER, Feb. 25, 2021 /PRNewswire/ -- CMG Capital began construction on Momentum at First Creek, a $50 million multifamily rental project in Denver. The company partnered with Massimino Development on the property located at 56th Avenue & Telluride Road within the high-growth corridor of the Denver International Airport.The Momentum project is the second CMG Capital and Massimino Development partnership in Colorado. The two companies broke ground on Farm Haus Apartments in Longmont in August 2019. (PRNewsfoto/CMG Capital) The development offers an astonishing array of amenities featuring a 7,750 square foot clubhouse with an impressive resort-style lobby and 24-hour state-of-the-art fitness center, a coffee bar, co-working offices, expansive lounge areas, a game room and indoor/outdoor kitchens, along with a dog wash. The property will offer the most robust outdoor amenity program in the market including a resort style pool, oversized spa, two water features, pool cabanas and a pool pavilion featuring two outdoor televisions. Fire pits, al fresco dining areas, a BBQ pavilion outfitted with gas grills and a pizza oven make for awesome meals. Televisions, outdoor game areas, a bocce ball court, dog park, playground and walking path complete the outdoor amenities. "There is nothing like this property in the sub-market," said Shawn Chemtov, CEO of CMG Capital. "The amenities are unparalleled and we believe that there is a pent-up demand for this type of development."Momentum at First Creek will offer 200 one, two, and three-bedroom luxury apartments encompassing six residential buildings on almost eight acres. Apartments include designer kitchens featuring stainless steel appliances, quartz countertops and large islands. They offer oversized private balconies, full-size washers and dryers and faux wood plank flooring. Master suites feature spacious walk-in closets, double vanities, oversized tubs, and nine-foot ceilings.Units range in size from 620 square feet to 1,412 square feet. Rents will start at $1,395 and units will be available in April 2022.Chemtov is a limited partner in Connect at First Creek, a 150-unit multi-family development directly adjacent to Momentum developed by Massimino Development. Connect at First Creek's property leaseup began at the peak of the pandemic and is currently stabilized, averaging 18 units per month during lease-up.SOURCE CMG Capital

edtsum7733

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, Dec. 10, 2020 /PRNewswire/ -- The "Beauty Drinks Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global beauty drinks market grew at a CAGR of around 12% during 2014-2019. Looking forward, the global beauty drinks market to continue its strong growth during the next five years.Beauty drinks refer to nutraceutical beverages that promote anti-aging, make the skin more radiant and minimize the appearance of acne, scars and pigmentation. These drinks assist in detoxifying the skin as they are formulated using botanical extracts of fruits and vegetables and fortified with essential amino acids, vitamins, minerals and antioxidants. They can also help in tightening the skin and maintaining healthy hair and nails. Beauty drinks generally contain collagen peptides that stimulate natural collagen-producing cells and reduce premature wrinkles.The global beauty drinks market is witnessing growth on account of the rising beauty consciousness among individuals. This can be accredited to inflating income levels and the strong influence of social media. Moreover, hectic lifestyles, rising air pollution, unhealthy dietary patterns and the increasing consumption of alcohol have led to premature aging issues among a significant portion of the young population. Apart from this, as the level of natural collagen in the body declines with age, it leads to saggy skin and other skin issues. This, in confluence with the growing willingness among individuals to attain healthy and youthful skin, is further bolstering the market growth. Furthermore, the leading players are focusing on the introduction of gluten- and lactose-free and vegan product variants with no added sugars, preservatives and flavorings to expand their market reach. Other factors anticipated to provide lucrative opportunities to manufacturers include the rising working population and the growing trend of nutricosmetics. Key Questions Answered in This Report: How has the global beauty drinks market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global beauty drinks market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the ingredients? What is the breakup of the market based on the function? What are the various stages in the value chain of the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global beauty drinks market and who are the key players? What is the degree of competition in the market? Key Topics Covered: 1 Preface2 Scope and Methodology 2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Beauty Drinks Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Type6.1 Natural Drinks6.2 Artificial Drinks7 Market Breakup by Ingredients7.1 Collagen Proteins7.2 Vitamins and Minerals7.3 Fruit Extracts7.4 Others8 Market Breakup by Function8.1 Anti-Ageing8.2 Detoxication8.3 Radiance8.4 Vitality8.5 Others9 Market Breakup by Distribution Channel9.1 Grocery Retailers9.2 Beauty Specialty Stores9.3 Drug Stores and Pharmacies9.4 Others10 Market Breakup by Region11 SWOT Analysis12 Value Chain Analysis13 Price Analysis14 Porters Five Forces Analysis15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players Asterism Healthcare Plus Inc. DECIEM The Abnormal Beauty Company Hangzhou Nutrition Biotechnology Co. Ltd. Kino Biotech Lacka Foods Limited Sappe Public Company Limited Shiseido Skinade The Coca-Cola Company Vital Proteins LLC (Nestle Health Science) For more information about this report visit https://www.researchandmarkets.com/r/rjqt9m Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Beauty Drinks Markets Report 2020-2025: Leading Players are Focusing on the Introduction of Gluten- and Lactose-free and Vegan Product Variants

DUBLIN, Dec. 10, 2020 /PRNewswire/ -- The "Beauty Drinks Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global beauty drinks market grew at a CAGR of around 12% during 2014-2019. Looking forward, the global beauty drinks market to continue its strong growth during the next five years.Beauty drinks refer to nutraceutical beverages that promote anti-aging, make the skin more radiant and minimize the appearance of acne, scars and pigmentation. These drinks assist in detoxifying the skin as they are formulated using botanical extracts of fruits and vegetables and fortified with essential amino acids, vitamins, minerals and antioxidants. They can also help in tightening the skin and maintaining healthy hair and nails. Beauty drinks generally contain collagen peptides that stimulate natural collagen-producing cells and reduce premature wrinkles.The global beauty drinks market is witnessing growth on account of the rising beauty consciousness among individuals. This can be accredited to inflating income levels and the strong influence of social media. Moreover, hectic lifestyles, rising air pollution, unhealthy dietary patterns and the increasing consumption of alcohol have led to premature aging issues among a significant portion of the young population. Apart from this, as the level of natural collagen in the body declines with age, it leads to saggy skin and other skin issues. This, in confluence with the growing willingness among individuals to attain healthy and youthful skin, is further bolstering the market growth. Furthermore, the leading players are focusing on the introduction of gluten- and lactose-free and vegan product variants with no added sugars, preservatives and flavorings to expand their market reach. Other factors anticipated to provide lucrative opportunities to manufacturers include the rising working population and the growing trend of nutricosmetics. Key Questions Answered in This Report: How has the global beauty drinks market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global beauty drinks market? What are the key regional markets? What is the breakup of the market based on the type? What is the breakup of the market based on the ingredients? What is the breakup of the market based on the function? What are the various stages in the value chain of the distribution channel? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the market? What is the structure of the global beauty drinks market and who are the key players? What is the degree of competition in the market? Key Topics Covered: 1 Preface2 Scope and Methodology 2.1 Objectives of the Study2.2 Stakeholders2.3 Data Sources2.4 Market Estimation2.5 Forecasting Methodology3 Executive Summary4 Introduction4.1 Overview4.2 Key Industry Trends5 Global Beauty Drinks Market5.1 Market Overview5.2 Market Performance5.3 Impact of COVID-195.4 Market Forecast6 Market Breakup by Type6.1 Natural Drinks6.2 Artificial Drinks7 Market Breakup by Ingredients7.1 Collagen Proteins7.2 Vitamins and Minerals7.3 Fruit Extracts7.4 Others8 Market Breakup by Function8.1 Anti-Ageing8.2 Detoxication8.3 Radiance8.4 Vitality8.5 Others9 Market Breakup by Distribution Channel9.1 Grocery Retailers9.2 Beauty Specialty Stores9.3 Drug Stores and Pharmacies9.4 Others10 Market Breakup by Region11 SWOT Analysis12 Value Chain Analysis13 Price Analysis14 Porters Five Forces Analysis15 Competitive Landscape15.1 Market Structure15.2 Key Players15.3 Profiles of Key Players Asterism Healthcare Plus Inc. DECIEM The Abnormal Beauty Company Hangzhou Nutrition Biotechnology Co. Ltd. Kino Biotech Lacka Foods Limited Sappe Public Company Limited Shiseido Skinade The Coca-Cola Company Vital Proteins LLC (Nestle Health Science) For more information about this report visit https://www.researchandmarkets.com/r/rjqt9m Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum7734

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--Advancements in technology, customers changing expectations, and increasing investment in the healthcare industry have influenced significant growth in the in-vitro diagnostics market. However, these advancements and changes have also made the market highly innovative and competitive. To compete in a market as fast-growing and competitive as this, companies must be aware of the factors influencing the market. Infinitis healthcare market research services enable companies in the in-vitro diagnostics market, and other segments of the healthcare industry to not only know about the trends, driving factors, and opportunities in the market but also enables them to capitalize on the same efficiently. To leverage Infinitis expertise in offering healthcare market research services, and compete in the rapidly evolving and innovative in-vitro diagnostics market, request a free proposal. The healthcare industry and in-vitro diagnostics market have grown exponentially in recent decades. As various trends and challenges affect the market, key players are shifting their focus to new strategies, such as M&A. However, the first step to achieving a greater market share is having a comprehensive understanding of the drivers influencing growth in the in-vitro diagnostics market, says an in-vitro diagnostics market expert at Infiniti Research. The in-vitro diagnostics market is expected to witness significant growth in the coming years. In-vitro diagnostics have gained substantial momentum as a modern medical diagnostic system. Factors such as advancing diagnostic technologies, acceptance of precision medicine, and improved quality of life are majorly influencing the in-vitro diagnostics market. As the in-vitro diagnostics market continues to grow, key players have started to shift their focus to strategic initiatives such as mergers and acquisitions (M&A). However, to dominate the market, companies must also understand the trends, challenges, and growth drivers impacting the market. Most importantly, companies must be aware of driving factors and the best way to capitalize on current and upcoming opportunities. Therefore, Infinitis healthcare market research experts discuss the most noteworthy market growth drivers in their recent article and highlight how market research services enable companies to capitalize on them. Aiming to be a leader in the in-vitro diagnostics market? To learn more about the driving factors in the market, and how to capitalize on them efficiently, request more information. Infinitis healthcare market research experts have identified four noteworthy driving factors in the in-vitro diagnostics market: About Infiniti Research Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us Answer:

Four Noteworthy Driving Factors in the In-Vitro Diagnostics Market | Infinitis Market Research Experts Discuss the Optimal Approach

LONDON--(BUSINESS WIRE)--Advancements in technology, customers changing expectations, and increasing investment in the healthcare industry have influenced significant growth in the in-vitro diagnostics market. However, these advancements and changes have also made the market highly innovative and competitive. To compete in a market as fast-growing and competitive as this, companies must be aware of the factors influencing the market. Infinitis healthcare market research services enable companies in the in-vitro diagnostics market, and other segments of the healthcare industry to not only know about the trends, driving factors, and opportunities in the market but also enables them to capitalize on the same efficiently. To leverage Infinitis expertise in offering healthcare market research services, and compete in the rapidly evolving and innovative in-vitro diagnostics market, request a free proposal. The healthcare industry and in-vitro diagnostics market have grown exponentially in recent decades. As various trends and challenges affect the market, key players are shifting their focus to new strategies, such as M&A. However, the first step to achieving a greater market share is having a comprehensive understanding of the drivers influencing growth in the in-vitro diagnostics market, says an in-vitro diagnostics market expert at Infiniti Research. The in-vitro diagnostics market is expected to witness significant growth in the coming years. In-vitro diagnostics have gained substantial momentum as a modern medical diagnostic system. Factors such as advancing diagnostic technologies, acceptance of precision medicine, and improved quality of life are majorly influencing the in-vitro diagnostics market. As the in-vitro diagnostics market continues to grow, key players have started to shift their focus to strategic initiatives such as mergers and acquisitions (M&A). However, to dominate the market, companies must also understand the trends, challenges, and growth drivers impacting the market. Most importantly, companies must be aware of driving factors and the best way to capitalize on current and upcoming opportunities. Therefore, Infinitis healthcare market research experts discuss the most noteworthy market growth drivers in their recent article and highlight how market research services enable companies to capitalize on them. Aiming to be a leader in the in-vitro diagnostics market? To learn more about the driving factors in the market, and how to capitalize on them efficiently, request more information. Infinitis healthcare market research experts have identified four noteworthy driving factors in the in-vitro diagnostics market: About Infiniti Research Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit: https://www.infinitiresearch.com/about-us

edtsum7735

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WOBURN, Mass.--(BUSINESS WIRE)--According to a new Kaspersky report Investment adjustment: aligning IT budgets with changing security priorities, cybersecurity remains a priority for investment among businesses. Its share of IT spending has grown from 23% in 2019 to 26% in 2020 for SMBs, and from 26% to 29% for enterprises. 71% of organizations also expect their cybersecurity budget will increase in the next three years, despite overall IT budgets decreasing in both segments amid the COVID-19 pandemic. External conditions and events can influence IT priorities for businesses. As a result of the COVID-19 pandemic, organizations have been forced to adjust plans to meet changing business needs. The report, based on a survey of more than 5,000 IT and cybersecurity practitioners, observes recent IT security economics trends and how they correlate with this years events1. While the overall IT budget has fallen from $1.2m in 2019 to $1.1m in 2020 among SMBs, and from $74.1m to $54.3m for enterprises, the share of IT budget dedicated to IT security continues to grow year-on-year. Decreases in budget are likely due to the consequences of the global coronavirus pandemic, according to Gartner, whose experts also predicted that budgets would decrease earlier this year. As a result, small and medium businesses allocated $275k to cybersecurity while enterprises invested $14m. According to the survey, the majority of companies are expecting these figures to grow in the next three years by 11% in enterprises and 12% in SMBs, on average. 17% believe it will remain at least the same as this year. Alternatively, one-in-ten (10%) organizations said they are going to spend less on IT security. Interestingly, the main reason for this across enterprises is the deliberate decision of top management, who sees no point in investing so much money in cybersecurity in the future (32%). Among SMBs, the reason to reduce spend in this area is primarily dictated by the need to cut overall company expenses and optimize budgets (29%). Small and medium organizations were hit hardest by the lockdown with more than half of small companies globally reported a decline in sales or experienced cash flow constraints. It is clear that those affected have needed to optimize their expenses to survive. But while this impacts cyber-protection, its important for businesses to find a way to keep safe from cyber-risks in such a challenging time. 2020 has put many companies in situations where they needed to respond, so they wisely concentrated all their resources and efforts on staying afloat, commented Alexander Moiseev, chief business officer at Kaspersky. Even though budgets get revised, it doesnt mean cybersecurity needs to go down on the priority list. We recommend that businesses, who have to spend less on cybersecurity in the coming years, get smart about it and use every available option to bolster their defenses by turning to free security solutions available on the market and introducing security awareness programs across the organization. Those are small steps that can make a difference, especially for SMBs. Kaspersky suggests the following advice to small and medium organizations in order to maintain their cybersecurity posture, even with low security investments: To read the full report Investment adjustment: aligning IT budgets with changing security priorities, please visit here. About Kaspersky Kaspersky is a global cybersecurity company founded in 1997. Kasperskys deep threat intelligence and security expertise is constantly transforming into innovative security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The companys comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky technologies and we help 270,000 corporate clients protect what matters most to them. Learn more at usa.kaspersky.com. 1 The Kaspersky Global Corporate IT Security Risks Survey (ITSRS) interviewed 5,266 respondents across 31 countries. Conducted by B2B International and commissioned by Kaspersky, fieldwork took place in July 2020. Answer:

2020 IT Spending: Cybersecurity Remains an Investment Priority Despite Overall IT Budget Cuts, Kaspersky Found

WOBURN, Mass.--(BUSINESS WIRE)--According to a new Kaspersky report Investment adjustment: aligning IT budgets with changing security priorities, cybersecurity remains a priority for investment among businesses. Its share of IT spending has grown from 23% in 2019 to 26% in 2020 for SMBs, and from 26% to 29% for enterprises. 71% of organizations also expect their cybersecurity budget will increase in the next three years, despite overall IT budgets decreasing in both segments amid the COVID-19 pandemic. External conditions and events can influence IT priorities for businesses. As a result of the COVID-19 pandemic, organizations have been forced to adjust plans to meet changing business needs. The report, based on a survey of more than 5,000 IT and cybersecurity practitioners, observes recent IT security economics trends and how they correlate with this years events1. While the overall IT budget has fallen from $1.2m in 2019 to $1.1m in 2020 among SMBs, and from $74.1m to $54.3m for enterprises, the share of IT budget dedicated to IT security continues to grow year-on-year. Decreases in budget are likely due to the consequences of the global coronavirus pandemic, according to Gartner, whose experts also predicted that budgets would decrease earlier this year. As a result, small and medium businesses allocated $275k to cybersecurity while enterprises invested $14m. According to the survey, the majority of companies are expecting these figures to grow in the next three years by 11% in enterprises and 12% in SMBs, on average. 17% believe it will remain at least the same as this year. Alternatively, one-in-ten (10%) organizations said they are going to spend less on IT security. Interestingly, the main reason for this across enterprises is the deliberate decision of top management, who sees no point in investing so much money in cybersecurity in the future (32%). Among SMBs, the reason to reduce spend in this area is primarily dictated by the need to cut overall company expenses and optimize budgets (29%). Small and medium organizations were hit hardest by the lockdown with more than half of small companies globally reported a decline in sales or experienced cash flow constraints. It is clear that those affected have needed to optimize their expenses to survive. But while this impacts cyber-protection, its important for businesses to find a way to keep safe from cyber-risks in such a challenging time. 2020 has put many companies in situations where they needed to respond, so they wisely concentrated all their resources and efforts on staying afloat, commented Alexander Moiseev, chief business officer at Kaspersky. Even though budgets get revised, it doesnt mean cybersecurity needs to go down on the priority list. We recommend that businesses, who have to spend less on cybersecurity in the coming years, get smart about it and use every available option to bolster their defenses by turning to free security solutions available on the market and introducing security awareness programs across the organization. Those are small steps that can make a difference, especially for SMBs. Kaspersky suggests the following advice to small and medium organizations in order to maintain their cybersecurity posture, even with low security investments: To read the full report Investment adjustment: aligning IT budgets with changing security priorities, please visit here. About Kaspersky Kaspersky is a global cybersecurity company founded in 1997. Kasperskys deep threat intelligence and security expertise is constantly transforming into innovative security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The companys comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky technologies and we help 270,000 corporate clients protect what matters most to them. Learn more at usa.kaspersky.com. 1 The Kaspersky Global Corporate IT Security Risks Survey (ITSRS) interviewed 5,266 respondents across 31 countries. Conducted by B2B International and commissioned by Kaspersky, fieldwork took place in July 2020.

edtsum7736

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: Bausch Health Is Working with Multiple Health Authorities to Make VIRAZOLE Available as a Potential Treatment for COVID-19 LAVAL, Quebec, April 13, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has initiated a clinical trial program in Canada evaluating an investigational use of VIRAZOLE (Ribavirin for Inhalation Solution, USP) in combination with standard of care therapy to treat hospitalized adult patients with respiratory distress due to COVID-19. Because ribavirin is a synthetic nucleoside that works to stop viral replication, VIRAZOLE may be effective in reducing the severity of COVID-19 infection. VIRAZOLE is currently approved in several countries around the world, including the United States and Canada, for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial virus (RSV). The initial clinical study has been approved by Health Canada and is expected to begin within the next few weeks. The Company is also in discussions with the U.S. Food and Drug Administration and health authorities in multiple countries regarding additional studies to evaluate VIRAZOLE as a treatment for COVID-19 infection. The Bausch Foundation is also continuing to work directly with health authorities in Italy to make VIRAZOLE for inhalation available free of charge in compassionate use in Italian hospitals. "VIRAZOLE has demonstrated antiviral activity in treating severe pediatric respiratory infections, and we believe it may be a valuable agent in reducing respiratory distress in adults suffering from COVID-19. We are actively pursuing approval of our trial protocol around the world to test the efficacy and safety of VIRAZOLE in this patient population," said Joseph C. Papa, chairman and CEO, Bausch Health. "Bausch Health will remain focused for as long as necessary on doing our part to help end this unprecedented global health pandemic, including donating our health care products, conducting research to find new treatment options and supporting patients, health care providers and our employees." The initial study protocol is an open label, interventional trial that will evaluate the safety and efficacy of VIRAZOLE in hospitalized adult patients, aged 18 or older, who have tested positive for COVID-19, and as a result of their infection, have significant respiratory distress. Two active study arms will compare different dosing regimens of VIRAZOLE in combination with standard of care therapy. More details on the study can be found on the Health Canada Clinical Trials Databaseand on Health Canada COVID-19 List of Clinical Trials. About VIRAZOLE VIRAZOLE (ribavirin for inhalation solution, USP) aerosol is indicated only for lower respiratory tract infection due to RSV. Treatment may be initiated while awaiting rapid diagnostic test results. However, treatment should not be continued without documentation of RSV infection. VIRAZOLE is not approved by Health Canada for use in COVID-19 patients. Limited clinical data indicate that VIRAZOLE administered as a small particle aerosol may be beneficial in the treatment of severe respiratory syncytial virus infection in neonates and infants when associated with underlying cardiovascular, pulmonary or immune deficiency. Treatment should be confined to hospitalized patients, and administration should be continuous during the period of therapy apart from the time required for ancillary care of the patient. Only severe RSV lower respiratory tract infection is to be treated with VIRAZOLE aerosol. VIRAZOLE aerosol treatment must be accompanied by and does not replace standard supportive respiratory and fluid management for infants and children with severe respiratory tract infection. Use of VIRAZOLE aerosol is contraindicated in women or girls who are or may become pregnant during exposure to the drug. VIRAZOLE may cause fetal harm, and respiratory syncytial virus infection is self-limited in this population. VIRAZOLE is not completely cleared from human blood even four weeks after administration. Although there are no pertinent human data, VIRAZOLE has been found to be teratogenic and/or embryolethal in nearly all species in which it has been tested; however, pregnant baboons given up to 120 mg/kg/day of ribavirin over a 4-day period within the 20 days of organogenesis during gestation failed to exhibit any teratogenic effect. WARNINGSClose monitoring of patients and respiratory equipment must be guaranteed when VIRAZOLE is used in infants requiring assisted ventilation. Precipitation of VIRAZOLE powder in respiratory equipment may interfere with safe and effective patient ventilation. Bronchospasm was observed in a tolerance study with ribavirin aerosol in adults with chronic obstructive pulmonary disease and asthma. Respiratory function should be carefully monitored during treatment. If initiation of VIRAZOLE aerosol treatment appears to produce sudden deterioration of respiratory function, treatment should be stopped and only reinstituted with caution and continuous monitoring. Although VIRAZOLE is not indicated in adults, the physician should be aware that it is teratogenic in animals. VIRAZOLE administered by aerosol produced cardiac lesions in mice and rats after 30 and 36 mg/kg, respectively, for 4 weeks, and after oral administration in monkeys at 120 mg/kg and rats at 154 to 200 mg/kg for 1 to 6 months. VIRAZOLE aerosol administered to developing ferrets at 60 mg/kg for 10 or 30 days resulted in inflammatory and possibly emphysematous changes in the lungs. Proliferative changes were seen at 131 mg/kg for 30 days. The significance of these findings to human administration is unknown. VIRAZOLE lyophilized in 6 gram vials is intended for use as an aerosol only. It has been noted that ribavirin has shown some evidence of mutagenesis in some in vitro test systems. Carcinogenicity studies are incomplete and inconclusive. Some evidence for the production of benign tumors has been shown. PRECAUTIONSVIRAZOLE has been in use for many years in human beings without any reported adverse effects in human fetuses. However, there are no adequate and well-controlled studies in pregnant women, and there is little published evidence of its safety in the early stages of human pregnancy. Since VIRAZOLE is delivered in aerosolized form and because of known teratogenic effects in animals, pregnant women should not care for patients receiving VIRAZOLE, although human teratogenic effects have not been proven. Patients with lower respiratory tract infection due to respiratory syncytial virus require optimum monitoring and attention to respiratory and fluid status. ADVERSE REACTIONSThe safety data from patients treated with VIRAZOLE aerosol has been carefully evaluated in 26 studies. Bronchospasm was observed in a tolerance study with VIRAZOLE aerosol (20 mg/mL) in adults. One of six adult patients with chronic obstructive pulmonary disease and two of six asthmatic adults became dyspneic during the period of VIRAZOLE aerosol administration. These patients required chronic administration of bronchodilators which were discontinued 24 hours prior to VIRAZOLE treatment. An inhalation of a bronchodilator by puffer produced symptomatic relief and return to baseline conditions. Several serious adverse events occurred in severely ill infants with life-threatening underlying diseases, many of whom required assisted ventilation. These events include: worsening of respiratory status, bacterial pneumonia and pneumothorax. The role of VIRAZOLE in these events is indeterminate. There were nineteen deaths during or shortly after treatment with VIRAZOLE aerosol. No death was attributed to ribavirin aerosol by the investigators. Some subjects requiring assisted ventilation have experienced serious difficulties, which may jeopardize adequate ventilation and gas exchange. Precipitation of drug within the ventilatory apparatus, including the endotracheal tube, has resulted in increased positive end expiratory pressure and increased positive inspiratory pressure. Accumulation of fluid in tubing ("rain out") has also been noted. Although anemia has not been reported with use of the aerosol, it occurs frequently with oral and intravenous ribavirin, and most infants treated with the aerosol have not been evaluated 1 or 2 weeks post-treatment when anemia is likely to occur. Reticulocytosis has been reported with aerosol use. Conjunctivitis has been reported in controlled studies with VIRAZOLE aerosol, however, no significant difference was observed between VIRAZOLE treated and control groups. In Canada, report any SUSPECTED ADVERSE REACTIONS to Bausch Health Companies Inc. at 1-800-321-4576 or Health Canada at 1-866-234-2345 or https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html. Please clickherefor full Prescribing Information in Canada. About the Bausch FoundationThe Bausch Foundation was established in 2017 to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world.Since its inception, the Bausch Foundation has contributed millions of dollars' worth of financial and product donations to global and local charitable health organizations. About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com. Forward-looking Statements This news release contains forward-looking statements, which may generally be identified by the use of the words "anticipates,""expects,""intends,""plans,""should,""could,""would,""may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third party suppliers, project development timelines, and costs (which may increase) and revenue and margins (both of which may decrease). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Investor Contact: Media Contact: Arthur Shannon Lainie Keller [emailprotected] [emailprotected] (514) 856-3855 (908) 927-1198 (877) 281-6642 (toll free) SOURCE Bausch Health Companies Inc. Related Links http://www.bauschhealth.com Answer:

Bausch Health Initiates VIRAZOLE (Ribavirin for Inhalation Solution, USP) Clinical Study in Patients with COVID-19

Bausch Health Is Working with Multiple Health Authorities to Make VIRAZOLE Available as a Potential Treatment for COVID-19 LAVAL, Quebec, April 13, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has initiated a clinical trial program in Canada evaluating an investigational use of VIRAZOLE (Ribavirin for Inhalation Solution, USP) in combination with standard of care therapy to treat hospitalized adult patients with respiratory distress due to COVID-19. Because ribavirin is a synthetic nucleoside that works to stop viral replication, VIRAZOLE may be effective in reducing the severity of COVID-19 infection. VIRAZOLE is currently approved in several countries around the world, including the United States and Canada, for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to respiratory syncytial virus (RSV). The initial clinical study has been approved by Health Canada and is expected to begin within the next few weeks. The Company is also in discussions with the U.S. Food and Drug Administration and health authorities in multiple countries regarding additional studies to evaluate VIRAZOLE as a treatment for COVID-19 infection. The Bausch Foundation is also continuing to work directly with health authorities in Italy to make VIRAZOLE for inhalation available free of charge in compassionate use in Italian hospitals. "VIRAZOLE has demonstrated antiviral activity in treating severe pediatric respiratory infections, and we believe it may be a valuable agent in reducing respiratory distress in adults suffering from COVID-19. We are actively pursuing approval of our trial protocol around the world to test the efficacy and safety of VIRAZOLE in this patient population," said Joseph C. Papa, chairman and CEO, Bausch Health. "Bausch Health will remain focused for as long as necessary on doing our part to help end this unprecedented global health pandemic, including donating our health care products, conducting research to find new treatment options and supporting patients, health care providers and our employees." The initial study protocol is an open label, interventional trial that will evaluate the safety and efficacy of VIRAZOLE in hospitalized adult patients, aged 18 or older, who have tested positive for COVID-19, and as a result of their infection, have significant respiratory distress. Two active study arms will compare different dosing regimens of VIRAZOLE in combination with standard of care therapy. More details on the study can be found on the Health Canada Clinical Trials Databaseand on Health Canada COVID-19 List of Clinical Trials. About VIRAZOLE VIRAZOLE (ribavirin for inhalation solution, USP) aerosol is indicated only for lower respiratory tract infection due to RSV. Treatment may be initiated while awaiting rapid diagnostic test results. However, treatment should not be continued without documentation of RSV infection. VIRAZOLE is not approved by Health Canada for use in COVID-19 patients. Limited clinical data indicate that VIRAZOLE administered as a small particle aerosol may be beneficial in the treatment of severe respiratory syncytial virus infection in neonates and infants when associated with underlying cardiovascular, pulmonary or immune deficiency. Treatment should be confined to hospitalized patients, and administration should be continuous during the period of therapy apart from the time required for ancillary care of the patient. Only severe RSV lower respiratory tract infection is to be treated with VIRAZOLE aerosol. VIRAZOLE aerosol treatment must be accompanied by and does not replace standard supportive respiratory and fluid management for infants and children with severe respiratory tract infection. Use of VIRAZOLE aerosol is contraindicated in women or girls who are or may become pregnant during exposure to the drug. VIRAZOLE may cause fetal harm, and respiratory syncytial virus infection is self-limited in this population. VIRAZOLE is not completely cleared from human blood even four weeks after administration. Although there are no pertinent human data, VIRAZOLE has been found to be teratogenic and/or embryolethal in nearly all species in which it has been tested; however, pregnant baboons given up to 120 mg/kg/day of ribavirin over a 4-day period within the 20 days of organogenesis during gestation failed to exhibit any teratogenic effect. WARNINGSClose monitoring of patients and respiratory equipment must be guaranteed when VIRAZOLE is used in infants requiring assisted ventilation. Precipitation of VIRAZOLE powder in respiratory equipment may interfere with safe and effective patient ventilation. Bronchospasm was observed in a tolerance study with ribavirin aerosol in adults with chronic obstructive pulmonary disease and asthma. Respiratory function should be carefully monitored during treatment. If initiation of VIRAZOLE aerosol treatment appears to produce sudden deterioration of respiratory function, treatment should be stopped and only reinstituted with caution and continuous monitoring. Although VIRAZOLE is not indicated in adults, the physician should be aware that it is teratogenic in animals. VIRAZOLE administered by aerosol produced cardiac lesions in mice and rats after 30 and 36 mg/kg, respectively, for 4 weeks, and after oral administration in monkeys at 120 mg/kg and rats at 154 to 200 mg/kg for 1 to 6 months. VIRAZOLE aerosol administered to developing ferrets at 60 mg/kg for 10 or 30 days resulted in inflammatory and possibly emphysematous changes in the lungs. Proliferative changes were seen at 131 mg/kg for 30 days. The significance of these findings to human administration is unknown. VIRAZOLE lyophilized in 6 gram vials is intended for use as an aerosol only. It has been noted that ribavirin has shown some evidence of mutagenesis in some in vitro test systems. Carcinogenicity studies are incomplete and inconclusive. Some evidence for the production of benign tumors has been shown. PRECAUTIONSVIRAZOLE has been in use for many years in human beings without any reported adverse effects in human fetuses. However, there are no adequate and well-controlled studies in pregnant women, and there is little published evidence of its safety in the early stages of human pregnancy. Since VIRAZOLE is delivered in aerosolized form and because of known teratogenic effects in animals, pregnant women should not care for patients receiving VIRAZOLE, although human teratogenic effects have not been proven. Patients with lower respiratory tract infection due to respiratory syncytial virus require optimum monitoring and attention to respiratory and fluid status. ADVERSE REACTIONSThe safety data from patients treated with VIRAZOLE aerosol has been carefully evaluated in 26 studies. Bronchospasm was observed in a tolerance study with VIRAZOLE aerosol (20 mg/mL) in adults. One of six adult patients with chronic obstructive pulmonary disease and two of six asthmatic adults became dyspneic during the period of VIRAZOLE aerosol administration. These patients required chronic administration of bronchodilators which were discontinued 24 hours prior to VIRAZOLE treatment. An inhalation of a bronchodilator by puffer produced symptomatic relief and return to baseline conditions. Several serious adverse events occurred in severely ill infants with life-threatening underlying diseases, many of whom required assisted ventilation. These events include: worsening of respiratory status, bacterial pneumonia and pneumothorax. The role of VIRAZOLE in these events is indeterminate. There were nineteen deaths during or shortly after treatment with VIRAZOLE aerosol. No death was attributed to ribavirin aerosol by the investigators. Some subjects requiring assisted ventilation have experienced serious difficulties, which may jeopardize adequate ventilation and gas exchange. Precipitation of drug within the ventilatory apparatus, including the endotracheal tube, has resulted in increased positive end expiratory pressure and increased positive inspiratory pressure. Accumulation of fluid in tubing ("rain out") has also been noted. Although anemia has not been reported with use of the aerosol, it occurs frequently with oral and intravenous ribavirin, and most infants treated with the aerosol have not been evaluated 1 or 2 weeks post-treatment when anemia is likely to occur. Reticulocytosis has been reported with aerosol use. Conjunctivitis has been reported in controlled studies with VIRAZOLE aerosol, however, no significant difference was observed between VIRAZOLE treated and control groups. In Canada, report any SUSPECTED ADVERSE REACTIONS to Bausch Health Companies Inc. at 1-800-321-4576 or Health Canada at 1-866-234-2345 or https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html. Please clickherefor full Prescribing Information in Canada. About the Bausch FoundationThe Bausch Foundation was established in 2017 to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world.Since its inception, the Bausch Foundation has contributed millions of dollars' worth of financial and product donations to global and local charitable health organizations. About Bausch HealthBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com. Forward-looking Statements This news release contains forward-looking statements, which may generally be identified by the use of the words "anticipates,""expects,""intends,""plans,""should,""could,""would,""may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in the Company's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on the Company, including but not limited to its supply chain, third party suppliers, project development timelines, and costs (which may increase) and revenue and margins (both of which may decrease). Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Investor Contact: Media Contact: Arthur Shannon Lainie Keller [emailprotected] [emailprotected] (514) 856-3855 (908) 927-1198 (877) 281-6642 (toll free) SOURCE Bausch Health Companies Inc. Related Links http://www.bauschhealth.com

edtsum7737

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LEXINGTON, Mass., April 7, 2021 /PRNewswire/ --Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2021, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 167,300 shares of Curis common stock to five new employees, with a grant date of April 1, 2021 (the "Q2 2021 Inducement Grants"). Each of the Q2 2021 Inducement Grants has an exercise price per share equal to the closing price of the Company's common stock on April 1, 2021. Each stock option has a 10 year term and vests over four years, with 25% of the original number of shares underlying the award vesting on the first anniversary of the employee's date of hire and an additional 6.25% of the original number of shares underlying the award vesting on each successive three-month period thereafter, subject to the employee's continued service with the Company through the respective vesting dates. Each stock option was granted as an inducement equity award outside of the Company's Third Amended and Restated 2010 Stock Incentive Plan and was made as an inducement material to the employee's acceptance of employment with the Company. About Curis, Inc. Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including theVISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin lymphomaboth as a monotherapy and in combination with BTK inhibitor, ibrutinib. Curis is also evaluating CA-4948 in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes.In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTAantibody, which is currently undergoing testing in a Phase 1a/1btrial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedgefor the treatment of advanced basal cell carcinoma. For more information, visit Curis' website atwww.curis.com. SOURCE Curis, Inc. Related Links http://www.curis.com Answer:

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., April 7, 2021 /PRNewswire/ --Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 1, 2021, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 167,300 shares of Curis common stock to five new employees, with a grant date of April 1, 2021 (the "Q2 2021 Inducement Grants"). Each of the Q2 2021 Inducement Grants has an exercise price per share equal to the closing price of the Company's common stock on April 1, 2021. Each stock option has a 10 year term and vests over four years, with 25% of the original number of shares underlying the award vesting on the first anniversary of the employee's date of hire and an additional 6.25% of the original number of shares underlying the award vesting on each successive three-month period thereafter, subject to the employee's continued service with the Company through the respective vesting dates. Each stock option was granted as an inducement equity award outside of the Company's Third Amended and Restated 2010 Stock Incentive Plan and was made as an inducement material to the employee's acceptance of employment with the Company. About Curis, Inc. Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including theVISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin lymphomaboth as a monotherapy and in combination with BTK inhibitor, ibrutinib. Curis is also evaluating CA-4948 in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes.In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTAantibody, which is currently undergoing testing in a Phase 1a/1btrial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedgefor the treatment of advanced basal cell carcinoma. For more information, visit Curis' website atwww.curis.com. SOURCE Curis, Inc. Related Links http://www.curis.com

edtsum7738

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ST. LOUIS, Mo., Dec. 17,2020 /PRNewswire/ --Amitech Solutions, a leading healthcare data, analytics and automation consulting firm, announced that it has won UiPath's Americas 2020 Innovation Partner of the Year Award. Amitech was awarded at UiPath's first Reboot Work Festival for demonstrating excellence in innovation and the positive impact on healthcare especially during the pandemic. Two years in the making, Amitech forged a strategic relationship with Robotics Process Automation (RPA) software platform company UiPath to bring innovative automation solutions to healthcare to lower total cost of care, improve quality of care and improve patient or member experience. Through Amitech's visionary products built on UiPath's innovative platform, Amitech has scaled RPA, provided numerous forward-thinking solutions and solved some of the day-to-day challenges in both clinical and administrative functions in healthcare. Amitech announced that it has won UiPath's Americas 2020 Innovation Partner of the Year Award. Tweet this Amitech is honored to receive this recognition. We are in a unique position to combine data and analytics with automation and use our deep roots in healthcare to innovate and support healthcare organizations through this pandemic and come out ahead. Amitech launched six new products this year, including Care Management, Remittance Posting, Patient Quality, and more, with the ability to drive $3.1B in value to top healthcare providers across the country. "COVID-19 has taken the need for automation in healthcare to an unprecedented level, and at Amitech we were fortunate to develop products that could transition quickly into the industry. We could not have done it so quickly without UiPath's platform. The team at UiPath has allowed us to be adaptive and innovative both at scale and with agility," said Jeff Hatfield, Amitech Vice President of Sales & Marketing. "Amitech's focus in 2020 (before COVID) was to do everything we could to make healthcare better, and even with the barrier that is COVID, we believe we have done just that."Amitech's chosen path to make healthcare better has allowed the team to remain humble and scalable to solve major challenges in providers and payers' current environments. Amitech has been working closely with our customers to help deploy innovative automation solutions for a variety of COVID-19 related workloads. Healthcare leaders need every tool at their disposal to help confront the unprecedented challenges posed by the COVID-19 pandemic and prepare them for an effective and efficient post pandemic world. "Our partner ecosystem gives us the reach to support customers anywhere in the world and the scale to handle even the most ambitious automation initiatives," said Chris Klayko, Senior Vice President Sales, UiPath. "UiPath is a partner-first organization that values its partnerships and continually invests in its partners to enable differentiation, growth and profitability. We are proud to recognize these Americas partners who have demonstrated a unique ability to deliver immense value to our customers and to grow their own businesses in the process."For additional information about Amitechplease contact Jessica Rosen at 866-870-8920 or via email at [emailprotected]. Additional information can also be found atwww.amitechsolutions.com.About AmitechAmitech is an award-winning data, analytics and automation healthcare consulting firm. AtAmitech, we believe healthcare can and should be better. With a single-minded focus on value, we combine people, process, culture and technology to drive real and lasting change. We partner with our customers to deliver data analytics and digital transformation strategies and solutions to make healthcare more proactive, higher quality and less expensive for everyone.For more information contact:Jessica Rosen [emailprotected](866)870-8920SOURCE Amitech Solutions Related Links http://www.amitechsolutions.com Answer:

UiPath Awards Amitech Solutions as Americas 2020 Innovation Partner of the Year

ST. LOUIS, Mo., Dec. 17,2020 /PRNewswire/ --Amitech Solutions, a leading healthcare data, analytics and automation consulting firm, announced that it has won UiPath's Americas 2020 Innovation Partner of the Year Award. Amitech was awarded at UiPath's first Reboot Work Festival for demonstrating excellence in innovation and the positive impact on healthcare especially during the pandemic. Two years in the making, Amitech forged a strategic relationship with Robotics Process Automation (RPA) software platform company UiPath to bring innovative automation solutions to healthcare to lower total cost of care, improve quality of care and improve patient or member experience. Through Amitech's visionary products built on UiPath's innovative platform, Amitech has scaled RPA, provided numerous forward-thinking solutions and solved some of the day-to-day challenges in both clinical and administrative functions in healthcare. Amitech announced that it has won UiPath's Americas 2020 Innovation Partner of the Year Award. Tweet this Amitech is honored to receive this recognition. We are in a unique position to combine data and analytics with automation and use our deep roots in healthcare to innovate and support healthcare organizations through this pandemic and come out ahead. Amitech launched six new products this year, including Care Management, Remittance Posting, Patient Quality, and more, with the ability to drive $3.1B in value to top healthcare providers across the country. "COVID-19 has taken the need for automation in healthcare to an unprecedented level, and at Amitech we were fortunate to develop products that could transition quickly into the industry. We could not have done it so quickly without UiPath's platform. The team at UiPath has allowed us to be adaptive and innovative both at scale and with agility," said Jeff Hatfield, Amitech Vice President of Sales & Marketing. "Amitech's focus in 2020 (before COVID) was to do everything we could to make healthcare better, and even with the barrier that is COVID, we believe we have done just that."Amitech's chosen path to make healthcare better has allowed the team to remain humble and scalable to solve major challenges in providers and payers' current environments. Amitech has been working closely with our customers to help deploy innovative automation solutions for a variety of COVID-19 related workloads. Healthcare leaders need every tool at their disposal to help confront the unprecedented challenges posed by the COVID-19 pandemic and prepare them for an effective and efficient post pandemic world. "Our partner ecosystem gives us the reach to support customers anywhere in the world and the scale to handle even the most ambitious automation initiatives," said Chris Klayko, Senior Vice President Sales, UiPath. "UiPath is a partner-first organization that values its partnerships and continually invests in its partners to enable differentiation, growth and profitability. We are proud to recognize these Americas partners who have demonstrated a unique ability to deliver immense value to our customers and to grow their own businesses in the process."For additional information about Amitechplease contact Jessica Rosen at 866-870-8920 or via email at [emailprotected]. Additional information can also be found atwww.amitechsolutions.com.About AmitechAmitech is an award-winning data, analytics and automation healthcare consulting firm. AtAmitech, we believe healthcare can and should be better. With a single-minded focus on value, we combine people, process, culture and technology to drive real and lasting change. We partner with our customers to deliver data analytics and digital transformation strategies and solutions to make healthcare more proactive, higher quality and less expensive for everyone.For more information contact:Jessica Rosen [emailprotected](866)870-8920SOURCE Amitech Solutions Related Links http://www.amitechsolutions.com

edtsum7739

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO, March 24, 2021 /PRNewswire/ --Ironclad, a leader in the contract lifecycle management space, according to Forrester, today announced the expansion of its partner ecosystem with Salesforce Ventures' investment in the company's $100 million Series D round. As part of the expansion, Ironclad has added Amy Guarino to company leadership as VP of Global Alliances and will be releasing new product integrations. The partner ecosystem is an integral part of the first digital contracting platform for modern businesses, which will be unveiled at Ironclad's flagship 2021 State of Digital Contracting (SDC) event on Thursday. "We are excited to partner with Ironclad as they transform the future of digital contracting, making our customers more agile and efficient as we pivot to a work from anywhere world," said Matt Garratt, Managing Partner, Salesforce Ventures. As a key part of the expansion of Ironclad's partner ecosystem, Amy Guarino has joined Ironclad as VP of Global Alliances. Formerly VP of Business Development at Marketo, Guarino brings over 35 years of experience in driving global expansion and strategic partnerships for companies that have defined their categories. Guarino joins a leadership team composed of former executives from Salesforce, Zendesk, and other leading companies. Ironclad will also release new integrations, focusing on Sales and Procurement, to enable digital contracting across the business. Teams from Sales and Procurement to Finance and HR use Ironclad, the only CLM solution flexible enough to handle all types of business contracts. "Ironclad is so much easier and more efficient to use," said Heather Quinn, Contracts Administrator at Cofense. "Sales and Procurement are now a lot happier with Legal's turnaround time and the visibility into their contracts." "Our goal is to build the digital contracting standard for modern business," said Guarino. "This is an ambitious goal, and it requires building an ecosystem of partners across consulting, software, platforms, as well as global strategic partners across all of our customer segments." Ironclad will share its latest innovation in creating a connected contracting ecosystem at the 2021 State of Digital Contracting (SDC) on March 25th. SDC is the only event that brings together the leading minds at the intersection of technology and business to prepare professionals for the evolving state of business contracting. To reserve your spot, visit here. About IroncladIronclad is the #1 contract lifecycle management platform for innovative companies. L'Oral, Staples, Mastercard, and other leading innovators use Ironclad to collaborate and negotiate on contracts, accelerate contracting while maintaining compliance, and turn contracts into critical carriers of operational business intelligence. It's the only platform flexible enough to handle every type of contract workflow, whether a sales agreement, an HR agreement or a complex NDA. The company was named one of the 20 Rising Stars on the Forbes 2019 Cloud 100 list, and is backed by leading investors like Accel, Sequoia, Y Combinator, and BOND. For more information, visitwww.ironcladapp.com or follow us onLinkedIn andTwitter. ContactAlice HuMedia Relations[emailprotected] SOURCE Ironclad Inc. Related Links https://www.ironcladapp.com Answer:

Ironclad Announces Expansion of Partner Ecosystem with New Investment and Growth of Company Leadership With the new Salesforce Ventures investment, Ironclad will expand its partner ecosystem with new VP of Global Alliances and product integrations

SAN FRANCISCO, March 24, 2021 /PRNewswire/ --Ironclad, a leader in the contract lifecycle management space, according to Forrester, today announced the expansion of its partner ecosystem with Salesforce Ventures' investment in the company's $100 million Series D round. As part of the expansion, Ironclad has added Amy Guarino to company leadership as VP of Global Alliances and will be releasing new product integrations. The partner ecosystem is an integral part of the first digital contracting platform for modern businesses, which will be unveiled at Ironclad's flagship 2021 State of Digital Contracting (SDC) event on Thursday. "We are excited to partner with Ironclad as they transform the future of digital contracting, making our customers more agile and efficient as we pivot to a work from anywhere world," said Matt Garratt, Managing Partner, Salesforce Ventures. As a key part of the expansion of Ironclad's partner ecosystem, Amy Guarino has joined Ironclad as VP of Global Alliances. Formerly VP of Business Development at Marketo, Guarino brings over 35 years of experience in driving global expansion and strategic partnerships for companies that have defined their categories. Guarino joins a leadership team composed of former executives from Salesforce, Zendesk, and other leading companies. Ironclad will also release new integrations, focusing on Sales and Procurement, to enable digital contracting across the business. Teams from Sales and Procurement to Finance and HR use Ironclad, the only CLM solution flexible enough to handle all types of business contracts. "Ironclad is so much easier and more efficient to use," said Heather Quinn, Contracts Administrator at Cofense. "Sales and Procurement are now a lot happier with Legal's turnaround time and the visibility into their contracts." "Our goal is to build the digital contracting standard for modern business," said Guarino. "This is an ambitious goal, and it requires building an ecosystem of partners across consulting, software, platforms, as well as global strategic partners across all of our customer segments." Ironclad will share its latest innovation in creating a connected contracting ecosystem at the 2021 State of Digital Contracting (SDC) on March 25th. SDC is the only event that brings together the leading minds at the intersection of technology and business to prepare professionals for the evolving state of business contracting. To reserve your spot, visit here. About IroncladIronclad is the #1 contract lifecycle management platform for innovative companies. L'Oral, Staples, Mastercard, and other leading innovators use Ironclad to collaborate and negotiate on contracts, accelerate contracting while maintaining compliance, and turn contracts into critical carriers of operational business intelligence. It's the only platform flexible enough to handle every type of contract workflow, whether a sales agreement, an HR agreement or a complex NDA. The company was named one of the 20 Rising Stars on the Forbes 2019 Cloud 100 list, and is backed by leading investors like Accel, Sequoia, Y Combinator, and BOND. For more information, visitwww.ironcladapp.com or follow us onLinkedIn andTwitter. ContactAlice HuMedia Relations[emailprotected] SOURCE Ironclad Inc. Related Links https://www.ironcladapp.com

edtsum7740

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DALLAS, April 8, 2021 /PRNewswire/ -- Pollo Campero, the fast service chicken restaurant founded in 1971 in Guatemala, celebrates its 50th anniversary in April with a month of 50%-off deals. Pollo Campero started as a small family-owned restaurant, using recipes passed down through generations to make Pollo Campero's famously flavorful hand-breaded, seasoned-to-perfection fried chicken and citrus-marinated grilled chicken. Today, the company has grown to more than 350 locations internationally while continuing to serve up the same delicious chicken along with unique sides and signature drinks made fresh daily. "When we think of our golden anniversary, we think of the delicious, golden-fried perfection we have been crafting since day one," said Pollo Campero USA Director of Marketing Federico Valiente. "Our month of 50%-off rewards is our way to celebrate with our loyal customers to thank them for 50 great years the best way we can: with more FLAVOR!" Guests who download the Pollo Campero app and sign up for the brand's loyalty program can receive the following anniversary rewards: April 6-12: 50% off purchase of two Empanada Meals April 13-19: 50% off purchase of two Sandwich Meals April 20-26: 50% off purchase of two Camperitos Meals On April 27, the actual day of Campero's birthday, the brand is going all out with what it does best: family meals. On this day, guests can receive 50% off any family meal, including 8-piece, 12-piece or 20-piece fried or grilled chicken meals served with a choice of family sides and tortillas or dinner rolls. To get the deal, guests must use the code HAPPYBDAY when they order online at campero.com, in-app or in-restaurant. "We are extremely honored and humbled to have been invited into so many homes throughout the past 50 years. Offering families great meals that they can share with one another is at the heart of everything we do," said Valiente. "Our April 27 offer gives us the opportunity to invite even more families to experience Pollo Campero's unique flavor from our fried and grilled chicken to our nine unique sides, fresh drinks and desserts." About Pollo Campero Founded in Guatemala in 1971, Pollo Campero is a fast service chicken restaurant brand specializing in uniquely flavorful chicken and a wholesome menu offering individual and family meals. Using family recipes passed down from generation to generation, Pollo Campero offers tender, juicy, hand-breaded fried chicken and citrus flavor-infused grilled chicken that is always fresh and hand-prepared daily. Since its beginnings as a tiny, family-owned restaurant, Pollo Campero has grown to more than 350 restaurants around the world. To learn more about Pollo Campero, visit us.campero.com and follow the flavor on Facebook, Twitter and Instagram. Media Contact: Callie Haddox or Kim Cooper [emailprotected]or [emailprotected]817-329-3257 SOURCE Pollo Campero Related Links http://us.campero.com Answer:

Pollo Campero Celebrates 50th Anniversary in April Brand gives the gift of 50%-off rewards to guests throughout the month

DALLAS, April 8, 2021 /PRNewswire/ -- Pollo Campero, the fast service chicken restaurant founded in 1971 in Guatemala, celebrates its 50th anniversary in April with a month of 50%-off deals. Pollo Campero started as a small family-owned restaurant, using recipes passed down through generations to make Pollo Campero's famously flavorful hand-breaded, seasoned-to-perfection fried chicken and citrus-marinated grilled chicken. Today, the company has grown to more than 350 locations internationally while continuing to serve up the same delicious chicken along with unique sides and signature drinks made fresh daily. "When we think of our golden anniversary, we think of the delicious, golden-fried perfection we have been crafting since day one," said Pollo Campero USA Director of Marketing Federico Valiente. "Our month of 50%-off rewards is our way to celebrate with our loyal customers to thank them for 50 great years the best way we can: with more FLAVOR!" Guests who download the Pollo Campero app and sign up for the brand's loyalty program can receive the following anniversary rewards: April 6-12: 50% off purchase of two Empanada Meals April 13-19: 50% off purchase of two Sandwich Meals April 20-26: 50% off purchase of two Camperitos Meals On April 27, the actual day of Campero's birthday, the brand is going all out with what it does best: family meals. On this day, guests can receive 50% off any family meal, including 8-piece, 12-piece or 20-piece fried or grilled chicken meals served with a choice of family sides and tortillas or dinner rolls. To get the deal, guests must use the code HAPPYBDAY when they order online at campero.com, in-app or in-restaurant. "We are extremely honored and humbled to have been invited into so many homes throughout the past 50 years. Offering families great meals that they can share with one another is at the heart of everything we do," said Valiente. "Our April 27 offer gives us the opportunity to invite even more families to experience Pollo Campero's unique flavor from our fried and grilled chicken to our nine unique sides, fresh drinks and desserts." About Pollo Campero Founded in Guatemala in 1971, Pollo Campero is a fast service chicken restaurant brand specializing in uniquely flavorful chicken and a wholesome menu offering individual and family meals. Using family recipes passed down from generation to generation, Pollo Campero offers tender, juicy, hand-breaded fried chicken and citrus flavor-infused grilled chicken that is always fresh and hand-prepared daily. Since its beginnings as a tiny, family-owned restaurant, Pollo Campero has grown to more than 350 restaurants around the world. To learn more about Pollo Campero, visit us.campero.com and follow the flavor on Facebook, Twitter and Instagram. Media Contact: Callie Haddox or Kim Cooper [emailprotected]or [emailprotected]817-329-3257 SOURCE Pollo Campero Related Links http://us.campero.com

edtsum7741

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: STOCKHOLM, July 7, 2020 /PRNewswire/ -- The shareholders in Starbreeze AB (publ), reg.no. 556551-8932, (the "Company") are hereby convened to the Extraordinary General Meeting (the "Meeting") on Thursday 13 August 2020 at 2.00 p.m. at Mannheimer Swartling's offices, Norrlandsgatan 21, Stockholm, Sweden. Notice: Shareholders who wish to participate at the Extraordinary General Meeting shall Beregisteredundertheshareholder'sownnameintheshareregisterkeptbyEuroclear Sweden AB on Friday 7 August 2020, and NotifytheCompanynolaterthanon Friday 7 August 2020,to addressStarbreezeAB,"Extra bolagsstmma 2020", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, or on the Company's website:www.starbreeze.com/investor-relations/corporate-governance/meetings-events/. Suchnotificationshallincludename,personalidentificationnumberorcorporateregistrationnumber,address, telephone number and the name of any representative and/or advisor. If the shareholder intends to be represented by a representative, a proxy, in original, shall be presented at the Meeting along with any certificate of registration and other documents of authorization. Copies of such documents of authorization should also be included in the notification.Aform ofproxy isavailable at the Company and on the Company's website,www.starbreeze.com,and can also be sent to the shareholders upon request. A proxy is valid one year from the date of issue or such longer period stated in the proxy, however, not more than five years. To be entitled to participate in the Meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names. Shareholders who wish to realize such re-registration must advise their nominees well in advance of Friday 7 August 2020, at which time such re-registration shall be executed. Information with regard to the coronavirus As part of the effort to minimize the risk of spreading the coronavirus, the Board of Directors has resolved that shareholders in the Company shall be able to exercise their voting rights at the Meeting in advance by so-called postal voting. The intention of the Board of Directors' resolution is to reduce the number of people gathered at the location of the Meeting. The Company encourages its shareholders to, in the manner stated below, exercise the possibility of postal voting. The Company has also decided to take the following measures due to the coronavirus: No beverages or food will be served, The number of non-shareholders, Board members, corporate officers and guests present will be limited, and The questions at the Meeting will be concentrated on matters on the agenda and other information that the participants are entitled to receive according to law, and the Meeting will as far as possible be minimized in time without restricting the rights of the shareholders. Further measures may be presented by the Board before the Meeting. Information will be announced and available on the Company's website. Please follow the recommendations regarding the coronavirus and the COVID-19 disease from the Public Health Agency. For up-to-date information, see www.folkhalsomyndigheten.se. Postal voting Shareholders who wish to exercise the possibility of postal voting shall, in addition to being included in the shareholder's register in accordance with the above, use a form for postal voting and notice of attendance, which is available at the Company's website,www.starbreeze.com. The postal voting form shall be sent to the Company by e-mail to[emailprotected]or by regular mail to Starbreeze AB, "Extra bolagsstmma 2020", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm. Shareholders who are natural persons may also give their notice and cast their postal votes digitally through BankID verification. Link to digital postal voting is available on the Company's website,www.starbreeze.com, and athttps://anmalan.vpc.se/EuroclearProxy/. The postal voting form must be the Company at hand no later than the same time as the notice of attendance to the Meeting, on Friday 7 August 2020. If the shareholder is a legal entity, a copy of the certificate of registration or a similar document of authorization is to be attached. Forthose who wish to postal vote via a representative, a proxy should also be attached. The shareholder may not provide the postal vote with specific instructions or conditions. If so, the vote is invalid. Proposed agenda Opening of theMeeting Election of Chairman of theMeeting Preparation and approval of the votinglist Approval of theagenda Determination as to whether the Meeting has been dulyconvened Election of one or two persons to verify theminutes Resolution on amendment of the Articles of Association Approval of the Board of Directors' resolution on a rights issue of new shares Closing of theMeeting Election of Chairman of the Meeting (item 2) It is proposed that attorney Patrik Marcelius shall be elected as Chairman of the Meeting. Resolution on amendment of the Articles of Association (item 7) For the purpose of enabling the rights issue of new shares, as resolved by the Board of Directors on 30June 2020 subject to the approval by the Meeting, the Board of Directors proposes that the limits of the share capital and the number of shares in the Articles of Association shall be adjusted by the Meeting resolving to amend 4 and 5, p. 5.1 of the Articles of Association, as follows: Current wording Proposed wording 4 Share capital shall be not less than SEK3,000,000 and not more than SEK12,000,000. Share capital shall be not less than SEK7,000,000and not more than SEK28,000,000. 5, p. 5.1 The number of shares in the company shall be not less than 150,000,000 and not more than 600,000,000. Shares may be issued in two classes: Class A shares and Class B shares. Shares of each class may be issued up to an amount corresponding to a total of 100 percent of share capital. Each Class A share shall carry ten (10) votes and each Class B share shall carry one (1) vote. Otherwise, Class A shares and Class B shares carry equal rights to a share in the company's assets and profits. The number of shares in the company shall be not less than350,000,000and not more than1,400,000,000. Shares may be issued in two classes: Class A shares and Class B shares. Shares of each class may be issued up to an amount corresponding to a total of 100 percent of share capital. Each Class A share shall carry ten (10) votes and each Class B share shall carry one (1) vote. Otherwise, Class A shares and Class B shares carry equal rights to a share in the company's assets and profits. The resolution in accordance with the above proposal is conditional upon the Meeting approving the Board of Directors' resolution on a rights issue of new shares under item 8. Majority requirement Under the Swedish Companies Act (2005:551), the resolution of the Meeting on amendment of the Articles of Association requires the support of shareholders representing at least two-thirds of both the number of votes cast and the shares represented at the Meeting in order to be valid. Approval of the Board of Directors' resolution on a rights issue of new shares (item 8) The Board of Directors proposes that the Meeting approves the Board's resolution of 30 June 2020 on a rights issue of new Class A and Class B shares with preferential right for existing shareholders, on the following main terms and conditions: The Board of Directors, or whoever the Board of Directors may appoint among its members, is authorised to resolve, on 12 August 2020 at the latest, on the maximum amount by which the share capital shall be increased, the maximum number of new shares to be issued, the number of existing shares that shall entitle to subscription for a certain number of new shares and the subscription price per share. The company's shareholders shall have preferential right to subscribe for the new shares in proportion to the shares previously owned. The record date for entitlement to participate in the rights issue with preferential right shall be 20 August 2020. Owners of Class A and of Class B shares will have preferential right to subscribe for new shares of the same class in proportion to the number of shares previously owned (primary preferential right). Shares that have not been subscribed for with primary preferential right will be offered to all existing shareholders in proportion to the number of shares previously owned, irrespective of share class (secondary preferential right) and, to the extent that this is not possible, by drawing of lots. In the event that all shares are not subscribed for with primary or secondary preferential right, the Board of Director shall, up to the maximum amount of the rights issue, resolve to allot the remaining shares firstly to others who have applied for subscription of shares without preferential right (the general public in Sweden and "qualified investors"), pro rata in relation to submitted applications, and secondly to those who have entered into underwriting undertakings with the company, pro rata in relation to their respective underwriting amounts. To the extent allotment in accordance with the above cannot be made pro rata, allotment shall be made by drawing of lots. Subscription for new shares shall be made during the period as from 24 August 2020 up to and including 7 September 2020, or, as regards the guarantors, up to and including 10 September 2020. The Board of Directors shall be entitled to extend the period for subscription. Subscription for new shares by exercise of subscription rights shall be made by simultaneous cash payment. Subscription for new shares without subscription rights shall be made on a separate subscription list where allotted shares shall be paid in cash no later than two (2) banking days from dispatch of the contract note to the subscriber setting forth the allotment of shares. The Board of Directors shall be entitled to extend the period for payment. The new shares shall entitle to dividend as from the first record date for dividend to occur after the registration of the new share issue with the Swedish Companies Registration Office. Class A shares are subject to a provision pursuant to Chapter 4 Section 6 of the Swedish Companies Act (conversion clause). The resolution is conditional on amendment of the Articles of Association. In accordance with theTerms and conditions for Starbreeze AB (publ) convertible bond 2016:2021:1, item 10.C.(i), conversion shall have been executed on 10 July 2020 at the latest in order for share issued through conversion to entitle to participation in the rights issue. Number of shares and votes At the time of the issue of the notice there are atotalof362,304,633shares in theCompany,whereof 85,444,417shares of class A and 276,860,216shares of classB,and in total1,131,304,386votes.The Company holds no own shares. Right to information The Board of Directors and the CEO shall, if any shareholder so requests and the Board believes that it can be done without significant harm to the Company, provide information regarding circumstances that may affect the assessment of items on the agenda, in accordance with Chapter 7 Section 32 of the Swedish Companies Act (2005:551). Documents Documents pursuant to Chapter 13 Section 6 of the Swedish Companies Act (2005:551) will no later than three weeks prior to the Meeting be available on the Company's website,www.starbreeze.com, and at the Company's office at Regeringsgatan38,Stockholm, Sweden.Thedocumentswillfurtherbesentfreeofchargetoshareholderswho request it and whostatetheiraddress. Processing of personal data For information about the processing of your personal data, seehttps://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. Stockholm in July 2020 Starbreeze AB (publ)The Board of Directors For more information, please contact: Torgny Hellstrm, Chairman of the Board[emailprotected] Maeva Sponbergs, EVP CommunicationPhone number: +46(0)8-209-208, email: [emailprotected] The information was submitted for publication, through the agency of the contact person set out above, at 10:00 CEST on7 July 2020. This information was brought to you by Cision http://news.cision.com https://news.cision.com/starbreeze-ab/r/notice-of-extraordinary-general-meeting-in-starbreeze-ab--publ-,c3150004 The following files are available for download: https://mb.cision.com/Main/14632/3150004/1275900.pdf Release SOURCE Starbreeze AB Answer:

Notice of Extraordinary General Meeting in Starbreeze AB (publ)

STOCKHOLM, July 7, 2020 /PRNewswire/ -- The shareholders in Starbreeze AB (publ), reg.no. 556551-8932, (the "Company") are hereby convened to the Extraordinary General Meeting (the "Meeting") on Thursday 13 August 2020 at 2.00 p.m. at Mannheimer Swartling's offices, Norrlandsgatan 21, Stockholm, Sweden. Notice: Shareholders who wish to participate at the Extraordinary General Meeting shall Beregisteredundertheshareholder'sownnameintheshareregisterkeptbyEuroclear Sweden AB on Friday 7 August 2020, and NotifytheCompanynolaterthanon Friday 7 August 2020,to addressStarbreezeAB,"Extra bolagsstmma 2020", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, or on the Company's website:www.starbreeze.com/investor-relations/corporate-governance/meetings-events/. Suchnotificationshallincludename,personalidentificationnumberorcorporateregistrationnumber,address, telephone number and the name of any representative and/or advisor. If the shareholder intends to be represented by a representative, a proxy, in original, shall be presented at the Meeting along with any certificate of registration and other documents of authorization. Copies of such documents of authorization should also be included in the notification.Aform ofproxy isavailable at the Company and on the Company's website,www.starbreeze.com,and can also be sent to the shareholders upon request. A proxy is valid one year from the date of issue or such longer period stated in the proxy, however, not more than five years. To be entitled to participate in the Meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names. Shareholders who wish to realize such re-registration must advise their nominees well in advance of Friday 7 August 2020, at which time such re-registration shall be executed. Information with regard to the coronavirus As part of the effort to minimize the risk of spreading the coronavirus, the Board of Directors has resolved that shareholders in the Company shall be able to exercise their voting rights at the Meeting in advance by so-called postal voting. The intention of the Board of Directors' resolution is to reduce the number of people gathered at the location of the Meeting. The Company encourages its shareholders to, in the manner stated below, exercise the possibility of postal voting. The Company has also decided to take the following measures due to the coronavirus: No beverages or food will be served, The number of non-shareholders, Board members, corporate officers and guests present will be limited, and The questions at the Meeting will be concentrated on matters on the agenda and other information that the participants are entitled to receive according to law, and the Meeting will as far as possible be minimized in time without restricting the rights of the shareholders. Further measures may be presented by the Board before the Meeting. Information will be announced and available on the Company's website. Please follow the recommendations regarding the coronavirus and the COVID-19 disease from the Public Health Agency. For up-to-date information, see www.folkhalsomyndigheten.se. Postal voting Shareholders who wish to exercise the possibility of postal voting shall, in addition to being included in the shareholder's register in accordance with the above, use a form for postal voting and notice of attendance, which is available at the Company's website,www.starbreeze.com. The postal voting form shall be sent to the Company by e-mail to[emailprotected]or by regular mail to Starbreeze AB, "Extra bolagsstmma 2020", c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm. Shareholders who are natural persons may also give their notice and cast their postal votes digitally through BankID verification. Link to digital postal voting is available on the Company's website,www.starbreeze.com, and athttps://anmalan.vpc.se/EuroclearProxy/. The postal voting form must be the Company at hand no later than the same time as the notice of attendance to the Meeting, on Friday 7 August 2020. If the shareholder is a legal entity, a copy of the certificate of registration or a similar document of authorization is to be attached. Forthose who wish to postal vote via a representative, a proxy should also be attached. The shareholder may not provide the postal vote with specific instructions or conditions. If so, the vote is invalid. Proposed agenda Opening of theMeeting Election of Chairman of theMeeting Preparation and approval of the votinglist Approval of theagenda Determination as to whether the Meeting has been dulyconvened Election of one or two persons to verify theminutes Resolution on amendment of the Articles of Association Approval of the Board of Directors' resolution on a rights issue of new shares Closing of theMeeting Election of Chairman of the Meeting (item 2) It is proposed that attorney Patrik Marcelius shall be elected as Chairman of the Meeting. Resolution on amendment of the Articles of Association (item 7) For the purpose of enabling the rights issue of new shares, as resolved by the Board of Directors on 30June 2020 subject to the approval by the Meeting, the Board of Directors proposes that the limits of the share capital and the number of shares in the Articles of Association shall be adjusted by the Meeting resolving to amend 4 and 5, p. 5.1 of the Articles of Association, as follows: Current wording Proposed wording 4 Share capital shall be not less than SEK3,000,000 and not more than SEK12,000,000. Share capital shall be not less than SEK7,000,000and not more than SEK28,000,000. 5, p. 5.1 The number of shares in the company shall be not less than 150,000,000 and not more than 600,000,000. Shares may be issued in two classes: Class A shares and Class B shares. Shares of each class may be issued up to an amount corresponding to a total of 100 percent of share capital. Each Class A share shall carry ten (10) votes and each Class B share shall carry one (1) vote. Otherwise, Class A shares and Class B shares carry equal rights to a share in the company's assets and profits. The number of shares in the company shall be not less than350,000,000and not more than1,400,000,000. Shares may be issued in two classes: Class A shares and Class B shares. Shares of each class may be issued up to an amount corresponding to a total of 100 percent of share capital. Each Class A share shall carry ten (10) votes and each Class B share shall carry one (1) vote. Otherwise, Class A shares and Class B shares carry equal rights to a share in the company's assets and profits. The resolution in accordance with the above proposal is conditional upon the Meeting approving the Board of Directors' resolution on a rights issue of new shares under item 8. Majority requirement Under the Swedish Companies Act (2005:551), the resolution of the Meeting on amendment of the Articles of Association requires the support of shareholders representing at least two-thirds of both the number of votes cast and the shares represented at the Meeting in order to be valid. Approval of the Board of Directors' resolution on a rights issue of new shares (item 8) The Board of Directors proposes that the Meeting approves the Board's resolution of 30 June 2020 on a rights issue of new Class A and Class B shares with preferential right for existing shareholders, on the following main terms and conditions: The Board of Directors, or whoever the Board of Directors may appoint among its members, is authorised to resolve, on 12 August 2020 at the latest, on the maximum amount by which the share capital shall be increased, the maximum number of new shares to be issued, the number of existing shares that shall entitle to subscription for a certain number of new shares and the subscription price per share. The company's shareholders shall have preferential right to subscribe for the new shares in proportion to the shares previously owned. The record date for entitlement to participate in the rights issue with preferential right shall be 20 August 2020. Owners of Class A and of Class B shares will have preferential right to subscribe for new shares of the same class in proportion to the number of shares previously owned (primary preferential right). Shares that have not been subscribed for with primary preferential right will be offered to all existing shareholders in proportion to the number of shares previously owned, irrespective of share class (secondary preferential right) and, to the extent that this is not possible, by drawing of lots. In the event that all shares are not subscribed for with primary or secondary preferential right, the Board of Director shall, up to the maximum amount of the rights issue, resolve to allot the remaining shares firstly to others who have applied for subscription of shares without preferential right (the general public in Sweden and "qualified investors"), pro rata in relation to submitted applications, and secondly to those who have entered into underwriting undertakings with the company, pro rata in relation to their respective underwriting amounts. To the extent allotment in accordance with the above cannot be made pro rata, allotment shall be made by drawing of lots. Subscription for new shares shall be made during the period as from 24 August 2020 up to and including 7 September 2020, or, as regards the guarantors, up to and including 10 September 2020. The Board of Directors shall be entitled to extend the period for subscription. Subscription for new shares by exercise of subscription rights shall be made by simultaneous cash payment. Subscription for new shares without subscription rights shall be made on a separate subscription list where allotted shares shall be paid in cash no later than two (2) banking days from dispatch of the contract note to the subscriber setting forth the allotment of shares. The Board of Directors shall be entitled to extend the period for payment. The new shares shall entitle to dividend as from the first record date for dividend to occur after the registration of the new share issue with the Swedish Companies Registration Office. Class A shares are subject to a provision pursuant to Chapter 4 Section 6 of the Swedish Companies Act (conversion clause). The resolution is conditional on amendment of the Articles of Association. In accordance with theTerms and conditions for Starbreeze AB (publ) convertible bond 2016:2021:1, item 10.C.(i), conversion shall have been executed on 10 July 2020 at the latest in order for share issued through conversion to entitle to participation in the rights issue. Number of shares and votes At the time of the issue of the notice there are atotalof362,304,633shares in theCompany,whereof 85,444,417shares of class A and 276,860,216shares of classB,and in total1,131,304,386votes.The Company holds no own shares. Right to information The Board of Directors and the CEO shall, if any shareholder so requests and the Board believes that it can be done without significant harm to the Company, provide information regarding circumstances that may affect the assessment of items on the agenda, in accordance with Chapter 7 Section 32 of the Swedish Companies Act (2005:551). Documents Documents pursuant to Chapter 13 Section 6 of the Swedish Companies Act (2005:551) will no later than three weeks prior to the Meeting be available on the Company's website,www.starbreeze.com, and at the Company's office at Regeringsgatan38,Stockholm, Sweden.Thedocumentswillfurtherbesentfreeofchargetoshareholderswho request it and whostatetheiraddress. Processing of personal data For information about the processing of your personal data, seehttps://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. Stockholm in July 2020 Starbreeze AB (publ)The Board of Directors For more information, please contact: Torgny Hellstrm, Chairman of the Board[emailprotected] Maeva Sponbergs, EVP CommunicationPhone number: +46(0)8-209-208, email: [emailprotected] The information was submitted for publication, through the agency of the contact person set out above, at 10:00 CEST on7 July 2020. This information was brought to you by Cision http://news.cision.com https://news.cision.com/starbreeze-ab/r/notice-of-extraordinary-general-meeting-in-starbreeze-ab--publ-,c3150004 The following files are available for download: https://mb.cision.com/Main/14632/3150004/1275900.pdf Release SOURCE Starbreeze AB

edtsum7742

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BOSTON, Oct. 8, 2020 /PRNewswire/ --Mendix, a Siemens business and global leader in low-code application development for the enterprise,today announced a strategic alliance with Deloitte Canada, a member firm of the world's largest professional services firm, to utilize the Mendix low-code software development platform on behalf of enterprise customers seeking business transitions enabled by technology. To build capacity and expertise, Deloitte's system engineering group has established centers of excellence (CoE) across the country to certify and deploy 50 Mendix rapid software developers to work on large-scale application development for customers in the financial services, insurance, logistics, public sector, and energy resource markets. "In order to thrive, companies we serve need to transform ongoing business operations, to increase efficiencies or to target new revenue streams," says Anthony Chan, a partner and the national systems engineering leader at Deloitte Canada. "Deloitte is a champion when it comes to embracing the trend of using low-code to develop enterprise software for key business operations. The demand for IT services is rapidly increasing, and this strategic alliance helps us bridge the low-code talent gap and unlocks our ability to bring digital solutions quickly to market." A paradigm shift for global system integrators One challenge facing legacy enterprises originally chartered in the 20th century is to engineer new ways to provide value and tailored services in the 21st century marketplace. Widespread adoption of next-generation technologies such as cloud-based software deployment, mobile access, microservices architecture, AI enablement, and chatbots has heightened expectations forfrictionless user experiences across multiple channels by enterprise customers and workforce employees. Low-code has proven itself to be a platform that readily supports integration of these and other next-generation technologies, while at the same time facilitating tremendous cost efficiency throughout the application lifecycle. A recent Forrester: Total Economic Impact (TEI) Report highlighted the financial benefits for a hypothetical composite organization an amalgam of four real-life enterprises using Mendix low-code for an average of almost six years gained by building and deploying software with the Mendix low-code platform. Those benefits include an estimated $8.1 million in savings over three years for application delivery and an additional $3.3 million in profits from accelerating the time to market for new products and services. Future-proofing legacy enterprises with low-code deployment Nick Ford, chief technology evangelist at Mendix, added, "Our alliance, and Deloitte's commitment as manifest in the new Centers of Excellence, will empower Deloitte to deliver all of the benefits of the Mendix low-code platform to its enterprise clients. A wider pool of developers, enhanced collaboration, accelerated time-to-impact, automation of routine IT maintenance and 'plumbing' chores, and greater efficiency throughout the entire application lifecycle combine to deliver real enterprise digital transformation." The strategic collaboration between Deloitte Canada and Mendix builds on the successful alliance in other regions of the world, including the U.S. Recently, Deloitte participated in the Mendix World 2.0 conference that explored groundbreaking uses of Mendix's low-code software development platform. On September 2, Peter Fever, managing director, Deloitte U.S., moderated an executive roundtable discussion with finance executives on "Banking's Perpetual Digital Transformation." Click hereto access content free of charge from Mendix World, the world's largest virtual low-code conference, featuring more than 60 sessions, including more than 20 by customers, and covering the gamut of low-code application development topics from strategy to practical, hands-on platform training. Learn more about the Mendix Platformand pricing and availability. BackgroundIn a pandemic-disrupted world, software is the new lifeblood of our daily lives and the connective tissue holding together the global economy. However, traditional software development takes far too long and very often fails to deliver the results business needs and users love. Even prior to COVID-19 there were simply not enough professional software developers in the world to build all the software currently required. The global pandemic has accelerated and exacerbated what was already a software and business crisis. Enter low-codesoftware development. Low-code from Mendix is a powerful enterprise-grade visual development approach empowering citizenand professional developers to make cloud-native applications more than 10X faster for web and mobile using drag-and-drop components and model-driven logic all through an intuitive graphical user interface. Connect with Mendix Follow @Mendix on Twitter Connect with Mendix on LinkedIn About Deloitte Deloitte provides audit and assurance, consulting, financial advisory, risk advisory, tax, and related services to public and private clients spanning multiple industries. Deloitte serves four out of five Fortune Global 500 companies through a globally connected network of member firms in more than 150 countries and territories bringing world-class capabilities, insights, and service to address clients' most complex business challenges. Deloitte LLP, an Ontario limited liability partnership, is the Canadian member firm of Deloitte Touche Tohmatsu Limited. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please seewww.deloitte.com/aboutfor a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Our global purpose is making an impact that matters. At Deloitte Canada, that translates into building a better future by accelerating and expanding access to knowledge. We believe we can achieve this Purpose by living our shared values to lead the way, serve with integrity, take care of each other, foster inclusion, and collaborate for measurable impact. To learn more about Deloitte's approximately 312,000 professionals, over 12,000 of whom are part of the Canadian firm, please connect with us onLinkedIn,Twitter,Instagram, orFacebook. About Mendix Mendix, a Siemens business and the global leader in enterprise low-code, is fundamentally reinventing the way applications are built in the digital enterprise. With the Mendix platform, enterprises can 'Make with More,' by broadening an enterprise's development capability to conquer the software development bottleneck; 'Make it Smart,' by making apps with rich native experiences that are intelligent, proactive, and contextual; and 'Make at Scale,' to modernize core systems and build large app portfolios to keep pace with business growth. The Mendix platform is built to promote intense collaboration between business and IT teams and dramatically accelerate application development cycles, while maintaining the highest standards of security, quality, and governance in short, to help enterprises confidently leap into their digital futures. Mendix's 'Go Make It' platform has been adopted by more than 4,000 leading companies around the world. Press InquiriesSara Black[emailprotected](213) 618-1501 Dan BerkowitzSenior Director Global Communications [emailprotected](415) 518-7870 SOURCE Mendix Answer:

Mendix and Deloitte Canada Announce Strategic Alliance to Build Low-Code Digital Solutions for Enterprise Customers World's leading professional services firm will create Canadian-based Centers of Excellence to train and certify 50 Mendix software developers

BOSTON, Oct. 8, 2020 /PRNewswire/ --Mendix, a Siemens business and global leader in low-code application development for the enterprise,today announced a strategic alliance with Deloitte Canada, a member firm of the world's largest professional services firm, to utilize the Mendix low-code software development platform on behalf of enterprise customers seeking business transitions enabled by technology. To build capacity and expertise, Deloitte's system engineering group has established centers of excellence (CoE) across the country to certify and deploy 50 Mendix rapid software developers to work on large-scale application development for customers in the financial services, insurance, logistics, public sector, and energy resource markets. "In order to thrive, companies we serve need to transform ongoing business operations, to increase efficiencies or to target new revenue streams," says Anthony Chan, a partner and the national systems engineering leader at Deloitte Canada. "Deloitte is a champion when it comes to embracing the trend of using low-code to develop enterprise software for key business operations. The demand for IT services is rapidly increasing, and this strategic alliance helps us bridge the low-code talent gap and unlocks our ability to bring digital solutions quickly to market." A paradigm shift for global system integrators One challenge facing legacy enterprises originally chartered in the 20th century is to engineer new ways to provide value and tailored services in the 21st century marketplace. Widespread adoption of next-generation technologies such as cloud-based software deployment, mobile access, microservices architecture, AI enablement, and chatbots has heightened expectations forfrictionless user experiences across multiple channels by enterprise customers and workforce employees. Low-code has proven itself to be a platform that readily supports integration of these and other next-generation technologies, while at the same time facilitating tremendous cost efficiency throughout the application lifecycle. A recent Forrester: Total Economic Impact (TEI) Report highlighted the financial benefits for a hypothetical composite organization an amalgam of four real-life enterprises using Mendix low-code for an average of almost six years gained by building and deploying software with the Mendix low-code platform. Those benefits include an estimated $8.1 million in savings over three years for application delivery and an additional $3.3 million in profits from accelerating the time to market for new products and services. Future-proofing legacy enterprises with low-code deployment Nick Ford, chief technology evangelist at Mendix, added, "Our alliance, and Deloitte's commitment as manifest in the new Centers of Excellence, will empower Deloitte to deliver all of the benefits of the Mendix low-code platform to its enterprise clients. A wider pool of developers, enhanced collaboration, accelerated time-to-impact, automation of routine IT maintenance and 'plumbing' chores, and greater efficiency throughout the entire application lifecycle combine to deliver real enterprise digital transformation." The strategic collaboration between Deloitte Canada and Mendix builds on the successful alliance in other regions of the world, including the U.S. Recently, Deloitte participated in the Mendix World 2.0 conference that explored groundbreaking uses of Mendix's low-code software development platform. On September 2, Peter Fever, managing director, Deloitte U.S., moderated an executive roundtable discussion with finance executives on "Banking's Perpetual Digital Transformation." Click hereto access content free of charge from Mendix World, the world's largest virtual low-code conference, featuring more than 60 sessions, including more than 20 by customers, and covering the gamut of low-code application development topics from strategy to practical, hands-on platform training. Learn more about the Mendix Platformand pricing and availability. BackgroundIn a pandemic-disrupted world, software is the new lifeblood of our daily lives and the connective tissue holding together the global economy. However, traditional software development takes far too long and very often fails to deliver the results business needs and users love. Even prior to COVID-19 there were simply not enough professional software developers in the world to build all the software currently required. The global pandemic has accelerated and exacerbated what was already a software and business crisis. Enter low-codesoftware development. Low-code from Mendix is a powerful enterprise-grade visual development approach empowering citizenand professional developers to make cloud-native applications more than 10X faster for web and mobile using drag-and-drop components and model-driven logic all through an intuitive graphical user interface. Connect with Mendix Follow @Mendix on Twitter Connect with Mendix on LinkedIn About Deloitte Deloitte provides audit and assurance, consulting, financial advisory, risk advisory, tax, and related services to public and private clients spanning multiple industries. Deloitte serves four out of five Fortune Global 500 companies through a globally connected network of member firms in more than 150 countries and territories bringing world-class capabilities, insights, and service to address clients' most complex business challenges. Deloitte LLP, an Ontario limited liability partnership, is the Canadian member firm of Deloitte Touche Tohmatsu Limited. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please seewww.deloitte.com/aboutfor a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Our global purpose is making an impact that matters. At Deloitte Canada, that translates into building a better future by accelerating and expanding access to knowledge. We believe we can achieve this Purpose by living our shared values to lead the way, serve with integrity, take care of each other, foster inclusion, and collaborate for measurable impact. To learn more about Deloitte's approximately 312,000 professionals, over 12,000 of whom are part of the Canadian firm, please connect with us onLinkedIn,Twitter,Instagram, orFacebook. About Mendix Mendix, a Siemens business and the global leader in enterprise low-code, is fundamentally reinventing the way applications are built in the digital enterprise. With the Mendix platform, enterprises can 'Make with More,' by broadening an enterprise's development capability to conquer the software development bottleneck; 'Make it Smart,' by making apps with rich native experiences that are intelligent, proactive, and contextual; and 'Make at Scale,' to modernize core systems and build large app portfolios to keep pace with business growth. The Mendix platform is built to promote intense collaboration between business and IT teams and dramatically accelerate application development cycles, while maintaining the highest standards of security, quality, and governance in short, to help enterprises confidently leap into their digital futures. Mendix's 'Go Make It' platform has been adopted by more than 4,000 leading companies around the world. Press InquiriesSara Black[emailprotected](213) 618-1501 Dan BerkowitzSenior Director Global Communications [emailprotected](415) 518-7870 SOURCE Mendix

edtsum7743

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BEDFORD, Mass.--(BUSINESS WIRE)--Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in asset optimization software, today announced selected financial results for the first quarter of fiscal 2021 ended September 30, 2020. AspenTechs first quarter results were solid in the context of the challenging economic environment, said Antonio Pietri, President and Chief Executive Officer of Aspen Technology. Customers continued to make significant investments in AspenTechs solutions as an essential part of their digitalization and sustainability initiatives, which we believe will be a primary focus for the process and other capital intensive industries in the coming years. Pietri continued, With the recent introduction of aspenONE v12 and the Aspen AIoT Hub, we are dramatically extending the bounds of what is possible in plant operations. By embedding AI across our product portfolio, we are laying the foundation for the delivery of our self-optimizing plant vision. We believe these product announcements will drive substantial incremental value for customers and be an important long-term growth driver for AspenTech. Selected First Quarter Fiscal 2021 Business Highlights Update on 10-K and 10-Q Filing As previously announced, the company will be delaying the release of its full financial results for the first fiscal quarter due to the additional time needed to complete the process of filing its Annual Report on Form 10-K for the fiscal year ended June 30, 2020. On September 1, 2020, AspenTech filed a notification with the Securities and Exchange Commission on Form 12b-25 of its inability to timely file the 2020 Form 10-K due to AspenTechs need for additional time to complete its procedures to finalize the 2020 Form 10-K, which has taken longer than anticipated as a result of additional errors identified by AspenTech in the transition adjustment recorded in the prior fiscal year related to the adoption of Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). Based on what is known today, the company does not expect the errors to be material to its previously reported financial information. Because of the delay in filing its 2020 Form 10-K, AspenTech will be unable to timely file its Quarterly Report on Form 10-Q for the first quarter of fiscal 2021. AspenTech estimates that it will be able to complete and file the first quarter Form 10-Q within several weeks after filing the 2020 Form 10-K. Business Outlook Based on information as of today, November 5, 2020, Aspen Technology is reiterating guidance for the following metrics for fiscal year 2021: These statements are forward-looking and actual results may differ materially. Refer to the Forward-Looking Statements safe harbor below for information on the factors that could cause our actual results to differ materially from these forward-looking statements. AspenTech has not reconciled its expectations as to non-GAAP items to their most directly comparable GAAP measure because certain items cannot be reasonably predicted. Use of Non-GAAP Financial Measures This press release refers to non-GAAP financial measures under the rules of the U.S. Securities and Exchange Commission. Certain of these non-GAAP measures exclude certain non-cash and non-recurring expenses such as stock-based compensation, amortization of intangibles and acquisition-related fees. Non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles. This non-GAAP information supplements, and is not intended to represent a measure of performance in accordance with, disclosures required by generally accepted accounting principles, or GAAP. Non-GAAP financial measures should be considered in addition to, not as a substitute for or superior to, financial measures determined in accordance with GAAP. Management considers both GAAP and non-GAAP financial results in managing Aspen Technologys business. As the result of adoption of new licensing models, management believes that a number of Aspen Technologys performance indicators based on GAAP, including revenue, gross profit, operating income and net income, should be viewed in conjunction with certain non-GAAP and other business metrics in assessing Aspen Technologys performance, growth and financial condition. Accordingly, management utilizes a number of non-GAAP and other business metrics, including the non-GAAP metrics set forth in this press release, to track Aspen Technologys business performance. None of these non-GAAP metrics should be considered as an alternative to any measure of financial performance calculated in accordance with GAAP. Conference Call and Webcast Aspen Technology will host a conference call and webcast today, November 5, 2020, at 4:30 p.m. (Eastern Time), to discuss the company's selected financial results, provide a business outlook and other matters. The live dial-in number is (866) 471-3828 or (678) 509-7573, conference ID code 9472326. Interested parties may also listen to a live webcast of the call by logging on to the Investor Relations section of Aspen Technologys website, http://ir.aspentech.com/events-and-presentations, and clicking on the webcast link. A replay of the call will be archived on Aspen Technologys website and will also be available via telephone at (855) 859-2056 or (404) 537-3406, conference ID code 9472326, through November 12, 2020. About Aspen Technology Aspen Technology (AspenTech) is a global leader in asset optimization software. Its solutions address complex, industrial environments where it is critical to optimize the asset design, operation and maintenance lifecycle. AspenTech uniquely combines decades of process modelling expertise with artificial intelligence. Its purpose-built software platform automates knowledge work and builds sustainable competitive advantage by delivering high returns over the entire asset lifecycle. As a result, companies in capital-intensive industries can maximize uptime and push the limits of performance, running their assets safer, greener, longer and faster. Visit AspenTech.com to find out more. Forward-Looking Statements The second and third paragraphs of this press release as well as the Update on 10-K and 10-Q Filing and Business Outlook sections contain forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from AspenTechs expectations based on a number of risks and uncertainties, including, without limitation: delays or reductions in demand for AspenTech solutions due to the COVID-19 pandemic; AspenTechs failure to increase usage and product adoption of aspenONE offerings, including aspenONE v12 and the Aspen AIoT Hub, or grow the aspenONE APM business, and failure to continue to provide innovative, market-leading solutions; the demand for, or usage of, aspenONE software declines for any reason, including declines due to adverse changes in the process or other capital-intensive industries and due to the drop in demand for oil due to the COVID-19 pandemic, compounded by the excess supply arising from producers failure to agree on production cuts; unfavorable economic and market conditions or a lessening demand in the market for asset process optimization software, including due to the significant drop in oil prices arising from drop in demand due to the COVID-19 pandemic and producers failure to agree on production cuts; risks of foreign operations or transacting business with customers outside the United States; risks of competition and other risk factors described from time to time in AspenTechs periodic reports filed with the Securities and Exchange Commission. AspenTech cannot guarantee any future results, levels of activity, performance, or achievements. AspenTech expressly disclaims any obligation to update forward-looking statements after the date of this press release. 2020 Aspen Technology, Inc. aspenONE, AspenTech and the Aspen leaf logo are trademarks of Aspen Technology, Inc. All rights reserved. All other trademarks are property of their respective owners. Answer:

Aspen Technology Announces Selected Financial Results for the First Quarter of Fiscal 2021

BEDFORD, Mass.--(BUSINESS WIRE)--Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in asset optimization software, today announced selected financial results for the first quarter of fiscal 2021 ended September 30, 2020. AspenTechs first quarter results were solid in the context of the challenging economic environment, said Antonio Pietri, President and Chief Executive Officer of Aspen Technology. Customers continued to make significant investments in AspenTechs solutions as an essential part of their digitalization and sustainability initiatives, which we believe will be a primary focus for the process and other capital intensive industries in the coming years. Pietri continued, With the recent introduction of aspenONE v12 and the Aspen AIoT Hub, we are dramatically extending the bounds of what is possible in plant operations. By embedding AI across our product portfolio, we are laying the foundation for the delivery of our self-optimizing plant vision. We believe these product announcements will drive substantial incremental value for customers and be an important long-term growth driver for AspenTech. Selected First Quarter Fiscal 2021 Business Highlights Update on 10-K and 10-Q Filing As previously announced, the company will be delaying the release of its full financial results for the first fiscal quarter due to the additional time needed to complete the process of filing its Annual Report on Form 10-K for the fiscal year ended June 30, 2020. On September 1, 2020, AspenTech filed a notification with the Securities and Exchange Commission on Form 12b-25 of its inability to timely file the 2020 Form 10-K due to AspenTechs need for additional time to complete its procedures to finalize the 2020 Form 10-K, which has taken longer than anticipated as a result of additional errors identified by AspenTech in the transition adjustment recorded in the prior fiscal year related to the adoption of Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). Based on what is known today, the company does not expect the errors to be material to its previously reported financial information. Because of the delay in filing its 2020 Form 10-K, AspenTech will be unable to timely file its Quarterly Report on Form 10-Q for the first quarter of fiscal 2021. AspenTech estimates that it will be able to complete and file the first quarter Form 10-Q within several weeks after filing the 2020 Form 10-K. Business Outlook Based on information as of today, November 5, 2020, Aspen Technology is reiterating guidance for the following metrics for fiscal year 2021: These statements are forward-looking and actual results may differ materially. Refer to the Forward-Looking Statements safe harbor below for information on the factors that could cause our actual results to differ materially from these forward-looking statements. AspenTech has not reconciled its expectations as to non-GAAP items to their most directly comparable GAAP measure because certain items cannot be reasonably predicted. Use of Non-GAAP Financial Measures This press release refers to non-GAAP financial measures under the rules of the U.S. Securities and Exchange Commission. Certain of these non-GAAP measures exclude certain non-cash and non-recurring expenses such as stock-based compensation, amortization of intangibles and acquisition-related fees. Non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles. This non-GAAP information supplements, and is not intended to represent a measure of performance in accordance with, disclosures required by generally accepted accounting principles, or GAAP. Non-GAAP financial measures should be considered in addition to, not as a substitute for or superior to, financial measures determined in accordance with GAAP. Management considers both GAAP and non-GAAP financial results in managing Aspen Technologys business. As the result of adoption of new licensing models, management believes that a number of Aspen Technologys performance indicators based on GAAP, including revenue, gross profit, operating income and net income, should be viewed in conjunction with certain non-GAAP and other business metrics in assessing Aspen Technologys performance, growth and financial condition. Accordingly, management utilizes a number of non-GAAP and other business metrics, including the non-GAAP metrics set forth in this press release, to track Aspen Technologys business performance. None of these non-GAAP metrics should be considered as an alternative to any measure of financial performance calculated in accordance with GAAP. Conference Call and Webcast Aspen Technology will host a conference call and webcast today, November 5, 2020, at 4:30 p.m. (Eastern Time), to discuss the company's selected financial results, provide a business outlook and other matters. The live dial-in number is (866) 471-3828 or (678) 509-7573, conference ID code 9472326. Interested parties may also listen to a live webcast of the call by logging on to the Investor Relations section of Aspen Technologys website, http://ir.aspentech.com/events-and-presentations, and clicking on the webcast link. A replay of the call will be archived on Aspen Technologys website and will also be available via telephone at (855) 859-2056 or (404) 537-3406, conference ID code 9472326, through November 12, 2020. About Aspen Technology Aspen Technology (AspenTech) is a global leader in asset optimization software. Its solutions address complex, industrial environments where it is critical to optimize the asset design, operation and maintenance lifecycle. AspenTech uniquely combines decades of process modelling expertise with artificial intelligence. Its purpose-built software platform automates knowledge work and builds sustainable competitive advantage by delivering high returns over the entire asset lifecycle. As a result, companies in capital-intensive industries can maximize uptime and push the limits of performance, running their assets safer, greener, longer and faster. Visit AspenTech.com to find out more. Forward-Looking Statements The second and third paragraphs of this press release as well as the Update on 10-K and 10-Q Filing and Business Outlook sections contain forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from AspenTechs expectations based on a number of risks and uncertainties, including, without limitation: delays or reductions in demand for AspenTech solutions due to the COVID-19 pandemic; AspenTechs failure to increase usage and product adoption of aspenONE offerings, including aspenONE v12 and the Aspen AIoT Hub, or grow the aspenONE APM business, and failure to continue to provide innovative, market-leading solutions; the demand for, or usage of, aspenONE software declines for any reason, including declines due to adverse changes in the process or other capital-intensive industries and due to the drop in demand for oil due to the COVID-19 pandemic, compounded by the excess supply arising from producers failure to agree on production cuts; unfavorable economic and market conditions or a lessening demand in the market for asset process optimization software, including due to the significant drop in oil prices arising from drop in demand due to the COVID-19 pandemic and producers failure to agree on production cuts; risks of foreign operations or transacting business with customers outside the United States; risks of competition and other risk factors described from time to time in AspenTechs periodic reports filed with the Securities and Exchange Commission. AspenTech cannot guarantee any future results, levels of activity, performance, or achievements. AspenTech expressly disclaims any obligation to update forward-looking statements after the date of this press release. 2020 Aspen Technology, Inc. aspenONE, AspenTech and the Aspen leaf logo are trademarks of Aspen Technology, Inc. All rights reserved. All other trademarks are property of their respective owners.

edtsum7744

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Nov. 9, 2020 /PRNewswire/ -- National law firm Wilson Elser today announced a collaboration with MindMeld Studios and myCEcourse.com to produce online legal compliance training videos. MindMeld's leading e-Learning Management System provides businesses an efficient and effective way to keep their workforces compliant with regulatory requirements. According to Wilson Elser, mandated workplace training is on the increase, and the firm has accelerated its efforts to help clients comply with state and local requirements. Among the training modules available for download are "Sexual Harassment Prevention and Awareness," "COVID-19 Returning to Work" and "Human Trafficking." These online training videos satisfy regulatory requirements in California, Illinois and New York. New titles will be added on a regular basis. "The MindMeldWilson Elser collaboration is a powerful combination. Wilson Elser offers the knowledge of experienced attorneys who are practicing on the cutting edge of these evolving areas," said Wilson Elser partner Bennet Heller. "Combine the legal training and risk mitigation expertise of Wilson Elser with MindMeld's understanding of relevant digital products and online adult learning principles, and you have industry-leading content." Mr. Heller added, "As Wilson Elser strives to continue to deliver premier legal services in the remote environment, this collaboration also will enable us to customize online training, compliance and risk management videos upon client request." "Collaborating with Wilson Elser to deliver relevant educational content for our clients will allow MindMeld to deliver the very best business training and compliance using the next generation of digital products and e-learning platforms," said Michael Aberle, CEO of MindMeld Studios. "Together, working as one team, we will unlock the full potential of e-learning and place our clients on the best path for success in the new digital business landscape." For more information, see the Wilson Elser Learning Center. About Wilson ElserMore than 800 attorneys strong, Wilson Elser serves clients of all sizes, across multiple industries and around the world. Wilson Elser has a national network of strategically located offices in the United States and another in London. It is a founding member of Legalign Global, a close alliance of some of the world's leading insurance law firms created to assist companies doing business internationally. This depth and scale makes Wilson Elser one of the nation's most influential law firms, ranked in the AmLaw 200 and 54th in The National Law Journal's NLJ 500. For more information, go to www.wilsonelser.com. About MindMeld StudiosMindMeld Studios & myCEcourse.comwas formed in 2018 by industry experts who knew online training had a future. When states make training mandatory, that is where MindMeld Studios picks up! We make it affordable and possible for businesses to stay compliant with the constant changes to complex labor and employment laws. Contact: Andrew Blum, AJB Communications 917.783.1680 [emailprotected] SOURCE Wilson Elser Answer:

National Law Firm Wilson Elser and MindMeld Studios Team to Produce Online Legal Compliance Training Videos

NEW YORK, Nov. 9, 2020 /PRNewswire/ -- National law firm Wilson Elser today announced a collaboration with MindMeld Studios and myCEcourse.com to produce online legal compliance training videos. MindMeld's leading e-Learning Management System provides businesses an efficient and effective way to keep their workforces compliant with regulatory requirements. According to Wilson Elser, mandated workplace training is on the increase, and the firm has accelerated its efforts to help clients comply with state and local requirements. Among the training modules available for download are "Sexual Harassment Prevention and Awareness," "COVID-19 Returning to Work" and "Human Trafficking." These online training videos satisfy regulatory requirements in California, Illinois and New York. New titles will be added on a regular basis. "The MindMeldWilson Elser collaboration is a powerful combination. Wilson Elser offers the knowledge of experienced attorneys who are practicing on the cutting edge of these evolving areas," said Wilson Elser partner Bennet Heller. "Combine the legal training and risk mitigation expertise of Wilson Elser with MindMeld's understanding of relevant digital products and online adult learning principles, and you have industry-leading content." Mr. Heller added, "As Wilson Elser strives to continue to deliver premier legal services in the remote environment, this collaboration also will enable us to customize online training, compliance and risk management videos upon client request." "Collaborating with Wilson Elser to deliver relevant educational content for our clients will allow MindMeld to deliver the very best business training and compliance using the next generation of digital products and e-learning platforms," said Michael Aberle, CEO of MindMeld Studios. "Together, working as one team, we will unlock the full potential of e-learning and place our clients on the best path for success in the new digital business landscape." For more information, see the Wilson Elser Learning Center. About Wilson ElserMore than 800 attorneys strong, Wilson Elser serves clients of all sizes, across multiple industries and around the world. Wilson Elser has a national network of strategically located offices in the United States and another in London. It is a founding member of Legalign Global, a close alliance of some of the world's leading insurance law firms created to assist companies doing business internationally. This depth and scale makes Wilson Elser one of the nation's most influential law firms, ranked in the AmLaw 200 and 54th in The National Law Journal's NLJ 500. For more information, go to www.wilsonelser.com. About MindMeld StudiosMindMeld Studios & myCEcourse.comwas formed in 2018 by industry experts who knew online training had a future. When states make training mandatory, that is where MindMeld Studios picks up! We make it affordable and possible for businesses to stay compliant with the constant changes to complex labor and employment laws. Contact: Andrew Blum, AJB Communications 917.783.1680 [emailprotected] SOURCE Wilson Elser

edtsum7745

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: HOUSTON--(BUSINESS WIRE)--Cheniere Energy Partners, L.P. (Cheniere Partners) (NYSE American: CQP) announced today that it has amended its earlier announced tender offer and consent solicitation in respect of its 5.250% Notes due 2025 (the Notes) to eliminate the tender cap and extend the offer to purchase any and all of the outstanding $1,500,000,000 aggregate principal amount of the Notes. Cheniere Partners currently expects the early settlement date, if any, to occur on March 11, 2021. In the tender offer, Cheniere Partners is offering to purchase any and all outstanding Notes upon the terms and conditions set forth in the related Offer to Purchase and Consent Solicitation Statement. In connection with the tender offer, Cheniere Partners is soliciting consents from holders of the Notes to amend the indenture with respect to the Notes to reduce the minimum notice period to optionally redeem the Notes (the Proposed Amendment). Holders of the Notes are urged to carefully read the Offer to Purchase and Consent Solicitation Statement, which sets forth a more detailed description of the tender offer, before making any decision with respect to the tender offer. Holders who have already validly tendered (and not validly withdrawn) their Notes do not need to re-tender their Notes. The table below sets forth certain information regarding the Notes and the tender offer. Series of Notes CUSIP Numbers Aggregate Principal Amount Outstanding Tender Consideration(1) Early Tender Premium(2) Total Consideration (1)(2) 5.250% Notes due 2025 16411QAB7 U16353AA9 $1,500,000,000 $977.27 $50.00 $1,027.27 ___________________ (1) Per $1,000 principal amount of Notes validly tendered (and not validly withdrawn) and accepted for purchase by Cheniere Partners. Excludes accrued and unpaid interest, which will be paid on Notes accepted for purchase by Cheniere Partners as described below. (2) Includes the $50.00 early tender premium for Notes validly tendered at or prior to the Early Tender Deadline (as defined below) (and not validly withdrawn) and accepted for purchase by us. Cheniere Partners will not be obligated to accept for purchase any Notes pursuant to the tender offer unless certain conditions are satisfied or waived by Cheniere Partners, including (1) entry by Cheniere Partners at or prior to the Expiration Date (as defined below) (or Early Tender Deadline, if Cheniere Partners elects to have an early settlement) into a definitive contract providing for the receipt by Cheniere Partners, on terms satisfactory to it in its sole discretion subject to applicable law, of a minimum of $1,500,000,000 in gross proceeds from one or more debt financings and (2) the receipt by Cheniere Partners at or prior to the final settlement date (or early settlement date, if Cheniere Partners elects to have an early settlement) of a minimum of $1,500,000,000 in gross proceeds from one or more debt financings upon fulfillment of customary conditions. The tender offer is not conditioned on any minimum amount of Notes being tendered or receipt of requisite consents to adopt the proposed amendments. Subject to applicable law, Cheniere Partners may amend, extend or terminate the tender offer in its sole discretion. The tender offer and consent solicitation is being made solely pursuant to the terms and conditions set forth in an Offer to Purchase and Consent Solicitation Statement, dated February 25, 2021, as amended by this press release. Holders of the Notes are urged to carefully read the Offer to Purchase and Consent Solicitation Statement before making any decision with respect to the tender offer and consent solicitation. The tender offer and consent solicitation will expire at 12:01 a.m., New York City time, on March 24, 2021, unless extended, earlier expired or terminated by Cheniere Partners (such time and date, as the same may be extended, earlier expired or terminated by Cheniere Partners in its sole discretion, subject to applicable law, the Expiration Date). Tendered Notes may be withdrawn and consents delivered may be revoked at or prior to 5:00 p.m., New York City time, on March 10, 2021 by following the procedures in the Offer to Purchase and Consent Solicitation Statement, but may not thereafter be validly withdrawn and validly revoked, except as provided for in the Offer to Purchase and Consent Solicitation Statement or required by applicable law. Holders of Notes must validly tender and not validly withdraw their Notes and validly deliver and not validly revoke their consents at or prior to 5:00 p.m., New York City time, on March 10, 2021 (such time and date, as the same may be extended by Cheniere Partners in its sole discretion, subject to applicable law, the Early Tender Deadline) in order to be eligible to receive the total consideration, which includes the early tender premium for the Notes of $1,027.27 per $1,000 principal amount of Notes tendered. Holders who validly tender their Notes and deliver their consents after the Early Tender Deadline and at or prior to the Expiration Date will be eligible to receive only the tender consideration, as set forth in the table above. Accrued and unpaid interest will be paid on all Notes validly tendered and accepted for purchase from the last interest payment date up to, but not including, the applicable settlement date. Cheniere Partners reserves the right, but is under no obligation, at any time after the Early Tender Deadline and before the Expiration Date, to accept for purchase Notes that have been validly tendered and not validly withdrawn at or prior to the Early Tender Deadline on the early settlement date. If Cheniere Partners chooses to exercise its option to have an early settlement date, Cheniere Partners will purchase any remaining Notes that have been validly tendered and not validly withdrawn after the Early Tender Deadline and at or prior to the Expiration Date, subject to all conditions to the tender offer having been satisfied or waived by Cheniere Partners, on a date following the Expiration Date. The final settlement date is expected to occur promptly following the Expiration Date, and is currently expected to occur on March 25, 2021, unless extended by Cheniere Partners. If Cheniere Partners chooses not to exercise its option to have an early settlement date, Cheniere Partners will purchase all Notes that have been validly tendered and not validly withdrawn at or prior to the Expiration Date, subject to all conditions to the tender offer having been satisfied or waived by Cheniere Partners, on the final settlement date. Tenders of Notes and delivery of consents submitted after the Expiration Date will not be valid. Subsequent to the commencement of the tender offer and the consent solicitation and conditioned upon the receipt of the net proceeds from the Debt Financing and the lack of receipt of the requisite consents on or prior to the Early Tender Deadline, Cheniere Partners issued a notice of redemption for any Notes that remain outstanding following the consummation or termination of the tender offer and consent solicitation. Any such redemption will be made pursuant to the existing notice period provisions in the indenture and in accordance with the terms of the indenture, as supplemented, pursuant to which the Notes were issued, which provides for a redemption price equal to 102.625% plus accrued and unpaid interest thereon to the redemption date. In addition, assuming the execution and delivery of the supplemental indenture, Cheniere Partners currently intends, in accordance with the terms and conditions of the indenture, as may be amended as a result of the Proposed Amendment, to mail a notice of redemption to the holders of any outstanding Notes on the early settlement date, if any, although Cheniere Partners has no legal obligation to do so and the selection of any particular redemption date is in Cheniere Partners discretion. These statements shall not constitute a notice of any such redemptions under the indenture. Any such notice, if made, will only be made in accordance with the provisions of the indenture. Cheniere Partners has retained J.P. Morgan Securities LLC to act as the dealer manager and solicitation agent and Ipreo LLC to act as the tender and information agent for the tender offer and consent solicitation. For additional information regarding the terms of the tender offer and consent solicitation, please contact J.P. Morgan Securities LLC collect at (212) 834-2045 or toll-free at (866) 834-4666. Requests for copies of the Offer to Purchase and Consent Solicitation Statement and questions regarding the tendering of notes and delivery of consents may be directed to Ipreo LLC at (212) 849-3880 (for banks and brokers) or (888) 593-9546 (all others, toll-free) or email [email protected]. This press release is for informational purposes only and does not constitute an offer to purchase securities or a solicitation of an offer to sell any securities or an offer to sell or the solicitation of an offer to purchase any securities nor does it constitute an offer or solicitation in any jurisdiction in which such offer or solicitation is unlawful. None of Cheniere Partners, the tender and information agent, the dealer manager and solicitation agent or the trustee (nor any of their respective directors, officers, employees or affiliates) makes any recommendation as to whether holders should tender their Notes pursuant to the tender offer and deliver any related consents, and no one has been authorized by any of them to make such a recommendation. Holders must make their own decisions as to whether to tender their Notes, and, if so, the principal amount of Notes to tender. Forward-Looking Statements This press release contains certain statements that may include forward-looking statements. All statements, other than statements of historical or present facts or conditions, included herein are forward-looking statements. Included among forward-looking statements are, among other things, statements regarding Cheniere Partners business strategy, plans and objectives, including statements regarding the intended conduct, timing and terms of the tender offer and consent solicitation, related financing plans and any future actions by Cheniere Partners in respect of the Notes. Although Cheniere Partners believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Cheniere Partners actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Cheniere Partners periodic reports that are filed with and available from the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, Cheniere Partners does not assume a duty to update these forward-looking statements. Answer:

Cheniere Partners Announces Upsize in Previously Announced Tender Offer

HOUSTON--(BUSINESS WIRE)--Cheniere Energy Partners, L.P. (Cheniere Partners) (NYSE American: CQP) announced today that it has amended its earlier announced tender offer and consent solicitation in respect of its 5.250% Notes due 2025 (the Notes) to eliminate the tender cap and extend the offer to purchase any and all of the outstanding $1,500,000,000 aggregate principal amount of the Notes. Cheniere Partners currently expects the early settlement date, if any, to occur on March 11, 2021. In the tender offer, Cheniere Partners is offering to purchase any and all outstanding Notes upon the terms and conditions set forth in the related Offer to Purchase and Consent Solicitation Statement. In connection with the tender offer, Cheniere Partners is soliciting consents from holders of the Notes to amend the indenture with respect to the Notes to reduce the minimum notice period to optionally redeem the Notes (the Proposed Amendment). Holders of the Notes are urged to carefully read the Offer to Purchase and Consent Solicitation Statement, which sets forth a more detailed description of the tender offer, before making any decision with respect to the tender offer. Holders who have already validly tendered (and not validly withdrawn) their Notes do not need to re-tender their Notes. The table below sets forth certain information regarding the Notes and the tender offer. Series of Notes CUSIP Numbers Aggregate Principal Amount Outstanding Tender Consideration(1) Early Tender Premium(2) Total Consideration (1)(2) 5.250% Notes due 2025 16411QAB7 U16353AA9 $1,500,000,000 $977.27 $50.00 $1,027.27 ___________________ (1) Per $1,000 principal amount of Notes validly tendered (and not validly withdrawn) and accepted for purchase by Cheniere Partners. Excludes accrued and unpaid interest, which will be paid on Notes accepted for purchase by Cheniere Partners as described below. (2) Includes the $50.00 early tender premium for Notes validly tendered at or prior to the Early Tender Deadline (as defined below) (and not validly withdrawn) and accepted for purchase by us. Cheniere Partners will not be obligated to accept for purchase any Notes pursuant to the tender offer unless certain conditions are satisfied or waived by Cheniere Partners, including (1) entry by Cheniere Partners at or prior to the Expiration Date (as defined below) (or Early Tender Deadline, if Cheniere Partners elects to have an early settlement) into a definitive contract providing for the receipt by Cheniere Partners, on terms satisfactory to it in its sole discretion subject to applicable law, of a minimum of $1,500,000,000 in gross proceeds from one or more debt financings and (2) the receipt by Cheniere Partners at or prior to the final settlement date (or early settlement date, if Cheniere Partners elects to have an early settlement) of a minimum of $1,500,000,000 in gross proceeds from one or more debt financings upon fulfillment of customary conditions. The tender offer is not conditioned on any minimum amount of Notes being tendered or receipt of requisite consents to adopt the proposed amendments. Subject to applicable law, Cheniere Partners may amend, extend or terminate the tender offer in its sole discretion. The tender offer and consent solicitation is being made solely pursuant to the terms and conditions set forth in an Offer to Purchase and Consent Solicitation Statement, dated February 25, 2021, as amended by this press release. Holders of the Notes are urged to carefully read the Offer to Purchase and Consent Solicitation Statement before making any decision with respect to the tender offer and consent solicitation. The tender offer and consent solicitation will expire at 12:01 a.m., New York City time, on March 24, 2021, unless extended, earlier expired or terminated by Cheniere Partners (such time and date, as the same may be extended, earlier expired or terminated by Cheniere Partners in its sole discretion, subject to applicable law, the Expiration Date). Tendered Notes may be withdrawn and consents delivered may be revoked at or prior to 5:00 p.m., New York City time, on March 10, 2021 by following the procedures in the Offer to Purchase and Consent Solicitation Statement, but may not thereafter be validly withdrawn and validly revoked, except as provided for in the Offer to Purchase and Consent Solicitation Statement or required by applicable law. Holders of Notes must validly tender and not validly withdraw their Notes and validly deliver and not validly revoke their consents at or prior to 5:00 p.m., New York City time, on March 10, 2021 (such time and date, as the same may be extended by Cheniere Partners in its sole discretion, subject to applicable law, the Early Tender Deadline) in order to be eligible to receive the total consideration, which includes the early tender premium for the Notes of $1,027.27 per $1,000 principal amount of Notes tendered. Holders who validly tender their Notes and deliver their consents after the Early Tender Deadline and at or prior to the Expiration Date will be eligible to receive only the tender consideration, as set forth in the table above. Accrued and unpaid interest will be paid on all Notes validly tendered and accepted for purchase from the last interest payment date up to, but not including, the applicable settlement date. Cheniere Partners reserves the right, but is under no obligation, at any time after the Early Tender Deadline and before the Expiration Date, to accept for purchase Notes that have been validly tendered and not validly withdrawn at or prior to the Early Tender Deadline on the early settlement date. If Cheniere Partners chooses to exercise its option to have an early settlement date, Cheniere Partners will purchase any remaining Notes that have been validly tendered and not validly withdrawn after the Early Tender Deadline and at or prior to the Expiration Date, subject to all conditions to the tender offer having been satisfied or waived by Cheniere Partners, on a date following the Expiration Date. The final settlement date is expected to occur promptly following the Expiration Date, and is currently expected to occur on March 25, 2021, unless extended by Cheniere Partners. If Cheniere Partners chooses not to exercise its option to have an early settlement date, Cheniere Partners will purchase all Notes that have been validly tendered and not validly withdrawn at or prior to the Expiration Date, subject to all conditions to the tender offer having been satisfied or waived by Cheniere Partners, on the final settlement date. Tenders of Notes and delivery of consents submitted after the Expiration Date will not be valid. Subsequent to the commencement of the tender offer and the consent solicitation and conditioned upon the receipt of the net proceeds from the Debt Financing and the lack of receipt of the requisite consents on or prior to the Early Tender Deadline, Cheniere Partners issued a notice of redemption for any Notes that remain outstanding following the consummation or termination of the tender offer and consent solicitation. Any such redemption will be made pursuant to the existing notice period provisions in the indenture and in accordance with the terms of the indenture, as supplemented, pursuant to which the Notes were issued, which provides for a redemption price equal to 102.625% plus accrued and unpaid interest thereon to the redemption date. In addition, assuming the execution and delivery of the supplemental indenture, Cheniere Partners currently intends, in accordance with the terms and conditions of the indenture, as may be amended as a result of the Proposed Amendment, to mail a notice of redemption to the holders of any outstanding Notes on the early settlement date, if any, although Cheniere Partners has no legal obligation to do so and the selection of any particular redemption date is in Cheniere Partners discretion. These statements shall not constitute a notice of any such redemptions under the indenture. Any such notice, if made, will only be made in accordance with the provisions of the indenture. Cheniere Partners has retained J.P. Morgan Securities LLC to act as the dealer manager and solicitation agent and Ipreo LLC to act as the tender and information agent for the tender offer and consent solicitation. For additional information regarding the terms of the tender offer and consent solicitation, please contact J.P. Morgan Securities LLC collect at (212) 834-2045 or toll-free at (866) 834-4666. Requests for copies of the Offer to Purchase and Consent Solicitation Statement and questions regarding the tendering of notes and delivery of consents may be directed to Ipreo LLC at (212) 849-3880 (for banks and brokers) or (888) 593-9546 (all others, toll-free) or email [email protected]. This press release is for informational purposes only and does not constitute an offer to purchase securities or a solicitation of an offer to sell any securities or an offer to sell or the solicitation of an offer to purchase any securities nor does it constitute an offer or solicitation in any jurisdiction in which such offer or solicitation is unlawful. None of Cheniere Partners, the tender and information agent, the dealer manager and solicitation agent or the trustee (nor any of their respective directors, officers, employees or affiliates) makes any recommendation as to whether holders should tender their Notes pursuant to the tender offer and deliver any related consents, and no one has been authorized by any of them to make such a recommendation. Holders must make their own decisions as to whether to tender their Notes, and, if so, the principal amount of Notes to tender. Forward-Looking Statements This press release contains certain statements that may include forward-looking statements. All statements, other than statements of historical or present facts or conditions, included herein are forward-looking statements. Included among forward-looking statements are, among other things, statements regarding Cheniere Partners business strategy, plans and objectives, including statements regarding the intended conduct, timing and terms of the tender offer and consent solicitation, related financing plans and any future actions by Cheniere Partners in respect of the Notes. Although Cheniere Partners believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Cheniere Partners actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Cheniere Partners periodic reports that are filed with and available from the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, Cheniere Partners does not assume a duty to update these forward-looking statements.

edtsum7746

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WORTHINGTON, Ohio and MINERVA, Ohio, Dec. 29, 2020 /PRNewswire/ --CFBank, National Association ("CFBank") and Consumers National Bank ("Consumers") have announced the signing of a branch purchase and assumption agreement pursuant to which Consumers will acquire the Wellsville, Ohio drive-up branch and the Calcutta, Ohio branch of CFBank. The purchase and assumption agreement provides for the transfer by CFBank to Consumers of the land, buildings and other associated assets of the two branches, approximately $100 million in deposits, and certain loans and other interest earning assets. In exchange, Consumers will pay to CFBank the net book value of the land, building and associated assets of the branches, the par value of the earning assets, and a deposit premium equal to 1.75% of the average daily deposits for the 30 days preceding closing. The purchase of the branches by Consumers is subject to regulatory approval and satisfaction of certain customary closing conditions. The parties expect to close on the purchase and sale of the two CFBank branches in the second calendar quarter of 2021, at which point the branches will be converted to operate as Consumers branch offices.Consumers expects approximately 10% EPS accretion and to recover the initial approximately 2% tangible book value per share dilution in 1.75 years.On a pro forma basis, Consumers' total assets will approximate $850 million and its capital ratios are projected to remain strong and supportive of continued balance sheet growth. "The acquisition of these branches will strengthen our competitive position in Columbiana County and will complement our four Jefferson County locations.Consumers will hold approximately 12.5% of the Columbiana County deposit market share. These locations will house commercial and mortgage lenders and will provide a full range of consumer and business services. We are excited that the current retail employees in Wellsville and Calcutta will help us serve the region's consumer, small business, and agricultural communities.They, and their predecessors, have served the community since 1892. We look forward to them joining our team as we continue the community bank tradition in the region," said Ralph J. Lober II, Consumers' President and CEO. Tim O'Dell, President and CEO of CFBank, commented:"The divestiture of these two branches is consistent with our strategic business plan and the overarching objective to deploy capital into areas that yield the greatest opportunity to strengthen franchise value. The sale of the Columbiana County branches allows us to gain greater efficiencies in our core markets and to focus our sales efforts in those communities. CFBank traces our bank's founding to the Columbiana County region in 1892, and we will remain incredibly grateful to the people of this region for their loyal support extended to our bank for these many decades.However, we are pleased that Consumers Bank will be taking over the reins from CFBank to continue serving the banking needs of the Columbiana County region. Consumers Bank and its leadership highly value local communities and personal relationships in much the same way we do, and we are pleased and confident that our loyal CFBank employees and staff in Columbiana County will be in good hands, and the people of the Columbiana County region will continue to have their banking needs well served." Boenning & Scattergood, Inc. and Vorys, Sater, Seymour and Pease LLP are acting as financial advisor and legal advisor, respectively, to CFBank.Piper Sandler & Co. and Tucker Ellis LLP are acting as financial advisor and legal advisor, respectively, to Consumers. About CFBank:CFBank, National Association is the wholly-owned national bank subsidiary of CF Bankshares Inc. (NASDAQ: CFBK), a financial holding company headquartered in Columbus, Ohio.CFBank, which has operated in Ohio since 1892, has a presence in four major Metro Ohio markets Columbus, Cleveland, Cincinnati and Akron markets as well as its two locations in Columbiana County, Ohio. CFBank provides personalized Business Banking products and services including commercial loans and leases, commercial and residential real estate loans and treasury management depository services, corporate treasury management, residential lending, and full-service retail banking services and products.In addition, CFBank also has a national residential lending platform.Additional information about CF Bankshares Inc. and CFBank is available at www.CFBankOnline.com. About Consumers National Bank:Consumers National Bank is the single bank subsidiary of Consumers Bancorp Inc (OTCQX: CBKM). The $750 million asset independent community bank provides a comprehensive line of banking and other investment services to business and personal customers through its main office in Minerva, 17 full-service branch locations throughout Carroll, Columbiana, Jefferson, Stark, and Summit counties, and its Wayne County loan production office. More information about Consumers National Bank can be accessed online at www.ConsumersBank.com. Member FDIC. SOURCE CF Bankshares Inc. Related Links https://www.cfbankonline.com Answer:

CFBank And Consumers National Bank Enter Into Agreement For Consumers To Purchase CFBank's Two Columbiana County, Ohio Branches

WORTHINGTON, Ohio and MINERVA, Ohio, Dec. 29, 2020 /PRNewswire/ --CFBank, National Association ("CFBank") and Consumers National Bank ("Consumers") have announced the signing of a branch purchase and assumption agreement pursuant to which Consumers will acquire the Wellsville, Ohio drive-up branch and the Calcutta, Ohio branch of CFBank. The purchase and assumption agreement provides for the transfer by CFBank to Consumers of the land, buildings and other associated assets of the two branches, approximately $100 million in deposits, and certain loans and other interest earning assets. In exchange, Consumers will pay to CFBank the net book value of the land, building and associated assets of the branches, the par value of the earning assets, and a deposit premium equal to 1.75% of the average daily deposits for the 30 days preceding closing. The purchase of the branches by Consumers is subject to regulatory approval and satisfaction of certain customary closing conditions. The parties expect to close on the purchase and sale of the two CFBank branches in the second calendar quarter of 2021, at which point the branches will be converted to operate as Consumers branch offices.Consumers expects approximately 10% EPS accretion and to recover the initial approximately 2% tangible book value per share dilution in 1.75 years.On a pro forma basis, Consumers' total assets will approximate $850 million and its capital ratios are projected to remain strong and supportive of continued balance sheet growth. "The acquisition of these branches will strengthen our competitive position in Columbiana County and will complement our four Jefferson County locations.Consumers will hold approximately 12.5% of the Columbiana County deposit market share. These locations will house commercial and mortgage lenders and will provide a full range of consumer and business services. We are excited that the current retail employees in Wellsville and Calcutta will help us serve the region's consumer, small business, and agricultural communities.They, and their predecessors, have served the community since 1892. We look forward to them joining our team as we continue the community bank tradition in the region," said Ralph J. Lober II, Consumers' President and CEO. Tim O'Dell, President and CEO of CFBank, commented:"The divestiture of these two branches is consistent with our strategic business plan and the overarching objective to deploy capital into areas that yield the greatest opportunity to strengthen franchise value. The sale of the Columbiana County branches allows us to gain greater efficiencies in our core markets and to focus our sales efforts in those communities. CFBank traces our bank's founding to the Columbiana County region in 1892, and we will remain incredibly grateful to the people of this region for their loyal support extended to our bank for these many decades.However, we are pleased that Consumers Bank will be taking over the reins from CFBank to continue serving the banking needs of the Columbiana County region. Consumers Bank and its leadership highly value local communities and personal relationships in much the same way we do, and we are pleased and confident that our loyal CFBank employees and staff in Columbiana County will be in good hands, and the people of the Columbiana County region will continue to have their banking needs well served." Boenning & Scattergood, Inc. and Vorys, Sater, Seymour and Pease LLP are acting as financial advisor and legal advisor, respectively, to CFBank.Piper Sandler & Co. and Tucker Ellis LLP are acting as financial advisor and legal advisor, respectively, to Consumers. About CFBank:CFBank, National Association is the wholly-owned national bank subsidiary of CF Bankshares Inc. (NASDAQ: CFBK), a financial holding company headquartered in Columbus, Ohio.CFBank, which has operated in Ohio since 1892, has a presence in four major Metro Ohio markets Columbus, Cleveland, Cincinnati and Akron markets as well as its two locations in Columbiana County, Ohio. CFBank provides personalized Business Banking products and services including commercial loans and leases, commercial and residential real estate loans and treasury management depository services, corporate treasury management, residential lending, and full-service retail banking services and products.In addition, CFBank also has a national residential lending platform.Additional information about CF Bankshares Inc. and CFBank is available at www.CFBankOnline.com. About Consumers National Bank:Consumers National Bank is the single bank subsidiary of Consumers Bancorp Inc (OTCQX: CBKM). The $750 million asset independent community bank provides a comprehensive line of banking and other investment services to business and personal customers through its main office in Minerva, 17 full-service branch locations throughout Carroll, Columbiana, Jefferson, Stark, and Summit counties, and its Wayne County loan production office. More information about Consumers National Bank can be accessed online at www.ConsumersBank.com. Member FDIC. SOURCE CF Bankshares Inc. Related Links https://www.cfbankonline.com

edtsum7747

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "UAE Air Purifier Market (2020-2026): Market Forecast by Technology, by Applications, by CADR Values, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. UAE Air Purifier Market size is projected to grow at a CAGR of 11.9% during 2020-2026. UAE air purifier market is anticipated to register significant growth during the forecast period on account of deteriorating air quality due to growing urbanization, an increasing number of vehicles on roads, and an expanding industrial sector in the country. Additionally, particulate matter, which is present in high concentrations in arid, desert areas such as the United Arab Emirates, is associated with chronic respiratory diseases and increases the mortality rates of these diseases. The growing awareness among people about the harmful health effects of air pollutants would propel the demand for air purifiers in the country over the coming years. The air quality in the United Arab Emirates is deemed unsafe based on guidelines issued by the World Health Organization. In 2019, the PM2.5 concentration in the country was approximately 3 times above the WHO exposure recommendation of 10g/m. Government initiatives and corporate efforts to increase awareness about the importance of clean air quality among people would drive the demand for air purifiers in the country over the coming years. Furthermore, people in the UAE tend to spend more time indoors to avoid the heat, thereby propelling concerns about indoor air quality, which would, in turn, bolster the air purifier market in the country during the forecast period. The coronavirus pandemic is expected to restrict the growth of the air purifier market in the country in 2020, owing to supply chain disruptions, the slowdown of commercial and industrial activities and the unwillingness of people to spend on unessential goods. However, the resumption of commercial and industrial operations, combined with increasing apprehensions among people about health and communicable diseases would drive the market recovery over the coming years. Based on technology, Type-I air purifiers acquired the majority share in the overall market in revenue terms in 2019 and is expected to maintain its position over the coming years on account of the improved cost/efficiency ratio offered by it, compared to other technologies. Additionally, Type-I air purifiers are expected to witness considerable growth in demand, owing to the preference of people in a relatively new air purifier market to opt for entry level products. Moreover, the demand for air purifiers from residential and commercial sectors is projected to grow substantially, on account of rising health concerns in households, as well as growing requirement for healthy working conditions in commercial spaces including hospitals and schools. The UAE Air Purifier market report thoroughly covers the market by technology, applications, and CADR values. The UAE air purifier market outlook report provides an unbiased and detailed analysis of the UAE air purifier market trends, opportunities/high growth areas, market drivers which would help the stakeholders to device and align their market strategies according to the current and future market dynamics. Key Highlights of the Report: Markets Covered UAE Air Purifier market report provides a detailed analysis of the following market segments: By Technology: By CADR Value: By Applications: Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/r650m Answer:

UAE Air Purifier Market Report 2020-2026: Market Forecast by Technology, Applications, CADR Values and Competitive Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UAE Air Purifier Market (2020-2026): Market Forecast by Technology, by Applications, by CADR Values, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. UAE Air Purifier Market size is projected to grow at a CAGR of 11.9% during 2020-2026. UAE air purifier market is anticipated to register significant growth during the forecast period on account of deteriorating air quality due to growing urbanization, an increasing number of vehicles on roads, and an expanding industrial sector in the country. Additionally, particulate matter, which is present in high concentrations in arid, desert areas such as the United Arab Emirates, is associated with chronic respiratory diseases and increases the mortality rates of these diseases. The growing awareness among people about the harmful health effects of air pollutants would propel the demand for air purifiers in the country over the coming years. The air quality in the United Arab Emirates is deemed unsafe based on guidelines issued by the World Health Organization. In 2019, the PM2.5 concentration in the country was approximately 3 times above the WHO exposure recommendation of 10g/m. Government initiatives and corporate efforts to increase awareness about the importance of clean air quality among people would drive the demand for air purifiers in the country over the coming years. Furthermore, people in the UAE tend to spend more time indoors to avoid the heat, thereby propelling concerns about indoor air quality, which would, in turn, bolster the air purifier market in the country during the forecast period. The coronavirus pandemic is expected to restrict the growth of the air purifier market in the country in 2020, owing to supply chain disruptions, the slowdown of commercial and industrial activities and the unwillingness of people to spend on unessential goods. However, the resumption of commercial and industrial operations, combined with increasing apprehensions among people about health and communicable diseases would drive the market recovery over the coming years. Based on technology, Type-I air purifiers acquired the majority share in the overall market in revenue terms in 2019 and is expected to maintain its position over the coming years on account of the improved cost/efficiency ratio offered by it, compared to other technologies. Additionally, Type-I air purifiers are expected to witness considerable growth in demand, owing to the preference of people in a relatively new air purifier market to opt for entry level products. Moreover, the demand for air purifiers from residential and commercial sectors is projected to grow substantially, on account of rising health concerns in households, as well as growing requirement for healthy working conditions in commercial spaces including hospitals and schools. The UAE Air Purifier market report thoroughly covers the market by technology, applications, and CADR values. The UAE air purifier market outlook report provides an unbiased and detailed analysis of the UAE air purifier market trends, opportunities/high growth areas, market drivers which would help the stakeholders to device and align their market strategies according to the current and future market dynamics. Key Highlights of the Report: Markets Covered UAE Air Purifier market report provides a detailed analysis of the following market segments: By Technology: By CADR Value: By Applications: Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/r650m

edtsum7748

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SEATTLE--(BUSINESS WIRE)--Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that Thomson Reuters, a leading global provider of business information services, has successfully completed a large scale migration to AWS a critical part of their digital transformation strategy which will enable the company to innovate faster, develop and act on new insights, and become a more agile business in the cloud. As part of its ongoing move to the cloud, Thomson Reuters migrated thousands of servers and hundreds of revenue-generating applications to AWS. Expanding its longstanding relationship with AWS, Thomson Reuters is also leveraging AWSs unparalleled portfolio of cloud services including analytics, database, containers, serverless, storage, machine learning, and security to innovate new digital products for its customers and reveal greater insights into the industries it covers. Thomson Reuters provides highly specialized information-enabled software and tools for legal, tax, accounting, and compliance professionals, combined with Reuters, the worlds global news service. Across these sectors, its products and tools help professionals better understand their industries, streamline operations, increase efficiencies, and mitigate risk. In 2018, Thomson Reuters partnered with AWS Professional Services, AWS Managed Services (where AWS operates infrastructure on a customer's behalf), and AWS Certified third-party experts from multiple consulting partners who provided hands-on expertise, day-to-day infrastructure management, and cost optimization. The decision to use these AWS resources enabled Thomson Reuters to complete this migration project five months ahead of schedule. By leveraging AWS Managed Services, Thomson Reuters moved hundreds of mission-critical, legacy applications from across their global business units to the cloud and into production quickly. To further streamline this migration, Thomson Reuters leveraged the AWS Marketplace to access simplified software contracting services to rapidly procure and integrate their preferred third-party software into their AWS environment. Additionally, Thomson Reuters has developed an internal platform to apply machine learning at scale using Amazon SageMaker AWSs service for building, training, and deploying machine learning models in the cloud and on the edge to help developers and data scientists quickly gain new insights from real-time and historical data in a fully managed and secure environment. The platform saves developers and data scientists countless hours of coding by providing all of the components used for machine learning in a single toolset so models get to production faster with much less effort and at a lower cost, enabling Thomson Reuters to deliver new, intelligent solutions for their customers. Thomson Reuters uses Amazon SageMaker to automatically shut down GPU instances when a training job is done and leverages Amazon Elastic Compute Cloud (Amazon EC2) Spot Instances unused EC2 capacity that is available at up to a 90% discount compared to On-Demand prices to reduce the cost of machine learning model inference. Thomson Reuters provides the intelligence, technology, and expertise that our customers need to solve their toughest regulatory, legal, and compliance challenges, said Justin Wright, Vice President of Architecture and Development, Thomson Reuters. Were leveraging AWSs comprehensive set of cloud services to develop insightful new products and services that will help our customers reinvent the way they work and operate effectively in complex arenas. AWS is a trusted resource for us especially AWS Managed Services and AWS Professional Services providing the expertise to accelerate our move to cloud and helped migrate data centers ahead of schedule. Thomson Reuters is using the cloud to put accurate data and information into the hands of professionals across the legal, tax and accounting, and news industries to make important and timely decisions, said Greg Pearson, Vice President, Worldwide Commercial Sales at Amazon Web Services, Inc. By leveraging AWSs depth and breadth of services with the expertise of AWS Managed Services, Thomson Reuters is able to eliminate the heavy lifting of managing infrastructure operations and focus on innovating new ways to deliver in-depth information and digital solutions to deliver new and timely insights to customers around the world. About Amazon Web Services For 14 years, Amazon Web Services has been the worlds most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 77 Availability Zones (AZs) within 24 geographic regions, with announced plans for 18 more Availability Zones and six more AWS Regions in Australia, India, Indonesia, Japan, Spain, and Switzerland. Millions of customersincluding the fastest-growing startups, largest enterprises, and leading government agenciestrust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com. About Amazon Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are just some of the products and services pioneered by Amazon. For more information visit www.amazon.com/about and follow @AmazonNews. Answer:

Thomson Reuters Taps AWS to Power Digital Transformation Leading provider of business information services taps AWS to drive large-scale migration to cloud, driving innovation and adopting machine learning across its business

SEATTLE--(BUSINESS WIRE)--Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that Thomson Reuters, a leading global provider of business information services, has successfully completed a large scale migration to AWS a critical part of their digital transformation strategy which will enable the company to innovate faster, develop and act on new insights, and become a more agile business in the cloud. As part of its ongoing move to the cloud, Thomson Reuters migrated thousands of servers and hundreds of revenue-generating applications to AWS. Expanding its longstanding relationship with AWS, Thomson Reuters is also leveraging AWSs unparalleled portfolio of cloud services including analytics, database, containers, serverless, storage, machine learning, and security to innovate new digital products for its customers and reveal greater insights into the industries it covers. Thomson Reuters provides highly specialized information-enabled software and tools for legal, tax, accounting, and compliance professionals, combined with Reuters, the worlds global news service. Across these sectors, its products and tools help professionals better understand their industries, streamline operations, increase efficiencies, and mitigate risk. In 2018, Thomson Reuters partnered with AWS Professional Services, AWS Managed Services (where AWS operates infrastructure on a customer's behalf), and AWS Certified third-party experts from multiple consulting partners who provided hands-on expertise, day-to-day infrastructure management, and cost optimization. The decision to use these AWS resources enabled Thomson Reuters to complete this migration project five months ahead of schedule. By leveraging AWS Managed Services, Thomson Reuters moved hundreds of mission-critical, legacy applications from across their global business units to the cloud and into production quickly. To further streamline this migration, Thomson Reuters leveraged the AWS Marketplace to access simplified software contracting services to rapidly procure and integrate their preferred third-party software into their AWS environment. Additionally, Thomson Reuters has developed an internal platform to apply machine learning at scale using Amazon SageMaker AWSs service for building, training, and deploying machine learning models in the cloud and on the edge to help developers and data scientists quickly gain new insights from real-time and historical data in a fully managed and secure environment. The platform saves developers and data scientists countless hours of coding by providing all of the components used for machine learning in a single toolset so models get to production faster with much less effort and at a lower cost, enabling Thomson Reuters to deliver new, intelligent solutions for their customers. Thomson Reuters uses Amazon SageMaker to automatically shut down GPU instances when a training job is done and leverages Amazon Elastic Compute Cloud (Amazon EC2) Spot Instances unused EC2 capacity that is available at up to a 90% discount compared to On-Demand prices to reduce the cost of machine learning model inference. Thomson Reuters provides the intelligence, technology, and expertise that our customers need to solve their toughest regulatory, legal, and compliance challenges, said Justin Wright, Vice President of Architecture and Development, Thomson Reuters. Were leveraging AWSs comprehensive set of cloud services to develop insightful new products and services that will help our customers reinvent the way they work and operate effectively in complex arenas. AWS is a trusted resource for us especially AWS Managed Services and AWS Professional Services providing the expertise to accelerate our move to cloud and helped migrate data centers ahead of schedule. Thomson Reuters is using the cloud to put accurate data and information into the hands of professionals across the legal, tax and accounting, and news industries to make important and timely decisions, said Greg Pearson, Vice President, Worldwide Commercial Sales at Amazon Web Services, Inc. By leveraging AWSs depth and breadth of services with the expertise of AWS Managed Services, Thomson Reuters is able to eliminate the heavy lifting of managing infrastructure operations and focus on innovating new ways to deliver in-depth information and digital solutions to deliver new and timely insights to customers around the world. About Amazon Web Services For 14 years, Amazon Web Services has been the worlds most comprehensive and broadly adopted cloud platform. AWS offers over 175 fully featured services for compute, storage, databases, networking, analytics, robotics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 77 Availability Zones (AZs) within 24 geographic regions, with announced plans for 18 more Availability Zones and six more AWS Regions in Australia, India, Indonesia, Japan, Spain, and Switzerland. Millions of customersincluding the fastest-growing startups, largest enterprises, and leading government agenciestrust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com. About Amazon Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Fire tablets, Fire TV, Amazon Echo, and Alexa are just some of the products and services pioneered by Amazon. For more information visit www.amazon.com/about and follow @AmazonNews.

edtsum7749

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ALEXANDRIA, Va., May 28, 2020 /PRNewswire/ --Research Innovations, Inc., a technology solutions company with expertise in big data analytics and artificial intelligence, announced its receipt of a Call Order to provide advanced data analytics technology to the Department of Justice's (DOJ's) Money Laundering and Asset Recovery Section (MLARS).RII's team will provide both technology and subject matter experts to help DOJ investigators and attorneys integrate and understand the department's complex and expansive data.Working directly with DOJ end users, the RII team will enable investigative teams to quickly identify and explore connections and patterns that indicate suspicious financial activities. The RII Team, which is comprised of RII, Eastport Analytics, DataWalk, BreakForth Solutions, and Ernst & Young,will apply its Search and Investigative Flexible Toolkit (SIFT) technology.SIFT is a comprehensive and agile technology platform that ingests and integrates massive amounts of structured and unstructured data.It performs advanced data analytics, creates actionable intelligence for planning, law enforcement, and crime prevention, and securely and collaboratively shares results within and across investigative teams.The intuitive user experience of DataWalk and other SIFT components were critical factors in securing this award. This project brings RII's cutting-edge solutions to a new set of customers, growing its impact across industries and around the world.Ellen Minderman, RII's VP of Special Programs and Operations commented that "the RII Team has proven expertise in deploying SIFT's advanced technologies in the law enforcement, military, intelligence, financial services, insurance, legal and healthcare environments. We are excited to bring our team's SIFT technology to the DOJ and look forward to leveraging its advanced capability and cost-effectiveness to a wide range of additional DOJ requirements going forward."Jack Harrington, RII's CEO, cited the company's core purpose in demonstrating his enthusiasm for the new opportunity, saying, "RII's core purpose is to create RIIdiculously Awesome solutions that make the world safer, and we're excited for this opportunity to work with new partners and to apply our capabilities to DOJ's data analytics challenges." This call order was competitively awarded under the DOJ's Data Analytics Solutions and Services Blanket Purchase Agreement. With offices nationwide, as well as staff embedded with key customers globally, RII supports critical defense, intelligence, cyber, and law enforcement customers across the U.S. Government and with select international customers.RII rapidly delivers transformative technology to customers and end-users to achieve its core purpose of "Creating RIIdiculously AwesomeTM solutions that make the world safer."Visit www.researchinnovations.com for more information. SOURCE Research Innovations, Inc. SOURCE Research Innovations, Inc. Related Links http://www.researchinnovations.com Answer:

Research Innovations, Inc. wins Call Order to deliver advanced data analytics to the Department of Justice's Money Laundering and Asset Recovery Section (MLARS) The Research Innovations Inc. (RII) team will deploy its flexible data analytics framework SIFTTM to support the Criminal Division's urgent and complex investigative needs, replacing Palantir as the incumbent solution provider.

ALEXANDRIA, Va., May 28, 2020 /PRNewswire/ --Research Innovations, Inc., a technology solutions company with expertise in big data analytics and artificial intelligence, announced its receipt of a Call Order to provide advanced data analytics technology to the Department of Justice's (DOJ's) Money Laundering and Asset Recovery Section (MLARS).RII's team will provide both technology and subject matter experts to help DOJ investigators and attorneys integrate and understand the department's complex and expansive data.Working directly with DOJ end users, the RII team will enable investigative teams to quickly identify and explore connections and patterns that indicate suspicious financial activities. The RII Team, which is comprised of RII, Eastport Analytics, DataWalk, BreakForth Solutions, and Ernst & Young,will apply its Search and Investigative Flexible Toolkit (SIFT) technology.SIFT is a comprehensive and agile technology platform that ingests and integrates massive amounts of structured and unstructured data.It performs advanced data analytics, creates actionable intelligence for planning, law enforcement, and crime prevention, and securely and collaboratively shares results within and across investigative teams.The intuitive user experience of DataWalk and other SIFT components were critical factors in securing this award. This project brings RII's cutting-edge solutions to a new set of customers, growing its impact across industries and around the world.Ellen Minderman, RII's VP of Special Programs and Operations commented that "the RII Team has proven expertise in deploying SIFT's advanced technologies in the law enforcement, military, intelligence, financial services, insurance, legal and healthcare environments. We are excited to bring our team's SIFT technology to the DOJ and look forward to leveraging its advanced capability and cost-effectiveness to a wide range of additional DOJ requirements going forward."Jack Harrington, RII's CEO, cited the company's core purpose in demonstrating his enthusiasm for the new opportunity, saying, "RII's core purpose is to create RIIdiculously Awesome solutions that make the world safer, and we're excited for this opportunity to work with new partners and to apply our capabilities to DOJ's data analytics challenges." This call order was competitively awarded under the DOJ's Data Analytics Solutions and Services Blanket Purchase Agreement. With offices nationwide, as well as staff embedded with key customers globally, RII supports critical defense, intelligence, cyber, and law enforcement customers across the U.S. Government and with select international customers.RII rapidly delivers transformative technology to customers and end-users to achieve its core purpose of "Creating RIIdiculously AwesomeTM solutions that make the world safer."Visit www.researchinnovations.com for more information. SOURCE Research Innovations, Inc. SOURCE Research Innovations, Inc. Related Links http://www.researchinnovations.com

edtsum7750

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC) announced today that management is scheduled to participate in the virtual Southwest IDEAS Investor Conference taking place on November 18 and 19, 2020. Intevacs presentation will be available via webcast starting at 7:00 am CST on November 18th. The presentation may be accessed through the Southwest IDEAS conference portal for registered participants, in the investor relations section of the Companys investor relations website: https://ir.intevac.com, and on the IDEAS conference website: www.IDEASconferences.com. About Intevac Intevac was founded in 1991 and has two businesses: Thin-film Equipment and Photonics. In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently. In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs. For more information, call 408-986-9888 or visit the Company's website at www.intevac.com. Answer:

Intevac Announces Participation in Virtual Southwest IDEAS Investor Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--Intevac, Inc. (Nasdaq: IVAC) announced today that management is scheduled to participate in the virtual Southwest IDEAS Investor Conference taking place on November 18 and 19, 2020. Intevacs presentation will be available via webcast starting at 7:00 am CST on November 18th. The presentation may be accessed through the Southwest IDEAS conference portal for registered participants, in the investor relations section of the Companys investor relations website: https://ir.intevac.com, and on the IDEAS conference website: www.IDEASconferences.com. About Intevac Intevac was founded in 1991 and has two businesses: Thin-film Equipment and Photonics. In our Thin-film Equipment business, we are a leader in the design and development of high-productivity, thin-film processing systems. Our production-proven platforms are designed for high-volume manufacturing of substrates with precise thin film properties, such as the hard drive media, display cover panel, and solar photovoltaic markets we serve currently. In our Photonics business, we are a recognized leading developer of advanced high-sensitivity digital sensors, cameras and systems that primarily serve the defense industry. We are the provider of integrated digital imaging systems for most U.S. military night vision programs. For more information, call 408-986-9888 or visit the Company's website at www.intevac.com.

edtsum7751

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Intelligent, Autonomous & Secure Car Report Portfolio" report has been added to ResearchAndMarkets.com's offering. Our Intelligent, Secure & Autonomous car report portfolio delivers the strategy and roadmap of 30 carmakers to reach Full-automation with detailed deployment forecasts in Europe, USA, China and Japan, segmented into driving and parking features. It also provides analysis and rankings of the capabilities of major Tier1 Suppliers of ADAS sensors and features with forward-looking ranking of ADAS leadership, such as technology and AD revenues. Finally, we map the evolution of regulation for Connected and Automated Driving as well as cyber security to give guidance on how to avoid techno-commercial roadblocks. Key Topics Covered: The Intelligent, Autonomous & Secure Car portfolio is priced at 10,000, providing savings of 28% for the 4 reports: 1) 30 Carmakers' Roadmaps in Automated Driving up to 2025: leading carmakers' roadmap and strategy to commercialize Autonomous Driving (individually priced at 5,000) 2) Automotive Cyber Security Market Forecast: the secure Connected Car (3,259) 3) Regulatory guide to Autonomous Driving, Automotive Cyber Security & V2X (2,699) 4) Rankings and market shares of Top Tier-1 ADAS Suppliers by 2020 (2,799) Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/b4cv20 Answer:

2020 Intelligent, Autonomous & Secure Car Report Portfolio - Rankings and Market Shares of Top Tier Suppliers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intelligent, Autonomous & Secure Car Report Portfolio" report has been added to ResearchAndMarkets.com's offering. Our Intelligent, Secure & Autonomous car report portfolio delivers the strategy and roadmap of 30 carmakers to reach Full-automation with detailed deployment forecasts in Europe, USA, China and Japan, segmented into driving and parking features. It also provides analysis and rankings of the capabilities of major Tier1 Suppliers of ADAS sensors and features with forward-looking ranking of ADAS leadership, such as technology and AD revenues. Finally, we map the evolution of regulation for Connected and Automated Driving as well as cyber security to give guidance on how to avoid techno-commercial roadblocks. Key Topics Covered: The Intelligent, Autonomous & Secure Car portfolio is priced at 10,000, providing savings of 28% for the 4 reports: 1) 30 Carmakers' Roadmaps in Automated Driving up to 2025: leading carmakers' roadmap and strategy to commercialize Autonomous Driving (individually priced at 5,000) 2) Automotive Cyber Security Market Forecast: the secure Connected Car (3,259) 3) Regulatory guide to Autonomous Driving, Automotive Cyber Security & V2X (2,699) 4) Rankings and market shares of Top Tier-1 ADAS Suppliers by 2020 (2,799) Companies Mentioned For more information about this report visit https://www.researchandmarkets.com/r/b4cv20

edtsum7752

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WASHINGTON, March 4, 2021 /PRNewswire/ --While there are many research studies that reveal consumers' desire to buy products and services from companies that are having a positive impact on the world (Zeno Group's 2020 Strength of Purpose study, 2018 Cone-Porter Novelli Purpose Study), there are fewer studies connecting consumers' likelihood to purchase with specific causes in specific industries. In January, 2021, Cause Partners, a cause marketing consultancy, commissioned The Harris Poll to conduct a survey that investigated whether Americans who purchase prescription eyeglasses or contact lenses would be more likely to buy from a company that supported a specific cause. The online poll, which surveyed over 1,400 prescription eyewear purchasers, revealedthat 85% of consumers would be more likely to buy eyewear from a company if that company was involved in an effort to prevent childhood blindness. "This data further validates consumers' interest in companies that give back", said Dan Cohen, President of Cause Partners. "The numbers are clearsupporting a cause can achieve better business and greater good." These findings can help optical industry retailers align with a cause that strongly resonates with their customers. In addition to benefitting retailers, other companies and brands in the optical industry can look to this survey as evidence that consumers would strongly approve of any efforts undertaken to support the prevention of childhood blindness. Survey Method:This survey was conducted online within the United States by The Harris Poll on behalf ofCause Partnersfrom January 12-14, 2021 among 2,065U.S.adults ages 18 and older, among whom 1,482 purchase prescription eyeglasses or contact lenses. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contactDan Cohen, President, Cause Partners: [emailprotected] About Cause Partners:Cause Partners is a boutique corporate and cause marketing consultancy based in Washington, D.C. Our decades of experience generating millions of dollars in revenue for both nonprofits and for-profits makes us uniquely qualified to bring the two worlds together in partnerships that do well and do good. Learn more at www.causepartners.com. About The Harris PollThe Harris Poll is one of the longest running surveys in the U.S. tracking public opinion, motivations and social sentiment since 1963 that is now part of Harris Insights & Analytics, a global consulting and market research firm. We strive to reveal the authentic values of modern society to inspire leaders to create a better tomorrow. We work with clients in three primary areas; building twenty-first-century corporate reputation, crafting brand strategy and performance tracking, and earning organic media through public relations research. Our mission is to provide insights and advisory to help leaders make the best decisions possible. Learn more at www.theharrispoll.com. Contact: Dan Cohen, [emailprotected] SOURCE Cause Partners Related Links https://www.causepartners.com Answer:

New survey reveals 85% of prescription eyewear consumers more likely to buy from a company that supports the prevention of childhood blindness Latest Consumer Research Provides Valuable Insight for Optical Industry Companies

WASHINGTON, March 4, 2021 /PRNewswire/ --While there are many research studies that reveal consumers' desire to buy products and services from companies that are having a positive impact on the world (Zeno Group's 2020 Strength of Purpose study, 2018 Cone-Porter Novelli Purpose Study), there are fewer studies connecting consumers' likelihood to purchase with specific causes in specific industries. In January, 2021, Cause Partners, a cause marketing consultancy, commissioned The Harris Poll to conduct a survey that investigated whether Americans who purchase prescription eyeglasses or contact lenses would be more likely to buy from a company that supported a specific cause. The online poll, which surveyed over 1,400 prescription eyewear purchasers, revealedthat 85% of consumers would be more likely to buy eyewear from a company if that company was involved in an effort to prevent childhood blindness. "This data further validates consumers' interest in companies that give back", said Dan Cohen, President of Cause Partners. "The numbers are clearsupporting a cause can achieve better business and greater good." These findings can help optical industry retailers align with a cause that strongly resonates with their customers. In addition to benefitting retailers, other companies and brands in the optical industry can look to this survey as evidence that consumers would strongly approve of any efforts undertaken to support the prevention of childhood blindness. Survey Method:This survey was conducted online within the United States by The Harris Poll on behalf ofCause Partnersfrom January 12-14, 2021 among 2,065U.S.adults ages 18 and older, among whom 1,482 purchase prescription eyeglasses or contact lenses. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contactDan Cohen, President, Cause Partners: [emailprotected] About Cause Partners:Cause Partners is a boutique corporate and cause marketing consultancy based in Washington, D.C. Our decades of experience generating millions of dollars in revenue for both nonprofits and for-profits makes us uniquely qualified to bring the two worlds together in partnerships that do well and do good. Learn more at www.causepartners.com. About The Harris PollThe Harris Poll is one of the longest running surveys in the U.S. tracking public opinion, motivations and social sentiment since 1963 that is now part of Harris Insights & Analytics, a global consulting and market research firm. We strive to reveal the authentic values of modern society to inspire leaders to create a better tomorrow. We work with clients in three primary areas; building twenty-first-century corporate reputation, crafting brand strategy and performance tracking, and earning organic media through public relations research. Our mission is to provide insights and advisory to help leaders make the best decisions possible. Learn more at www.theharrispoll.com. Contact: Dan Cohen, [emailprotected] SOURCE Cause Partners Related Links https://www.causepartners.com

edtsum7753

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SALEM, N.H., Aug. 18, 2020 /PRNewswire/ --Standex International Corporation (NYSE:SXI) will announce its fourth quarter fiscal 2020 financial results on Monday, August 24, 2020 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Tuesday, August 25, 2020. On the call, David Dunbar, Chairman, President & CEO, and Ademir Sarcevic, Vice President, CFO & Treasurer, will review the Company's fourth quarter financial results, business highlights and outlook. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located atwww.standex.com. A replay of the webcast also will be available on the Company's web site shortly after the conclusion of the presentation. About Standex Standex International Corporation is a global multi-industry manufacturer in five broad business segments: Engraving, Electronics, Engineering Technologies, Hydraulics and Food Service Equipment with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Brazil, Turkey, South Africa, India and China. For additional information, visit the Company's website at www.standex.com. SOURCE Standex International Corporation Related Links www.standex.com Answer:

Standex Announces Timing of Fourth Quarter Fiscal 2020 Results

SALEM, N.H., Aug. 18, 2020 /PRNewswire/ --Standex International Corporation (NYSE:SXI) will announce its fourth quarter fiscal 2020 financial results on Monday, August 24, 2020 after the close of the market and will broadcast its conference call live over the Internet at 8:30 a.m. ET on Tuesday, August 25, 2020. On the call, David Dunbar, Chairman, President & CEO, and Ademir Sarcevic, Vice President, CFO & Treasurer, will review the Company's fourth quarter financial results, business highlights and outlook. Investors interested in listening to the webcast and viewing the slide presentation should log on to the "Investors" section of Standex's website under the subheading, "Events and Presentations," located atwww.standex.com. A replay of the webcast also will be available on the Company's web site shortly after the conclusion of the presentation. About Standex Standex International Corporation is a global multi-industry manufacturer in five broad business segments: Engraving, Electronics, Engineering Technologies, Hydraulics and Food Service Equipment with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Brazil, Turkey, South Africa, India and China. For additional information, visit the Company's website at www.standex.com. SOURCE Standex International Corporation Related Links www.standex.com

edtsum7754

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: --(BUSINESS WIRE)--()-- (Womens Entrepreneurship Accelerator, WEA)1000 COVID-1939%54%2030GDP131 COVID-19 Anita Bhatia Pamela Coke-Hamilton (ITC) Annemarie Hou Deborah Gibbins (Mary Kay Inc.)(UN Women)(UNOP)(ILO)(ITC)(UNGC)(UNDP)20301000 https://www.we-accelerate.com/Twitter (We_Accelerator)Instagram (@we_accelerator)Facebook (@womensentrepreneurshipaccelerator) 2030 (ITC)ITC ITCSheTrades2021300SheTradeswww.shetrades.comwww.intracen.orgTwitter | Facebook | LinkedIn | Instagram | FlickrITC (ILO)1919ILOILO ILO(ILO-WED)(SME)ILO-WEDILOwww.ilo.org | Twitter - @ILOWED | Facebook ILO WED 20001603,00060 @globalcompactunglobalcompact.org (UNOP) (United Nations Fund for International Partnerships)(United Nations Democracy Fund)(SDG Action Hub)(Secretary-Generals SDG Advocates)https://www.un.org/partnerships/ 5740www.marykay.com 1COVID-19(COVID-19 and gender equality: Countering the regressive effects)Anu MadgavkarOlivia WhiteMekala KrishnanDeepa MahajanXavier Azcue20207 2(UNDP)COVID-19COVID-19https://www.undp.org/content/undp/en/home/covid-19-gender-dashboard.html 3COVID-19p.2https://www.empowerwomen.org/en/resources/documents/2020/09/strengthening-support-for-women-entrepreneurs-in-covid-19-response-and-recovery?lang=en businesswire.comhttps://www.businesswire.com/news/home/20200924005283/en/ Answer:

--(BUSINESS WIRE)--()-- (Womens Entrepreneurship Accelerator, WEA)1000 COVID-1939%54%2030GDP131 COVID-19 Anita Bhatia Pamela Coke-Hamilton (ITC) Annemarie Hou Deborah Gibbins (Mary Kay Inc.)(UN Women)(UNOP)(ILO)(ITC)(UNGC)(UNDP)20301000 https://www.we-accelerate.com/Twitter (We_Accelerator)Instagram (@we_accelerator)Facebook (@womensentrepreneurshipaccelerator) 2030 (ITC)ITC ITCSheTrades2021300SheTradeswww.shetrades.comwww.intracen.orgTwitter | Facebook | LinkedIn | Instagram | FlickrITC (ILO)1919ILOILO ILO(ILO-WED)(SME)ILO-WEDILOwww.ilo.org | Twitter - @ILOWED | Facebook ILO WED 20001603,00060 @globalcompactunglobalcompact.org (UNOP) (United Nations Fund for International Partnerships)(United Nations Democracy Fund)(SDG Action Hub)(Secretary-Generals SDG Advocates)https://www.un.org/partnerships/ 5740www.marykay.com 1COVID-19(COVID-19 and gender equality: Countering the regressive effects)Anu MadgavkarOlivia WhiteMekala KrishnanDeepa MahajanXavier Azcue20207 2(UNDP)COVID-19COVID-19https://www.undp.org/content/undp/en/home/covid-19-gender-dashboard.html 3COVID-19p.2https://www.empowerwomen.org/en/resources/documents/2020/09/strengthening-support-for-women-entrepreneurs-in-covid-19-response-and-recovery?lang=en businesswire.comhttps://www.businesswire.com/news/home/20200924005283/en/

edtsum7755

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BIRMINGHAM, Ala., Feb. 11, 2021 /PRNewswire/ --Hibbett Sports (NASDAQ:HIBB), the Birmingham-based premium athleisure and footwear retailer operating more than 1,000 stores nationwide, today announced the opening of the newest Hibbett Sports location in Columbia, located at; 2734 Decker Blvd in the Fashion Place Shopping Center. "We are excited to expand our brand in the Columbia community and welcome sneakerheads, families and sports enthusiasts alike into our new store," said Ricardo Rawlinson, Head Coach, Hibbett Sports. The new 5,000 square foot boutique-style store featuresan open-concept and easy navigation of newly released, exclusive and hard-to-find footwear, athletic apparel and equipment from brands like Nike, Jordan, adidas and more.The unique store design includes multiple mannequins showcasing stylist curated head-to-toe outfits to inspire customers while they shop. There are also phone charging stations and other upscale amenities for customers to enjoy along with the exceptional customer service Hibbett is known for. The new store offers convenient shopping options such as; such as Buy Online Pick Up In Store, Reserve Online Pick Up In Store and Curbside Pick Up, making it easy for consumers to find exactly what they want, when they want it. This is the second Hibbett Sports location in Columbia and thepublic is invited to attend a Grand Opening party on February 13, 2021 from 11am 1pm. There will be door prizes, special promotions and fun for all. About Hibbett Sports Hibbett, headquartered in Birmingham, Alabama, is a leading athletic-inspired fashion retailer with nearly 1,100 Hibbett Sports and City Gear specialty stores, located in 35 states nationwide. Hibbett has a rich history of serving customers for more than 75 years with convenient locations, personalized service and access to coveted footwear, apparel and equipment from top brands like Nike, Jordan, and adidas. Consumers can browse styles, find new releases, shop looks and make purchases online or in their nearest store by visitingwww.hibbett.com.Follow us on Facebook, Instagram and Twitter @hibbettsports and @citygear. Media Contact: Wendy Yellin Phone: 925-519-3363 email: [emailprotected] or [emailprotected] SOURCE Hibbett Sporting Goods Inc. Related Links http://www.hibbett.com Answer:

Newest Hibbett Sports Now Open For Business In Columbia

BIRMINGHAM, Ala., Feb. 11, 2021 /PRNewswire/ --Hibbett Sports (NASDAQ:HIBB), the Birmingham-based premium athleisure and footwear retailer operating more than 1,000 stores nationwide, today announced the opening of the newest Hibbett Sports location in Columbia, located at; 2734 Decker Blvd in the Fashion Place Shopping Center. "We are excited to expand our brand in the Columbia community and welcome sneakerheads, families and sports enthusiasts alike into our new store," said Ricardo Rawlinson, Head Coach, Hibbett Sports. The new 5,000 square foot boutique-style store featuresan open-concept and easy navigation of newly released, exclusive and hard-to-find footwear, athletic apparel and equipment from brands like Nike, Jordan, adidas and more.The unique store design includes multiple mannequins showcasing stylist curated head-to-toe outfits to inspire customers while they shop. There are also phone charging stations and other upscale amenities for customers to enjoy along with the exceptional customer service Hibbett is known for. The new store offers convenient shopping options such as; such as Buy Online Pick Up In Store, Reserve Online Pick Up In Store and Curbside Pick Up, making it easy for consumers to find exactly what they want, when they want it. This is the second Hibbett Sports location in Columbia and thepublic is invited to attend a Grand Opening party on February 13, 2021 from 11am 1pm. There will be door prizes, special promotions and fun for all. About Hibbett Sports Hibbett, headquartered in Birmingham, Alabama, is a leading athletic-inspired fashion retailer with nearly 1,100 Hibbett Sports and City Gear specialty stores, located in 35 states nationwide. Hibbett has a rich history of serving customers for more than 75 years with convenient locations, personalized service and access to coveted footwear, apparel and equipment from top brands like Nike, Jordan, and adidas. Consumers can browse styles, find new releases, shop looks and make purchases online or in their nearest store by visitingwww.hibbett.com.Follow us on Facebook, Instagram and Twitter @hibbettsports and @citygear. Media Contact: Wendy Yellin Phone: 925-519-3363 email: [emailprotected] or [emailprotected] SOURCE Hibbett Sporting Goods Inc. Related Links http://www.hibbett.com

edtsum7756

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo (Nasdaq: DOMO), provider of the Domo Business Cloud, today announced management will present at the UBS Global TMT Virtual Conference. The presentation is scheduled for December 8, 2020 at 12:05pm ET. A live webcast of the conference presentation will be available on the Domo Investor Relations website at http://www.domo.com/IR. About Domo Domo is the Business Cloud, empowering organizations of all sizes with BI leverage at cloud scale, in record time. With Domo, BI-critical processes that took weeks, months or more can now be done on-the-fly, in minutes or seconds, at unbelievable scale. For more information about how Domo (Nasdaq: DOMO) helps its customers go fast, go big and go bold, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn. Domo, Domo Business Cloud and Domo is the Business Cloud are registered trademarks of Domo, Inc. Domo Disclosure Channels to Disseminate Information Domo investors and others should note that we announce material information to the public about our company, products and services, and other issues through a variety of means, including Domos website, press releases, SEC filings, blogs and social media, in order to achieve broad, non-exclusionary distribution of information to the public. We intend to use the Domo Facebook page, the Domo LinkedIn page, the Domo blog, the @Domotalk Twitter account and the @JoshJames Twitter account as a means of disclosing information about the Company and its services and for complying with the disclosure obligations under Regulation FD. The information we post through these social media channels may be deemed material. Accordingly, we encourage investors and others to monitor these social media channels in addition to following our press releases, SEC filings and public conference calls and webcasts. The social media channels that we intend to use as a means of disclosing the information described here may be updated from time to time as listed on our investor relations webpage. Answer:

Domo to Present at the UBS Global TMT Virtual Conference

SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo (Nasdaq: DOMO), provider of the Domo Business Cloud, today announced management will present at the UBS Global TMT Virtual Conference. The presentation is scheduled for December 8, 2020 at 12:05pm ET. A live webcast of the conference presentation will be available on the Domo Investor Relations website at http://www.domo.com/IR. About Domo Domo is the Business Cloud, empowering organizations of all sizes with BI leverage at cloud scale, in record time. With Domo, BI-critical processes that took weeks, months or more can now be done on-the-fly, in minutes or seconds, at unbelievable scale. For more information about how Domo (Nasdaq: DOMO) helps its customers go fast, go big and go bold, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn. Domo, Domo Business Cloud and Domo is the Business Cloud are registered trademarks of Domo, Inc. Domo Disclosure Channels to Disseminate Information Domo investors and others should note that we announce material information to the public about our company, products and services, and other issues through a variety of means, including Domos website, press releases, SEC filings, blogs and social media, in order to achieve broad, non-exclusionary distribution of information to the public. We intend to use the Domo Facebook page, the Domo LinkedIn page, the Domo blog, the @Domotalk Twitter account and the @JoshJames Twitter account as a means of disclosing information about the Company and its services and for complying with the disclosure obligations under Regulation FD. The information we post through these social media channels may be deemed material. Accordingly, we encourage investors and others to monitor these social media channels in addition to following our press releases, SEC filings and public conference calls and webcasts. The social media channels that we intend to use as a means of disclosing the information described here may be updated from time to time as listed on our investor relations webpage.

edtsum7757

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: HAVRE DE GRACE, Md., April 30, 2020 /PRNewswire/ --Today Dunlop Protective Footwear is excited to announce a partnership with LineDrive to be Dunlop's sales agency in the industrial sector. LineDrive is the leading national industrial sales agency with a suite of technology-enabled services and solutions designed to achieve the utmost worker safety and facility productivity. LineDrive will focus on growing and developing national and key account distribution partnerships, as well as expanding Dunlop Protective Footwear's innovative good, better, best product range options for workers in target vertical markets such as oil and gas and food processing. Dunlop Protective Footwear Logo "As Dunlop Protective Footwear accelerates their business plans in the USA and enhances the product and service offerings for the industrial, food processing, oil, gas, & mining market segments we are pleased to join forces with LineDrive", said Mary Steinebrunner, Dunlop General Manager. "Our partnership with the LineDrive organization extends our reach and resources in the channel in a very structured way that will allow us to grow together in a sustainable way for the future". "Adding a brand like Dunlop to our solutions offering to improve workers safety is a huge win for LineDrive, Dunlop and ultimately the end customer base. The quality and innovation they provide allow our team to make a real difference in those critical market verticals they specialize in," commented LineDrive Sales EVP Carlo Emanuele. LineDrive will be a key growth engine for the launch of Dunlop's latest innovation: the Dunlop Snugboot. The new Snugboot collection reinvents how a boot should fit for all day comfort and protection. LineDrive will also represent Dunlop's industrial protective footwear range featuring the iconic Purofort assortment, and the best in class Made in the USA PVC line for the OGM, construction, and other industrial sectors.About Dunlop Protective Footwear We are Dunlop Protective Footwear, the leading global manufacturer of professional and leisure waterproof boots. In more than 50 countries worldwide, we provide comfortable and protective footwear for you, the workers in agriculture & fishery, food processing, Industry and the Oil, Gas & Mining industry. Our continuous innovation combined with a solid dose of craftsmanship, makes the best working boot in the world, to give you the protection and comfort you deserve. About LineDriveLineDrive is a privately owned, nationwide consulting and sales agency focused on increasing worker safety and facility productivity. Our business model is defined by industry leading innovation and consistent growth over the past 20 years. LineDrive is trusted industry and nationwide for Making Powerful Connections! For more about LineDrive's services and solutions please visit: https://www.linedriveu.com/how-we-can-helpMedia Inquiries:Colin Clark Global Brand Director Dunlop Protective Footwear E: [emailprotected]P: 443 608 6996Anthony R. CrissieSales Enablement EVPE: [emailprotected]P: 847 531 0512SOURCE LineDrive Related Links linedriveu.com Answer:

Dunlop Protective Footwear Partners with LineDrive to Reinvent Its Way to Market in Industrial Sector

HAVRE DE GRACE, Md., April 30, 2020 /PRNewswire/ --Today Dunlop Protective Footwear is excited to announce a partnership with LineDrive to be Dunlop's sales agency in the industrial sector. LineDrive is the leading national industrial sales agency with a suite of technology-enabled services and solutions designed to achieve the utmost worker safety and facility productivity. LineDrive will focus on growing and developing national and key account distribution partnerships, as well as expanding Dunlop Protective Footwear's innovative good, better, best product range options for workers in target vertical markets such as oil and gas and food processing. Dunlop Protective Footwear Logo "As Dunlop Protective Footwear accelerates their business plans in the USA and enhances the product and service offerings for the industrial, food processing, oil, gas, & mining market segments we are pleased to join forces with LineDrive", said Mary Steinebrunner, Dunlop General Manager. "Our partnership with the LineDrive organization extends our reach and resources in the channel in a very structured way that will allow us to grow together in a sustainable way for the future". "Adding a brand like Dunlop to our solutions offering to improve workers safety is a huge win for LineDrive, Dunlop and ultimately the end customer base. The quality and innovation they provide allow our team to make a real difference in those critical market verticals they specialize in," commented LineDrive Sales EVP Carlo Emanuele. LineDrive will be a key growth engine for the launch of Dunlop's latest innovation: the Dunlop Snugboot. The new Snugboot collection reinvents how a boot should fit for all day comfort and protection. LineDrive will also represent Dunlop's industrial protective footwear range featuring the iconic Purofort assortment, and the best in class Made in the USA PVC line for the OGM, construction, and other industrial sectors.About Dunlop Protective Footwear We are Dunlop Protective Footwear, the leading global manufacturer of professional and leisure waterproof boots. In more than 50 countries worldwide, we provide comfortable and protective footwear for you, the workers in agriculture & fishery, food processing, Industry and the Oil, Gas & Mining industry. Our continuous innovation combined with a solid dose of craftsmanship, makes the best working boot in the world, to give you the protection and comfort you deserve. About LineDriveLineDrive is a privately owned, nationwide consulting and sales agency focused on increasing worker safety and facility productivity. Our business model is defined by industry leading innovation and consistent growth over the past 20 years. LineDrive is trusted industry and nationwide for Making Powerful Connections! For more about LineDrive's services and solutions please visit: https://www.linedriveu.com/how-we-can-helpMedia Inquiries:Colin Clark Global Brand Director Dunlop Protective Footwear E: [emailprotected]P: 443 608 6996Anthony R. CrissieSales Enablement EVPE: [emailprotected]P: 847 531 0512SOURCE LineDrive Related Links linedriveu.com

edtsum7758

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ORLANDO, Fla., Feb. 22, 2021 /PRNewswire/ --Project Opioid, a Central Florida based initiative, announced this week it would be expanding its business- and faith-leader directed collaborative on the opioid overdose crisis into the five largest markets in Florida. In partnership with Florida Blue and the Florida Blue Foundation, Project Opioid will coordinate with the most established regional business development boards to create collaboratives in Jacksonville, Tampa Bay, West Palm Beach, Fort Lauderdale and Miami. These Regional Super Advocates will spearhead the Project Opioid program in their communities, and will be responsible for recruiting business, faith and philanthropic leaders to the Project Opioid initiative. They will be instrumental in driving the mission of Project Opioid to reduce opioid overdoses and overdose deaths by 50% in the next 36 months. The designated Regional Super Advocates include: JAX Chamber Foundation. The Miami-Dade Beacon Council Foundation. The Greater Fort Lauderdale Alliance Foundation. The Business Development Board of Palm Beach Foundation. The Tampa Bay Partnership Foundation. The Jax Chamber, Tampa Bay Partnership, Miami-Dade Beacon Council, Greater Fort Lauderdale Alliance and the Business Development Board of Palm Beach Foundations are led by some of Florida's top business champions, and will look to find solutions to the increasing overdose crisis around the state and identify specific, actionable steps to create a major impact on this epidemic in 2021. This expansion comes as new numbers show the opioid crisis having entered its new most deadly phase in 2020. "The COVID Overdose Crisis," has caused a dramatic increase in the number of overdose deaths seen across the country. In Florida, it is projected that at least 55 people a day died from a drug overdose in 2020, a projected 59% increase in drug overdoses from 2019. Younger generations have been hit particularly hard with 53% of all drug overdoses in the state occurring in individuals between the ages of 25 and 44, even though this segment only represents 25% of the population statewide. "The number of overdose deaths we are seeing across the state of Florida is unprecedented," said Andrae Bailey, founder and CEO of Project Opioid. "The mental health anguish from COVID-19 has caused Floridians, predominantly Millennials, to turn to drugs to cope. These drugs, particularly when they contain fentanyl, are killing our young residents in record numbers and it is time for community leaders to step up and help solve this crisis." "There has never been a more important time in our community for the leaders to come together to address this issue," said Sheriff Dennis Lemma, Sheriff of Seminole County and Project Opioid Co-Chair. "The citizens of this state deserve access to treatment and care, not incarceration." The Florida Blue Foundation has awarded a grant for Project Opioid to expand the program and bring support to Jacksonville, South Florida and Tampa Bay. With the latest community investment, Florida Blue's financial contribution to Project Opioid and Regional Super Advocates to date is $1.7 million. "The opioid crisis is not something one organization can solve on its own it takes a team of dedicated individuals and organizations committed to the cause," said Dr. Nick Dewan, vice president of Behavioral Health at Florida Blue and chair of Florida Blue's Opioid Task Force. "We all have a responsibility to help those in the communities we serve, and that is why Florida Blue is proud to be part of the initiative and we look forward to our ongoing collaboration with Project Opioid and the Regional Super Advocates." In 2021, Project Opioid seeks to mobilize new resources, drive policy changes and reduce the stigma and overdoses in our state. The collaborative will look to bring leaders together to find and implement key solutions to confront the overdose crisis in each of the five key regions. Expanding access to Medication Assisted Treatment (MAT), an FDA approved treatment for opioid use disorder, and access to mental health services by promoting policy changes are at the forefront of this initiative. Through Project Opioids new partnerships, it hopes to align cross-sector leaders to form high-impact strategies that will transform and save the greatest number of lives across Florida this year. SOURCE Florida Blue Answer:

Project Opioid partners with Florida Blue Foundation to build statewide collaboration to address opioid crisis

ORLANDO, Fla., Feb. 22, 2021 /PRNewswire/ --Project Opioid, a Central Florida based initiative, announced this week it would be expanding its business- and faith-leader directed collaborative on the opioid overdose crisis into the five largest markets in Florida. In partnership with Florida Blue and the Florida Blue Foundation, Project Opioid will coordinate with the most established regional business development boards to create collaboratives in Jacksonville, Tampa Bay, West Palm Beach, Fort Lauderdale and Miami. These Regional Super Advocates will spearhead the Project Opioid program in their communities, and will be responsible for recruiting business, faith and philanthropic leaders to the Project Opioid initiative. They will be instrumental in driving the mission of Project Opioid to reduce opioid overdoses and overdose deaths by 50% in the next 36 months. The designated Regional Super Advocates include: JAX Chamber Foundation. The Miami-Dade Beacon Council Foundation. The Greater Fort Lauderdale Alliance Foundation. The Business Development Board of Palm Beach Foundation. The Tampa Bay Partnership Foundation. The Jax Chamber, Tampa Bay Partnership, Miami-Dade Beacon Council, Greater Fort Lauderdale Alliance and the Business Development Board of Palm Beach Foundations are led by some of Florida's top business champions, and will look to find solutions to the increasing overdose crisis around the state and identify specific, actionable steps to create a major impact on this epidemic in 2021. This expansion comes as new numbers show the opioid crisis having entered its new most deadly phase in 2020. "The COVID Overdose Crisis," has caused a dramatic increase in the number of overdose deaths seen across the country. In Florida, it is projected that at least 55 people a day died from a drug overdose in 2020, a projected 59% increase in drug overdoses from 2019. Younger generations have been hit particularly hard with 53% of all drug overdoses in the state occurring in individuals between the ages of 25 and 44, even though this segment only represents 25% of the population statewide. "The number of overdose deaths we are seeing across the state of Florida is unprecedented," said Andrae Bailey, founder and CEO of Project Opioid. "The mental health anguish from COVID-19 has caused Floridians, predominantly Millennials, to turn to drugs to cope. These drugs, particularly when they contain fentanyl, are killing our young residents in record numbers and it is time for community leaders to step up and help solve this crisis." "There has never been a more important time in our community for the leaders to come together to address this issue," said Sheriff Dennis Lemma, Sheriff of Seminole County and Project Opioid Co-Chair. "The citizens of this state deserve access to treatment and care, not incarceration." The Florida Blue Foundation has awarded a grant for Project Opioid to expand the program and bring support to Jacksonville, South Florida and Tampa Bay. With the latest community investment, Florida Blue's financial contribution to Project Opioid and Regional Super Advocates to date is $1.7 million. "The opioid crisis is not something one organization can solve on its own it takes a team of dedicated individuals and organizations committed to the cause," said Dr. Nick Dewan, vice president of Behavioral Health at Florida Blue and chair of Florida Blue's Opioid Task Force. "We all have a responsibility to help those in the communities we serve, and that is why Florida Blue is proud to be part of the initiative and we look forward to our ongoing collaboration with Project Opioid and the Regional Super Advocates." In 2021, Project Opioid seeks to mobilize new resources, drive policy changes and reduce the stigma and overdoses in our state. The collaborative will look to bring leaders together to find and implement key solutions to confront the overdose crisis in each of the five key regions. Expanding access to Medication Assisted Treatment (MAT), an FDA approved treatment for opioid use disorder, and access to mental health services by promoting policy changes are at the forefront of this initiative. Through Project Opioids new partnerships, it hopes to align cross-sector leaders to form high-impact strategies that will transform and save the greatest number of lives across Florida this year. SOURCE Florida Blue

edtsum7759

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, April 26, 2021 /PRNewswire/ --Today, Khaled Salem, running for the U.S. Senate against Chuck Schumer in 2022, has announced some of his legislative priorities, guaranteeing congressional approval for budgets needed to support his programs. Some of these programs have been developed because the COVID-19 pandemic has affected Americans who have lost jobs and businesses. It has hurt not only peoples' economic standing but also their personal lives, mental health and emotional stamina while continuing efforts to support themselves and their families. Continue Reading U.S. Senate Candidate Khaled Salem U.S. Senate Candidate Khaled Salem With the labor market depleted of well-paying jobs, Khaled will establish career training when elected. He and his congressional colleagues will support the establishment of national psychosocial rehabilitation and will shore up the U.S. labor market. As Khaled put it, "When it comes to helping the American people, I am determined to be their champion and make significant changes to enhance the quality of their lives." To achieve these goals, Khaled plan to act on the following: deliver free medical insurance to all Americans, reduce the NY State Sales Tax for six years until the state recovers from COVID-19 economic hardship, establish a home loan program for middle class single parents with no penalty for credit history and make it compulsory to end personal attacks between candidates. Khaled has answers to many problems affecting the United States and guarantees that congress will agree with his ideas and take these new legislation proposals very seriously.Khaled asks New York Voters to look not at his religion or where he came from, but rather what he offers to the citizenry in terms of policy.Khaled policy positions argue for free university education, Khaled highlighted the irony of the US sending money to countries likeEgyptandMiddle East, which do provide free university, but whose people tend not to like America.Some other key policy positions from Mr. Salem's agenda include: Free university education for American students with a $0 budget from the government to support this plan. Laws and procedures to reduce domestic violence nationwide. A reduction in U.S. military activity and presence in the Middle East. A policy that requires these regions pay for American military services. The establishment of a home loan program for middle class single parents. Salem is running in the next general election, scheduled for November 8, 2022. Thirty-four of the Senate's 100 seats are being contested in these elections.For more information, visit https://www.khaled2022forcongress.com/https://www.americanhumanrights.org/https://www.youtube.com/watch?v=IaBldfu_ma0[emailprotected]/twitter.com/KhaledYork Contact:U.S. Senate Candidate Khaled Salem [emailprotected]1518 348 6868SOURCE U.S. Senate Candidate Khaled Salem Answer:

U.S. Senate Candidate Khaled Salem Declares His Legislative Priorities, Including Bills to Re-Educate Americans Affected by COVID-19 Job Losses Announces ambitious policy agenda to help Americans and economy

NEW YORK, April 26, 2021 /PRNewswire/ --Today, Khaled Salem, running for the U.S. Senate against Chuck Schumer in 2022, has announced some of his legislative priorities, guaranteeing congressional approval for budgets needed to support his programs. Some of these programs have been developed because the COVID-19 pandemic has affected Americans who have lost jobs and businesses. It has hurt not only peoples' economic standing but also their personal lives, mental health and emotional stamina while continuing efforts to support themselves and their families. Continue Reading U.S. Senate Candidate Khaled Salem U.S. Senate Candidate Khaled Salem With the labor market depleted of well-paying jobs, Khaled will establish career training when elected. He and his congressional colleagues will support the establishment of national psychosocial rehabilitation and will shore up the U.S. labor market. As Khaled put it, "When it comes to helping the American people, I am determined to be their champion and make significant changes to enhance the quality of their lives." To achieve these goals, Khaled plan to act on the following: deliver free medical insurance to all Americans, reduce the NY State Sales Tax for six years until the state recovers from COVID-19 economic hardship, establish a home loan program for middle class single parents with no penalty for credit history and make it compulsory to end personal attacks between candidates. Khaled has answers to many problems affecting the United States and guarantees that congress will agree with his ideas and take these new legislation proposals very seriously.Khaled asks New York Voters to look not at his religion or where he came from, but rather what he offers to the citizenry in terms of policy.Khaled policy positions argue for free university education, Khaled highlighted the irony of the US sending money to countries likeEgyptandMiddle East, which do provide free university, but whose people tend not to like America.Some other key policy positions from Mr. Salem's agenda include: Free university education for American students with a $0 budget from the government to support this plan. Laws and procedures to reduce domestic violence nationwide. A reduction in U.S. military activity and presence in the Middle East. A policy that requires these regions pay for American military services. The establishment of a home loan program for middle class single parents. Salem is running in the next general election, scheduled for November 8, 2022. Thirty-four of the Senate's 100 seats are being contested in these elections.For more information, visit https://www.khaled2022forcongress.com/https://www.americanhumanrights.org/https://www.youtube.com/watch?v=IaBldfu_ma0[emailprotected]/twitter.com/KhaledYork Contact:U.S. Senate Candidate Khaled Salem [emailprotected]1518 348 6868SOURCE U.S. Senate Candidate Khaled Salem

edtsum7760

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--The new high-pressure processing (HPP) equipment market research from Technavio indicates neutral growth in the short term as the business impact of COVID-19 spreads. Get detailed insights on the COVID-19 pandemic Crisis and Recovery analysis of the high-pressure processing (HPP) equipment market. Download free report sample "One of the primary growth drivers for this market is the growing need to reduce food contamination, says a senior analyst for Industrials at Technavio. The growing focus on reducing food contamination has compelled players in the F&B industry to adopt advanced technologies to ensure optimum food safety. HPP equipment protects food products from bacteria by subjecting them to high pressure. Also, HPP is a natural process that uses purified cold water to neutralize foodborne pathogens without preservatives and chemicals. Such benefits have increased the adoption of HPP equipment in the food processing industry, which is driving market growth. As the markets recover Technavio expects the high-pressure processing (HPP) equipment market size to grow by USD 209.45 million during the period 2020-2024". High-pressure Processing (HPP) Equipment Market Segment Highlights for 2020 Regional Analysis Click here to learn about report detailed analysis and insights on how you can leverage them to grow your business. Notes: Register for a free trial today to access 17,000+ market research reports using Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Answer:

High-Pressure Processing Equipment Market to Grow Over $ 209 Million During 2020-2024 | Led by Need to Reduce Food Contamination | Technavio

LONDON--(BUSINESS WIRE)--The new high-pressure processing (HPP) equipment market research from Technavio indicates neutral growth in the short term as the business impact of COVID-19 spreads. Get detailed insights on the COVID-19 pandemic Crisis and Recovery analysis of the high-pressure processing (HPP) equipment market. Download free report sample "One of the primary growth drivers for this market is the growing need to reduce food contamination, says a senior analyst for Industrials at Technavio. The growing focus on reducing food contamination has compelled players in the F&B industry to adopt advanced technologies to ensure optimum food safety. HPP equipment protects food products from bacteria by subjecting them to high pressure. Also, HPP is a natural process that uses purified cold water to neutralize foodborne pathogens without preservatives and chemicals. Such benefits have increased the adoption of HPP equipment in the food processing industry, which is driving market growth. As the markets recover Technavio expects the high-pressure processing (HPP) equipment market size to grow by USD 209.45 million during the period 2020-2024". High-pressure Processing (HPP) Equipment Market Segment Highlights for 2020 Regional Analysis Click here to learn about report detailed analysis and insights on how you can leverage them to grow your business. Notes: Register for a free trial today to access 17,000+ market research reports using Technavio's SUBSCRIPTION platform About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

edtsum7761

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: INDEPENDENCE, Ohio, Feb. 5, 2021 /PRNewswire/ --When it comes to home dcor and design, some styles can stand the test of time, while others tend to have more of an expiration date. For building professionals, designers, and DIY enthusiasts, incorporating trends based on both functionality and design appeal during the decorating process can help keep things exciting and fresh, while catering to homeowners' needs. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8690758-kichler-lighting-design-trend-upgrades/ Kichler Lighting Ellerbeck 1 Light Wall Sconce Kichler Lighting Armand 12-Light Linear Chandelier Kichler Lighting Zeo Collection Kichler Lighting, a leader in the lighting industry, offers an array of innovative and on-trend products to complement every space in your home. Whether it is an emerging colorway or finish, layout, or fixture type, there are numerous elements that contribute to lighting trends. Taking into consideration lifestyle, functional needs and design preferences, trends have a way of upgrading and updating a space to make it your own. "Finish"-ing Touches As people continue to spend more time at home, they are making improvements that reflect their personal style and current trends, specifically, with new and exciting finish options. White finishes can elevate a space by adding a light, airy accent. The lan Clevo LED 3000K 24" Pendant in White, for example, is a beautiful interpretation of wire sculptures in a sleek Mid-Century Modern style at its most refined. Off-kilter angles blend with thin lines to create visual interest. When illuminated, the result is a playful blend of light and shadows.Another trend, growing in popularity, is mixed-finish fixtures. The Tollis 18 inch 1 Light Hanging Pendant, features Clear Ribbed Glass with options such as White and Natural Brass or Black and Brushed Nickel. With mixed-finishes, homeowners can tie together their look in individual rooms or throughout the house by adding fixtures that pair as well with everything from cabinet hardware to appliances, for the perfect finishing touch to any space. Customizable Collections Because rooms in the home may serve many purposes throughout the day a place to gather for meals or entertainment, a home office, a family or activity room, or a quiet nook the trend toward customization is also top of mind. As such, each space requires an optimal lighting plan that can create ambiance or ideal illumination for functionality and safety. One way to achieve a desired and unique lighting look is by selecting fixtures that offer adjustable elements. Whether the fixtures feature movable arms or can change their look depending on the type of shades or bulbs used, tailoring the look and feel of lighting is a personalized touch. An example of this is the Elias 15.25" 1 Light Convertible Pendant Black, that converts to a semi-flush installation, ideal for spaces with less over-head room. Or, choose a chandelier with interchangeable bulbs, like the Armand 42.75" 12 Light Linear Chandelier. Try globe-shaped bulbs to achieve a Mid-Century look or use candle or T lamp bulbs for a soft contemporary look.Another way to tailor a space is by adding functional downlights, such as Kichler Lighting's Zeo Collection, for activities that require focus. Downlights that offer the flexibility to dim lights are helpful for homeowners. LEDs also continue to grow in popularity and are increasingly integrated into fixtures, allowing homeowners to not only dim their lights, but adjust the color to fit the task at hand. DeLIGHTful Designs A perfect lighting fixture is equal parts functional and aesthetically pleasing. The design of the fixture itself is also just as critical as the amount of light it gives off, and the way the light fills the room. Sconces are having a moment, favored for their ability to easily spruce up a space, provide symmetry, or add a layered lighting effect complementary to overhead lighting. The Ellerbeck 1 Light Wall Sconce offers a stylish and flexible design, while the Kennewick 1 Light Wall Sconce is simple and cool rounding out the design of the bedroom, study or bathroom. Do not underestimate the effect that a stunning lighting fixture can have on a space to set the mood and provide a sculptural focal point. The Calyssa 5 Light Chandelier in Fox Gold, for example, brings metalwork and crystal work together to deliver a sleek, traditional look that gently reflects the light. The simple piece fills a room with light without overtaking the space, epitomizing form and function. For additional design inspiration, view Kichler Lighting's Lighting Ideas guide or visit Kichler.com. SOURCE Kichler Lighting LLC Answer:

Design Trend Upgrades and Updates with Kichler Lighting

INDEPENDENCE, Ohio, Feb. 5, 2021 /PRNewswire/ --When it comes to home dcor and design, some styles can stand the test of time, while others tend to have more of an expiration date. For building professionals, designers, and DIY enthusiasts, incorporating trends based on both functionality and design appeal during the decorating process can help keep things exciting and fresh, while catering to homeowners' needs. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8690758-kichler-lighting-design-trend-upgrades/ Kichler Lighting Ellerbeck 1 Light Wall Sconce Kichler Lighting Armand 12-Light Linear Chandelier Kichler Lighting Zeo Collection Kichler Lighting, a leader in the lighting industry, offers an array of innovative and on-trend products to complement every space in your home. Whether it is an emerging colorway or finish, layout, or fixture type, there are numerous elements that contribute to lighting trends. Taking into consideration lifestyle, functional needs and design preferences, trends have a way of upgrading and updating a space to make it your own. "Finish"-ing Touches As people continue to spend more time at home, they are making improvements that reflect their personal style and current trends, specifically, with new and exciting finish options. White finishes can elevate a space by adding a light, airy accent. The lan Clevo LED 3000K 24" Pendant in White, for example, is a beautiful interpretation of wire sculptures in a sleek Mid-Century Modern style at its most refined. Off-kilter angles blend with thin lines to create visual interest. When illuminated, the result is a playful blend of light and shadows.Another trend, growing in popularity, is mixed-finish fixtures. The Tollis 18 inch 1 Light Hanging Pendant, features Clear Ribbed Glass with options such as White and Natural Brass or Black and Brushed Nickel. With mixed-finishes, homeowners can tie together their look in individual rooms or throughout the house by adding fixtures that pair as well with everything from cabinet hardware to appliances, for the perfect finishing touch to any space. Customizable Collections Because rooms in the home may serve many purposes throughout the day a place to gather for meals or entertainment, a home office, a family or activity room, or a quiet nook the trend toward customization is also top of mind. As such, each space requires an optimal lighting plan that can create ambiance or ideal illumination for functionality and safety. One way to achieve a desired and unique lighting look is by selecting fixtures that offer adjustable elements. Whether the fixtures feature movable arms or can change their look depending on the type of shades or bulbs used, tailoring the look and feel of lighting is a personalized touch. An example of this is the Elias 15.25" 1 Light Convertible Pendant Black, that converts to a semi-flush installation, ideal for spaces with less over-head room. Or, choose a chandelier with interchangeable bulbs, like the Armand 42.75" 12 Light Linear Chandelier. Try globe-shaped bulbs to achieve a Mid-Century look or use candle or T lamp bulbs for a soft contemporary look.Another way to tailor a space is by adding functional downlights, such as Kichler Lighting's Zeo Collection, for activities that require focus. Downlights that offer the flexibility to dim lights are helpful for homeowners. LEDs also continue to grow in popularity and are increasingly integrated into fixtures, allowing homeowners to not only dim their lights, but adjust the color to fit the task at hand. DeLIGHTful Designs A perfect lighting fixture is equal parts functional and aesthetically pleasing. The design of the fixture itself is also just as critical as the amount of light it gives off, and the way the light fills the room. Sconces are having a moment, favored for their ability to easily spruce up a space, provide symmetry, or add a layered lighting effect complementary to overhead lighting. The Ellerbeck 1 Light Wall Sconce offers a stylish and flexible design, while the Kennewick 1 Light Wall Sconce is simple and cool rounding out the design of the bedroom, study or bathroom. Do not underestimate the effect that a stunning lighting fixture can have on a space to set the mood and provide a sculptural focal point. The Calyssa 5 Light Chandelier in Fox Gold, for example, brings metalwork and crystal work together to deliver a sleek, traditional look that gently reflects the light. The simple piece fills a room with light without overtaking the space, epitomizing form and function. For additional design inspiration, view Kichler Lighting's Lighting Ideas guide or visit Kichler.com. SOURCE Kichler Lighting LLC

edtsum7762

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: WASHINGTON, July 28, 2020 /PRNewswire/ -- DC-based opera companyIN Seriescut the virtual ribbon yesterday on INVISION, its first-of-its-kind digital performing arts center. Featuring several distinct venues, the dynamic website is designed to house the company's first fully digital opera season. Continue Reading The Tale of Serse: A Collaboration with the Tehran Symphony IN Series marked the occasion of this pioneering launch with a multicast digital ribbon cutting ceremony, culminating in the premiere of a historic collaboration between IN Series and the Tehran Symphony Orchestra (under the patronage of the Roudaki Foundation). The video features seven DC-area opera singers and nineteen instrumentalists from the Tehran Symphony performing in English translation and layered with text by the famed Sufi poet Rumi, the work takes on deep significance as musicians from opposite sides of the world unite in concert digitally in spite of COVID-19 restrictions and strained relations between their countries to perform a chorus celebrating "faith, hope, joy, laughter, and love." IN Series Artistic Director Timothy Nelson enthusiastically embraced the collaboration saying "If we have to make virtualwork," he said, "let us use this as an opportunity to make the sort of collaborative creative experiences that would not only be otherwise inconceivable, but which really do what only art can do: make the impossible possible." This project was initiated by Fatemeh Keshavarz, chair of Roshan Institute for Persian Studies at University of Maryland, College Park, who approached IN Series with the request issued from the North American Iranian Friendship Association. "The musicians on both sides are tremendously excited about helping us transcend the toxic threats of war and sanctions, rise above politics, and acknowledge each other's art and humanity," Keshavarz observed."This is particularly needed at a time like this when the world is in the grips of a ferocious pandemic. It is a time to see each other's humanity and help each other heal. Nothing can do this better than art."The video of this historic collaboration is available to view globally at no cost on IN Series' INvision: OPERAhouse Without Walls.Link directly to the video within INVISION's Education Annex at https://invision.inseries.org/full-feature/the-tale-of-serse-a-collaboration-with-the-tehran-symphonyABOUT ROSHAN INSTITUTE FOR PERSIAN STUDIESRoshan Institute for Persian Studiesat the University of Maryland aspires to be the premier center for the learning, understanding, and appreciation of Persian culture in the United States. Toward this end, Roshan Institute seeks to provide outstanding course offerings and programs in Persian language, literature, history, and culture; to foster communication and community ties among people of Persian heritage and those interested in Persian studies; and to serve as a model for encouraging intercultural communication among peoples of varying backgrounds.ABOUT THE ROUDAKI FOUNDATIONThe Roudaki Foundation is a public, non-governmental, cultural foundation tasked with supervising the Tehran Symphony Orchestra and Iran's National Orchestra.Information:http://bonyadroudaki.com/default.aspx?lang=en-USABOUT THE NORTH AMERICAN IRANIAN FRIENDSHIP ASSOCIATIONFounded by Vahid Abideh, the North American Iranian Friendship Society is dedicated to building relationships between Iranians and Americans through cultural exchange.ABOUT IN SERIESIN Series is the standard-bearer for innovative opera theater in Washington DC. Working with local artists and diverse communities worldwide to create novel works grounded in opera and song, we challenge and reimagine these forms, folding in an expanding range of aesthetic and cultural traditions. IN Series: Opera that speaks. Theater that sings. www.inseries.orgMedia Contact: Cara Schaefer, Director of Communications202-204-7763[emailprotected]Facebook: @INSeriesDC Twitter: @INSeriesDC Instagram: @inseriesoperaSOURCE IN Series Related Links http://www.inseries.org Answer:

IN Series Celebrates Launch of INVISION with Historic Iranian-American Musical Collaboration

WASHINGTON, July 28, 2020 /PRNewswire/ -- DC-based opera companyIN Seriescut the virtual ribbon yesterday on INVISION, its first-of-its-kind digital performing arts center. Featuring several distinct venues, the dynamic website is designed to house the company's first fully digital opera season. Continue Reading The Tale of Serse: A Collaboration with the Tehran Symphony IN Series marked the occasion of this pioneering launch with a multicast digital ribbon cutting ceremony, culminating in the premiere of a historic collaboration between IN Series and the Tehran Symphony Orchestra (under the patronage of the Roudaki Foundation). The video features seven DC-area opera singers and nineteen instrumentalists from the Tehran Symphony performing in English translation and layered with text by the famed Sufi poet Rumi, the work takes on deep significance as musicians from opposite sides of the world unite in concert digitally in spite of COVID-19 restrictions and strained relations between their countries to perform a chorus celebrating "faith, hope, joy, laughter, and love." IN Series Artistic Director Timothy Nelson enthusiastically embraced the collaboration saying "If we have to make virtualwork," he said, "let us use this as an opportunity to make the sort of collaborative creative experiences that would not only be otherwise inconceivable, but which really do what only art can do: make the impossible possible." This project was initiated by Fatemeh Keshavarz, chair of Roshan Institute for Persian Studies at University of Maryland, College Park, who approached IN Series with the request issued from the North American Iranian Friendship Association. "The musicians on both sides are tremendously excited about helping us transcend the toxic threats of war and sanctions, rise above politics, and acknowledge each other's art and humanity," Keshavarz observed."This is particularly needed at a time like this when the world is in the grips of a ferocious pandemic. It is a time to see each other's humanity and help each other heal. Nothing can do this better than art."The video of this historic collaboration is available to view globally at no cost on IN Series' INvision: OPERAhouse Without Walls.Link directly to the video within INVISION's Education Annex at https://invision.inseries.org/full-feature/the-tale-of-serse-a-collaboration-with-the-tehran-symphonyABOUT ROSHAN INSTITUTE FOR PERSIAN STUDIESRoshan Institute for Persian Studiesat the University of Maryland aspires to be the premier center for the learning, understanding, and appreciation of Persian culture in the United States. Toward this end, Roshan Institute seeks to provide outstanding course offerings and programs in Persian language, literature, history, and culture; to foster communication and community ties among people of Persian heritage and those interested in Persian studies; and to serve as a model for encouraging intercultural communication among peoples of varying backgrounds.ABOUT THE ROUDAKI FOUNDATIONThe Roudaki Foundation is a public, non-governmental, cultural foundation tasked with supervising the Tehran Symphony Orchestra and Iran's National Orchestra.Information:http://bonyadroudaki.com/default.aspx?lang=en-USABOUT THE NORTH AMERICAN IRANIAN FRIENDSHIP ASSOCIATIONFounded by Vahid Abideh, the North American Iranian Friendship Society is dedicated to building relationships between Iranians and Americans through cultural exchange.ABOUT IN SERIESIN Series is the standard-bearer for innovative opera theater in Washington DC. Working with local artists and diverse communities worldwide to create novel works grounded in opera and song, we challenge and reimagine these forms, folding in an expanding range of aesthetic and cultural traditions. IN Series: Opera that speaks. Theater that sings. www.inseries.orgMedia Contact: Cara Schaefer, Director of Communications202-204-7763[emailprotected]Facebook: @INSeriesDC Twitter: @INSeriesDC Instagram: @inseriesoperaSOURCE IN Series Related Links http://www.inseries.org

edtsum7763

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Oct. 1, 2020 /PRNewswire/ -- Hispanic and Latinx Heritage month is going strong and CheapOair's celebration also continues with a series of cultural spotlights, blog posts, and travel tips that honor Hispanic, Latino, and Latinx heritages. This week, the travel experts at CheapOair offer their recommendations for travelers looking to experience the importance of U.S. Hispanic culture first-hand. Please note:Due to travel restrictions as a result of Covid-19, please check local state safety guides, location websites, and CDC guidelines before visiting any of these sites. Csar E. Chvez National Monument Keene, CaliforniaAs one of the most prolific figures in 20th century Hispanic history, Csar Chvez was a powerful voice for the plight of agricultural workers across the U.S. As a result of his leadership, the United Farm Workers of America was established and became the country's first permanent agricultural union. Nearest Airport:Visalia Municipal Airport La Villita San Antonio, TexasThis unique village-turned-arts-community is located on the south bank of the San Antonio River Walk and is chock full of Hispanic history and artifacts. With Mexican folk art, handmade jewelry, and beautiful architecture, this destination is a must-visit for anyone who loves immersing themselves in history and culture. Nearest Airport:San Antonio International Airport Sangre de Cristo National Heritage Area - Colorado's San Luis Valley, ColoradoThe Sangre de Cristo National Heritage Area, which is an expansive 3,000 square miles of south-central Colorado, exists as a testament of the strength and determination of 19th century Hispanic settlers. The ranch of Teofilo Trujillo, known as the Trujillo Homestead, is a still-standing log cabin and property of one of the families who struggled and triumphed while navigating their way through what was then a brand-new territory. Nearest Airport:San Luis Valley Regional Airport About CheapOairCheapOairis an online travel agency that specializes in providing cheap flights and great last-minute flight deals for travelers worldwide. Consumers can book online, on mobile apps for iOSand Android, by phone (1-646-738-4820) or live chat. Part of Fareportal'sfamily of travel brands, CheapOair bridges the gap between an online travel agency and a traditional agency with certified travel agents available to help find flight tickets to global destinations on over 600 airlines, a million hotels, and 100s of car rental companies. Follow CheapOair on Facebook, Twitter, Instagram, and Pinterestto learn how to travel the world for less. SOURCE CheapOair Related Links http://www.cheapoair.com Answer:

CheapOair Recommends the U.S. Hispanic Sites Everyone Should Visit

NEW YORK, Oct. 1, 2020 /PRNewswire/ -- Hispanic and Latinx Heritage month is going strong and CheapOair's celebration also continues with a series of cultural spotlights, blog posts, and travel tips that honor Hispanic, Latino, and Latinx heritages. This week, the travel experts at CheapOair offer their recommendations for travelers looking to experience the importance of U.S. Hispanic culture first-hand. Please note:Due to travel restrictions as a result of Covid-19, please check local state safety guides, location websites, and CDC guidelines before visiting any of these sites. Csar E. Chvez National Monument Keene, CaliforniaAs one of the most prolific figures in 20th century Hispanic history, Csar Chvez was a powerful voice for the plight of agricultural workers across the U.S. As a result of his leadership, the United Farm Workers of America was established and became the country's first permanent agricultural union. Nearest Airport:Visalia Municipal Airport La Villita San Antonio, TexasThis unique village-turned-arts-community is located on the south bank of the San Antonio River Walk and is chock full of Hispanic history and artifacts. With Mexican folk art, handmade jewelry, and beautiful architecture, this destination is a must-visit for anyone who loves immersing themselves in history and culture. Nearest Airport:San Antonio International Airport Sangre de Cristo National Heritage Area - Colorado's San Luis Valley, ColoradoThe Sangre de Cristo National Heritage Area, which is an expansive 3,000 square miles of south-central Colorado, exists as a testament of the strength and determination of 19th century Hispanic settlers. The ranch of Teofilo Trujillo, known as the Trujillo Homestead, is a still-standing log cabin and property of one of the families who struggled and triumphed while navigating their way through what was then a brand-new territory. Nearest Airport:San Luis Valley Regional Airport About CheapOairCheapOairis an online travel agency that specializes in providing cheap flights and great last-minute flight deals for travelers worldwide. Consumers can book online, on mobile apps for iOSand Android, by phone (1-646-738-4820) or live chat. Part of Fareportal'sfamily of travel brands, CheapOair bridges the gap between an online travel agency and a traditional agency with certified travel agents available to help find flight tickets to global destinations on over 600 airlines, a million hotels, and 100s of car rental companies. Follow CheapOair on Facebook, Twitter, Instagram, and Pinterestto learn how to travel the world for less. SOURCE CheapOair Related Links http://www.cheapoair.com

edtsum7764

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ANN ARBOR, Mich.--(BUSINESS WIRE)--The key to manufacturing success is keeping equipment running. Unfortunately, it can be hard to find and retain workers for tedious and potentially dangerous jobs such as machine tending. Its not surprising that more than half of U.S. manufacturers are redesigning their workforce architecture around automation with machine tending as one of the most sought-after applications to automate. But what tasks should you automate first? How do you make the cobot interface with the machine? Do you need a dedicated cell? Can you use the cobot on multiple machines? What about safety? Our Machine Tending Expo will help manufacturers address all these questions, says Joe Campbell, Senior Manager of Applications Development at Universal Robots (UR). Attendees at the Expo will be able to visit virtual booths featuring a wide range of turnkey solutions and application kits for easy deployment. In live demos and educational keynotes, they will learn all the ins and outs of machine tending with UR cobots. The Machine Tending Expo is free to attend with registration now open at: urrobots.com/machinetending New robot tending systems on display Universal Robots is building a rapidly expanding network of Certified System Integrators (CSIs); many CSIs offer not only help with UR cobot deployment but also develop turnkey robot tending systems to address parts presentation and robot-machine communication. Alex Webster, owner of UR CSI SDMS Robotics, has helped machine shops of all kinds integrate UR cobots. This is the essential technology that was needed to bring robots into widespread use for machine tending, he says, calling Universal Robots the most important step forward in machine shop automation since the advent of CNC, the pallet changer, and the bar feeder. At the Expo, SDMS will introduce the SDMS Machine Tending System consisting of the UR10e cobot arm, SDMS robot interface system, and specially-designed robot mount. Often, manufacturers just need help to get started, whereafter they can succeed with cobot automation by becoming autonomous and do DIY projects. That is the goal for UR CSI Revtech Systems, launching the new CNC Loader Revflex at the Expo. We strive to share our knowledge with customers so they require us less and less throughout their other projects, says Catherine Bernier, application engineer at Revtech Systems, who will present the keynote "How Robotics Done Right Can Change Your Business." Brian Knopp, general manager of UR CSI ProCobots, emphasizes that buying a standardized machine tending system eliminates the mystery and misery manufacturers face when trying to navigate a fragmented market of cobot products and accessories. When someone wants a fishing boat, they go buy one. They dont buy the motor and then build the boat themselves, says the general manager of ProCobots, that will be showcasing the companys practical CNC machine automation solutions with UR cobots. When Universal Robots released the e-series line of cobots featuring repeatability down to 30 microns, Troy Ojalehto, owner of UR CSI Rapid Design Solutions, was excited. When youre doing multi-op precision machining, the accuracy requirements go way up, he says. Universal Robots repeatability really competes in the same space as traditional industrial robots but with all the safety and flexibility that cobots offer. Rapid Design Solutions Expo booth will focus on how small to medium size machine shops can efficiently automate even low-run production with UR cobots without major process overhaul. UR+ Application Kits reduce project risk and complexity With the UR+ platform, Universal Robots launched the industrys largest and most comprehensive ecosystem of products certified to integrate seamlessly with UR cobots. Several UR+ partners will exhibit new machine tending related UR+ products and Application Kits at the Expo, among them Robotiq that launched the CNC machine tending kit. Adam Schmidt, Robotiqs Director of Sales for Americas, will present the keynote "8 Key Learnings in CNC Machine Tending Cell Deployment From 13 Years of Experience." The companys Expo booth is a rich educational experience with both eLearning programs and demos featuring solutions and products Robotiq provides to simplify the design and programming of a CNC machine tending cell deployment. Manufacturers visiting UR+ partner New Scale Robotics Expo booth will learn the benefits of enhanced machine tending with real-time part measurement. The companys UR+ certified Q-Span Workstation Kits powered by UR3e cobots combines part handling, QC measurements, and data logging for small parts. Cobots never staying idle and always monitored Moving cobots between different machining cells presents a whole new set of programming and logistical complexities that can be overwhelming at first. UR+ partner Flexxbotics mission is to free robots from being fixed in place. At the Expo, Flexxbotics will show attendees how the Flexx Connect product platform provides localization and communication tools to redeploy UR cobots on multiple jobs and stations, driving up the utilization rate of the robot while reducing the time needed to achieve a positive ROI. Remotely monitoring the cobot is another key to machine uptime. In the live demo "Do you know what your cobot is doing right now? Get your cobot to tell you in less than 10 minutes," UR OEM partner Hirebotics will show how using the companys software platform Beacon allows manufacturers full monitoring capabilities by cloud-connecting their cobots through a smartphone app to maximize productivity. Through Beacon, manufacturers get real-time access to program variables, IO, and log files while receiving alerts if production is down. The innovation happening right now within cobot-powered machine tending operations is phenomenal. We look forward to sharing these solutions with Expo attendees soon, says Universal Robots Joe Campbell. Press kit Download photos of products and solutions exhibited at the Machine Tending Expo here. About Universal Robots Universal Robots (UR) was founded in 2005 to make robot technology accessible to all by developing small, user-friendly, reasonably priced, flexible collaborative robots (cobots) that can be safe to work side by side with people. Since the first cobot was launched in 2008, the company has experienced considerable growth with the user-friendly cobot now sold worldwide. The company, which is a part of Teradyne Inc., is headquartered in Odense, Denmark, and has regional offices in the United States, Germany, France, Spain, Italy, UK, Czech Republic, Poland, Hungary, Romania, Russia, Turkey, China, India, Singapore, Japan, South Korea, Taiwan and Mexico. For more information, please visit www.universal-robots.com. Answer:

Universal Robots Launches First Virtual Expo Focused on Automating Machine Tending Tasks with Collaborative Robots The two-day Machine Tending Expo February 23-24 focuses on manufacturers looking for concrete insights on deploying cobots to tend machines such as CNC, press brakes, injection molding machines or 3D printers. In live demos, keynotes and interactive booth sessions with exhibiting partners, Universal Robots offers solutions on how to seamlessly implement cobots, tackling the labor shortage, while improving crucial machine uptime.

ANN ARBOR, Mich.--(BUSINESS WIRE)--The key to manufacturing success is keeping equipment running. Unfortunately, it can be hard to find and retain workers for tedious and potentially dangerous jobs such as machine tending. Its not surprising that more than half of U.S. manufacturers are redesigning their workforce architecture around automation with machine tending as one of the most sought-after applications to automate. But what tasks should you automate first? How do you make the cobot interface with the machine? Do you need a dedicated cell? Can you use the cobot on multiple machines? What about safety? Our Machine Tending Expo will help manufacturers address all these questions, says Joe Campbell, Senior Manager of Applications Development at Universal Robots (UR). Attendees at the Expo will be able to visit virtual booths featuring a wide range of turnkey solutions and application kits for easy deployment. In live demos and educational keynotes, they will learn all the ins and outs of machine tending with UR cobots. The Machine Tending Expo is free to attend with registration now open at: urrobots.com/machinetending New robot tending systems on display Universal Robots is building a rapidly expanding network of Certified System Integrators (CSIs); many CSIs offer not only help with UR cobot deployment but also develop turnkey robot tending systems to address parts presentation and robot-machine communication. Alex Webster, owner of UR CSI SDMS Robotics, has helped machine shops of all kinds integrate UR cobots. This is the essential technology that was needed to bring robots into widespread use for machine tending, he says, calling Universal Robots the most important step forward in machine shop automation since the advent of CNC, the pallet changer, and the bar feeder. At the Expo, SDMS will introduce the SDMS Machine Tending System consisting of the UR10e cobot arm, SDMS robot interface system, and specially-designed robot mount. Often, manufacturers just need help to get started, whereafter they can succeed with cobot automation by becoming autonomous and do DIY projects. That is the goal for UR CSI Revtech Systems, launching the new CNC Loader Revflex at the Expo. We strive to share our knowledge with customers so they require us less and less throughout their other projects, says Catherine Bernier, application engineer at Revtech Systems, who will present the keynote "How Robotics Done Right Can Change Your Business." Brian Knopp, general manager of UR CSI ProCobots, emphasizes that buying a standardized machine tending system eliminates the mystery and misery manufacturers face when trying to navigate a fragmented market of cobot products and accessories. When someone wants a fishing boat, they go buy one. They dont buy the motor and then build the boat themselves, says the general manager of ProCobots, that will be showcasing the companys practical CNC machine automation solutions with UR cobots. When Universal Robots released the e-series line of cobots featuring repeatability down to 30 microns, Troy Ojalehto, owner of UR CSI Rapid Design Solutions, was excited. When youre doing multi-op precision machining, the accuracy requirements go way up, he says. Universal Robots repeatability really competes in the same space as traditional industrial robots but with all the safety and flexibility that cobots offer. Rapid Design Solutions Expo booth will focus on how small to medium size machine shops can efficiently automate even low-run production with UR cobots without major process overhaul. UR+ Application Kits reduce project risk and complexity With the UR+ platform, Universal Robots launched the industrys largest and most comprehensive ecosystem of products certified to integrate seamlessly with UR cobots. Several UR+ partners will exhibit new machine tending related UR+ products and Application Kits at the Expo, among them Robotiq that launched the CNC machine tending kit. Adam Schmidt, Robotiqs Director of Sales for Americas, will present the keynote "8 Key Learnings in CNC Machine Tending Cell Deployment From 13 Years of Experience." The companys Expo booth is a rich educational experience with both eLearning programs and demos featuring solutions and products Robotiq provides to simplify the design and programming of a CNC machine tending cell deployment. Manufacturers visiting UR+ partner New Scale Robotics Expo booth will learn the benefits of enhanced machine tending with real-time part measurement. The companys UR+ certified Q-Span Workstation Kits powered by UR3e cobots combines part handling, QC measurements, and data logging for small parts. Cobots never staying idle and always monitored Moving cobots between different machining cells presents a whole new set of programming and logistical complexities that can be overwhelming at first. UR+ partner Flexxbotics mission is to free robots from being fixed in place. At the Expo, Flexxbotics will show attendees how the Flexx Connect product platform provides localization and communication tools to redeploy UR cobots on multiple jobs and stations, driving up the utilization rate of the robot while reducing the time needed to achieve a positive ROI. Remotely monitoring the cobot is another key to machine uptime. In the live demo "Do you know what your cobot is doing right now? Get your cobot to tell you in less than 10 minutes," UR OEM partner Hirebotics will show how using the companys software platform Beacon allows manufacturers full monitoring capabilities by cloud-connecting their cobots through a smartphone app to maximize productivity. Through Beacon, manufacturers get real-time access to program variables, IO, and log files while receiving alerts if production is down. The innovation happening right now within cobot-powered machine tending operations is phenomenal. We look forward to sharing these solutions with Expo attendees soon, says Universal Robots Joe Campbell. Press kit Download photos of products and solutions exhibited at the Machine Tending Expo here. About Universal Robots Universal Robots (UR) was founded in 2005 to make robot technology accessible to all by developing small, user-friendly, reasonably priced, flexible collaborative robots (cobots) that can be safe to work side by side with people. Since the first cobot was launched in 2008, the company has experienced considerable growth with the user-friendly cobot now sold worldwide. The company, which is a part of Teradyne Inc., is headquartered in Odense, Denmark, and has regional offices in the United States, Germany, France, Spain, Italy, UK, Czech Republic, Poland, Hungary, Romania, Russia, Turkey, China, India, Singapore, Japan, South Korea, Taiwan and Mexico. For more information, please visit www.universal-robots.com.

edtsum7765

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, May 11, 2020 /PRNewswire/ --Store brands posted double-digit sales increases across U.S. supermarkets, discounters, and drug stores as shoppers stocked up on products during the first stages of the coronavirus pandemic. Nielsen reports that first quarter dollar sales of private label products across all retail outlets compared to the year before climbed nearly 15% during the first quarter, up $4.9 billion. Unit volume increased nearly 13%, representing a gain of around 1.5 billion products sold. Total dollar sales of store brands in the first quarter were $38.4 billion and units were 13.2 billion. Store brands more than held their own against the national brands. During the quarter, private label gained about one third more in both dollar and unit sales than national brands, according to data provided to the Private Label Manufacturers Association by Nielsen. In all U.S. retail outlets, store brands grew +14.6% in dollar volume and +12.8% in unit volume, compared to gains of +11.5% in dollars and +9.2% in units for national brands. Private label manufacturers, meanwhile, are making some significant operational changes to cope with the rising demand. In certain categories, such as paper goods, over-the counter medicines, and hand sanitizers, factories are operating 24-hours a day, seven days a week. Some companies are creating fair share allocations for high-demand products, while many are simplifying SKU offerings, extending lead times to build inventories, and retooling to be more efficient for growing e-commerce business. Among the retail channels, the strongest gains for store brands occurred in mass, which consists of mass merchandisers, club, and dollar stores. Store brands gained +16.6% in dollar sales and +16.5% in unit sales compared to the same quarter in 2019. That expansion surpassed national brands, which advanced +10.1% in dollars and +7.3% in units. As a result, store brands market shares increased by 1.2 points in dollars to 21.7%, and 1.5 points in units to 25.8%, as compared to the same quarter a year ago. In supermarkets, store brands also increased, up +12.7% in dollar volume and +9.7% in unit volume. National brands did slightly better, up +15% in dollars and up +11.4% in units. Store brands market shares were unchanged for the quarter, at 18% of dollars and 22.3% of units. In drug stores, where sales of all brands have had rough going the past few years, store brands did quite well. Dollar sales were up +13% and unit sales were ahead +12.4%, both substantially better than national brands, which were up +7% and +1%, respectively. When compared to the first quarter of 2019, store brands share moved up about one full point to 17% of dollars and to 15.9% of units. PLMA President Brian Sharoff said "There's no doubt that shopper behavior was highly influenced by consumer fears. Nonetheless the statistics point to greater acceptance of retailer brands as the coronavirus crisis evolves." SOURCE Private Label Manufacturers Association Related Links http://www.plma.com Answer:

Nielsen first quarter numbers show growth of store brands as shoppers stock up during crisis

NEW YORK, May 11, 2020 /PRNewswire/ --Store brands posted double-digit sales increases across U.S. supermarkets, discounters, and drug stores as shoppers stocked up on products during the first stages of the coronavirus pandemic. Nielsen reports that first quarter dollar sales of private label products across all retail outlets compared to the year before climbed nearly 15% during the first quarter, up $4.9 billion. Unit volume increased nearly 13%, representing a gain of around 1.5 billion products sold. Total dollar sales of store brands in the first quarter were $38.4 billion and units were 13.2 billion. Store brands more than held their own against the national brands. During the quarter, private label gained about one third more in both dollar and unit sales than national brands, according to data provided to the Private Label Manufacturers Association by Nielsen. In all U.S. retail outlets, store brands grew +14.6% in dollar volume and +12.8% in unit volume, compared to gains of +11.5% in dollars and +9.2% in units for national brands. Private label manufacturers, meanwhile, are making some significant operational changes to cope with the rising demand. In certain categories, such as paper goods, over-the counter medicines, and hand sanitizers, factories are operating 24-hours a day, seven days a week. Some companies are creating fair share allocations for high-demand products, while many are simplifying SKU offerings, extending lead times to build inventories, and retooling to be more efficient for growing e-commerce business. Among the retail channels, the strongest gains for store brands occurred in mass, which consists of mass merchandisers, club, and dollar stores. Store brands gained +16.6% in dollar sales and +16.5% in unit sales compared to the same quarter in 2019. That expansion surpassed national brands, which advanced +10.1% in dollars and +7.3% in units. As a result, store brands market shares increased by 1.2 points in dollars to 21.7%, and 1.5 points in units to 25.8%, as compared to the same quarter a year ago. In supermarkets, store brands also increased, up +12.7% in dollar volume and +9.7% in unit volume. National brands did slightly better, up +15% in dollars and up +11.4% in units. Store brands market shares were unchanged for the quarter, at 18% of dollars and 22.3% of units. In drug stores, where sales of all brands have had rough going the past few years, store brands did quite well. Dollar sales were up +13% and unit sales were ahead +12.4%, both substantially better than national brands, which were up +7% and +1%, respectively. When compared to the first quarter of 2019, store brands share moved up about one full point to 17% of dollars and to 15.9% of units. PLMA President Brian Sharoff said "There's no doubt that shopper behavior was highly influenced by consumer fears. Nonetheless the statistics point to greater acceptance of retailer brands as the coronavirus crisis evolves." SOURCE Private Label Manufacturers Association Related Links http://www.plma.com

edtsum7766

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the blast furnaces market and it is poised to grow by USD 869.14 mn during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts The market is fragmented, and the degree of fragmentation will decelerate during the forecast period. Danieli & C. Officine Meccaniche Spa, Gillanders Arbuthnot and Co. Ltd., IHI Corp., Larsen and Toubro Ltd., MECON Ltd., Metallurgical Corp. of China Ltd., Nippon Steel Corp., Noble Industrial Furnace Co. Inc., Primetals Technologies Ltd., and SMS Group GmbH are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Large installed base of blast furnaces has been instrumental in driving the growth of the market. Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Blast Furnaces Market 2020-2024: Segmentation Blast Furnaces Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43130 Blast Furnaces Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The blast furnaces market report covers the following areas: This study identifies the increasing adoption of telerehabilitation as one of the prime reasons driving the blast furnaces market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Blast Furnaces Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer Landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Answer:

Analysis on Impact of COVID-19: Blast Furnaces Market 2020-2024 | Large Installed Base of Blast Furnaces to Boost the Market Growth | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the blast furnaces market and it is poised to grow by USD 869.14 mn during 2020-2024. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts The market is fragmented, and the degree of fragmentation will decelerate during the forecast period. Danieli & C. Officine Meccaniche Spa, Gillanders Arbuthnot and Co. Ltd., IHI Corp., Larsen and Toubro Ltd., MECON Ltd., Metallurgical Corp. of China Ltd., Nippon Steel Corp., Noble Industrial Furnace Co. Inc., Primetals Technologies Ltd., and SMS Group GmbH are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Large installed base of blast furnaces has been instrumental in driving the growth of the market. Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Blast Furnaces Market 2020-2024: Segmentation Blast Furnaces Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43130 Blast Furnaces Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The blast furnaces market report covers the following areas: This study identifies the increasing adoption of telerehabilitation as one of the prime reasons driving the blast furnaces market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Blast Furnaces Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Customer Landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

edtsum7767

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN FRANCISCO, June 9, 2020 /PRNewswire/ -- The global technical insulation marketsize is expected to reach USD 8.8 billion by 2027, expanding at a CAGR of 2.5%, according to a new report by Grand View Research, Inc. Increasing acceptance of technical insulation across a wide range of applications such as commercial, energy, industrial and OEM is projected to benefit industry growth. Rapid industrialization across the globe on account of the rising population is anticipated to promote the market. In addition, rising awareness related to the benefits of technical protection of the equipment, personnel, and system is anticipated to drive the market over the forecast period. Key suggestions from the report: The hot insulation segment accounted for USD 2.9 billion in 2019 and is projected to witness a CAGR of 2.9% from 2020 to 2027. Rising demand for hot insulation in industries, OEM, and other applications is projected to benefit segment growth The heating and plumbing application segment accounted for 35.4% of market share in 2019 and is projected to witness a CAGR of 2.9% from 2020 to 2027 owing to the rising demand from the industrial and commercial sector The industrial and OEM end-use segment is anticipated to grow at a faster rate over the forecast period and reach USD 3.4 billion in 2027 on account of the rising demand for the insulating materials due to its benefits such as protection of pipes and equipment In Asia Pacific, the market is projected to witness a CAGR of 3.0% from 2020 to 2027 owing to the rapid expansion of industrial and commercial sector in the economies including India, China, Indonesia, and South Korea China accounted for the highest market share in Asia Pacific on account of the growing number of manufacturing industries in the country. Read 120 page research report with ToC on "Technical Insulation Market Size, Share & Trends Analysis Report By Type, By Application (Heating & Plumbing, Acoustic), By End Use (Industrial & OEM, Energy), By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/technical-insulation-market Rapid expansion of the commercial sector across the developing economies including China, India, Indonesia, and South Korea is projected to stimulate the demand for HVAC systems, acoustic protection, refrigeration, heating and plumbing protection facilities, thereby driving the industry. Low awareness related to technical protection coupled with the high capital investment at the initial state is estimated to restrict the expansion of the market. In addition, lack of skilled labors and high cost of raw materials are factors likely to pose a threat to the market over the forecast period. Grand View Research has segmented the global technical insulation market on the basis of type, application, end use, and region: Technical Insulation Type Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Hot Cold-Flexible Cold-Rigid Technical Insulation Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Heating & Plumbing HVAC Acoustic Refrigeration Technical Insulation End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Industrial & OEM Energy Commercial Buildings Technical Insulation Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) North America U.S. Canada Europe Germany U.K. Asia Pacific China India Japan Central & South America Brazil Middle East & Africa List of Key Players of Technical Insulation Market: Zotefoams Plc Owens Corning Kingspan Group Plc Rockwool International A/S Recticel NV/SA Morgan Advanced Materials plc Armacell International S.A. Aspen Aerogels, Inc. Knauf Insulation Saint-Gobain Palziv Inc. Find more research reports on Advanced Interior Materials Industry, by Grand View Research: Welded Plate And Block Heat Exchangers Market The global market is expected to witness significant growth on account of rising product demand from various end-use industries including HVAC and refrigeration, food & beverages, petrochemicals, and power generation, among others. Europe Heating Radiators Market Growing employment opportunities in construction sector, attractive interest rates, and other such policies are projected to favor the industry growth, thereby boosting the demand for residential and commercial heating radiators. Steel Rebar Market The expansion of construction sector is anticipated to remain a key driver for market growth. Growing construction output, especially in emerging countries, such as China, Brazil, and India, and diversification program in the Middle East countries, are contributing to the demand for steel rebar. Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: +1-415-349-0058Toll Free: 1-888-202-9519Email: [emailprotected] Web: https://www.grandviewresearch.comFollow Us: LinkedIn | Twitter SOURCE Grand View Research, Inc. Answer:

Technical Insulation Market Size Worth $8.8 Billion by 2027: Grand View Research, Inc.

SAN FRANCISCO, June 9, 2020 /PRNewswire/ -- The global technical insulation marketsize is expected to reach USD 8.8 billion by 2027, expanding at a CAGR of 2.5%, according to a new report by Grand View Research, Inc. Increasing acceptance of technical insulation across a wide range of applications such as commercial, energy, industrial and OEM is projected to benefit industry growth. Rapid industrialization across the globe on account of the rising population is anticipated to promote the market. In addition, rising awareness related to the benefits of technical protection of the equipment, personnel, and system is anticipated to drive the market over the forecast period. Key suggestions from the report: The hot insulation segment accounted for USD 2.9 billion in 2019 and is projected to witness a CAGR of 2.9% from 2020 to 2027. Rising demand for hot insulation in industries, OEM, and other applications is projected to benefit segment growth The heating and plumbing application segment accounted for 35.4% of market share in 2019 and is projected to witness a CAGR of 2.9% from 2020 to 2027 owing to the rising demand from the industrial and commercial sector The industrial and OEM end-use segment is anticipated to grow at a faster rate over the forecast period and reach USD 3.4 billion in 2027 on account of the rising demand for the insulating materials due to its benefits such as protection of pipes and equipment In Asia Pacific, the market is projected to witness a CAGR of 3.0% from 2020 to 2027 owing to the rapid expansion of industrial and commercial sector in the economies including India, China, Indonesia, and South Korea China accounted for the highest market share in Asia Pacific on account of the growing number of manufacturing industries in the country. Read 120 page research report with ToC on "Technical Insulation Market Size, Share & Trends Analysis Report By Type, By Application (Heating & Plumbing, Acoustic), By End Use (Industrial & OEM, Energy), By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/technical-insulation-market Rapid expansion of the commercial sector across the developing economies including China, India, Indonesia, and South Korea is projected to stimulate the demand for HVAC systems, acoustic protection, refrigeration, heating and plumbing protection facilities, thereby driving the industry. Low awareness related to technical protection coupled with the high capital investment at the initial state is estimated to restrict the expansion of the market. In addition, lack of skilled labors and high cost of raw materials are factors likely to pose a threat to the market over the forecast period. Grand View Research has segmented the global technical insulation market on the basis of type, application, end use, and region: Technical Insulation Type Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Hot Cold-Flexible Cold-Rigid Technical Insulation Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Heating & Plumbing HVAC Acoustic Refrigeration Technical Insulation End-use Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) Industrial & OEM Energy Commercial Buildings Technical Insulation Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2027) North America U.S. Canada Europe Germany U.K. Asia Pacific China India Japan Central & South America Brazil Middle East & Africa List of Key Players of Technical Insulation Market: Zotefoams Plc Owens Corning Kingspan Group Plc Rockwool International A/S Recticel NV/SA Morgan Advanced Materials plc Armacell International S.A. Aspen Aerogels, Inc. Knauf Insulation Saint-Gobain Palziv Inc. Find more research reports on Advanced Interior Materials Industry, by Grand View Research: Welded Plate And Block Heat Exchangers Market The global market is expected to witness significant growth on account of rising product demand from various end-use industries including HVAC and refrigeration, food & beverages, petrochemicals, and power generation, among others. Europe Heating Radiators Market Growing employment opportunities in construction sector, attractive interest rates, and other such policies are projected to favor the industry growth, thereby boosting the demand for residential and commercial heating radiators. Steel Rebar Market The expansion of construction sector is anticipated to remain a key driver for market growth. Growing construction output, especially in emerging countries, such as China, Brazil, and India, and diversification program in the Middle East countries, are contributing to the demand for steel rebar. Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: +1-415-349-0058Toll Free: 1-888-202-9519Email: [emailprotected] Web: https://www.grandviewresearch.comFollow Us: LinkedIn | Twitter SOURCE Grand View Research, Inc.

edtsum7768

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--Build America Mutual, the only mutual, U.S. municipal-only bond insurer, today published its 2020 statutory financial results, reporting record par insured and total premiums. In addition to strong organic growth in capital during 2020, BAM completed a $150 million, fully collateralized reinsurance agreement with Fidus Re Ltd in the first quarter of 2021 that expands its claims-paying resources to more than $1.1 billion. The substantial growth in claims-paying resources is the result of the continued execution of our long-term capital plan, which allows BAM to build unparalleled financial strength both through organic growth and periodically accessing the capital markets, said Sen W. McCarthy, Chief Executive Officer of BAM. Fidus Re is a special-purpose insurer created solely to provide reinsurance protection to BAM, and previously provided $100 million of claims-paying resources to BAM through a similar transaction in 2018, which remains in force. Both agreements were funded by the sale of insurance-linked notes by Fidus Re, which carry AA ratings from Kroll Bond Rating Agency. BAMs Statutory Financial Statements and Operating Supplements are available in the Financial Information section of BAMs website. The financial statements have also been filed with the National Association of Insurance Commissioners and the 50 state insurance regulators that license BAM. The latest Fidus Re transaction will be reflected in BAMs first quarter results, which will be published in May. About Build America Mutual BAM is a mutual bond insurance company operated for the benefit of its members the cities, states, and other municipal entities that use BAMs financial guaranty to lower their cost of borrowing and BAM is the preferred provider of bond insurance for members of the National League of Cities. As of December 31, 2020, there were more than $75 billion of BAM-insured municipal bonds outstanding for more than 4,200 member-issuers. Answer:

BAM Announces 2020 Statutory Financial Results Claims-Paying Resources Grow Past $1.1 Billon

NEW YORK--(BUSINESS WIRE)--Build America Mutual, the only mutual, U.S. municipal-only bond insurer, today published its 2020 statutory financial results, reporting record par insured and total premiums. In addition to strong organic growth in capital during 2020, BAM completed a $150 million, fully collateralized reinsurance agreement with Fidus Re Ltd in the first quarter of 2021 that expands its claims-paying resources to more than $1.1 billion. The substantial growth in claims-paying resources is the result of the continued execution of our long-term capital plan, which allows BAM to build unparalleled financial strength both through organic growth and periodically accessing the capital markets, said Sen W. McCarthy, Chief Executive Officer of BAM. Fidus Re is a special-purpose insurer created solely to provide reinsurance protection to BAM, and previously provided $100 million of claims-paying resources to BAM through a similar transaction in 2018, which remains in force. Both agreements were funded by the sale of insurance-linked notes by Fidus Re, which carry AA ratings from Kroll Bond Rating Agency. BAMs Statutory Financial Statements and Operating Supplements are available in the Financial Information section of BAMs website. The financial statements have also been filed with the National Association of Insurance Commissioners and the 50 state insurance regulators that license BAM. The latest Fidus Re transaction will be reflected in BAMs first quarter results, which will be published in May. About Build America Mutual BAM is a mutual bond insurance company operated for the benefit of its members the cities, states, and other municipal entities that use BAMs financial guaranty to lower their cost of borrowing and BAM is the preferred provider of bond insurance for members of the National League of Cities. As of December 31, 2020, there were more than $75 billion of BAM-insured municipal bonds outstanding for more than 4,200 member-issuers.

edtsum7769

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TORONTO, July 1, 2020 /PRNewswire/ -Clik.ai, a fastest growing automated underwriting platform that helps brokers and lenders underwrite faster, today announced it has entered an agreement with Merchants Capital, a top nationwide mortgage banking company with expertise in multifamily, affordable, senior and student housing finance, to implement Clik.ai's AI-driven workflow automation engine into Merchants' loan servicing operations. Merchants Capital is a top nationwide lender for the refinance, acquisition, new construction and substantial rehabilitation of multifamily, affordable, senior and student housing. Merchants will benefit from Clik.ai's service as its automation software will optimize workload management and assist with the massive influx of loan applications fromsmall to mid-size commercial real estate property owners. Additionally, the new partnership with Clik.ai will support the digitization of Merchants Capital, serve as a time-effective solution, and offer customers the best services while Clik.ai ensures the security and confidentiality of their data. The automation software provided by Clik.ai is a proprietary extraction and classification engine that, alongside asset managers and underwriters, the data extracted by the system can be easily moved into the bank's proprietary platform and servicing operations. Merchants Capital will be able to review rent roll and property cash flow data in minutes, which will enable the bank to capitalize on asset management. "We are excited to announce Merchants Capital as our partner in leveraging quick and accurate technology that will enable FSA & Rent Roll Automation in minutes coupled with efficient customer support to ensure sustainable competitive advantage in the industry," commented Parag Goswami, Chief Executive Officer and Co-Founder of Clik.ai. "We at Clik.ai are pleased to work with such a committed and successful company. Merchants' mission is to provide its loan products with exceptional customer service, accuracy, creativity, speed, and conformance to regulations. We look forward to witnessing Merchants Capital grow exponentially while maintaining a strong bottom line," continued Goswami. "Implementing Clik.ai technology at Merchants Capital was a natural fit for our business, as they are a best-in-class automation software for our industry," said John Karazsia, Vice President of Loan Production at Merchants Capital. "The adaptable, AI-driven programming will provide numerous benefits for our originations teams, ultimately optimizing our workflow and helping us service our clients in a reliable, fast and flexible way." About Clik.ai Clik.ai is a fastest growing automated underwriting platform that serves over 20 North American companies in mortgage banking, servicing, and real estate with $1 billion in commercial real estate transactions evaluated every month. Four of the top ten real estate banking firms use Clik.ai to automate and optimize workflow for property valuation and transaction due-diligence. Clik.ai's simple plug-n-play cloud software tools assist deal makers in running their deal valuations and transaction due-diligence at 5X speed. About Merchants Capital Established in 1990, Merchants Capital is one of the nation's top lenders for the refinance, acquisition, new construction and substantial rehabilitation of multifamily, affordable, senior and student housing. Whether you are considering Freddie Mac, Fannie Mae, HUD/FHA insured or balance sheet financing, let our personalized services help you meet your financing objectives. Experience the creativity of a small lender, with all the capabilities of a large institution. To learn more about Merchants Capital, visit www.merchantscapital.com. SOURCE Clik technologies Inc Related Links https://www.clik.ai Answer:

Merchants Capital Launches Clik.ai to Automate Loan Servicing Operations

TORONTO, July 1, 2020 /PRNewswire/ -Clik.ai, a fastest growing automated underwriting platform that helps brokers and lenders underwrite faster, today announced it has entered an agreement with Merchants Capital, a top nationwide mortgage banking company with expertise in multifamily, affordable, senior and student housing finance, to implement Clik.ai's AI-driven workflow automation engine into Merchants' loan servicing operations. Merchants Capital is a top nationwide lender for the refinance, acquisition, new construction and substantial rehabilitation of multifamily, affordable, senior and student housing. Merchants will benefit from Clik.ai's service as its automation software will optimize workload management and assist with the massive influx of loan applications fromsmall to mid-size commercial real estate property owners. Additionally, the new partnership with Clik.ai will support the digitization of Merchants Capital, serve as a time-effective solution, and offer customers the best services while Clik.ai ensures the security and confidentiality of their data. The automation software provided by Clik.ai is a proprietary extraction and classification engine that, alongside asset managers and underwriters, the data extracted by the system can be easily moved into the bank's proprietary platform and servicing operations. Merchants Capital will be able to review rent roll and property cash flow data in minutes, which will enable the bank to capitalize on asset management. "We are excited to announce Merchants Capital as our partner in leveraging quick and accurate technology that will enable FSA & Rent Roll Automation in minutes coupled with efficient customer support to ensure sustainable competitive advantage in the industry," commented Parag Goswami, Chief Executive Officer and Co-Founder of Clik.ai. "We at Clik.ai are pleased to work with such a committed and successful company. Merchants' mission is to provide its loan products with exceptional customer service, accuracy, creativity, speed, and conformance to regulations. We look forward to witnessing Merchants Capital grow exponentially while maintaining a strong bottom line," continued Goswami. "Implementing Clik.ai technology at Merchants Capital was a natural fit for our business, as they are a best-in-class automation software for our industry," said John Karazsia, Vice President of Loan Production at Merchants Capital. "The adaptable, AI-driven programming will provide numerous benefits for our originations teams, ultimately optimizing our workflow and helping us service our clients in a reliable, fast and flexible way." About Clik.ai Clik.ai is a fastest growing automated underwriting platform that serves over 20 North American companies in mortgage banking, servicing, and real estate with $1 billion in commercial real estate transactions evaluated every month. Four of the top ten real estate banking firms use Clik.ai to automate and optimize workflow for property valuation and transaction due-diligence. Clik.ai's simple plug-n-play cloud software tools assist deal makers in running their deal valuations and transaction due-diligence at 5X speed. About Merchants Capital Established in 1990, Merchants Capital is one of the nation's top lenders for the refinance, acquisition, new construction and substantial rehabilitation of multifamily, affordable, senior and student housing. Whether you are considering Freddie Mac, Fannie Mae, HUD/FHA insured or balance sheet financing, let our personalized services help you meet your financing objectives. Experience the creativity of a small lender, with all the capabilities of a large institution. To learn more about Merchants Capital, visit www.merchantscapital.com. SOURCE Clik technologies Inc Related Links https://www.clik.ai

edtsum7770

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK--(BUSINESS WIRE)--A new study released today by MAGNA, Roku, Inc. (NASDAQ: ROKU) and IPG Media Lab, Valuing the Value Exchange, demonstrates how marketers can use brand experiences that aide TV streaming content discovery while sponsorships for live events and sports are limited. The study reveals video ads and brand experiences together generate 4X greater purchase intent than video advertising alone. The study investigated how consumers feel about brand experiences on TV streaming that support content discovery, and how advertisers can assess and measure impact. Brand experiences are ads that offer free experiences to streamers, such as promo codes to free movies, ungated TV shows/movies, and more. The most important benefit of brand experiences is being able to give something back to individuals by offering them real utility and the study found this to be mutually beneficial for both consumers and brands, said Kara Manatt, SVP, Group Director, Intelligence Solutions, MAGNA. In the end, relevance is king. We found that it was more critical for a brand to deliver a content offer that consumers deemed relevant than to deliver a deeper discount offer that the consumer found irrelevant. We also found that diversifying ad types and serving both video and brand experience ads contributed to significant branding impact. Of note, the study found brand experiences felt less intrusive than most video ads, provided greater differentiation from traditional advertising, and seemed more fun. Key findings include: Based on previous studies, we know that consumers tend to respond more favorably to personalized ads that cater to their interests. Offering up curated brand experiences alongside content discovery is a huge opportunity for brands looking to reach new audiences and convert them to longtime customers. I strongly feel well see major growth of brands incorporating relevant brand experiences in their media campaigns, particularly in the streaming space as it offers a unique and customizable advertising experience said Chad Stoller, EVP, Managing Partner, IPG Media Lab, and Global Chief Innovation Officer, UM. The growth in TV streaming has become a CMO-level priority, said Dan Robbins, VP of Ad Marketing & Partners Solutions, Roku. Marketers can go beyond the video ad to engage with streamers and use branded experiences to drive more brand affinity, purchase consideration and intent. Media plans that miss this opportunity only give brands one piece of the puzzle. Methodology The study was conducted by IPG Media Labs and commissioned by Roku in two survey phases reaching over 2,300+ respondents total. The first conducted in Q4 2019 to measure the impact of brand experiences in the wild from brands like Energizer and a major CPG brand, and the second in May 2020 to dive deep into consumer perceptions of brand experiences and their impact on brand opinion. The full study can be found here. About Roku, Inc. Roku pioneered streaming to the TV. We connect users to the streaming content they love, enable content publishers to build and monetize large audiences, and provide advertisers with unique capabilities to engage consumers. RokuTV models and Roku streaming players are available in select countries around the world through direct retail sales and licensing arrangements with TV brands and service operators. Roku audio products are available in the U.S. through direct retail sales. Roku is headquartered in San Jose, Calif. U.S.A. Roku is a registered trademark of Roku, Inc. in the U.S. and in other countries. Trade names, trademarks and service marks of other companies appearing in this press release are the property of their respective holders. About MAGNA MAGNA is the centralized IPG Mediabrands resource that provides strategic investment and media intelligence for agency teams and clients. We utilize our insights, forecasts and strategic relationships to provide clients with a competitive marketplace advantage. MAGNA harnesses the aggregate power of all IPG media investments to develop go-to-market strategies, designing unique partnerships to drive maximum value for our clients. MAGNA has set the industry standard for more than 60 years by predicting the future of media value. We publish more than 40 annual reports on audience trends, media spend and market demand as well as ad effectiveness. MAGNA infuses the organization with knowledge that empowers better decision-making. We are a team of experts across five key competencies who support IPG cross-functional teams through: Partnership, Enablement, Accountability and Connectivity. Follow us on Twitter @MAGNAGLOBAL. About IPG Media Lab Part of the Interpublic network, the IPG Media Lab identifies and researches innovations and trends that will change the media landscape and how brands engage with their audiences. Since 2006, the Lab has worked with our clients and with industry partners who can help them best adapt to disruptive change. Its expertise, resources and consulting services also help to inform the learnings, strategies and business outcomes of all Interpublic agencies. For more information, please visit www.ipglab.com or follow @ipglab. Answer:

Roku, MAGNA and IPG Media Lab Study Reveals Advertisers Benefit 4X From Brand Experiences That Help Consumers Find Free Content

NEW YORK--(BUSINESS WIRE)--A new study released today by MAGNA, Roku, Inc. (NASDAQ: ROKU) and IPG Media Lab, Valuing the Value Exchange, demonstrates how marketers can use brand experiences that aide TV streaming content discovery while sponsorships for live events and sports are limited. The study reveals video ads and brand experiences together generate 4X greater purchase intent than video advertising alone. The study investigated how consumers feel about brand experiences on TV streaming that support content discovery, and how advertisers can assess and measure impact. Brand experiences are ads that offer free experiences to streamers, such as promo codes to free movies, ungated TV shows/movies, and more. The most important benefit of brand experiences is being able to give something back to individuals by offering them real utility and the study found this to be mutually beneficial for both consumers and brands, said Kara Manatt, SVP, Group Director, Intelligence Solutions, MAGNA. In the end, relevance is king. We found that it was more critical for a brand to deliver a content offer that consumers deemed relevant than to deliver a deeper discount offer that the consumer found irrelevant. We also found that diversifying ad types and serving both video and brand experience ads contributed to significant branding impact. Of note, the study found brand experiences felt less intrusive than most video ads, provided greater differentiation from traditional advertising, and seemed more fun. Key findings include: Based on previous studies, we know that consumers tend to respond more favorably to personalized ads that cater to their interests. Offering up curated brand experiences alongside content discovery is a huge opportunity for brands looking to reach new audiences and convert them to longtime customers. I strongly feel well see major growth of brands incorporating relevant brand experiences in their media campaigns, particularly in the streaming space as it offers a unique and customizable advertising experience said Chad Stoller, EVP, Managing Partner, IPG Media Lab, and Global Chief Innovation Officer, UM. The growth in TV streaming has become a CMO-level priority, said Dan Robbins, VP of Ad Marketing & Partners Solutions, Roku. Marketers can go beyond the video ad to engage with streamers and use branded experiences to drive more brand affinity, purchase consideration and intent. Media plans that miss this opportunity only give brands one piece of the puzzle. Methodology The study was conducted by IPG Media Labs and commissioned by Roku in two survey phases reaching over 2,300+ respondents total. The first conducted in Q4 2019 to measure the impact of brand experiences in the wild from brands like Energizer and a major CPG brand, and the second in May 2020 to dive deep into consumer perceptions of brand experiences and their impact on brand opinion. The full study can be found here. About Roku, Inc. Roku pioneered streaming to the TV. We connect users to the streaming content they love, enable content publishers to build and monetize large audiences, and provide advertisers with unique capabilities to engage consumers. RokuTV models and Roku streaming players are available in select countries around the world through direct retail sales and licensing arrangements with TV brands and service operators. Roku audio products are available in the U.S. through direct retail sales. Roku is headquartered in San Jose, Calif. U.S.A. Roku is a registered trademark of Roku, Inc. in the U.S. and in other countries. Trade names, trademarks and service marks of other companies appearing in this press release are the property of their respective holders. About MAGNA MAGNA is the centralized IPG Mediabrands resource that provides strategic investment and media intelligence for agency teams and clients. We utilize our insights, forecasts and strategic relationships to provide clients with a competitive marketplace advantage. MAGNA harnesses the aggregate power of all IPG media investments to develop go-to-market strategies, designing unique partnerships to drive maximum value for our clients. MAGNA has set the industry standard for more than 60 years by predicting the future of media value. We publish more than 40 annual reports on audience trends, media spend and market demand as well as ad effectiveness. MAGNA infuses the organization with knowledge that empowers better decision-making. We are a team of experts across five key competencies who support IPG cross-functional teams through: Partnership, Enablement, Accountability and Connectivity. Follow us on Twitter @MAGNAGLOBAL. About IPG Media Lab Part of the Interpublic network, the IPG Media Lab identifies and researches innovations and trends that will change the media landscape and how brands engage with their audiences. Since 2006, the Lab has worked with our clients and with industry partners who can help them best adapt to disruptive change. Its expertise, resources and consulting services also help to inform the learnings, strategies and business outcomes of all Interpublic agencies. For more information, please visit www.ipglab.com or follow @ipglab.

edtsum7771

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PITTSBURGH, Aug. 24, 2020 /PRNewswire/ -- "I was putting a new lock on my door and I kept dropping the little screws," said an inventor, from Destin, Fla. "I thought there could be a better way to hold them while working, so I invented the J T EASY TOOL." The invention provides an effective way to keep a quantity of screws readily accessible while working. In doing so, it eliminates the need to hold screws in the hand, a pocket or container. As a result, it saves time and effort and it helps to prevent lost or dropped screws. The invention features a practical design that is convenient and easy to use so it is ideal for households, construction workers, trade workers, do-it-yourselfers, etc. Additionally, it is producible in design variations. The inventor described the invention design. "My design provides added convenience by preventing lost screws." The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-AVZ-1889, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com Answer:

InventHelp Inventor Develops Convenient Tool for Holding Screws while Working (AVZ-1889)

PITTSBURGH, Aug. 24, 2020 /PRNewswire/ -- "I was putting a new lock on my door and I kept dropping the little screws," said an inventor, from Destin, Fla. "I thought there could be a better way to hold them while working, so I invented the J T EASY TOOL." The invention provides an effective way to keep a quantity of screws readily accessible while working. In doing so, it eliminates the need to hold screws in the hand, a pocket or container. As a result, it saves time and effort and it helps to prevent lost or dropped screws. The invention features a practical design that is convenient and easy to use so it is ideal for households, construction workers, trade workers, do-it-yourselfers, etc. Additionally, it is producible in design variations. The inventor described the invention design. "My design provides added convenience by preventing lost screws." The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-AVZ-1889, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com

edtsum7772

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SHENZHEN, China, Nov. 10, 2020 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company" or "we"), a leading technology-driven personal finance company in China, today announced that it will change the ratio of its American depositary shares ("ADSs") representing its Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to one (1) ADS representing six (6) Class A ordinary shares. From the perspective of an ADS holder, the ADS ratio change will have the same effect as a one-for-three reverse ADS split. There will be no change to the Company's Class A ordinary shares. The effect of the ratio change on the ADS trading price on the New York Stock Exchange is expected to take place at the open of trading on November 19, 2020 (U.S. Eastern Time). On expected effective date, ADS holders of the Company will be required to surrender their old ADSs to the Company's depositary bank, The Bank of New York Mellon as Depositary (the "Depositary"), for cancellation of every three (3) existing ADSs for one (1) new ADS. Only whole ADSs will be distributed. The Depositary will attempt to sell any fractional ADSs and distribute the cash proceeds to ADR holders. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than three times the ADS price before the change. About X Financial X Financial (NYSE: XYF) (the "Company") is a leading technology-driven personal finance company in China focused on meeting the huge demand for credit from individuals and small-to-medium-sized enterprise owners. The Company's proprietary big data-driven risk control system, WinSAFE, builds risk profiles of prospective borrowers using a variety data-driven credit assessment methodology to accurately evaluate a borrower's value, payment capability, payment attitude and overall creditworthiness. X Financial has established a strategic partnership with ZhongAn Online P&C Insurance Co., Ltd. in multiple areas of its business operations to directly complement its cutting-edge risk management and credit assessment capabilities. ZhongAn Online P&C Insurance Co., Ltd. provides credit insurance on X Financial's investment products which significantly enhances investor confidence and allows the Company to attract a diversified and low-cost funding base from individuals, enterprises and financial institutions to support its growth. X Financial leverages financial technology to provide convenient, efficient, and secure investment services to a wide range of high-quality borrowers and mass affluent investors which complements traditional financial institutions and helps to promote the development of inclusive finance in China. For more information, please visit: http://ir.xiaoyinggroup.com. Safe Harbor Statements This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "potential," "continue," "ongoing," "targets," "guidance" and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements that involve factors, risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors and risks include, but not limited to the following: the Company's goals and strategies; its future business development, financial condition and results of operations; the expected growth of the credit industry, and marketplace lending in particular, in China; the demand for and market acceptance of its marketplace's products and services; its ability to attract and retain borrowers and investors on its marketplace; its relationships with its strategic cooperation partners; competition in its industry; and relevant government policies and regulations relating to the corporate structure, business and industry. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC. All information provided in this announcement is current as of the date of this announcement, and the Company does not undertake any obligation to update such information, except as required under applicable law. For investor and media inquiries, please contact: X FinancialMr. Frank Fuya ZhengEmail: [emailprotected] ChristensenIn ChinaMr.Eric YuanPhone: +86-10- 5900-1548E-mail: [emailprotected] In USMs.Linda BergkampPhone: +1-480-614-3004Email: [emailprotected] SOURCE X Financial Related Links www.xiaoyinggroup.com Answer:

X Financial Announces ADS Ratio Change

SHENZHEN, China, Nov. 10, 2020 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company" or "we"), a leading technology-driven personal finance company in China, today announced that it will change the ratio of its American depositary shares ("ADSs") representing its Class A ordinary shares from one (1) ADS representing two (2) Class A ordinary shares to one (1) ADS representing six (6) Class A ordinary shares. From the perspective of an ADS holder, the ADS ratio change will have the same effect as a one-for-three reverse ADS split. There will be no change to the Company's Class A ordinary shares. The effect of the ratio change on the ADS trading price on the New York Stock Exchange is expected to take place at the open of trading on November 19, 2020 (U.S. Eastern Time). On expected effective date, ADS holders of the Company will be required to surrender their old ADSs to the Company's depositary bank, The Bank of New York Mellon as Depositary (the "Depositary"), for cancellation of every three (3) existing ADSs for one (1) new ADS. Only whole ADSs will be distributed. The Depositary will attempt to sell any fractional ADSs and distribute the cash proceeds to ADR holders. As a result of the change in the ADS ratio, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the change in the ADS ratio will be equal to or greater than three times the ADS price before the change. About X Financial X Financial (NYSE: XYF) (the "Company") is a leading technology-driven personal finance company in China focused on meeting the huge demand for credit from individuals and small-to-medium-sized enterprise owners. The Company's proprietary big data-driven risk control system, WinSAFE, builds risk profiles of prospective borrowers using a variety data-driven credit assessment methodology to accurately evaluate a borrower's value, payment capability, payment attitude and overall creditworthiness. X Financial has established a strategic partnership with ZhongAn Online P&C Insurance Co., Ltd. in multiple areas of its business operations to directly complement its cutting-edge risk management and credit assessment capabilities. ZhongAn Online P&C Insurance Co., Ltd. provides credit insurance on X Financial's investment products which significantly enhances investor confidence and allows the Company to attract a diversified and low-cost funding base from individuals, enterprises and financial institutions to support its growth. X Financial leverages financial technology to provide convenient, efficient, and secure investment services to a wide range of high-quality borrowers and mass affluent investors which complements traditional financial institutions and helps to promote the development of inclusive finance in China. For more information, please visit: http://ir.xiaoyinggroup.com. Safe Harbor Statements This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "potential," "continue," "ongoing," "targets," "guidance" and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements that involve factors, risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors and risks include, but not limited to the following: the Company's goals and strategies; its future business development, financial condition and results of operations; the expected growth of the credit industry, and marketplace lending in particular, in China; the demand for and market acceptance of its marketplace's products and services; its ability to attract and retain borrowers and investors on its marketplace; its relationships with its strategic cooperation partners; competition in its industry; and relevant government policies and regulations relating to the corporate structure, business and industry. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC. All information provided in this announcement is current as of the date of this announcement, and the Company does not undertake any obligation to update such information, except as required under applicable law. For investor and media inquiries, please contact: X FinancialMr. Frank Fuya ZhengEmail: [emailprotected] ChristensenIn ChinaMr.Eric YuanPhone: +86-10- 5900-1548E-mail: [emailprotected] In USMs.Linda BergkampPhone: +1-480-614-3004Email: [emailprotected] SOURCE X Financial Related Links www.xiaoyinggroup.com

edtsum7773

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PALO ALTO, Calif. & BANGALORE, India--(BUSINESS WIRE)--Iron Pillar, a venture growth investor backing companies built from India, today announced a $4M investment in CoreStack, the leading cloud governance and compliance SaaS startup based in Seattle with development in Chennai. Iron Pillar Fund II is targeting growth stage cloud software companies. CoreStack announced its $8.5 million Series A in March, 2020 led by Dallas Venture Capital (DVC) with participation from Jim Dubois, former Microsoft CIO, and Abidali Neemuchwala, former Wipro CEO. The company and its Board decided to create an investment opportunity specifically for Iron Pillar given the value that the Iron Pillar team brought through access to global customers, partners, investors and the Iron Pillar Network. CoreStack will use the funds for continued market expansion. CoreStack enables enterprises to continuously, securely and autonomously keep their cloud infrastructure compliant with industry standards and regulations while significantly boosting operational efficiencies and reducing costs. CoreStack has grown over 200% per year over the past three years, adding to its roster of marquee clients across U.S., Europe and India. Enterprise customers leverage CoreStack for their cloud governance and compliance needs, as pre-requisites for broader, large scale cloud adoption and migration. Ezhilarasan EZ Natarajan, Founder/CEO CoreStack, said "Over the past couple of years, CoreStack has delivered needle-moving value to enterprise companies. Customers see consistent outcomes such as 50% improvement in cloud operational efficiencies, 100% compliance to standards and 40% savings in cloud costs. Iron Pillar came along as the perfect partner to help us expand globally, not only by way of expanded investment interest to Series-A financing, but more importantly by way of introduction to customers, partners and advisors. We're thrilled to be working with Iron Pillar," he added. Mohanjit Jolly, Partner at Iron Pillar, added We are thrilled to be investing in CoreStack, that has built and delivered world class cloud governance and compliance solutions to a discerning global customer base. To see a company get the sort of traction that CoreStack has, and that too with relatively little capital, is truly rare in the SaaS world. The company is at the leading edge of the cloud-based digital transformation movement that has been accelerated in 2020. The Iron Pillar team looks forward to working closely with CoreStack management and existing investors in creating a differentiated cloud software unicorn. Download press release PDF https://ironpillarfund.com/press-release/iron-pillar-invests-4m-in-corestack/ About CoreStack: CoreStack is a rapidly growing venture-backed startup that empowers enterprises to achieve continuous and autonomous cloud governance at scale. Gartner has recognized CoreStack both in its Magic Quadrant for Cloud Management Platforms -2020 and Cool Vendors in Cloud Computing -2019. The Company was also recognized as IDC Innovator in Multi-cloud Management Platforms in 2020. CoreStack was awarded a key U.S. Patent on Orchestration of Multiple Cloud Platforms and Services, and recently won the prestigious Nasscom Emerge50 award. CoreStack is a Microsoft Azure Gold & Co-sell Partner and Amazon AWS Advanced Technology Partner. CoreStack was founded in 2016 by Ezhilarasan Natarajan, Rathinasabapathy Arumugam, Krishnakumar Narayanan and Thiruvalluvar NB. To learn more about CoreStacks Enterprise Cloud Governance visit https://www.corestack.io/ About Iron Pillar: Iron Pillar is a venture growth investor specializing in mid stage technology companies Built from India. Founded in January 2016, Iron Pillar provides growth capital and active help in global business expansion to companies in the enterprise and consumer technology sectors. The Fund backs founding teams who want to create $1B+ enterprise value companies that are built to last. Additional information on Iron Pillar is available at https://ironpillarfund.com Answer:

Iron Pillar Invests $4M in CoreStack Maiden investment by Iron Pillar Fund II

PALO ALTO, Calif. & BANGALORE, India--(BUSINESS WIRE)--Iron Pillar, a venture growth investor backing companies built from India, today announced a $4M investment in CoreStack, the leading cloud governance and compliance SaaS startup based in Seattle with development in Chennai. Iron Pillar Fund II is targeting growth stage cloud software companies. CoreStack announced its $8.5 million Series A in March, 2020 led by Dallas Venture Capital (DVC) with participation from Jim Dubois, former Microsoft CIO, and Abidali Neemuchwala, former Wipro CEO. The company and its Board decided to create an investment opportunity specifically for Iron Pillar given the value that the Iron Pillar team brought through access to global customers, partners, investors and the Iron Pillar Network. CoreStack will use the funds for continued market expansion. CoreStack enables enterprises to continuously, securely and autonomously keep their cloud infrastructure compliant with industry standards and regulations while significantly boosting operational efficiencies and reducing costs. CoreStack has grown over 200% per year over the past three years, adding to its roster of marquee clients across U.S., Europe and India. Enterprise customers leverage CoreStack for their cloud governance and compliance needs, as pre-requisites for broader, large scale cloud adoption and migration. Ezhilarasan EZ Natarajan, Founder/CEO CoreStack, said "Over the past couple of years, CoreStack has delivered needle-moving value to enterprise companies. Customers see consistent outcomes such as 50% improvement in cloud operational efficiencies, 100% compliance to standards and 40% savings in cloud costs. Iron Pillar came along as the perfect partner to help us expand globally, not only by way of expanded investment interest to Series-A financing, but more importantly by way of introduction to customers, partners and advisors. We're thrilled to be working with Iron Pillar," he added. Mohanjit Jolly, Partner at Iron Pillar, added We are thrilled to be investing in CoreStack, that has built and delivered world class cloud governance and compliance solutions to a discerning global customer base. To see a company get the sort of traction that CoreStack has, and that too with relatively little capital, is truly rare in the SaaS world. The company is at the leading edge of the cloud-based digital transformation movement that has been accelerated in 2020. The Iron Pillar team looks forward to working closely with CoreStack management and existing investors in creating a differentiated cloud software unicorn. Download press release PDF https://ironpillarfund.com/press-release/iron-pillar-invests-4m-in-corestack/ About CoreStack: CoreStack is a rapidly growing venture-backed startup that empowers enterprises to achieve continuous and autonomous cloud governance at scale. Gartner has recognized CoreStack both in its Magic Quadrant for Cloud Management Platforms -2020 and Cool Vendors in Cloud Computing -2019. The Company was also recognized as IDC Innovator in Multi-cloud Management Platforms in 2020. CoreStack was awarded a key U.S. Patent on Orchestration of Multiple Cloud Platforms and Services, and recently won the prestigious Nasscom Emerge50 award. CoreStack is a Microsoft Azure Gold & Co-sell Partner and Amazon AWS Advanced Technology Partner. CoreStack was founded in 2016 by Ezhilarasan Natarajan, Rathinasabapathy Arumugam, Krishnakumar Narayanan and Thiruvalluvar NB. To learn more about CoreStacks Enterprise Cloud Governance visit https://www.corestack.io/ About Iron Pillar: Iron Pillar is a venture growth investor specializing in mid stage technology companies Built from India. Founded in January 2016, Iron Pillar provides growth capital and active help in global business expansion to companies in the enterprise and consumer technology sectors. The Fund backs founding teams who want to create $1B+ enterprise value companies that are built to last. Additional information on Iron Pillar is available at https://ironpillarfund.com

edtsum7774

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MISSION, Kan., Dec. 29, 2020 /PRNewswire/ -- (Family Features) A new year brings new opportunities for personal changes and improvement from taking steps forward in a career to bettering personal relationships and perhaps most common starting on a path toward better health. For many, the worthwhile challenge of enhancing physical health begins with the foods and beverages you eat and drink. Photos courtesy of Getty Images Step one is to leave behind the habit of turning to unhealthy meals and instead focus on dishes that call for fresh fruits and veggies like this Quinoa Salad with Orange Cilantro Salad Dressing. Simply start with cooked quinoa and mix together with your preferred produce like orange slices, grapefruit and diced avocado. Add feta cheese, lime juice and diced red onion to bring the flavor to life and drizzle with the light, zesty dressing. Making nutritious choices goes beyond just your meals, however. Take your commitment to the next level with beverages that don't cancel out your effort to eat healthy. This Spiced Citrus Ginger Mocktail combines a concentrate made of orange juice, orange peel, lime juice and lime peel with zero-sugar, zero-calorie ginger ale. These health-conscious recipes are made possible with the flavor enhancement of Zevia beverages, which are naturally sweetened with stevia and include no artificial ingredients, colors or preservatives. Ranging from sodas to organic teas, energy drinks, sparkling water and mixers for cocktails and mocktails, the zero-sugar beverages fit nearly any lifestyle including eating patterns like paleo, keto, intermittent fasting and gluten-free. Visit zevia.com/recipes to find more nutritious food and drink solutions. Quinoa Salad with Orange Cilantro Salad Dressing Yield: 2 cupsDressing: 1/2 cup Zevia Orange Soda 1/4 cup lime juice 1/2 cup olive oil 1 cup fresh cilantro 1/2 avocado 1 teaspoon garlicQuinoa Salad: 1 cup quinoa leafy greens (optional) 1 orange, cut into pieces (optional) 1 grapefruit, cut into pieces (optional) 1 lime, juice only 1/2 avocado, diced (optional) 1/4 cup feta cheese (optional) 1/4 cup diced red onion (optional)To make dressing: In food processor, pulse orange soda, lime juice, olive oil, cilantro, avocado and garlic until consistency is smooth.To make quinoa salad: Cook quinoa according to package directions and let cool.Once quinoa is cool, add to bowl with orange pieces, if desired; grapefruit pieces, if desired; lime juice; avocado, if desired; feta cheese, if desired; and diced onion, if desired. Top with orange cilantro salad dressing. Spiced Citrus Ginger Mocktail Yield: 1 mocktailConcentrate: 1 cup fresh-squeezed orange juice 1/2 cup fresh-squeezed lime juice 1 orange peel 1 lime peel 1/2 teaspoon black peppercorns, lightly crushed 5 cardamom pods, lightly crushed 2 cinnamon sticks, lightly crushedMocktail: 1/3 cup concentrate 1 can Zevia Ginger Ale ice lime wedge, for garnish (optional) orange wedge, for garnish (optional)To make concentrate: In small saucepan, combine orange juice, lime juice, orange peel, lime peel, black peppercorns, cardamom pods and cinnamon sticks. Bring to boil over high heat then turn to low; simmer until liquid has reduced by half, 3-4 minutes. Let cool and strain out solids. Transfer to glass jar and store until ready to use.To make mocktail: Combine concentrate with ginger ale over ice.Garnish with lime wedge or orange wedge, if desired. Photos courtesy of Getty ImagesMichael French [emailprotected] 1-888-824-3337 editors.familyfeatures.comAbout Family Features Editorial Syndicate A leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com. SOURCE Family Features Editorial Syndicate Related Links http://www.familyfeatures.com Answer:

Nutritional Inspiration for the New Year

MISSION, Kan., Dec. 29, 2020 /PRNewswire/ -- (Family Features) A new year brings new opportunities for personal changes and improvement from taking steps forward in a career to bettering personal relationships and perhaps most common starting on a path toward better health. For many, the worthwhile challenge of enhancing physical health begins with the foods and beverages you eat and drink. Photos courtesy of Getty Images Step one is to leave behind the habit of turning to unhealthy meals and instead focus on dishes that call for fresh fruits and veggies like this Quinoa Salad with Orange Cilantro Salad Dressing. Simply start with cooked quinoa and mix together with your preferred produce like orange slices, grapefruit and diced avocado. Add feta cheese, lime juice and diced red onion to bring the flavor to life and drizzle with the light, zesty dressing. Making nutritious choices goes beyond just your meals, however. Take your commitment to the next level with beverages that don't cancel out your effort to eat healthy. This Spiced Citrus Ginger Mocktail combines a concentrate made of orange juice, orange peel, lime juice and lime peel with zero-sugar, zero-calorie ginger ale. These health-conscious recipes are made possible with the flavor enhancement of Zevia beverages, which are naturally sweetened with stevia and include no artificial ingredients, colors or preservatives. Ranging from sodas to organic teas, energy drinks, sparkling water and mixers for cocktails and mocktails, the zero-sugar beverages fit nearly any lifestyle including eating patterns like paleo, keto, intermittent fasting and gluten-free. Visit zevia.com/recipes to find more nutritious food and drink solutions. Quinoa Salad with Orange Cilantro Salad Dressing Yield: 2 cupsDressing: 1/2 cup Zevia Orange Soda 1/4 cup lime juice 1/2 cup olive oil 1 cup fresh cilantro 1/2 avocado 1 teaspoon garlicQuinoa Salad: 1 cup quinoa leafy greens (optional) 1 orange, cut into pieces (optional) 1 grapefruit, cut into pieces (optional) 1 lime, juice only 1/2 avocado, diced (optional) 1/4 cup feta cheese (optional) 1/4 cup diced red onion (optional)To make dressing: In food processor, pulse orange soda, lime juice, olive oil, cilantro, avocado and garlic until consistency is smooth.To make quinoa salad: Cook quinoa according to package directions and let cool.Once quinoa is cool, add to bowl with orange pieces, if desired; grapefruit pieces, if desired; lime juice; avocado, if desired; feta cheese, if desired; and diced onion, if desired. Top with orange cilantro salad dressing. Spiced Citrus Ginger Mocktail Yield: 1 mocktailConcentrate: 1 cup fresh-squeezed orange juice 1/2 cup fresh-squeezed lime juice 1 orange peel 1 lime peel 1/2 teaspoon black peppercorns, lightly crushed 5 cardamom pods, lightly crushed 2 cinnamon sticks, lightly crushedMocktail: 1/3 cup concentrate 1 can Zevia Ginger Ale ice lime wedge, for garnish (optional) orange wedge, for garnish (optional)To make concentrate: In small saucepan, combine orange juice, lime juice, orange peel, lime peel, black peppercorns, cardamom pods and cinnamon sticks. Bring to boil over high heat then turn to low; simmer until liquid has reduced by half, 3-4 minutes. Let cool and strain out solids. Transfer to glass jar and store until ready to use.To make mocktail: Combine concentrate with ginger ale over ice.Garnish with lime wedge or orange wedge, if desired. Photos courtesy of Getty ImagesMichael French [emailprotected] 1-888-824-3337 editors.familyfeatures.comAbout Family Features Editorial Syndicate A leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com. SOURCE Family Features Editorial Syndicate Related Links http://www.familyfeatures.com

edtsum7775

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael Nally, executive vice president and chief marketing officer, is scheduled to participate in a virtual fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference on Sept. 17, 2020, at 10:00 a.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://www.merck.com/investor-relations/events-and-presentations/. About Merck For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the worlds most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the company) includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the companys ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the companys patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the companys 2019 Annual Report on Form 10-K and the companys other filings with the Securities and Exchange Commission (SEC) available at the SECs Internet site (www.sec.gov). Answer:

Merck to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael Nally, executive vice president and chief marketing officer, is scheduled to participate in a virtual fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference on Sept. 17, 2020, at 10:00 a.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at https://www.merck.com/investor-relations/events-and-presentations/. About Merck For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the worlds most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the company) includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the companys ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the companys patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the companys 2019 Annual Report on Form 10-K and the companys other filings with the Securities and Exchange Commission (SEC) available at the SECs Internet site (www.sec.gov).

edtsum7776

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOS ANGELES, April 2, 2020 /PRNewswire/ --In honor of World Autism Month this April, Loot Crate announced a Loot Launcher exclusive Sensory Crate Supporting Autism Speaks filled with high-sensory toys designed with children on the autism spectrum in mind, with proceeds benefiting Autism Speaks. Sensory differences are often experienced by people on the spectrum and can involve both hyper-sensitivities and hypo-sensitivities to a wide range of stimuli including sights, sounds, touch and more. The Sensory Crate will include toys and activities that provide sensory stimulation. "Loot is proud to partner with Autism Speaks during World Autism Month for this one-of-a-kind Sensory Crate," said The Loot Company owner Joel Weinshanker. "This cause is very important to me, especially during this time of uncertainty. Despite the global crisis we face ourselves in, I'm thrilled that together we are finding new and creative ways to stay connected to the ones we love." The Sensory Crate will include toys designed with children on the spectrum in mind, featuring products from some of your favorite animated titles (to be announced) and will ship in the Fall of 2020. The crate will also include a teaching story, offering families a method of safely sharing the experience with family members of the spectrum. Each crate will cost $45.00 plus shipping and handling. Supporters will only be charged once the project has met or exceeded its goal of 2,000 backers by April 30. All net proceeds to the Loot Launcher crowdfunding goal, up to $50,000, will go directly to Autism Speaks to their mission of promoting solutions, across the spectrum and throughout the lifespan, for the needs of individuals with autism and their families and creating a kinder, more inclusive world. "During this time of uncertainty, we remain committed to the spirit of World Autism Month and sharing support, kindness and compassion," said Val Paradiz, Ph.D., vice president of services and support at Autism Speaks. "We are so appreciative that Loot Crate shares our dedication to our community, as we continue to provide resources that will help everyone on the spectrum feel supported during these unprecedented times." To back this Loot Launcher Sensory Crate Supporting Autism Speaks, please visit:https://www.lootcrate.com/crates/autism-speaks About AutismAutism, or autism spectrum disorder, refers to a broad range of conditions characterized by challenges with social skills, repetitive behaviors, speech and nonverbal communication. We now know that there is not one autism but many subtypes, and each person with autism can have unique strengths and challenges. A combination of genetic and environmental factors influence the development of autism, and autism often is accompanied by medical issues such as GI disorders, seizures and sleep disturbances. Autism affects an estimated 1 in 54 children. About Autism SpeaksAutism Speaks is dedicated to promoting solutions, across the spectrum and throughout the lifespan, for the needs of individuals with autism and their families. We do this through advocacy and support; increasing understanding and acceptance of people with autism spectrum disorder; and advancing research into causes and better interventions for autism spectrum disorder and related conditions. To find resources, join an event or make a donation, go towww.AutismSpeaks.org. Learn more by following @AutismSpeaks onFacebook,Twitter,Instagram andLinkedIn. About the Loot CompanyThe Loot Company is a leading subscription eCommerce service for fans of pop culture, video games, anime, and more. The Loot Company collaborates with global entertainment properties to help audiences discover their favorite products. With over 20 premium consumer product lines in themed and limited-edition crates, as well as crowdfunded Loot Launcher exclusives, fandom is delivered directly to subscribers' doorsteps.Loot Crate was acquired by the Loot Company in 2019 and is supported by the heart of a diverse subscriber community affectionately known as Looters.The Loot Company is a wholly-owned subsidiary of Money Chest LLC, with sister brands including NECA, Kidrobot and WizKids.To sign up for a Loot Company subscription, visit www.lootcrate.com.Facebook:facebook.com/lootcrate/Twitter:@lootcrateInstagram:@lootcrate SOURCE Loot Crate Related Links http://www.lootcrate.com/ Answer:

Loot Crate and Autism Speaks Introduce a 'Sensory Crate Supporting Autism Speaks' on Loot Launcher April is World Autism Month and to celebrate, The Loot Company is unveiling a toy crate designed for children on the spectrum

LOS ANGELES, April 2, 2020 /PRNewswire/ --In honor of World Autism Month this April, Loot Crate announced a Loot Launcher exclusive Sensory Crate Supporting Autism Speaks filled with high-sensory toys designed with children on the autism spectrum in mind, with proceeds benefiting Autism Speaks. Sensory differences are often experienced by people on the spectrum and can involve both hyper-sensitivities and hypo-sensitivities to a wide range of stimuli including sights, sounds, touch and more. The Sensory Crate will include toys and activities that provide sensory stimulation. "Loot is proud to partner with Autism Speaks during World Autism Month for this one-of-a-kind Sensory Crate," said The Loot Company owner Joel Weinshanker. "This cause is very important to me, especially during this time of uncertainty. Despite the global crisis we face ourselves in, I'm thrilled that together we are finding new and creative ways to stay connected to the ones we love." The Sensory Crate will include toys designed with children on the spectrum in mind, featuring products from some of your favorite animated titles (to be announced) and will ship in the Fall of 2020. The crate will also include a teaching story, offering families a method of safely sharing the experience with family members of the spectrum. Each crate will cost $45.00 plus shipping and handling. Supporters will only be charged once the project has met or exceeded its goal of 2,000 backers by April 30. All net proceeds to the Loot Launcher crowdfunding goal, up to $50,000, will go directly to Autism Speaks to their mission of promoting solutions, across the spectrum and throughout the lifespan, for the needs of individuals with autism and their families and creating a kinder, more inclusive world. "During this time of uncertainty, we remain committed to the spirit of World Autism Month and sharing support, kindness and compassion," said Val Paradiz, Ph.D., vice president of services and support at Autism Speaks. "We are so appreciative that Loot Crate shares our dedication to our community, as we continue to provide resources that will help everyone on the spectrum feel supported during these unprecedented times." To back this Loot Launcher Sensory Crate Supporting Autism Speaks, please visit:https://www.lootcrate.com/crates/autism-speaks About AutismAutism, or autism spectrum disorder, refers to a broad range of conditions characterized by challenges with social skills, repetitive behaviors, speech and nonverbal communication. We now know that there is not one autism but many subtypes, and each person with autism can have unique strengths and challenges. A combination of genetic and environmental factors influence the development of autism, and autism often is accompanied by medical issues such as GI disorders, seizures and sleep disturbances. Autism affects an estimated 1 in 54 children. About Autism SpeaksAutism Speaks is dedicated to promoting solutions, across the spectrum and throughout the lifespan, for the needs of individuals with autism and their families. We do this through advocacy and support; increasing understanding and acceptance of people with autism spectrum disorder; and advancing research into causes and better interventions for autism spectrum disorder and related conditions. To find resources, join an event or make a donation, go towww.AutismSpeaks.org. Learn more by following @AutismSpeaks onFacebook,Twitter,Instagram andLinkedIn. About the Loot CompanyThe Loot Company is a leading subscription eCommerce service for fans of pop culture, video games, anime, and more. The Loot Company collaborates with global entertainment properties to help audiences discover their favorite products. With over 20 premium consumer product lines in themed and limited-edition crates, as well as crowdfunded Loot Launcher exclusives, fandom is delivered directly to subscribers' doorsteps.Loot Crate was acquired by the Loot Company in 2019 and is supported by the heart of a diverse subscriber community affectionately known as Looters.The Loot Company is a wholly-owned subsidiary of Money Chest LLC, with sister brands including NECA, Kidrobot and WizKids.To sign up for a Loot Company subscription, visit www.lootcrate.com.Facebook:facebook.com/lootcrate/Twitter:@lootcrateInstagram:@lootcrate SOURCE Loot Crate Related Links http://www.lootcrate.com/

edtsum7777

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN--(BUSINESS WIRE)--The "Competitive Intensity of Tuhu in the Automotive Aftermarket in China, 2019" report has been added to ResearchAndMarkets.com's offering. Tuhu is a leading service aggregator in the Chinese automotive aftermarket. It has developed a vertical value chain, by interconnecting domestic and international automotive parts manufacturers, distributors, small and medium aftermarket workshops, and consumers - moving from online sales involvement to offline service presence. In 2019, the registered users of Tuhu accounted for 21.7% of the private passenger vehicles in operation, equivalent to 45 million people. With direct operation and cooperation structures, more than 14,000 Tuhu's workshops are operating in 405 cities in China. Tuhu is highly concentrated on the tire business. It provides a variety of brand choices, through direct supply or authorized cooperation. Brands include Bridgestone, Chaoyang, Continental, Dunlop, Giti, Goodyear, Hankook, Kumho, Linglong, Maxxis, Michelin, and Yokohama, among others. It also provides 1-year tire insurance (without additional charges) and unlimited free nitrogen filling services. The main sources of revenue include: commissions from automotive parts procurement (ranging from 5-40%) and franchise fee from cooperative workshops. Automotive parts procurement includes supplying automotive parts directly to the workshops and end-users. Franchise set-up cost includes comprehensive technical and software supports. Tuhu aims to further focus on authentic assurance and greater transparency, such as a full chain traceability system for automotive parts. Consumers can check the status of their shipment in the entire process - from factory production to terminal consumption. Tuhu will further penetrate offline retailing, with a special flagship store of leading automotive parts brands. Key Topics Covered: 1. Executive Summary 2. The Strategic Imperative 8 3. Growth Environment 4. Research Scope, Objectives, Methodology, and Background 5. Growth Opportunity Analysis, Tuhu 6. Growth Opportunity Universe, 2020 7. Conclusions and Future Outlook 8. Appendix For more information about this report visit https://www.researchandmarkets.com/r/9bosjh Answer:

Market Study into the Competitive Intensity of Tuhu in the Automotive Aftermarket in China - 2019 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Competitive Intensity of Tuhu in the Automotive Aftermarket in China, 2019" report has been added to ResearchAndMarkets.com's offering. Tuhu is a leading service aggregator in the Chinese automotive aftermarket. It has developed a vertical value chain, by interconnecting domestic and international automotive parts manufacturers, distributors, small and medium aftermarket workshops, and consumers - moving from online sales involvement to offline service presence. In 2019, the registered users of Tuhu accounted for 21.7% of the private passenger vehicles in operation, equivalent to 45 million people. With direct operation and cooperation structures, more than 14,000 Tuhu's workshops are operating in 405 cities in China. Tuhu is highly concentrated on the tire business. It provides a variety of brand choices, through direct supply or authorized cooperation. Brands include Bridgestone, Chaoyang, Continental, Dunlop, Giti, Goodyear, Hankook, Kumho, Linglong, Maxxis, Michelin, and Yokohama, among others. It also provides 1-year tire insurance (without additional charges) and unlimited free nitrogen filling services. The main sources of revenue include: commissions from automotive parts procurement (ranging from 5-40%) and franchise fee from cooperative workshops. Automotive parts procurement includes supplying automotive parts directly to the workshops and end-users. Franchise set-up cost includes comprehensive technical and software supports. Tuhu aims to further focus on authentic assurance and greater transparency, such as a full chain traceability system for automotive parts. Consumers can check the status of their shipment in the entire process - from factory production to terminal consumption. Tuhu will further penetrate offline retailing, with a special flagship store of leading automotive parts brands. Key Topics Covered: 1. Executive Summary 2. The Strategic Imperative 8 3. Growth Environment 4. Research Scope, Objectives, Methodology, and Background 5. Growth Opportunity Analysis, Tuhu 6. Growth Opportunity Universe, 2020 7. Conclusions and Future Outlook 8. Appendix For more information about this report visit https://www.researchandmarkets.com/r/9bosjh

edtsum7778

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BERWYN, Pa., Oct. 16, 2020 /PRNewswire/ --RM LAW, P.C.announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Portland General Electric Company ("Portland General Electric" or the "Company") (NYSE: POR) securities during the period from April 24, 2020 through August 24, 2020 inclusive (the "Class Period"). Portland General Electric shareholders may, no later than November 2, 2020, move the Court for appointment as a lead plaintiff of the Class. If you purchased shares of Portland General Electric and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here. The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) PGE lacked effective internal controls over its energy trading practices; (2) PGE personnel had entered energy trades during 2020, with increasing volume accumulating late in the second quarter and into the third quarter, that created significant negative financial exposure for PGE; (3) as a result, the Company was reasonably likely to incur significant losses; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. If you are a member of the class, you may, no later than November 2, 2020, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain RM LAW, P.C. or other counsel of your choice, to serve as your counsel in this action. For more information regarding this, please contact RM LAW, P.C. (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at [emailprotected]or click here. For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here. RM LAW, P.C. is a national shareholder litigation firm. RM LAW, P.C. is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. CONTACT: RM LAW, P.C. Richard A. Maniskas, Esquire 1055 Westlakes Dr., Ste. 300 Berwyn, PA 19312 484-324-6800 844-291-9299 [emailprotected] SOURCE RM LAW, P.C. Related Links http://www.rmclasslaw.com Answer:

RM LAW Announces Class Action Lawsuit Against Portland General Electric Company

BERWYN, Pa., Oct. 16, 2020 /PRNewswire/ --RM LAW, P.C.announces that a class action lawsuit has been filed on behalf of all persons or entities that purchased Portland General Electric Company ("Portland General Electric" or the "Company") (NYSE: POR) securities during the period from April 24, 2020 through August 24, 2020 inclusive (the "Class Period"). Portland General Electric shareholders may, no later than November 2, 2020, move the Court for appointment as a lead plaintiff of the Class. If you purchased shares of Portland General Electric and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (844) 291-9299 or to sign up online, click here. The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) PGE lacked effective internal controls over its energy trading practices; (2) PGE personnel had entered energy trades during 2020, with increasing volume accumulating late in the second quarter and into the third quarter, that created significant negative financial exposure for PGE; (3) as a result, the Company was reasonably likely to incur significant losses; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. If you are a member of the class, you may, no later than November 2, 2020, request that the Court appoint you as lead plaintiff of the class. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain RM LAW, P.C. or other counsel of your choice, to serve as your counsel in this action. For more information regarding this, please contact RM LAW, P.C. (Richard A. Maniskas, Esquire) toll-free at (844) 291-9299 or by email at [emailprotected]or click here. For more information about class action cases in general or to learn more about RM LAW, P.C. please visit our website by clicking here. RM LAW, P.C. is a national shareholder litigation firm. RM LAW, P.C. is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide. CONTACT: RM LAW, P.C. Richard A. Maniskas, Esquire 1055 Westlakes Dr., Ste. 300 Berwyn, PA 19312 484-324-6800 844-291-9299 [emailprotected] SOURCE RM LAW, P.C. Related Links http://www.rmclasslaw.com

edtsum7779

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, June 2, 2020 /PRNewswire/ --Global Acrylic Fibers Market 2020-2024 The analyst has been monitoring the acrylic fibers market and it is poised to grow by 251.34 million tons during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on acrylic fibers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Read the full report: https://www.reportlinker.com/p05356593/?utm_source=PRN The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in demand from developing countries and growth in textile and apparel industry. In addition, rise in demand from developing countries is anticipated to boost the growth of the market as well. The acrylic fibers market analysis includes type segment and geographic landscapes The acrylic fibers market is segmented as below: By Type Staple Filament By Geographic Landscapes APAC MEA Europe North America South America This study identifies the increase in demand for acrylic fibers in blended fabrics as one of the prime reasons driving the acrylic fibers market growth during the next few years. The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our acrylic fibers market covers the following areas: Acrylic fibers market sizing Acrylic fibers market forecast Acrylic fibers market industry analysis" Read the full report: https://www.reportlinker.com/p05356593/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com Answer:

The Global Acrylic Fibers Market is expected to grow by 251.34 million tons during 2020-2024 progressing at a CAGR of 3% during the forecast period

NEW YORK, June 2, 2020 /PRNewswire/ --Global Acrylic Fibers Market 2020-2024 The analyst has been monitoring the acrylic fibers market and it is poised to grow by 251.34 million tons during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on acrylic fibers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Read the full report: https://www.reportlinker.com/p05356593/?utm_source=PRN The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in demand from developing countries and growth in textile and apparel industry. In addition, rise in demand from developing countries is anticipated to boost the growth of the market as well. The acrylic fibers market analysis includes type segment and geographic landscapes The acrylic fibers market is segmented as below: By Type Staple Filament By Geographic Landscapes APAC MEA Europe North America South America This study identifies the increase in demand for acrylic fibers in blended fabrics as one of the prime reasons driving the acrylic fibers market growth during the next few years. The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our acrylic fibers market covers the following areas: Acrylic fibers market sizing Acrylic fibers market forecast Acrylic fibers market industry analysis" Read the full report: https://www.reportlinker.com/p05356593/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com

edtsum7780

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SCOTTSDALE, Ariz.--(BUSINESS WIRE)--STORE Capital Corporation (NYSE: STOR), an internally managed net-lease real estate investment trust (REIT) that invests in Single Tenant Operational Real Estate, today announced August rent collections and the repayment of the majority of borrowings on its credit facility. As of August 17, STORE Capital had received rent payments representing 86% of contractual base rent and interest for the month of August. July collections also increased to 86%, up from the previously announced 85%. Based on an updated survey of STORE Capital tenants, the percentage of properties open in August also increased to 93% from 92% in July. The number of our locations open for business has continued to increase since May, and rent collections have risen accordingly, said Christopher Volk, President and Chief Executive Officer of STORE Capital. During August, no new tenants requested lease deferrals. Moreover, the high level of rent collections and the consistency of our portfolio performance have given us the confidence to repay $450 million of borrowings on our credit facility, returning our borrowings on the credit facility to pre-COVID levels. As our tenants have been able to conduct commerce, STORE has predictably realized elevated rental income, which we believe will continue as more locations are able to reopen. We are also gratified that the confidence in our tenants and business model has been recognized by our stockholders. Notably, Berkshire Hathaway increased its ownership of STORE Capital by 31%, to nearly 10% of shares outstanding as of June 30, Volk concluded. About STORE Capital STORE Capital Corporation is an internally managed net-lease real estate investment trust, or REIT, that is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market and the inspiration for its name. STORE Capital is one of the largest and fastest growing net-lease REITs and owns a large, well-diversified portfolio that consists of investments in more than 2,500 property locations across the United States, substantially all of which are profit centers. Additional information about STORE Capital can be found on its website at www.storecapital.com. Answer:

STORE Capital Announces August Rent Collections of 86% Credit facility repaid reflecting higher rent collections and stronger portfolio performance

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--STORE Capital Corporation (NYSE: STOR), an internally managed net-lease real estate investment trust (REIT) that invests in Single Tenant Operational Real Estate, today announced August rent collections and the repayment of the majority of borrowings on its credit facility. As of August 17, STORE Capital had received rent payments representing 86% of contractual base rent and interest for the month of August. July collections also increased to 86%, up from the previously announced 85%. Based on an updated survey of STORE Capital tenants, the percentage of properties open in August also increased to 93% from 92% in July. The number of our locations open for business has continued to increase since May, and rent collections have risen accordingly, said Christopher Volk, President and Chief Executive Officer of STORE Capital. During August, no new tenants requested lease deferrals. Moreover, the high level of rent collections and the consistency of our portfolio performance have given us the confidence to repay $450 million of borrowings on our credit facility, returning our borrowings on the credit facility to pre-COVID levels. As our tenants have been able to conduct commerce, STORE has predictably realized elevated rental income, which we believe will continue as more locations are able to reopen. We are also gratified that the confidence in our tenants and business model has been recognized by our stockholders. Notably, Berkshire Hathaway increased its ownership of STORE Capital by 31%, to nearly 10% of shares outstanding as of June 30, Volk concluded. About STORE Capital STORE Capital Corporation is an internally managed net-lease real estate investment trust, or REIT, that is the leader in the acquisition, investment and management of Single Tenant Operational Real Estate, which is its target market and the inspiration for its name. STORE Capital is one of the largest and fastest growing net-lease REITs and owns a large, well-diversified portfolio that consists of investments in more than 2,500 property locations across the United States, substantially all of which are profit centers. Additional information about STORE Capital can be found on its website at www.storecapital.com.

edtsum7781

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PHOENIX--(BUSINESS WIRE)--Pinnacle West Capital Corp. (NYSE: PNW) announced today that it plans to release its 2020 third-quarter financial results before the U.S. financial markets open on Friday, Oct. 30, 2020. That same day at noon ET (9 a.m. Arizona time), management will host a live webcast and conference call to discuss financial results and recent developments. To access the live session: To access the replay: Pinnacle West Capital Corp., an energy holding company based in Phoenix, has consolidated assets of approximately $19 billion, about 6,300 megawatts of generating capacity, and 6,200 employees in Arizona and New Mexico. Through its principal subsidiary, Arizona Public Service, the company provides retail electricity service to nearly 1.3 million Arizona homes and businesses. For more information about Pinnacle West, visit the companys website at pinnaclewest.com. Answer:

Pinnacle West Sets Date for 2020 Third-Quarter Financial Results, Webcast/Conference Call

PHOENIX--(BUSINESS WIRE)--Pinnacle West Capital Corp. (NYSE: PNW) announced today that it plans to release its 2020 third-quarter financial results before the U.S. financial markets open on Friday, Oct. 30, 2020. That same day at noon ET (9 a.m. Arizona time), management will host a live webcast and conference call to discuss financial results and recent developments. To access the live session: To access the replay: Pinnacle West Capital Corp., an energy holding company based in Phoenix, has consolidated assets of approximately $19 billion, about 6,300 megawatts of generating capacity, and 6,200 employees in Arizona and New Mexico. Through its principal subsidiary, Arizona Public Service, the company provides retail electricity service to nearly 1.3 million Arizona homes and businesses. For more information about Pinnacle West, visit the companys website at pinnaclewest.com.

edtsum7782

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TARRYTOWN, N.Y., Feb. 27, 2021 /PRNewswire/ -- Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced significant improvements in lung function and cat allergen tolerance from the first assessment at week 1 Results presented at the virtual 2021 AAAAI Annual Meeting Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The trial met the primary endpoint of preventing early asthma reactions (EAR, defined as a 20% decline in forced expiratory volume over one second [FEV1]). The trial also met key secondary endpoints, including improved lung function and an increased amount of cat allergen that patients could tolerate following a single dose of treatment, from as early as the first assessment conducted at week 1. The results were shared in an oral presentation at the virtual 2021 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting. "Cat allergy is one of the most common allergic respiratory diseases, impacting millions of people who must alter their lives by withdrawing from certain social situations, occupations and relationships. For those with co-existing asthma, cat allergies can trigger exacerbations that, although rare, can lead to hospitalization," said Frederic J. de Blay, M.D., Professor of Pulmonology and Allergist at the Strasbourg University and principal investigator of the trial performed at ALYATEC."These encouraging trial results showed that a single dose of REGN1908-1909 prevented early asthma reactions in cat-allergic patients with mild asthma rapidly and durably as early as one week after treatment and up to three months." Cat allergy is primarily caused by exposure to Fel d 1, the major allergen in cat dander produced by all cats. Fel d 1 is spread to surrounding environments through airborne particles that adhere to clothing, carpets and furniture. Patients typically experience rapid onset of mild to severe symptoms including nasal congestion, itchy and watery eyes, chest tightening and wheezing. Currently, cat-induced allergic rhinitis is treated with antihistamines and intranasal corticosteroids with moderate efficacy. Allergen-specific immunotherapy (otherwise known as allergy shots) takes 12-24 months to see clinical benefit and is contraindicated for patients with severe or uncontrolled asthma. Importantly, the association between cat allergy and asthma is significant, as more than 50% of cat-allergic patients have co-existing asthma. Although rare, cat allergy in these patients can potentially trigger life-threatening asthma attacks leading to hospitalization. REGN1908-1909 is a novel cocktail of two fully-human monoclonal IgG antibodies, designed to specifically bind and block the Fel d 1 allergen, thus preventing it from binding and triggering the endogenous antibodies that cause allergies (i.e., Immunoglobulin E, or IgE, antibodies). REGN1908-1909 was invented using Regeneron's proprietary VelocImmune technology. "These data add further evidence supporting a completely new way to combat common allergies," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron. "Under this new approach pioneered by Regeneron, patients are given antibodies that provide immediate and durable protection against offending allergens, a type of passive immunity. We have developed and are currently studying several allergen-specific antibodies, including REGN1908-1909 for cat allergy and a Phase 3 trial investigating REGN5713-5715 in patients with birch allergy." The Phase 2 randomized, double-blind proof-of-concept trial enrolled 56 cat-allergic patients with mild asthma who received a single dose of REGN1908-1909 600 mg or placebo delivered subcutaneously. This was followed by a 12-week assessment period during which patients underwent a 4-hour Cat Allergen Challenge (CAC) at weeks 1, 4, 8 and 12 in an environmental exposure unit (EEU) where they were exposed to cat allergen and monitored for allergic reactions. In order to establish a baseline, patients were also exposed to the EEU 1 week prior to receiving either REGN1908-1909 or placebo. Patients who took REGN1908-1909 experienced significant improvements during the Cat Allergen Challenge compared to those on placebo, which included: Reduced time to EAR for up to 3 months: REGN1908-1909 significantly extended the median time before patients experienced an early asthma reaction compared to placebo at all time points assessed, including at week 1 (>4 hours REGN1908-1909 vs. 51 minutes placebo, p=0.0083, the primary endpoint). Improved ability to breathe: REGN1908-1909 prevented 68% of the lung function decline observed upon cat allergen exposure, compared to 23% with placebo (measured by comparing the lung function decline induced by cat allergen exposure pre-treatment, with that seen 1 week following treatment; similar benefit was seen throughout the 3-month post-treatment assessment period). Improved cat allergen tolerance: Patients taking REGN1908-1909 were able to tolerate a three-fold higher allergen quantity from baseline without experiencing an early asthma reaction compared to placebo (60 nanograms [ng] REGN1908-1909 vs. 20 ng placebo, p=0.003). Adverse events (AEs) occurred in 76% of patients who received REGN1908-1909 and 78% of patients who received placebo. AEs more commonly observed with those receiving REGN1908-1909 included injection site reactions (7% for REGN1908-1909, 4% for placebo). The use of REGN1908-1909 to treat cat-allergic patients with mild asthma is investigational and its efficacy and safety have not been fully evaluated by any regulatory authority. About the Phase 2 TrialThe randomized, double-blind, parallel-group, single-dose proof-of-concept trial enrolled 56 cat-allergic patients with mild asthma who were not living with a cat. The trial consisted of up to a 12-week screening period followed by 1:1 randomization on day 1 to receive 600 mg REGN1908-1909 or placebo administered subcutaneously, followed by a 12-week assessment period and a 4-week safety follow-up period. During the screening period, patients underwent a 2-hour CAC in an EEU after initially being evaluated in a placebo challenge. Patients performed spirometry every 10 minutes during the EEU CAC until they experienced an EAR, or bronchoconstriction when their FEV1was reduced by 20%. Following the CAC, patients were monitored for 6 hours and those meeting eligibility requirements were then randomized to receive a single 600 mg subcutaneous dose of REGN1908-1909 or placebo, and returned to the trial site to undergo a 4-hour CAC in the EEU (plus a 6-hour observation period) at weeks 1, 4, 8 and 12 following treatment administration. The primary endpoint was prevention of EAR, as measured by FEV1, compared to placebo 1 week after treatment, following the CAC. Key secondary endpoints included the prevention of EAR on weeks 4, 8 and 12; change in FEV1on weeks 1, 4, 8 and 12; and change in cat allergen quantity, as experienced by patients during exposure on weeks 1, 4, 8 and 12. About Regeneron's VelocImmune TechnologyREGN1908-1909 was invented using Regeneron's VelocImmune technology that utilizes a proprietary genetically-engineered mouse platform endowed with a genetically-humanized immune system to produce optimized fully-human antibodies. When Regeneron's co-Founder, President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985, they were the first to envision making such a genetically-humanized mouse, and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite technologies. Dr. Yancopoulos and his team have used VelocImmune technology to create multiple antibodies including Dupixent (dupilumab), Libtayo, Praluent (alirocumab), Kevzara (sarilumab), Evkeeza (evinacumab-dgnb), Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) and Regeneron's antibody cocktail for COVID-19, which was recently granted Emergency Use Authorization (EUA) in the U.S. About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter. Forward-Looking Statements and Use of Digital MediaThis press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron's and its collaborators' ability to continue to conduct research and clinical programs, Regeneron's ability to manage its supply chain, net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and product candidates being developed by Regeneron and/or its collaborators (collectively, "Regeneron's Product Candidates") and research and clinical programs now underway or planned, including without limitation the investigational Fel d 1 antibody cocktail REGN1908-1909; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates, such as REGN1908-1909 for the treatment of cat allergic patients with mild asthma (as well as other potential indications), and new indications for Regeneron's Products; uncertainty of market acceptance and commercial success of Regeneron's Products and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary), including the study discussed in this press release, on the commercial success of Regeneron's Products and Regeneron's Product Candidates (such as REGN1908-1909); safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates (such as REGN1908-1909) in patients, including serious complications or side effects in connection with the use of Regeneron's Products and Regeneron's Product Candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; the availability and extent of reimbursement of Regeneron's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product Candidates; the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; the ability of Regeneron's collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license, collaboration, or supply agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA (aflibercept) Injection, Dupixent (dupilumab), Praluent (alirocumab), and REGEN-COVTM (casirivimab and imdevimab)), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2020. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (http://newsroom.regeneron.com) and its Twitter feed (http://twitter.com/regeneron). Media Relations Sharon Chen Tel: +1 (914) 847-1546 [emailprotected] Investor Relations Mark Hudson Tel: +1 914-847-3482 [emailprotected] SOURCE Regeneron Pharmaceuticals, Inc. Related Links www.regeneron.com Answer:

Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthma

TARRYTOWN, N.Y., Feb. 27, 2021 /PRNewswire/ -- Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced significant improvements in lung function and cat allergen tolerance from the first assessment at week 1 Results presented at the virtual 2021 AAAAI Annual Meeting Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The trial met the primary endpoint of preventing early asthma reactions (EAR, defined as a 20% decline in forced expiratory volume over one second [FEV1]). The trial also met key secondary endpoints, including improved lung function and an increased amount of cat allergen that patients could tolerate following a single dose of treatment, from as early as the first assessment conducted at week 1. The results were shared in an oral presentation at the virtual 2021 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting. "Cat allergy is one of the most common allergic respiratory diseases, impacting millions of people who must alter their lives by withdrawing from certain social situations, occupations and relationships. For those with co-existing asthma, cat allergies can trigger exacerbations that, although rare, can lead to hospitalization," said Frederic J. de Blay, M.D., Professor of Pulmonology and Allergist at the Strasbourg University and principal investigator of the trial performed at ALYATEC."These encouraging trial results showed that a single dose of REGN1908-1909 prevented early asthma reactions in cat-allergic patients with mild asthma rapidly and durably as early as one week after treatment and up to three months." Cat allergy is primarily caused by exposure to Fel d 1, the major allergen in cat dander produced by all cats. Fel d 1 is spread to surrounding environments through airborne particles that adhere to clothing, carpets and furniture. Patients typically experience rapid onset of mild to severe symptoms including nasal congestion, itchy and watery eyes, chest tightening and wheezing. Currently, cat-induced allergic rhinitis is treated with antihistamines and intranasal corticosteroids with moderate efficacy. Allergen-specific immunotherapy (otherwise known as allergy shots) takes 12-24 months to see clinical benefit and is contraindicated for patients with severe or uncontrolled asthma. Importantly, the association between cat allergy and asthma is significant, as more than 50% of cat-allergic patients have co-existing asthma. Although rare, cat allergy in these patients can potentially trigger life-threatening asthma attacks leading to hospitalization. REGN1908-1909 is a novel cocktail of two fully-human monoclonal IgG antibodies, designed to specifically bind and block the Fel d 1 allergen, thus preventing it from binding and triggering the endogenous antibodies that cause allergies (i.e., Immunoglobulin E, or IgE, antibodies). REGN1908-1909 was invented using Regeneron's proprietary VelocImmune technology. "These data add further evidence supporting a completely new way to combat common allergies," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron. "Under this new approach pioneered by Regeneron, patients are given antibodies that provide immediate and durable protection against offending allergens, a type of passive immunity. We have developed and are currently studying several allergen-specific antibodies, including REGN1908-1909 for cat allergy and a Phase 3 trial investigating REGN5713-5715 in patients with birch allergy." The Phase 2 randomized, double-blind proof-of-concept trial enrolled 56 cat-allergic patients with mild asthma who received a single dose of REGN1908-1909 600 mg or placebo delivered subcutaneously. This was followed by a 12-week assessment period during which patients underwent a 4-hour Cat Allergen Challenge (CAC) at weeks 1, 4, 8 and 12 in an environmental exposure unit (EEU) where they were exposed to cat allergen and monitored for allergic reactions. In order to establish a baseline, patients were also exposed to the EEU 1 week prior to receiving either REGN1908-1909 or placebo. Patients who took REGN1908-1909 experienced significant improvements during the Cat Allergen Challenge compared to those on placebo, which included: Reduced time to EAR for up to 3 months: REGN1908-1909 significantly extended the median time before patients experienced an early asthma reaction compared to placebo at all time points assessed, including at week 1 (>4 hours REGN1908-1909 vs. 51 minutes placebo, p=0.0083, the primary endpoint). Improved ability to breathe: REGN1908-1909 prevented 68% of the lung function decline observed upon cat allergen exposure, compared to 23% with placebo (measured by comparing the lung function decline induced by cat allergen exposure pre-treatment, with that seen 1 week following treatment; similar benefit was seen throughout the 3-month post-treatment assessment period). Improved cat allergen tolerance: Patients taking REGN1908-1909 were able to tolerate a three-fold higher allergen quantity from baseline without experiencing an early asthma reaction compared to placebo (60 nanograms [ng] REGN1908-1909 vs. 20 ng placebo, p=0.003). Adverse events (AEs) occurred in 76% of patients who received REGN1908-1909 and 78% of patients who received placebo. AEs more commonly observed with those receiving REGN1908-1909 included injection site reactions (7% for REGN1908-1909, 4% for placebo). The use of REGN1908-1909 to treat cat-allergic patients with mild asthma is investigational and its efficacy and safety have not been fully evaluated by any regulatory authority. About the Phase 2 TrialThe randomized, double-blind, parallel-group, single-dose proof-of-concept trial enrolled 56 cat-allergic patients with mild asthma who were not living with a cat. The trial consisted of up to a 12-week screening period followed by 1:1 randomization on day 1 to receive 600 mg REGN1908-1909 or placebo administered subcutaneously, followed by a 12-week assessment period and a 4-week safety follow-up period. During the screening period, patients underwent a 2-hour CAC in an EEU after initially being evaluated in a placebo challenge. Patients performed spirometry every 10 minutes during the EEU CAC until they experienced an EAR, or bronchoconstriction when their FEV1was reduced by 20%. Following the CAC, patients were monitored for 6 hours and those meeting eligibility requirements were then randomized to receive a single 600 mg subcutaneous dose of REGN1908-1909 or placebo, and returned to the trial site to undergo a 4-hour CAC in the EEU (plus a 6-hour observation period) at weeks 1, 4, 8 and 12 following treatment administration. The primary endpoint was prevention of EAR, as measured by FEV1, compared to placebo 1 week after treatment, following the CAC. Key secondary endpoints included the prevention of EAR on weeks 4, 8 and 12; change in FEV1on weeks 1, 4, 8 and 12; and change in cat allergen quantity, as experienced by patients during exposure on weeks 1, 4, 8 and 12. About Regeneron's VelocImmune TechnologyREGN1908-1909 was invented using Regeneron's VelocImmune technology that utilizes a proprietary genetically-engineered mouse platform endowed with a genetically-humanized immune system to produce optimized fully-human antibodies. When Regeneron's co-Founder, President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985, they were the first to envision making such a genetically-humanized mouse, and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite technologies. Dr. Yancopoulos and his team have used VelocImmune technology to create multiple antibodies including Dupixent (dupilumab), Libtayo, Praluent (alirocumab), Kevzara (sarilumab), Evkeeza (evinacumab-dgnb), Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) and Regeneron's antibody cocktail for COVID-19, which was recently granted Emergency Use Authorization (EUA) in the U.S. About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter. Forward-Looking Statements and Use of Digital MediaThis press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron's and its collaborators' ability to continue to conduct research and clinical programs, Regeneron's ability to manage its supply chain, net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and product candidates being developed by Regeneron and/or its collaborators (collectively, "Regeneron's Product Candidates") and research and clinical programs now underway or planned, including without limitation the investigational Fel d 1 antibody cocktail REGN1908-1909; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates, such as REGN1908-1909 for the treatment of cat allergic patients with mild asthma (as well as other potential indications), and new indications for Regeneron's Products; uncertainty of market acceptance and commercial success of Regeneron's Products and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary), including the study discussed in this press release, on the commercial success of Regeneron's Products and Regeneron's Product Candidates (such as REGN1908-1909); safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates (such as REGN1908-1909) in patients, including serious complications or side effects in connection with the use of Regeneron's Products and Regeneron's Product Candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; the availability and extent of reimbursement of Regeneron's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product Candidates; the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; the ability of Regeneron's collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license, collaboration, or supply agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA (aflibercept) Injection, Dupixent (dupilumab), Praluent (alirocumab), and REGEN-COVTM (casirivimab and imdevimab)), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2020. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise. Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (http://newsroom.regeneron.com) and its Twitter feed (http://twitter.com/regeneron). Media Relations Sharon Chen Tel: +1 (914) 847-1546 [emailprotected] Investor Relations Mark Hudson Tel: +1 914-847-3482 [emailprotected] SOURCE Regeneron Pharmaceuticals, Inc. Related Links www.regeneron.com

edtsum7783

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOS ANGELES, April 16, 2020 /PRNewswire/ -- Cathay General Bancorp (Nasdaq: CATY), the holding company for Cathay Bank, is scheduled to announce its first quarter 2020 financial results after the markets close on Monday, April 27, 2020. Cathay General Bancorp has scheduled a conference call as set forth below. Analysts and investors may participate in the question-and-answer session. Conference Call and Webcast Information: Date: Monday, April 27, 2020 Time: 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time) Duration: 1 hour Dial-In Number: (855) 761-3186 Conference ID: 2954129 Participants should join the live conference call 5 to 10 minutes before its scheduled start. Webcast Access: The conference will be broadcast live in a listen-only mode and is available at www.cathaygeneralbancorp.com. A recorded version for replay will be available within 24 hours after the end of the call until April 27, 2021. ABOUT CATHAY GENERAL BANCORP Cathay General Bancorp is the holding company for Cathay Bank, a California state-chartered bank. Founded in 1962, Cathay Bank offers a wide range of financial services. Cathay Bank currently operates 38 branches in California, 10 branches in New York State, four in Washington State, three in Illinois, two in Texas, one in Maryland, one in Massachusetts, one in Nevada, one in New Jersey, one in Hong Kong, and a representative office in Taipei, Beijing, and Shanghai. Cathay Bank's website is found at www.cathaybank.com. Cathay General Bancorp's website is found at www.cathaygeneralbancorp.com. Information set forth on such websites is not incorporated into this press release. SOURCE Cathay General Bancorp Related Links http://www.cathaybank.com Answer:

Cathay General Bancorp to Announce First Quarter 2020 Financial Results

LOS ANGELES, April 16, 2020 /PRNewswire/ -- Cathay General Bancorp (Nasdaq: CATY), the holding company for Cathay Bank, is scheduled to announce its first quarter 2020 financial results after the markets close on Monday, April 27, 2020. Cathay General Bancorp has scheduled a conference call as set forth below. Analysts and investors may participate in the question-and-answer session. Conference Call and Webcast Information: Date: Monday, April 27, 2020 Time: 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time) Duration: 1 hour Dial-In Number: (855) 761-3186 Conference ID: 2954129 Participants should join the live conference call 5 to 10 minutes before its scheduled start. Webcast Access: The conference will be broadcast live in a listen-only mode and is available at www.cathaygeneralbancorp.com. A recorded version for replay will be available within 24 hours after the end of the call until April 27, 2021. ABOUT CATHAY GENERAL BANCORP Cathay General Bancorp is the holding company for Cathay Bank, a California state-chartered bank. Founded in 1962, Cathay Bank offers a wide range of financial services. Cathay Bank currently operates 38 branches in California, 10 branches in New York State, four in Washington State, three in Illinois, two in Texas, one in Maryland, one in Massachusetts, one in Nevada, one in New Jersey, one in Hong Kong, and a representative office in Taipei, Beijing, and Shanghai. Cathay Bank's website is found at www.cathaybank.com. Cathay General Bancorp's website is found at www.cathaygeneralbancorp.com. Information set forth on such websites is not incorporated into this press release. SOURCE Cathay General Bancorp Related Links http://www.cathaybank.com

edtsum7784

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: ATLANTA, Oct. 8, 2020 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN), a leading omnichannel provider of lease-purchase solutions, and its divisions Aaron's and Progressive Leasing, joined forces with former NFL star Warrick Dunn this summer to provide furnishings for four "Homes for the Holidays" surprise presentations, bringing the running total of home celebrations to 181 over the nearly 23-year history of the program. The donations, representing a $40,000 commitment by Aaron's to help first-time homeowners, came in collaboration with Warrick Dunn Charities, a national nonprofit that has counted Aaron's as a critical supporter for over 16 years. "Homes for the Holidays" celebrates single parents who are actively working to help themselves through first-time homeownership by alleviating the additional financial burdens that can come along with establishing a new home. While the houses themselves are constructed and financed through Habitat for Humanity, the surprise comes when the families discover they are fully furnished and stocked thanks to Aaron's, with Warrick Dunn Charities contributing down-payment assistance. With new social distancing measures put in place to ensure everyone's safety, the summer events celebrated milestones for extraordinary families in Pleasantville, Iowa, Snellville,GA, Spartanburg, SC and Concord, NC. The Pleasantville project supported a mother of four whose husband was lost in a tragic construction accident; Snellville was for a military veteran and mom of five boys; Spartanburg celebrated a dedicated hospital caretaker who also cares for two boys at home; and Concord rewarded a schoolbus driver who previously shared a small bed with her only son in her grandmother's overcrowded home. "Even during a global pandemic, Warrick Dunn and his team are an inspiration, as their tireless work allows these families to proudly call themselves homeowners," said John Robinson, CEO of Aaron's, Inc. "This partnership benefits single parents everywhere, and Aaron's is honored to help give these deserving families the support they need to truly own the life they want." Aaron's has partnered with Dunn, the former Atlanta Falcons and Tampa Bay Buccaneers running back, to lift up families for over 16 years. Dunn's drive to help single mothers is inspired by his mom, a single parent and police officer who was killed off-duty when Dunn was 18. "I'm so proud of my team for finding a way to bring these homes to life, regardless of the difficult circumstances presented by COVID-19," said Dunn. "We have now completed 181 homes as part of this longstanding program, and each home and family represent a singular testament to my mom's memory. I'm eternally grateful to Aaron's for being on our team as we continue our mission we simply wouldn't be where we are today without them." Additional support for the Iowa and Georgia homes was provided by Ryan Jumonville, while the Carolina Panthers Player Impact Committee sponsored the projects in South Carolina and North Carolina. AboutAaron's, Inc.Headquartered in Atlanta, Aaron's, Inc. (NYSE: AAN), is a leading omnichannel provider of lease-purchase solutions. Aaron's Business engages in the sales and lease ownership and specialty retailing of furniture, consumer electronics, home appliances and accessories through its approximately 1,400 company-operated and franchised stores in 47 states and Canada as well as its e-commerce platform, Aarons.com. In addition, Progressive Leasing, a virtual lease-to-own company, provides lease-purchase solutions through over 20,000 retail locations in 46 states. Vive Financial, provides a variety of second-look credit products that are originated through federally insured banks. For more information, visit Aarons.com, ProgLeasing.com, and ViveCard.com. About Warrick Dunn Charities Warrick Dunn Charities, Inc. improves lives through innovative programming inspired by our Founder's life journey. Homes for the Holidays partners with local community organizations to reduce the financial burden on single parent homeowners by fully furnishing their new house, providing down payment assistance, and stocking the pantry with food and other household necessities. Since 1997, "Homes for the Holidays" has rewarded 181 single parents nationwide who have achieved first-time homeownership. Today, Warrick Dunn Charities, Inc. has expanded their flagship Homes for the Holidays initiative with three additional programs:Count on Your Future,SCULPT, andHearts for Community Service Scholarships. Together, our four programs are dedicated to strengthening families and transforming communities by combating poverty, hunger, and improving their quality of life academically, socially, and economically. For more information, visit www.wdc.org. SOURCE Aaron's, Inc. Related Links http://www.aarons.com Answer:

Aaron's & Former NFL Star Turn Homeownership Dreams Into Reality

ATLANTA, Oct. 8, 2020 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN), a leading omnichannel provider of lease-purchase solutions, and its divisions Aaron's and Progressive Leasing, joined forces with former NFL star Warrick Dunn this summer to provide furnishings for four "Homes for the Holidays" surprise presentations, bringing the running total of home celebrations to 181 over the nearly 23-year history of the program. The donations, representing a $40,000 commitment by Aaron's to help first-time homeowners, came in collaboration with Warrick Dunn Charities, a national nonprofit that has counted Aaron's as a critical supporter for over 16 years. "Homes for the Holidays" celebrates single parents who are actively working to help themselves through first-time homeownership by alleviating the additional financial burdens that can come along with establishing a new home. While the houses themselves are constructed and financed through Habitat for Humanity, the surprise comes when the families discover they are fully furnished and stocked thanks to Aaron's, with Warrick Dunn Charities contributing down-payment assistance. With new social distancing measures put in place to ensure everyone's safety, the summer events celebrated milestones for extraordinary families in Pleasantville, Iowa, Snellville,GA, Spartanburg, SC and Concord, NC. The Pleasantville project supported a mother of four whose husband was lost in a tragic construction accident; Snellville was for a military veteran and mom of five boys; Spartanburg celebrated a dedicated hospital caretaker who also cares for two boys at home; and Concord rewarded a schoolbus driver who previously shared a small bed with her only son in her grandmother's overcrowded home. "Even during a global pandemic, Warrick Dunn and his team are an inspiration, as their tireless work allows these families to proudly call themselves homeowners," said John Robinson, CEO of Aaron's, Inc. "This partnership benefits single parents everywhere, and Aaron's is honored to help give these deserving families the support they need to truly own the life they want." Aaron's has partnered with Dunn, the former Atlanta Falcons and Tampa Bay Buccaneers running back, to lift up families for over 16 years. Dunn's drive to help single mothers is inspired by his mom, a single parent and police officer who was killed off-duty when Dunn was 18. "I'm so proud of my team for finding a way to bring these homes to life, regardless of the difficult circumstances presented by COVID-19," said Dunn. "We have now completed 181 homes as part of this longstanding program, and each home and family represent a singular testament to my mom's memory. I'm eternally grateful to Aaron's for being on our team as we continue our mission we simply wouldn't be where we are today without them." Additional support for the Iowa and Georgia homes was provided by Ryan Jumonville, while the Carolina Panthers Player Impact Committee sponsored the projects in South Carolina and North Carolina. AboutAaron's, Inc.Headquartered in Atlanta, Aaron's, Inc. (NYSE: AAN), is a leading omnichannel provider of lease-purchase solutions. Aaron's Business engages in the sales and lease ownership and specialty retailing of furniture, consumer electronics, home appliances and accessories through its approximately 1,400 company-operated and franchised stores in 47 states and Canada as well as its e-commerce platform, Aarons.com. In addition, Progressive Leasing, a virtual lease-to-own company, provides lease-purchase solutions through over 20,000 retail locations in 46 states. Vive Financial, provides a variety of second-look credit products that are originated through federally insured banks. For more information, visit Aarons.com, ProgLeasing.com, and ViveCard.com. About Warrick Dunn Charities Warrick Dunn Charities, Inc. improves lives through innovative programming inspired by our Founder's life journey. Homes for the Holidays partners with local community organizations to reduce the financial burden on single parent homeowners by fully furnishing their new house, providing down payment assistance, and stocking the pantry with food and other household necessities. Since 1997, "Homes for the Holidays" has rewarded 181 single parents nationwide who have achieved first-time homeownership. Today, Warrick Dunn Charities, Inc. has expanded their flagship Homes for the Holidays initiative with three additional programs:Count on Your Future,SCULPT, andHearts for Community Service Scholarships. Together, our four programs are dedicated to strengthening families and transforming communities by combating poverty, hunger, and improving their quality of life academically, socially, and economically. For more information, visit www.wdc.org. SOURCE Aaron's, Inc. Related Links http://www.aarons.com

edtsum7785

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Sept. 30, 2020 /PRNewswire/ -- BGC Partners, Inc. (NASDAQ: BGCP) ("BGC Partners" or "BGC" or the "Company"), a leading global brokerage and financial technology company, today announced that it has updated its outlook for the quarter ending September 30, 2020. Updated OutlookAgainst a backdrop of lower industry volumes across rates, foreign exchange, and credit,1 BGC's revenue and pre-tax Adjusted Earnings for the third quarter of 2020 are now expected to be between the mid-point and the low-end of the range of its previously stated outlook.The Company's outlook was contained in BGC's financial results press release issued on July 30, 2020, which can be found at http://ir.bgcpartners.com. Non-GAAP Financial Measures This document contains non-GAAP financial measures that differ from the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles in the United States ("GAAP"). Non-GAAP financial measures used by the Company include "Adjusted Earnings before noncontrolling interests and taxes", which is used interchangeably with "pre-tax Adjusted Earnings"; "Post-tax Adjusted Earnings to fully diluted shareholders", which is used interchangeably with "post-tax Adjusted Earnings"; "Adjusted EBITDA"; and "Liquidity". The definitions of these terms are below. Adjusted Earnings DefinedBGC uses non-GAAP financial measures, including "Adjusted Earnings before noncontrolling interests and taxes" and "Post-tax Adjusted Earnings to fully diluted shareholders", which are supplemental measures of operating results used by management to evaluate the financial performance of the Company and its consolidated subsidiaries. BGC believes that Adjusted Earnings best reflect the operating earnings generated by the Company on a consolidated basis and are the earnings which management considers when managing its business. As compared with "Income (loss) from operations before income taxes" and "Net income (loss) for fully diluted shares", both prepared in accordance with GAAP, Adjusted Earnings calculations primarily exclude certain non-cash items and other expenses that generally do not involve the receipt or outlay of cash by the Company and/or which do not dilute existing stockholders. In addition, Adjusted Earnings calculations exclude certain gains and charges that management believes do not best reflect the ordinary results of BGC. Adjusted Earnings is calculated by taking the most comparable GAAP measures and adjusting for certain items with respect to compensation expenses, non-compensation expenses, and other income, as discussed below. Calculations of Compensation Adjustments for Adjusted Earnings and Adjusted EBITDA Treatment of Equity-Based Compensation Line Item for Adjusted Earnings and Adjusted EBITDAThe Company's Adjusted Earnings and Adjusted EBITDA measures exclude all GAAP charges included in the line item "Equity-based compensation and allocations of net income to limited partnership units and FPUs" (or "equity-based compensation" for purposes of defining the Company's non-GAAP results) as recorded on the Company's GAAP Consolidated Statements of Operations and GAAP Consolidated Statements of Cash Flows. These GAAP equity-based compensation charges reflect the following items: * Charges with respect to grants of exchangeability, which reflect the right of holders of limited partnership units with no capital accounts, such as LPUs and PSUs, to exchange these units into shares of common stock, or into partnership units with capital accounts, such as HDUs, as well as cash paid with respect to taxes withheld or expected to be owed by the unit holder upon such exchange. The withholding taxes related to the exchange of certain non-exchangeable units without a capital account into either common shares or units with a capital account may be funded by the redemption of preferred units such as PPSUs. * Charges with respect to preferred units. Any preferred units would not be included in the Company's fully diluted share count because they cannot be made exchangeable into shares of common stock and are entitled only to a fixed distribution. Preferred units are granted in connection with the grant of certain limited partnership units that may be granted exchangeability or redeemed in connection with the grant of shares of common stock at ratios designed to cover any withholding taxes expected to be paid. This is an alternative to the common practice among public companies of issuing the gross amount of shares to employees, subject to cashless withholding of shares, to pay applicable withholding taxes. * GAAP equity-based compensation charges with respect to the grant of an offsetting amount of common stock or partnership units with capital accounts in connection with the redemption of non-exchangeable units, including PSUs and LPUs.* Charges related to amortization of RSUs and limited partnership units.* Charges related to grants of equity awards, including common stock or partnership units with capital accounts.* Allocations of net income to limited partnership units and FPUs. Such allocations represent the pro-rata portion of post-tax GAAP earnings available to such unit holders. The amounts of certain quarterly equity-based compensationcharges are based upon the Company's estimate of such expected charges during the annual period, as described further below under "Methodology for Calculating Adjusted Earnings Taxes." Virtually all of BGC's key executives and producers have equity or partnership stakes in the Company and its subsidiaries and generally receive deferred equity or limited partnership units as part of their compensation. A significant percentage of BGC's fully diluted shares are owned by its executives, partners and employees. The Company issues limited partnership units as well as other forms of equity-based compensation, including grants of exchangeability into shares of common stock, to provide liquidity to its employees, to align the interests of its employees and management with those of common stockholders, to help motivate and retain key employees, and to encourage a collaborative culture that drives cross-selling and revenue growth. All share equivalents that are part of the Company's equity-based compensation program, including REUs, PSUs, LPUs, HDUs, and other unitsthat may be made exchangeable into common stock, as well as RSUs (which are recorded using the treasury stock method), are included in the fully diluted share count when issued or at the beginning of the subsequent quarter after the date of grant. Generally, limited partnership units other than preferred unitsare expected to be paid a pro-rata distribution based on BGC's calculation of Adjusted Earnings per fully diluted share. However, out of an abundance of caution and in order to strengthen the Company's balance sheet due the uncertain macroeconomic conditions with respect to the COVID-19 pandemic, BGC Holdings, L.P. has reduced its distributions of income from the operations of BGC's businesses to its partners. Compensation charges are also adjusted for certain other cash and non-cash items, including those related to the amortization of GFI employee forgivable loans granted prior to the closing of the January 11, 2016 back-end merger with GFI. Certain Other Compensation-Related Adjustments for Adjusted Earnings BGC also excludes various other GAAP items that management views as not reflective of the Company's underlying performance in a given period from its calculation of Adjusted Earnings. These may include compensation-related items with respect to cost-saving initiatives, such as severance charges incurred in connection with headcount reductions as part of broad restructuring and/or cost savings plans. Calculation of Non-Compensation Adjustments for Adjusted Earnings Adjusted Earnings calculations may also exclude items such as: * Non-cash GAAP charges related to the amortization of intangibles with respect to acquisitions; * Acquisition related costs;* Certain rent charges;* Non-cash GAAP asset impairment charges; and* Various other GAAP items that management views as not reflective of the Company's underlying performance in a given period, including non-compensation-related charges incurred as part of broad restructuring and/or cost savings plans. Such GAAP items may include charges for exiting leases and/or other long-term contracts as part of cost-saving initiatives, as well as non-cash impairment charges related to assets, goodwill and/or intangibles created from acquisitions. Calculation of Adjustments for Other (income) losses for Adjusted Earnings Adjusted Earnings calculations also exclude certain other non-cash, non-dilutive, and/or non-economic items, which may, in some periods, include: * Gains or losses on divestitures; * Fair value adjustment of investments;* Certain other GAAP items, including gains or losses related to BGC's investments accounted for under the equity method; and * Any unusual, one-time, non-ordinary, or non-recurring gains or losses. Methodology for Calculating Adjusted Earnings Taxes Although Adjusted Earnings are calculated on a pre-tax basis, BGC also reports post-tax Adjusted Earnings to fully diluted shareholders. The Company defines post-tax Adjusted Earnings to fully diluted shareholders as pre-tax Adjusted Earnings reduced by the non-GAAP tax provision described below and net income (loss) attributable to noncontrolling interest for Adjusted Earnings. The Company calculates its tax provision for post-tax Adjusted Earnings using an annual estimate similar to how it accounts for its income tax provision under GAAP. To calculate the quarterly tax provision under GAAP, BGC estimates its full fiscal year GAAP income (loss) from operations before income taxes and noncontrolling interests in subsidiaries and the expected inclusions and deductions for income tax purposes, including expected equity-based compensation during the annual period. The resulting annualized tax rate is applied to BGC's quarterly GAAP income (loss) from operations before income taxes and noncontrolling interests in subsidiaries. At the end of the annual period, the Company updates its estimate to reflect the actual tax amounts owed for the period. To determine the non-GAAP tax provision, BGC first adjusts pre-tax Adjusted Earnings by recognizing any, and only, amounts for which a tax deduction applies under applicable law. The amounts include charges with respect to equity-based compensation; certain charges related to employee loan forgiveness; certain net operating loss carryforwards when taken for statutory purposes; and certain charges related to tax goodwill amortization. These adjustments may also reflect timing and measurement differences, including treatment of employee loans; changes in the value of units between the dates of grants of exchangeability and the date of actual unit exchange; variations in the value of certain deferred tax assets; and liabilities and the different timing of permitted deductions for tax under GAAP and statutory tax requirements. After application of these adjustments, the result is the Company's taxable income for its pre-tax Adjusted Earnings, to which BGC then applies the statutory tax rates to determine its non-GAAP tax provision. BGC views the effective tax rate on pre-tax Adjusted Earnings as equal to the amount of its non-GAAP tax provision divided by the amount of pre-tax Adjusted Earnings. Generally, the most significant factor affecting this non-GAAP tax provision is the amount of charges relating to equity-based compensation. Because the charges relating to equity-based compensation are deductible in accordance with applicable tax laws, increases in such charges have the effect of lowering the Company's non-GAAP effective tax rate and thereby increasing its post-tax Adjusted Earnings. BGC incurs income tax expenses based on the location, legal structure and jurisdictional taxing authorities of each of its subsidiaries. Certain of the Company's entities are taxed as U.S. partnerships and are subject to the Unincorporated Business Tax ("UBT") in New York City. Any U.S. federal and state income tax liability or benefit related to the partnership income or loss, with the exception of UBT, rests with the unit holders rather than with the partnership entity. The Company's consolidated financial statements include U.S. federal, state, and local income taxes on the Company's allocable share of the U.S. results of operations. Outside of the U.S., BGC is expected to operate principally through subsidiary corporations subject to local income taxes. For these reasons, taxes for Adjusted Earnings are expected to be presented to show the tax provision the consolidated Company would expect to pay if 100 percent of earnings were taxed at global corporate rates. Calculations of Pre- and Post-Tax Adjusted Earnings per ShareBGC's pre- and post-tax Adjusted Earnings per share calculations assume either that: * The fully diluted share count includes the shares related to any dilutive instruments, but excludes the associated expense, net of tax, when the impact would be dilutive; or* The fully diluted share count excludes the shares related to these instruments, but includes the associated expense, net of tax. The share count for Adjusted Earnings excludes certain shares and share equivalents expected to be issued in future periods but not yet eligible to receive dividends and/or distributions. Each quarter, the dividend payable to BGC's stockholders, if any, is expected to be determined by the Company's Board of Directors with reference to a number of factors, including post-tax Adjusted Earnings per share. BGC may also pay a pro-rata distribution of net income to limited partnership units, as well as to Cantor for its noncontrolling interest. The amount of this net income, and therefore of these payments per unit, would be determined using the above definition of Adjusted Earnings per share on a pre-tax basis. The declaration, payment, timing, and amount of any future dividends payable by the Company will be at the discretion of its Board of Directors using the fully diluted share count. For more information on any share count adjustments, see the table titled "Fully Diluted Weighted-Average Share Count under GAAP and for Adjusted Earnings". Management Rationale for Using Adjusted Earnings BGC's calculation of Adjusted Earnings excludes the items discussed above because they are either non-cash in nature, because the anticipated benefits from the expenditures are not expected to be fully realized until future periods, or because the Company views results excluding these items as a better reflection of the underlying performance of BGC's ongoing operations. Management uses Adjusted Earnings in part to help it evaluate, among other things, the overall performance of the Company's business, to make decisions with respect to the Company's operations, and to determine the amount of dividends payable to common stockholders and distributions payable to holders of limited partnership units. Dividends payable to common stockholders and distributions payable to holders of limited partnership units are included within "Dividends to stockholders" and "Earnings distributions to limited partnership interests and noncontrolling interests," respectively, in our unaudited, condensed, consolidated statements of cash flows. The term "Adjusted Earnings" should not be considered in isolation or as an alternative to GAAP net income (loss). The Company views Adjusted Earnings as a metric that is not indicative of liquidity, or the cash available to fund its operations, but rather as a performance measure. Pre- and post-tax Adjusted Earnings, as well as related measures, are not intended to replace the Company's presentation of its GAAP financial results. However, management believes that these measures help provide investors with a clearer understanding of BGC's financial performance and offer useful information to both management and investors regarding certain financial and business trends related to the Company's financial condition and results of operations. Management believes that the GAAP and Adjusted Earnings measures of financial performance should be considered together. For more information regarding Adjusted Earnings, see the sections of this document and/or the Company's most recent financial results press release titled "Reconciliation of GAAP Income (Loss) from Operations before Income Taxes to Adjusted Earnings and GAAP Fully Diluted EPS to Post-Tax Adjusted EPS", including the related footnotes, for details about how BGC's non-GAAP results are reconciled to those under GAAP. Adjusted EBITDA DefinedBGC also provides an additional non-GAAP financial performance measure, "Adjusted EBITDA", which it defines as GAAP "Net income (loss) available to common stockholders", adjusted to add back the following items: * Provision (benefit) for income taxes;* Net income (loss) attributable to noncontrolling interest in subsidiaries;* Interest expense;* Fixed asset depreciation and intangible asset amortization;* Equity-based compensation and allocations of net income to limited partnership units and FPUs; * Impairment of long-lived assets; * (Gains) losses on equity method investments; and* Certain other non-cash GAAP items, such as non-cash charges of amortized rents incurred by the Company for its new UK based headquarters. The Company's management believes that its Adjusted EBITDA measure is useful in evaluating BGC's operating performance, because the calculation of this measure generally eliminates the effects of financing and income taxes and the accounting effects of capital spending and acquisitions, which would include impairment charges of goodwill and intangibles created from acquisitions. Such items may vary for different companies for reasons unrelated to overall operating performance. As a result, the Company's management uses this measure to evaluate operating performance and for other discretionary purposes. BGC believes that Adjusted EBITDA is useful to investors to assist them in getting a more complete picture of the Company's financial results and operations. Since BGC's Adjusted EBITDA is not a recognized measurement under GAAP, investors should use this measure in addition to GAAP measures of net income when analyzing BGC's operating performance. Because not all companies use identical EBITDA calculations, the Company's presentation of Adjusted EBITDA may not be comparable to similarly titled measures of other companies. Furthermore, Adjusted EBITDA is not intended to be a measure of free cash flow or GAAP cash flow from operations because the Company's Adjusted EBITDA does not consider certain cash requirements, such as tax and debt service payments. For more information regarding Adjusted EBITDA, see the section of this document and/or the Company's most recent financial results press release titled "Reconciliation of GAAP Net Income (Loss) Available to Common Stockholders to Adjusted EBITDA", including the footnotes to the same, for details about how BGC's non-GAAP results are reconciled to those under GAAP. Timing of Outlook for Certain GAAP and Non-GAAP ItemsBGC anticipates providing forward-looking guidance for GAAP revenues and for certain non-GAAP measures from time to time. However, the Company does not anticipate providing an outlook for other GAAP results. This is because certain GAAP items, which are excluded from Adjusted Earnings and/or Adjusted EBITDA, are difficult to forecast with precision before the end of each period. The Company therefore believes that it is not possible for it to have the required information necessary to forecast GAAP results or to quantitatively reconcile GAAP forecasts to non-GAAP forecasts with sufficient precision without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The relevant items that are difficult to predict on a quarterly and/or annual basis with precision and may materially impact the Company's GAAP results include, but are not limited, to the following: * Certain equity-based compensation charges that may be determined at the discretion of management throughout and up to the period-end; * Unusual, one-time, non-ordinary, or non-recurring items;* The impact of gains or losses on certain marketable securities, as well as any gains or losses related to associated mark-to- market movements and/or hedging. These items are calculated using period-end closing prices;* Non-cash asset impairment charges, which are calculated and analyzed based on the period-end values of the underlying assets. These amounts may not be known until after period-end; * Acquisitions, dispositions and/or resolutions of litigation, which are fluid and unpredictable in nature. Liquidity DefinedBGC may also use a non-GAAP measure called "liquidity". The Company considers liquidity to be comprised of the sum of cash and cash equivalents, reverse repurchase agreements (if any), securities owned, and marketable securities, less securities lent out in securities loaned transactions and repurchase agreements (if any). The Company considers liquidity to be an important metric for determining the amount of cash that is available or that could be readily available to the Company on short notice. For more information regarding Liquidity, see the section of this document and/or the Company's most recent financial results press release titled "Liquidity Analysis", including any footnotes to the same, for details about how BGC's non-GAAP results are reconciled to those under GAAP. About BGC Partners, Inc.BGC Partners is a leading global brokerage and financial technology company. BGC specializes in the brokerage of a broad range of products, including fixed income (rates and credit), foreign exchange, equities, energy and commodities, shipping, insurance, and futures. BGC also provides a wide variety of services, including trade execution, brokerage, clearing, trade compression, post-trade, information, and other back-office services to a broad range of financial and non-financial institutions. Through brands including Fenics, BGC Trader, Capitalab, Lucera, and Fenics Market Data, BGC offers financial technology solutions, market data, and analytics related to numerous financial instruments and markets. BGC, BGC Trader, GFI, Fenics, Fenics Market Data, Capitalab, and Lucera are trademarks/service marks and/or registered trademarks/service marks of BGC Partners, Inc. and/or its affiliates. BGC's customers include many of the world's largest banks, broker-dealers, investment banks, trading firms, hedge funds, governments, corporations, and investment firms. BGC's Class A common stock trades on the NASDAQ Global Select Market under the ticker symbol "BGCP". BGC Partners is led by Chairman of the Board and Chief Executive Officer Howard W. Lutnick. For more information, please visit http://www.bgcpartners.com. You can also follow BGC at https://twitter.com/bgcpartners, https://www.linkedin.com/company/bgc-partners and/or http://ir.bgcpartners.com/Investors/default.aspx. Discussion of Forward-Looking Statements about BGC Statements in this document regarding BGC that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company's business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, BGC undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see BGC's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K. Media Contact:Karen Laureano-Rikardsen+1 212-829-4975 Investor Contacts:Jason Chryssicas or Grant Filer+1 212-610-2426 1Industry rates volumes include CME interest rate futures and options, Deutsche Brse (Eurex) European interest rate derivatives, FIA SEF non-forward rate agreement IRS, ICE short-term and medium & L-T interest rates, ISDA interest rate derivatives, LSE's MTS Cash, MarketAxess U.S. government bonds (which represents U.S. Treasury volumes on LiquidityEdge), Nasdaq U.S. fixed income, NEX (CME) U.S. Treasuries, and Tradeweb U.S. government bonds. Industry foreign exchange volumes include CBOE Hotspot (spot) FX, CLS forward, swap, and spot FX, CME FX futures and options, Deutsche Brse FX (360T), Euronext FX (Fastmatch), FIA SEF FX products, NEX (CME) EBS spot FX, and Refinitiv FX spot volume and other volume. Industry credit volumes include FIA CDS and options, ISDA credit derivatives, MarketAxess total credit, primary dealer U.S. corporate bonds (source: Bloomberg), and Tradeweb total credit. SOURCE BGC Partners, Inc. Related Links http://www.bgcpartners.com Answer:

BGC Partners Updates its Outlook for the Third Quarter of 2020

NEW YORK, Sept. 30, 2020 /PRNewswire/ -- BGC Partners, Inc. (NASDAQ: BGCP) ("BGC Partners" or "BGC" or the "Company"), a leading global brokerage and financial technology company, today announced that it has updated its outlook for the quarter ending September 30, 2020. Updated OutlookAgainst a backdrop of lower industry volumes across rates, foreign exchange, and credit,1 BGC's revenue and pre-tax Adjusted Earnings for the third quarter of 2020 are now expected to be between the mid-point and the low-end of the range of its previously stated outlook.The Company's outlook was contained in BGC's financial results press release issued on July 30, 2020, which can be found at http://ir.bgcpartners.com. Non-GAAP Financial Measures This document contains non-GAAP financial measures that differ from the most directly comparable measures calculated and presented in accordance with Generally Accepted Accounting Principles in the United States ("GAAP"). Non-GAAP financial measures used by the Company include "Adjusted Earnings before noncontrolling interests and taxes", which is used interchangeably with "pre-tax Adjusted Earnings"; "Post-tax Adjusted Earnings to fully diluted shareholders", which is used interchangeably with "post-tax Adjusted Earnings"; "Adjusted EBITDA"; and "Liquidity". The definitions of these terms are below. Adjusted Earnings DefinedBGC uses non-GAAP financial measures, including "Adjusted Earnings before noncontrolling interests and taxes" and "Post-tax Adjusted Earnings to fully diluted shareholders", which are supplemental measures of operating results used by management to evaluate the financial performance of the Company and its consolidated subsidiaries. BGC believes that Adjusted Earnings best reflect the operating earnings generated by the Company on a consolidated basis and are the earnings which management considers when managing its business. As compared with "Income (loss) from operations before income taxes" and "Net income (loss) for fully diluted shares", both prepared in accordance with GAAP, Adjusted Earnings calculations primarily exclude certain non-cash items and other expenses that generally do not involve the receipt or outlay of cash by the Company and/or which do not dilute existing stockholders. In addition, Adjusted Earnings calculations exclude certain gains and charges that management believes do not best reflect the ordinary results of BGC. Adjusted Earnings is calculated by taking the most comparable GAAP measures and adjusting for certain items with respect to compensation expenses, non-compensation expenses, and other income, as discussed below. Calculations of Compensation Adjustments for Adjusted Earnings and Adjusted EBITDA Treatment of Equity-Based Compensation Line Item for Adjusted Earnings and Adjusted EBITDAThe Company's Adjusted Earnings and Adjusted EBITDA measures exclude all GAAP charges included in the line item "Equity-based compensation and allocations of net income to limited partnership units and FPUs" (or "equity-based compensation" for purposes of defining the Company's non-GAAP results) as recorded on the Company's GAAP Consolidated Statements of Operations and GAAP Consolidated Statements of Cash Flows. These GAAP equity-based compensation charges reflect the following items: * Charges with respect to grants of exchangeability, which reflect the right of holders of limited partnership units with no capital accounts, such as LPUs and PSUs, to exchange these units into shares of common stock, or into partnership units with capital accounts, such as HDUs, as well as cash paid with respect to taxes withheld or expected to be owed by the unit holder upon such exchange. The withholding taxes related to the exchange of certain non-exchangeable units without a capital account into either common shares or units with a capital account may be funded by the redemption of preferred units such as PPSUs. * Charges with respect to preferred units. Any preferred units would not be included in the Company's fully diluted share count because they cannot be made exchangeable into shares of common stock and are entitled only to a fixed distribution. Preferred units are granted in connection with the grant of certain limited partnership units that may be granted exchangeability or redeemed in connection with the grant of shares of common stock at ratios designed to cover any withholding taxes expected to be paid. This is an alternative to the common practice among public companies of issuing the gross amount of shares to employees, subject to cashless withholding of shares, to pay applicable withholding taxes. * GAAP equity-based compensation charges with respect to the grant of an offsetting amount of common stock or partnership units with capital accounts in connection with the redemption of non-exchangeable units, including PSUs and LPUs.* Charges related to amortization of RSUs and limited partnership units.* Charges related to grants of equity awards, including common stock or partnership units with capital accounts.* Allocations of net income to limited partnership units and FPUs. Such allocations represent the pro-rata portion of post-tax GAAP earnings available to such unit holders. The amounts of certain quarterly equity-based compensationcharges are based upon the Company's estimate of such expected charges during the annual period, as described further below under "Methodology for Calculating Adjusted Earnings Taxes." Virtually all of BGC's key executives and producers have equity or partnership stakes in the Company and its subsidiaries and generally receive deferred equity or limited partnership units as part of their compensation. A significant percentage of BGC's fully diluted shares are owned by its executives, partners and employees. The Company issues limited partnership units as well as other forms of equity-based compensation, including grants of exchangeability into shares of common stock, to provide liquidity to its employees, to align the interests of its employees and management with those of common stockholders, to help motivate and retain key employees, and to encourage a collaborative culture that drives cross-selling and revenue growth. All share equivalents that are part of the Company's equity-based compensation program, including REUs, PSUs, LPUs, HDUs, and other unitsthat may be made exchangeable into common stock, as well as RSUs (which are recorded using the treasury stock method), are included in the fully diluted share count when issued or at the beginning of the subsequent quarter after the date of grant. Generally, limited partnership units other than preferred unitsare expected to be paid a pro-rata distribution based on BGC's calculation of Adjusted Earnings per fully diluted share. However, out of an abundance of caution and in order to strengthen the Company's balance sheet due the uncertain macroeconomic conditions with respect to the COVID-19 pandemic, BGC Holdings, L.P. has reduced its distributions of income from the operations of BGC's businesses to its partners. Compensation charges are also adjusted for certain other cash and non-cash items, including those related to the amortization of GFI employee forgivable loans granted prior to the closing of the January 11, 2016 back-end merger with GFI. Certain Other Compensation-Related Adjustments for Adjusted Earnings BGC also excludes various other GAAP items that management views as not reflective of the Company's underlying performance in a given period from its calculation of Adjusted Earnings. These may include compensation-related items with respect to cost-saving initiatives, such as severance charges incurred in connection with headcount reductions as part of broad restructuring and/or cost savings plans. Calculation of Non-Compensation Adjustments for Adjusted Earnings Adjusted Earnings calculations may also exclude items such as: * Non-cash GAAP charges related to the amortization of intangibles with respect to acquisitions; * Acquisition related costs;* Certain rent charges;* Non-cash GAAP asset impairment charges; and* Various other GAAP items that management views as not reflective of the Company's underlying performance in a given period, including non-compensation-related charges incurred as part of broad restructuring and/or cost savings plans. Such GAAP items may include charges for exiting leases and/or other long-term contracts as part of cost-saving initiatives, as well as non-cash impairment charges related to assets, goodwill and/or intangibles created from acquisitions. Calculation of Adjustments for Other (income) losses for Adjusted Earnings Adjusted Earnings calculations also exclude certain other non-cash, non-dilutive, and/or non-economic items, which may, in some periods, include: * Gains or losses on divestitures; * Fair value adjustment of investments;* Certain other GAAP items, including gains or losses related to BGC's investments accounted for under the equity method; and * Any unusual, one-time, non-ordinary, or non-recurring gains or losses. Methodology for Calculating Adjusted Earnings Taxes Although Adjusted Earnings are calculated on a pre-tax basis, BGC also reports post-tax Adjusted Earnings to fully diluted shareholders. The Company defines post-tax Adjusted Earnings to fully diluted shareholders as pre-tax Adjusted Earnings reduced by the non-GAAP tax provision described below and net income (loss) attributable to noncontrolling interest for Adjusted Earnings. The Company calculates its tax provision for post-tax Adjusted Earnings using an annual estimate similar to how it accounts for its income tax provision under GAAP. To calculate the quarterly tax provision under GAAP, BGC estimates its full fiscal year GAAP income (loss) from operations before income taxes and noncontrolling interests in subsidiaries and the expected inclusions and deductions for income tax purposes, including expected equity-based compensation during the annual period. The resulting annualized tax rate is applied to BGC's quarterly GAAP income (loss) from operations before income taxes and noncontrolling interests in subsidiaries. At the end of the annual period, the Company updates its estimate to reflect the actual tax amounts owed for the period. To determine the non-GAAP tax provision, BGC first adjusts pre-tax Adjusted Earnings by recognizing any, and only, amounts for which a tax deduction applies under applicable law. The amounts include charges with respect to equity-based compensation; certain charges related to employee loan forgiveness; certain net operating loss carryforwards when taken for statutory purposes; and certain charges related to tax goodwill amortization. These adjustments may also reflect timing and measurement differences, including treatment of employee loans; changes in the value of units between the dates of grants of exchangeability and the date of actual unit exchange; variations in the value of certain deferred tax assets; and liabilities and the different timing of permitted deductions for tax under GAAP and statutory tax requirements. After application of these adjustments, the result is the Company's taxable income for its pre-tax Adjusted Earnings, to which BGC then applies the statutory tax rates to determine its non-GAAP tax provision. BGC views the effective tax rate on pre-tax Adjusted Earnings as equal to the amount of its non-GAAP tax provision divided by the amount of pre-tax Adjusted Earnings. Generally, the most significant factor affecting this non-GAAP tax provision is the amount of charges relating to equity-based compensation. Because the charges relating to equity-based compensation are deductible in accordance with applicable tax laws, increases in such charges have the effect of lowering the Company's non-GAAP effective tax rate and thereby increasing its post-tax Adjusted Earnings. BGC incurs income tax expenses based on the location, legal structure and jurisdictional taxing authorities of each of its subsidiaries. Certain of the Company's entities are taxed as U.S. partnerships and are subject to the Unincorporated Business Tax ("UBT") in New York City. Any U.S. federal and state income tax liability or benefit related to the partnership income or loss, with the exception of UBT, rests with the unit holders rather than with the partnership entity. The Company's consolidated financial statements include U.S. federal, state, and local income taxes on the Company's allocable share of the U.S. results of operations. Outside of the U.S., BGC is expected to operate principally through subsidiary corporations subject to local income taxes. For these reasons, taxes for Adjusted Earnings are expected to be presented to show the tax provision the consolidated Company would expect to pay if 100 percent of earnings were taxed at global corporate rates. Calculations of Pre- and Post-Tax Adjusted Earnings per ShareBGC's pre- and post-tax Adjusted Earnings per share calculations assume either that: * The fully diluted share count includes the shares related to any dilutive instruments, but excludes the associated expense, net of tax, when the impact would be dilutive; or* The fully diluted share count excludes the shares related to these instruments, but includes the associated expense, net of tax. The share count for Adjusted Earnings excludes certain shares and share equivalents expected to be issued in future periods but not yet eligible to receive dividends and/or distributions. Each quarter, the dividend payable to BGC's stockholders, if any, is expected to be determined by the Company's Board of Directors with reference to a number of factors, including post-tax Adjusted Earnings per share. BGC may also pay a pro-rata distribution of net income to limited partnership units, as well as to Cantor for its noncontrolling interest. The amount of this net income, and therefore of these payments per unit, would be determined using the above definition of Adjusted Earnings per share on a pre-tax basis. The declaration, payment, timing, and amount of any future dividends payable by the Company will be at the discretion of its Board of Directors using the fully diluted share count. For more information on any share count adjustments, see the table titled "Fully Diluted Weighted-Average Share Count under GAAP and for Adjusted Earnings". Management Rationale for Using Adjusted Earnings BGC's calculation of Adjusted Earnings excludes the items discussed above because they are either non-cash in nature, because the anticipated benefits from the expenditures are not expected to be fully realized until future periods, or because the Company views results excluding these items as a better reflection of the underlying performance of BGC's ongoing operations. Management uses Adjusted Earnings in part to help it evaluate, among other things, the overall performance of the Company's business, to make decisions with respect to the Company's operations, and to determine the amount of dividends payable to common stockholders and distributions payable to holders of limited partnership units. Dividends payable to common stockholders and distributions payable to holders of limited partnership units are included within "Dividends to stockholders" and "Earnings distributions to limited partnership interests and noncontrolling interests," respectively, in our unaudited, condensed, consolidated statements of cash flows. The term "Adjusted Earnings" should not be considered in isolation or as an alternative to GAAP net income (loss). The Company views Adjusted Earnings as a metric that is not indicative of liquidity, or the cash available to fund its operations, but rather as a performance measure. Pre- and post-tax Adjusted Earnings, as well as related measures, are not intended to replace the Company's presentation of its GAAP financial results. However, management believes that these measures help provide investors with a clearer understanding of BGC's financial performance and offer useful information to both management and investors regarding certain financial and business trends related to the Company's financial condition and results of operations. Management believes that the GAAP and Adjusted Earnings measures of financial performance should be considered together. For more information regarding Adjusted Earnings, see the sections of this document and/or the Company's most recent financial results press release titled "Reconciliation of GAAP Income (Loss) from Operations before Income Taxes to Adjusted Earnings and GAAP Fully Diluted EPS to Post-Tax Adjusted EPS", including the related footnotes, for details about how BGC's non-GAAP results are reconciled to those under GAAP. Adjusted EBITDA DefinedBGC also provides an additional non-GAAP financial performance measure, "Adjusted EBITDA", which it defines as GAAP "Net income (loss) available to common stockholders", adjusted to add back the following items: * Provision (benefit) for income taxes;* Net income (loss) attributable to noncontrolling interest in subsidiaries;* Interest expense;* Fixed asset depreciation and intangible asset amortization;* Equity-based compensation and allocations of net income to limited partnership units and FPUs; * Impairment of long-lived assets; * (Gains) losses on equity method investments; and* Certain other non-cash GAAP items, such as non-cash charges of amortized rents incurred by the Company for its new UK based headquarters. The Company's management believes that its Adjusted EBITDA measure is useful in evaluating BGC's operating performance, because the calculation of this measure generally eliminates the effects of financing and income taxes and the accounting effects of capital spending and acquisitions, which would include impairment charges of goodwill and intangibles created from acquisitions. Such items may vary for different companies for reasons unrelated to overall operating performance. As a result, the Company's management uses this measure to evaluate operating performance and for other discretionary purposes. BGC believes that Adjusted EBITDA is useful to investors to assist them in getting a more complete picture of the Company's financial results and operations. Since BGC's Adjusted EBITDA is not a recognized measurement under GAAP, investors should use this measure in addition to GAAP measures of net income when analyzing BGC's operating performance. Because not all companies use identical EBITDA calculations, the Company's presentation of Adjusted EBITDA may not be comparable to similarly titled measures of other companies. Furthermore, Adjusted EBITDA is not intended to be a measure of free cash flow or GAAP cash flow from operations because the Company's Adjusted EBITDA does not consider certain cash requirements, such as tax and debt service payments. For more information regarding Adjusted EBITDA, see the section of this document and/or the Company's most recent financial results press release titled "Reconciliation of GAAP Net Income (Loss) Available to Common Stockholders to Adjusted EBITDA", including the footnotes to the same, for details about how BGC's non-GAAP results are reconciled to those under GAAP. Timing of Outlook for Certain GAAP and Non-GAAP ItemsBGC anticipates providing forward-looking guidance for GAAP revenues and for certain non-GAAP measures from time to time. However, the Company does not anticipate providing an outlook for other GAAP results. This is because certain GAAP items, which are excluded from Adjusted Earnings and/or Adjusted EBITDA, are difficult to forecast with precision before the end of each period. The Company therefore believes that it is not possible for it to have the required information necessary to forecast GAAP results or to quantitatively reconcile GAAP forecasts to non-GAAP forecasts with sufficient precision without unreasonable efforts. For the same reasons, the Company is unable to address the probable significance of the unavailable information. The relevant items that are difficult to predict on a quarterly and/or annual basis with precision and may materially impact the Company's GAAP results include, but are not limited, to the following: * Certain equity-based compensation charges that may be determined at the discretion of management throughout and up to the period-end; * Unusual, one-time, non-ordinary, or non-recurring items;* The impact of gains or losses on certain marketable securities, as well as any gains or losses related to associated mark-to- market movements and/or hedging. These items are calculated using period-end closing prices;* Non-cash asset impairment charges, which are calculated and analyzed based on the period-end values of the underlying assets. These amounts may not be known until after period-end; * Acquisitions, dispositions and/or resolutions of litigation, which are fluid and unpredictable in nature. Liquidity DefinedBGC may also use a non-GAAP measure called "liquidity". The Company considers liquidity to be comprised of the sum of cash and cash equivalents, reverse repurchase agreements (if any), securities owned, and marketable securities, less securities lent out in securities loaned transactions and repurchase agreements (if any). The Company considers liquidity to be an important metric for determining the amount of cash that is available or that could be readily available to the Company on short notice. For more information regarding Liquidity, see the section of this document and/or the Company's most recent financial results press release titled "Liquidity Analysis", including any footnotes to the same, for details about how BGC's non-GAAP results are reconciled to those under GAAP. About BGC Partners, Inc.BGC Partners is a leading global brokerage and financial technology company. BGC specializes in the brokerage of a broad range of products, including fixed income (rates and credit), foreign exchange, equities, energy and commodities, shipping, insurance, and futures. BGC also provides a wide variety of services, including trade execution, brokerage, clearing, trade compression, post-trade, information, and other back-office services to a broad range of financial and non-financial institutions. Through brands including Fenics, BGC Trader, Capitalab, Lucera, and Fenics Market Data, BGC offers financial technology solutions, market data, and analytics related to numerous financial instruments and markets. BGC, BGC Trader, GFI, Fenics, Fenics Market Data, Capitalab, and Lucera are trademarks/service marks and/or registered trademarks/service marks of BGC Partners, Inc. and/or its affiliates. BGC's customers include many of the world's largest banks, broker-dealers, investment banks, trading firms, hedge funds, governments, corporations, and investment firms. BGC's Class A common stock trades on the NASDAQ Global Select Market under the ticker symbol "BGCP". BGC Partners is led by Chairman of the Board and Chief Executive Officer Howard W. Lutnick. For more information, please visit http://www.bgcpartners.com. You can also follow BGC at https://twitter.com/bgcpartners, https://www.linkedin.com/company/bgc-partners and/or http://ir.bgcpartners.com/Investors/default.aspx. Discussion of Forward-Looking Statements about BGC Statements in this document regarding BGC that are not historical facts are "forward-looking statements" that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the effects of the COVID-19 pandemic on the Company's business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, BGC undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see BGC's Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K. Media Contact:Karen Laureano-Rikardsen+1 212-829-4975 Investor Contacts:Jason Chryssicas or Grant Filer+1 212-610-2426 1Industry rates volumes include CME interest rate futures and options, Deutsche Brse (Eurex) European interest rate derivatives, FIA SEF non-forward rate agreement IRS, ICE short-term and medium & L-T interest rates, ISDA interest rate derivatives, LSE's MTS Cash, MarketAxess U.S. government bonds (which represents U.S. Treasury volumes on LiquidityEdge), Nasdaq U.S. fixed income, NEX (CME) U.S. Treasuries, and Tradeweb U.S. government bonds. Industry foreign exchange volumes include CBOE Hotspot (spot) FX, CLS forward, swap, and spot FX, CME FX futures and options, Deutsche Brse FX (360T), Euronext FX (Fastmatch), FIA SEF FX products, NEX (CME) EBS spot FX, and Refinitiv FX spot volume and other volume. Industry credit volumes include FIA CDS and options, ISDA credit derivatives, MarketAxess total credit, primary dealer U.S. corporate bonds (source: Bloomberg), and Tradeweb total credit. SOURCE BGC Partners, Inc. Related Links http://www.bgcpartners.com

edtsum7786

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: BOSTON--(BUSINESS WIRE)--Googles entry into the infotainment space as a full-stack infotainment platform provider is having tectonic implications in the navigation and location-based services market as platform and data providers consider their future strategy. The Strategy Analytics Automotive Infotainment and Telematics (AIT) service report, 2020 Navigation and Location-Based Services Market Landscape - Multi-Layered Partnerships reviews the key players, providers and forecasts in the navigation and location-based services space. Once reserved only for flagship luxury models and brands, navigation has now become a common and desired feature in mainstream brands and models. However, there is a wide diversity of approaches to implementation, feature sets and service tiers. Within the last few years, navigation has increasingly become a must-have feature for many customers, said Edward Sanchez, Senior Analyst for Strategy Analytics Global Automotive Practice. However, theres no one-size-fits-all formula. Different market segments and models define the feature set and attributes in each case. Navigation has advanced a great deal in sophistication and features over the last decade, said Richard Robinson, Director of Strategy Analytics Automotive Infotainment and Telematics service. The challenge for OEMs going forward will be on combining the different data layers in a compelling package to the consumer. Its not an overstatement to say Googles emergence in this space is a game-changer and wake-up call for the segment. #SA_Automotive About Strategy Analytics Strategy Analytics, Inc. is a global leader in supporting companies across their planning lifecycle through a range of customized market research solutions. Our multi-discipline capabilities include: industry research advisory services, customer insights, user experience design and innovation expertise, mobile consumer on-device tracking and business-to-business consulting competencies. With domain expertise in: smart devices, connected cars, intelligent home, service providers, IoT, strategic components and media, Strategy Analytics can develop a solution to meet your specific planning need. For more information, visit us at www.strategyanalytics.com. For more information about Strategy Analytics Strategy Analytics Global Automotive Practice Strategy Analytics Automotive Infotainment and Telematics Answer:

Strategy Analytics: Googles Emergence as Full-Stack Infotainment Provider Intensifies Competition in Navigation Market

BOSTON--(BUSINESS WIRE)--Googles entry into the infotainment space as a full-stack infotainment platform provider is having tectonic implications in the navigation and location-based services market as platform and data providers consider their future strategy. The Strategy Analytics Automotive Infotainment and Telematics (AIT) service report, 2020 Navigation and Location-Based Services Market Landscape - Multi-Layered Partnerships reviews the key players, providers and forecasts in the navigation and location-based services space. Once reserved only for flagship luxury models and brands, navigation has now become a common and desired feature in mainstream brands and models. However, there is a wide diversity of approaches to implementation, feature sets and service tiers. Within the last few years, navigation has increasingly become a must-have feature for many customers, said Edward Sanchez, Senior Analyst for Strategy Analytics Global Automotive Practice. However, theres no one-size-fits-all formula. Different market segments and models define the feature set and attributes in each case. Navigation has advanced a great deal in sophistication and features over the last decade, said Richard Robinson, Director of Strategy Analytics Automotive Infotainment and Telematics service. The challenge for OEMs going forward will be on combining the different data layers in a compelling package to the consumer. Its not an overstatement to say Googles emergence in this space is a game-changer and wake-up call for the segment. #SA_Automotive About Strategy Analytics Strategy Analytics, Inc. is a global leader in supporting companies across their planning lifecycle through a range of customized market research solutions. Our multi-discipline capabilities include: industry research advisory services, customer insights, user experience design and innovation expertise, mobile consumer on-device tracking and business-to-business consulting competencies. With domain expertise in: smart devices, connected cars, intelligent home, service providers, IoT, strategic components and media, Strategy Analytics can develop a solution to meet your specific planning need. For more information, visit us at www.strategyanalytics.com. For more information about Strategy Analytics Strategy Analytics Global Automotive Practice Strategy Analytics Automotive Infotainment and Telematics

edtsum7787

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, July 21, 2020 /PRNewswire/ -- The "Liquefied Petroleum Gas (LPG) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to this 9th edition of this report. The 284-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Liquefied Petroleum Gas (LPG) Market to Reach US$289.9 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Liquefied Petroleum Gas (LPG) estimated at US$257.6 Billion in the year 2020, is projected to reach a revised size of US$289.9 Billion by 2027, growing at a CAGR of 1.7% over the period 2020-2027.Natural Gas Well, one of the segments analyzed in the report, is projected to grow at a 1.7% CAGR to reach US$168.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Refineries segment is readjusted to a revised 1.7% CAGR for the next 7-year period. This segment currently accounts for a 41.7% share of the global Liquefied Petroleum Gas (LPG) market.The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 3.4% CAGR for the Period of 2020-2027The Liquefied Petroleum Gas (LPG) market in the U.S. is estimated at US$69.8 Billion in the year 2020. The country currently accounts for a 27.09% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$55.4 Billion in the year 2027 trailing a CAGR of 3.3% through 2027.Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.2% and 1.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.6% CAGR while Rest of European market (as defined in the study) will reach US$55.4 Billion by the year 2027.Competitors identified in this market include, among others: Bharat Petroleum Corp. Ltd. BP PLC Chevron Corporation China Gas Holdings Ltd. Copagaz Distribuidora de Gas SA ExxonMobil Corporation Kleenheat Gas Pty Limited Oman Oil Co. SAOC Origin Energy Limited Petroleos de Venezuela SA (Venezuela) Phillips 66 Company Qatargas Operating Company Limited Reliance Industries Ltd. Repsol SA Royal Dutch Shell PLC Sinopec Corporation Total SA UGI Corporation Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/eo88x1 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Liquefied Petroleum Gas (LPG) Industry Outlook, 2020-2027 with Profiles of 41 Market Players

DUBLIN, July 21, 2020 /PRNewswire/ -- The "Liquefied Petroleum Gas (LPG) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings years of research experience to this 9th edition of this report. The 284-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.Global Liquefied Petroleum Gas (LPG) Market to Reach US$289.9 Billion by the Year 2027Amid the COVID-19 crisis, the global market for Liquefied Petroleum Gas (LPG) estimated at US$257.6 Billion in the year 2020, is projected to reach a revised size of US$289.9 Billion by 2027, growing at a CAGR of 1.7% over the period 2020-2027.Natural Gas Well, one of the segments analyzed in the report, is projected to grow at a 1.7% CAGR to reach US$168.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Refineries segment is readjusted to a revised 1.7% CAGR for the next 7-year period. This segment currently accounts for a 41.7% share of the global Liquefied Petroleum Gas (LPG) market.The U.S. Accounts for Over 27.1% of Global Market Size in 2020, While China is Forecast to Grow at a 3.4% CAGR for the Period of 2020-2027The Liquefied Petroleum Gas (LPG) market in the U.S. is estimated at US$69.8 Billion in the year 2020. The country currently accounts for a 27.09% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$55.4 Billion in the year 2027 trailing a CAGR of 3.3% through 2027.Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.2% and 1.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 0.6% CAGR while Rest of European market (as defined in the study) will reach US$55.4 Billion by the year 2027.Competitors identified in this market include, among others: Bharat Petroleum Corp. Ltd. BP PLC Chevron Corporation China Gas Holdings Ltd. Copagaz Distribuidora de Gas SA ExxonMobil Corporation Kleenheat Gas Pty Limited Oman Oil Co. SAOC Origin Energy Limited Petroleos de Venezuela SA (Venezuela) Phillips 66 Company Qatargas Operating Company Limited Reliance Industries Ltd. Repsol SA Royal Dutch Shell PLC Sinopec Corporation Total SA UGI Corporation Total Companies Profiled: 41 For more information about this report visit https://www.researchandmarkets.com/r/eo88x1 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum7788

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: PEARLAND, Texas, April 16, 2020 /PRNewswire/ -- Ask any pediatrician about the financial affairs of their practice, and they will agree that the financial aspect of a pediatric practice is akin to running a local Walmart, with high volume and low margins to keep their doors open. Most pediatric practices run operational overhead rates well above 65% before considering reasonable compensation for themselves, nurse practitioners and/or physician assistants. Despite their best efforts to work within these realities, they remain at the bottom in terms of physician compensation. Since the announcement of the Paycheck Protection Program (PPP), the Pediatric Management Institute (PMI) has been working with pediatric practices from around the country to develop various strategies to bridge the divide between now and a new future that awaits them. Despite an unprecedented shift to telemedicine visits from less than 1% of visits to over 50% in less than four weeks, pediatric practices are limited in their options to remain financially solvent. Like many other businesses in the United States, these uncertain economic times are forcing pediatric practices to turn to a variety of financing options during this time. Based on the experiences of PMI clients, the PPP, while noble in its intent, is not providing the needed timely assistance to those whose mission is to care for our most vulnerable population - the children of our country. The PPP was designed to provide businesses such as pediatric practices a lifeline to obtain low-cost financing that could be forgiven if used for qualifying expenses. Unfortunately, the viability of the PPP as the solution for pediatric practices is predicated on the pandemic being a relatively short-term event and reasonable access to funding - both of which are unpredictable. Access to the full white paper can be found here: https://www.pediatricsupport.com/covid19info Media Contact: Paul D. Vanchiere, MBA 888-253-0413 Related Files PMI_COVID_19_White_Paper.pdf Related Images image1.png Related Links White Paper COVID Impact Forum SOURCE Pediatric Management Institute Answer:

PMI Reports Growing Uncertainty for the Future of Pediatric Practices as the COVID-19 Pandemic Evolves For pediatric practices to remain financially viable and care for the millions of children every day, it is incumbent that they have a steady flow of patients through their office to generate the revenue needed to cover their high fixed costs. Pediatric practices are locked into juggling between the mission of their profession and financial impact stemming from the COVID-19 pandemic.

PEARLAND, Texas, April 16, 2020 /PRNewswire/ -- Ask any pediatrician about the financial affairs of their practice, and they will agree that the financial aspect of a pediatric practice is akin to running a local Walmart, with high volume and low margins to keep their doors open. Most pediatric practices run operational overhead rates well above 65% before considering reasonable compensation for themselves, nurse practitioners and/or physician assistants. Despite their best efforts to work within these realities, they remain at the bottom in terms of physician compensation. Since the announcement of the Paycheck Protection Program (PPP), the Pediatric Management Institute (PMI) has been working with pediatric practices from around the country to develop various strategies to bridge the divide between now and a new future that awaits them. Despite an unprecedented shift to telemedicine visits from less than 1% of visits to over 50% in less than four weeks, pediatric practices are limited in their options to remain financially solvent. Like many other businesses in the United States, these uncertain economic times are forcing pediatric practices to turn to a variety of financing options during this time. Based on the experiences of PMI clients, the PPP, while noble in its intent, is not providing the needed timely assistance to those whose mission is to care for our most vulnerable population - the children of our country. The PPP was designed to provide businesses such as pediatric practices a lifeline to obtain low-cost financing that could be forgiven if used for qualifying expenses. Unfortunately, the viability of the PPP as the solution for pediatric practices is predicated on the pandemic being a relatively short-term event and reasonable access to funding - both of which are unpredictable. Access to the full white paper can be found here: https://www.pediatricsupport.com/covid19info Media Contact: Paul D. Vanchiere, MBA 888-253-0413 Related Files PMI_COVID_19_White_Paper.pdf Related Images image1.png Related Links White Paper COVID Impact Forum SOURCE Pediatric Management Institute

edtsum7789

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: AUBURN HILLS, Mich., Feb. 11, 2021 /PRNewswire/ -- Today, Mopar announced accessories for the new, redesigned 2021 Chrysler Pacifica America's most capable minivan with all-wheel drive (AWD) and still the first and only plug-in hybrid minivan. Mopar offers more than 85 quality-tested, factory-backed accessories for the new, redesigned 2021 Chrysler Pacifica Americas most capable minivan with all-wheel drive (AWD) and still the first and only plug-in hybrid minivan. Mopar offers more than 85 quality-tested, factory-backed accessories for Chrysler brand's minivan lineup Accessories, including carriers, cargo bins and a pet kennel, available to customize the refreshed exterior and interior of the 2021 Chrysler Pacifica For more information on Mopar accessories for new 2021 Chrysler minivan models, visit the Mopar eStore "Mopar offers more than 85 quality-tested, factory-backed accessories across Chrysler brand's award-winning minivan lineup," saidMark Bosanac,North America Vice President, Mopar Service, Parts & Customer Care. "From roof racks to pet kennels, Mopar offers even more innovative storage options for the new, redesigned Chrysler Pacifica." Below are select Mopar accessories available for the new 2021 Chrysler Pacifica, as well as the entry-level Chrysler Voyager (with Mopar part number and U.S. MSRP). For more information, visit the Mopar eStore.Rooftop cargo boxes (TCBOX624 - 13 cubic feet capacity, $565 | TCBOX614 - 14 cu. ft. capacity, $490 | TCBOX625 17 cu. ft. capacity, $595):Regardless of weather conditions, these tough, lockable, thermoplastic carriers keep cargo dry and secure. Each carrier features a gas-cylinder opening system, allowing the hinged lid to gently open and close. Aerodynamic design limits wind resistance and provides sleek styling. For use with crossbars and/or side rails, which are sold separately.Rooftop cargo bags (82207198 - 11 cu. ft. capacity, $148 | TCINT869 - 16 cu. ft. capacity, $225):Black nylon and soft-sided cargo bags are weatherproof and provide additional storage space. Each cargo bag features a covered zipper opening, lined seams and sewn-in tie-down straps. For use with crossbars and/or side rails, which are sold separately.Ski and snowboard carrier (TCS92725 | $255):For winter sports enthusiasts, this carrier provides convenient, safe transportation of skis and snowboards. This roof-mounted carrier can hold up to six pairs of skis or four snowboards, or a combination of both. The unit features silver anodized-aluminum construction and integrated locks that open from either side for easy loading and unloading. For use with crossbars and/or side rails, which are sold separately.Upright bike carrier (TCOES599 | $200):Roof-mounted carrier uses worry-free automatic self-adjusting jaws for secure clamping every time. Mounts to production Stow 'n Place Roof Rack Kit or Mopar Roof Rack Kit (82214552 | $410 - sold separately).Fork-mount bike carrier (TCFKM526AB | $175):Roof-mounted carrier for one bicycle features a reinforced head that combines aerodynamics, durability and style. Mounts to production Stow 'n Place Roof Rack Kit or Mopar Roof Rack Kit (82214552 | $410 - sold separately).Pet kennel (82214536 | $190):The soft-sided temporary kennel with a Chrysler logo is perfect for safely transporting pets. The kennel is collapsible and stores flat when not in use.Stow 'n Go cargo bins (82214532AC | $139):This set of two black bins provide additional removable storage options underneath the second-row floor. Bins are lightweight and washable.Foldable cooler (82214506AB | $41.25):The Chrysler-branded, soft-sided, collapsible cooler has carry handles and fits into most storage spaces.All-weather floor mats (82214515AE gas model, $260 | 82214516AE - PHEV model, $260):For maximum protection of carpeted floors, this five-piece mat set (first, second and third rows with second- to third-row runner) are molded and feature deep ribs to trap water, snow, salt, mud, dirt and grime.Media/radio screen protector film (82215574 - 7-inch, $20 | 82215337 - 8.4-inch, $20 | 82216070AA - 10.1-inch, $25):Scratch-resistant, anti-glare clear film reduces fingerprints and smudges and also provides increased clarity. Protector film does not negatively affect the touchscreen accuracy and is removable with no damage to the screen.Roadside safety kit (82213499AB | $116):Includes safety flashlight, fleece blanket, six-gauge jumper cables, safety triangle, pliers, gloves, flathead and Phillips-head screwdrivers, and two bungee cords.Chrysler PacificaThe Chrysler brand continues to set the pace for the minivan segment with the new 2021 Chrysler Pacifica. The first-ever minivan to offer both gas and hybrid powertrains, Chrysler is elevating its minivan game to new levels, creating a new top-of-the-line Pinnacle model in the segment, offering AWD capability paired with Pacifica's class-exclusive Stow 'n Go seating, more standard safety features than any vehicle in the industry, new FamCAM interior camera, wireless charging, next-generation Uconnect 5 connectivity, an athletic new look and loads more creature comforts and interior storage for the 2021 model year. The Pacifica Hybrid delivers more than 80 miles per gallon equivalent (MPGe) in electric-only mode, an all-electric range of more than 30 miles and a total range of more than 500 miles.The Chrysler Pacifica continues to hold its status as the most awarded minivan five years in a row with more than 140 honors and industry accolades. As the first company to introduce the minivan and through six generations of the vehicle, 116 minivan firsts have been produced, including nearly 40 minivan-first features on the Pacifica. The company has sold more than 15 million minivans globally since 1983, twice as many as any other manufacturer over 37 years.MoparMopar (a simple contraction of the words MOtor and PARts) offers exceptional service, parts and customer-care. Born in 1937 as the name of a line of antifreeze products, the Mopar brand has evolved over more than 80 years to represent both complete care and authentic performance for owners and enthusiasts worldwide.Mopar made its mark in the 1960s during the muscle-car era, with Mopar Performance Parts to enhance speed and handling for both road and racing use, and expanded to include technical service and customer support. Today, the Mopar brand's global reach distributes more than 500,000 parts and accessories in more than130 markets. With more than 50 parts distribution centers and 25 customer-contact centers globally, Mopar integrates service, parts and customer-care operations in order to enhance customer and dealer support worldwide.Complete information on the Mopar brand is available at www.mopar.com.Mopar is part of the portfolio of brands offered by leading global automaker and mobility provider Stellantis. For more information regarding Stellantis (NYSE: STLA), please visit www.stellantis.com.Follow Mopar and company news and video on:Company blog: http://blog.stellantisnorthamerica.comMedia website: http://media.stellantisnorthamerica.comFacebook: https://www.facebook.com/moparInstagram: https://www.instagram.com/officialmoparTwitter: https://twitter.com/OfficialMOPARYouTube: https://www.youtube.com/c/moparorhttps://www.youtube.com/StellantisNA SOURCE Stellantis Related Links http://www.stellantis.com Answer:

Mopar Announces Accessories for New, Redesigned 2021 Chrysler Pacifica

AUBURN HILLS, Mich., Feb. 11, 2021 /PRNewswire/ -- Today, Mopar announced accessories for the new, redesigned 2021 Chrysler Pacifica America's most capable minivan with all-wheel drive (AWD) and still the first and only plug-in hybrid minivan. Mopar offers more than 85 quality-tested, factory-backed accessories for the new, redesigned 2021 Chrysler Pacifica Americas most capable minivan with all-wheel drive (AWD) and still the first and only plug-in hybrid minivan. Mopar offers more than 85 quality-tested, factory-backed accessories for Chrysler brand's minivan lineup Accessories, including carriers, cargo bins and a pet kennel, available to customize the refreshed exterior and interior of the 2021 Chrysler Pacifica For more information on Mopar accessories for new 2021 Chrysler minivan models, visit the Mopar eStore "Mopar offers more than 85 quality-tested, factory-backed accessories across Chrysler brand's award-winning minivan lineup," saidMark Bosanac,North America Vice President, Mopar Service, Parts & Customer Care. "From roof racks to pet kennels, Mopar offers even more innovative storage options for the new, redesigned Chrysler Pacifica." Below are select Mopar accessories available for the new 2021 Chrysler Pacifica, as well as the entry-level Chrysler Voyager (with Mopar part number and U.S. MSRP). For more information, visit the Mopar eStore.Rooftop cargo boxes (TCBOX624 - 13 cubic feet capacity, $565 | TCBOX614 - 14 cu. ft. capacity, $490 | TCBOX625 17 cu. ft. capacity, $595):Regardless of weather conditions, these tough, lockable, thermoplastic carriers keep cargo dry and secure. Each carrier features a gas-cylinder opening system, allowing the hinged lid to gently open and close. Aerodynamic design limits wind resistance and provides sleek styling. For use with crossbars and/or side rails, which are sold separately.Rooftop cargo bags (82207198 - 11 cu. ft. capacity, $148 | TCINT869 - 16 cu. ft. capacity, $225):Black nylon and soft-sided cargo bags are weatherproof and provide additional storage space. Each cargo bag features a covered zipper opening, lined seams and sewn-in tie-down straps. For use with crossbars and/or side rails, which are sold separately.Ski and snowboard carrier (TCS92725 | $255):For winter sports enthusiasts, this carrier provides convenient, safe transportation of skis and snowboards. This roof-mounted carrier can hold up to six pairs of skis or four snowboards, or a combination of both. The unit features silver anodized-aluminum construction and integrated locks that open from either side for easy loading and unloading. For use with crossbars and/or side rails, which are sold separately.Upright bike carrier (TCOES599 | $200):Roof-mounted carrier uses worry-free automatic self-adjusting jaws for secure clamping every time. Mounts to production Stow 'n Place Roof Rack Kit or Mopar Roof Rack Kit (82214552 | $410 - sold separately).Fork-mount bike carrier (TCFKM526AB | $175):Roof-mounted carrier for one bicycle features a reinforced head that combines aerodynamics, durability and style. Mounts to production Stow 'n Place Roof Rack Kit or Mopar Roof Rack Kit (82214552 | $410 - sold separately).Pet kennel (82214536 | $190):The soft-sided temporary kennel with a Chrysler logo is perfect for safely transporting pets. The kennel is collapsible and stores flat when not in use.Stow 'n Go cargo bins (82214532AC | $139):This set of two black bins provide additional removable storage options underneath the second-row floor. Bins are lightweight and washable.Foldable cooler (82214506AB | $41.25):The Chrysler-branded, soft-sided, collapsible cooler has carry handles and fits into most storage spaces.All-weather floor mats (82214515AE gas model, $260 | 82214516AE - PHEV model, $260):For maximum protection of carpeted floors, this five-piece mat set (first, second and third rows with second- to third-row runner) are molded and feature deep ribs to trap water, snow, salt, mud, dirt and grime.Media/radio screen protector film (82215574 - 7-inch, $20 | 82215337 - 8.4-inch, $20 | 82216070AA - 10.1-inch, $25):Scratch-resistant, anti-glare clear film reduces fingerprints and smudges and also provides increased clarity. Protector film does not negatively affect the touchscreen accuracy and is removable with no damage to the screen.Roadside safety kit (82213499AB | $116):Includes safety flashlight, fleece blanket, six-gauge jumper cables, safety triangle, pliers, gloves, flathead and Phillips-head screwdrivers, and two bungee cords.Chrysler PacificaThe Chrysler brand continues to set the pace for the minivan segment with the new 2021 Chrysler Pacifica. The first-ever minivan to offer both gas and hybrid powertrains, Chrysler is elevating its minivan game to new levels, creating a new top-of-the-line Pinnacle model in the segment, offering AWD capability paired with Pacifica's class-exclusive Stow 'n Go seating, more standard safety features than any vehicle in the industry, new FamCAM interior camera, wireless charging, next-generation Uconnect 5 connectivity, an athletic new look and loads more creature comforts and interior storage for the 2021 model year. The Pacifica Hybrid delivers more than 80 miles per gallon equivalent (MPGe) in electric-only mode, an all-electric range of more than 30 miles and a total range of more than 500 miles.The Chrysler Pacifica continues to hold its status as the most awarded minivan five years in a row with more than 140 honors and industry accolades. As the first company to introduce the minivan and through six generations of the vehicle, 116 minivan firsts have been produced, including nearly 40 minivan-first features on the Pacifica. The company has sold more than 15 million minivans globally since 1983, twice as many as any other manufacturer over 37 years.MoparMopar (a simple contraction of the words MOtor and PARts) offers exceptional service, parts and customer-care. Born in 1937 as the name of a line of antifreeze products, the Mopar brand has evolved over more than 80 years to represent both complete care and authentic performance for owners and enthusiasts worldwide.Mopar made its mark in the 1960s during the muscle-car era, with Mopar Performance Parts to enhance speed and handling for both road and racing use, and expanded to include technical service and customer support. Today, the Mopar brand's global reach distributes more than 500,000 parts and accessories in more than130 markets. With more than 50 parts distribution centers and 25 customer-contact centers globally, Mopar integrates service, parts and customer-care operations in order to enhance customer and dealer support worldwide.Complete information on the Mopar brand is available at www.mopar.com.Mopar is part of the portfolio of brands offered by leading global automaker and mobility provider Stellantis. For more information regarding Stellantis (NYSE: STLA), please visit www.stellantis.com.Follow Mopar and company news and video on:Company blog: http://blog.stellantisnorthamerica.comMedia website: http://media.stellantisnorthamerica.comFacebook: https://www.facebook.com/moparInstagram: https://www.instagram.com/officialmoparTwitter: https://twitter.com/OfficialMOPARYouTube: https://www.youtube.com/c/moparorhttps://www.youtube.com/StellantisNA SOURCE Stellantis Related Links http://www.stellantis.com

edtsum7790

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: TULSA, Okla., July 27, 2020 /PRNewswire/ -- Rebellion Energy II, LLC ("Rebellion"), supported by certain investment funds managed by NGP Energy Capital, announced today results of two recently completed wells in the prolific resource plays of the Powder River Basin ("PRB"), Wyoming. The Diablo E 4174-6-7-4NH ("Diablo") Niobrara well, located in Section 6 & 7-41N-74W, Campbell County WY, API Number 49005650410100 generated an 24 hour IP rate of 3,060 barrels of oil equivalent per day ("boe/d") (80% oil) on a 24/64 choke and an IP 30 day rate of 2,056 boe/d (77% oil) from a 9,143-foot lateral length, or 225 boe/d per 1,000' of lateral. The Coronado W 8S 4174-17-20 MWB-1H ("Coronado") Mowry horizontal well, located in Section 17 & 20-41N-74W, Campbell County WY, API Number 49005720390000 generated an 24 hour IP rate of 2,283 barrels of oil equivalent per day ("boe/d") (50% oil) on a 30/64 choke and an 30-day IP rate of 1,798 boe/d (49% oil) from a 8,271-foot lateral length, or 217 boe/d per 1,000' of lateral. Staci Taruscio, President and CEO of Rebellion stated, "These wells further substantiate the tremendous potential of the unconventional Niobrara and Mowry targets in the Powder River Basin and, alongside nearby successes in the Shannon, Frontier, Niobrara, and Mowry intervals, highlights the prolific stacked oil pay nature of the Powder River Basin. Our team's ability to execute at such a high level at this point in the basin's life-cycle demonstrates the viability of these resource plays as both predictable and repeatable. The caliber of both our team and assets is encouraging as we look to push development in the PRB." Rebellion, based in Tulsa, Oklahoma, is an oil and gas exploration company focused on identifying, acquiring and developing oil and natural gas assets. Rebellion owns approximately 63,000 net acres in the Powder River Basin. CONTACT: Amanda O'Quinn, [emailprotected] SOURCE Rebellion Energy II, LLC Answer:

Rebellion Energy II, LLC pushes unconventional Powder River Basin development with the announcement of premium 30-day IP's in both the Niobrara and Mowry Formations

TULSA, Okla., July 27, 2020 /PRNewswire/ -- Rebellion Energy II, LLC ("Rebellion"), supported by certain investment funds managed by NGP Energy Capital, announced today results of two recently completed wells in the prolific resource plays of the Powder River Basin ("PRB"), Wyoming. The Diablo E 4174-6-7-4NH ("Diablo") Niobrara well, located in Section 6 & 7-41N-74W, Campbell County WY, API Number 49005650410100 generated an 24 hour IP rate of 3,060 barrels of oil equivalent per day ("boe/d") (80% oil) on a 24/64 choke and an IP 30 day rate of 2,056 boe/d (77% oil) from a 9,143-foot lateral length, or 225 boe/d per 1,000' of lateral. The Coronado W 8S 4174-17-20 MWB-1H ("Coronado") Mowry horizontal well, located in Section 17 & 20-41N-74W, Campbell County WY, API Number 49005720390000 generated an 24 hour IP rate of 2,283 barrels of oil equivalent per day ("boe/d") (50% oil) on a 30/64 choke and an 30-day IP rate of 1,798 boe/d (49% oil) from a 8,271-foot lateral length, or 217 boe/d per 1,000' of lateral. Staci Taruscio, President and CEO of Rebellion stated, "These wells further substantiate the tremendous potential of the unconventional Niobrara and Mowry targets in the Powder River Basin and, alongside nearby successes in the Shannon, Frontier, Niobrara, and Mowry intervals, highlights the prolific stacked oil pay nature of the Powder River Basin. Our team's ability to execute at such a high level at this point in the basin's life-cycle demonstrates the viability of these resource plays as both predictable and repeatable. The caliber of both our team and assets is encouraging as we look to push development in the PRB." Rebellion, based in Tulsa, Oklahoma, is an oil and gas exploration company focused on identifying, acquiring and developing oil and natural gas assets. Rebellion owns approximately 63,000 net acres in the Powder River Basin. CONTACT: Amanda O'Quinn, [emailprotected] SOURCE Rebellion Energy II, LLC

edtsum7791

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: DUBLIN, Nov. 9, 2020 /PRNewswire/ --The "Silicon Photonics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Silicon Photonics Market accounted for $0.8 billion in 2019 and is expected to reach $3.77 billion by 2027, growing at a CAGR of 21.4% during the forecast period.Some of the key factors propelling the growth of the market are increasing demand for high-speed broadband services, deployment of 5G technologies in developing nations, and growing demand for CMOS-integrated silicon photonics technology. However, the risk of thermal effect is the restraining factor for the growth of the market.Silicon photonic devices contain optical systems that use silicon as the optical medium. Since silicon is used as a substrate for most ICs, it is easily possible to manufacture hybrid devices in which electronic as well as the optic components are integrated on a single microchip. They are increasingly used in data transfer between microchips, through optical rays. Moreover, they are capable of carrying a large amount of data in a short time as compared to the electrical conductors.By application, the IT and telecommunication segment is expected to grow at a significant market share during the forecast period because of the growing demand for smartphone products and the need for maximizing the performance of existing fixed and mobile infrastructures. Based on geography, Asia-Pacific is anticipated to hold considerable market share during the forecast period owing to the strong growth in the data centres, long haul & transport networks, and presence of consumer electronics manufacturers.Some of the key players in Silicon Photonics Market include Intel, Cisco, IBM, Globalfoundries, STMicroelectronics, Rockley Photonics, Inphi, Mellanox, Ranovus, Neophotonics, Lumentum, broadcom, Ii-Vi Incorporated, Macom, and Sicoya.What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2018, 2019, 2020, 2024 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary2 Preface2.1 Abstract2.2 Stake Holders2.3 Research Scope2.4 Research Methodology2.5 Research Sources3 Market Trend Analysis3.1 Introduction3.2 Drivers3.3 Restraints3.4 Opportunities3.5 Threats3.6 Product Analysis3.7 Application Analysis3.8 Technology Analysis3.9 Emerging Markets3.10 Impact of COVID-194 Porters Five Forces Analysis4.1 Bargaining Power of Suppliers4.2 Bargaining Power of Buyers4.3 Threat of Substitutes4.4 Threat of New Entrants4.5 Competitive Rivalry5 Global Silicon Photonics Market, By Product5.1 Introduction5.2 Switches5.3 Sensors5.4 Optical Multiplexers5.5 Cables5.6 Optical Transceivers5.6.1 Parallel Channel5.6.2 Single Channel5.7 Photovoltaic Cells/Solar Cells5.8 Light Emitting Diode5.9 Microring Laser5.10 Photonic Integrated Circuit5.11 Variable Optical Attenuators5.12 Distributed Feedback Integrated Laser5.13 Optical Interconnects5.13.1 Intrachip Interconnects5.13.2 Backplane Interconnects5.13.3 Interchip Interconnects5.14 Other Products5.14.1 Optical Engines5.14.2 Radio Frequency Circuits6 Global Silicon Photonics Market, By Material6.1 Introduction6.2 Photonic Integrated Circuits (ICs) Materials6.2.1 Gallium Arsenide6.2.2 Lithium Niobate6.2.3 Indium Phosphide6.2.4 Silicon on Insulator6.2.5 Silica on Silicon6.3 Silicon Photonics Materials6.3.1 Silicon6.3.2 Silicon-Germanium Alloys6.3.3 Indium-Phosphide (InP) Based Alloys6.3.4 Other III-V Alloys7 Global Silicon Photonics Market, By Range7.1 Introduction7.2 400-1,500 nm7.3 1,310-1,550 nm7.4 900-7,000 nm8 Global Silicon Photonics Market, By Component8.1 Introduction8.2 Active Components8.2.1 Micro-Optics8.2.1.1 Micro Lens8.2.1.2 Micromirror8.2.1.3 Light Diffuser8.2.1.4 Beam Shapers8.2.2 Splitters8.2.3 Waveguide8.2.3.1 Optical Waveguide8.2.3.2 Planar Waveguides8.2.3.3 Strip Waveguides8.2.3.4 Rib Waveguides8.2.3.5 Fiber Waveguides8.2.5 Laser8.3 Passive Components8.3.1 Photo Detectors8.3.2 Optical Modulator8.3.2.1 Refractive Modulators8.3.2.1.1 Polarization Changes in Liquid Crystals8.3.2.1.2 Electro-optic Effect8.3.2.1.3 Thermo-optic Effect8.3.2.1.4 Magneto-optic Effect8.3.2.2 Absorptive Modulators8.3.2.2.1 Franz-Keldysh8.3.2.2.2 Plasma Dispersion8.3.2.2.3 Quantum-confined Stark8.3.3 Optical Receptacles8.3.4 AWG Terminals8.3.5 Optical Isolators8.3.6 Mux/Demux Modules8.3.7 Silicon Lens8.3.7.1 Hemispherical8.3.7.2 Plano-Convex8.3.8 Filters8.3.8.1 Wavelength Division Multiplexing (WDM) Filters8.3.8.2 Micro-Optical Filters9 Global Silicon Photonics Market, By Application9.1 Introduction9.2 IT and Telecommunication9.2.1 Fiber to the Home (FTTH)9.2.2 Metro and Long Haul Applications9.2.3 Optical Switching9.2.4 High Speed Modulation9.2.5 Signal Routers9.2.6 Free Space Applications9.2.7 Point to Point (PTP)9.2.8 Optical Fiber Communication9.2.9 Information Processing9.2.10 Optical Down Converter to Microwave9.2.11 Active Optical Cables (AOCs)9.3 Data Center and High-Performance Computing9.3.1 Embedded Optical Modules9.3.2 Aggregate Bandwidth9.3.3 Parallel Optic Transceivers9.4 Military, Defense, and Aerospace9.5 Consumer Electronics & Display9.5.1 Connecting PCs with HDTVs9.5.2 Desktop PC Devices9.6 Commercial9.7 Metrology9.7.1 Time & Frequency Measurement9.7.2 Range Finding9.8 Medical and Life Science9.9 Sensing and Instruments9.9.1 Automotive Lidar9.9.2 Silicon Photonic Thermometer9.10 Research and Development9.11 Holography9.12 Spectroscopy9.13 Data Communication9.14 Media & Advertising10 Global Silicon Photonics Market, By Technology10.1 Introduction10.2 Complementary Metal Oxide Semiconductor (CMOS)10.3 Micro-Electro-Mechanical Systems (MEMS)10.4 3D Stacking11 Global Silicon Photonics Market, By Geography12 Key Developments12.1 Agreements, Partnerships, Collaborations and Joint Ventures12.2 Acquisitions & Mergers12.3 New Product Launches12.4 Expansions12.5 Other Key Strategies13 Company Profiling13.1 Intel13.2 Cisco13.3 IBM13.4 Globalfoundries13.5 STMicroelectronics13.6 Rockley Photonics13.7 Inphi13.8 Mellanox13.9 Ranovus13.10 Neophotonics13.11 Lumentum13.12 Broadcom13.13 Ii-Vi Incorporated13.14 Macom13.15 SicoyaFor more information about this report visit https://www.researchandmarkets.com/r/1xf19b Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com Answer:

Global Silicon Photonics Market Outlook 2019-2027 - Risk of Thermal Effect is Restraining Market Growth

DUBLIN, Nov. 9, 2020 /PRNewswire/ --The "Silicon Photonics - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering. Global Silicon Photonics Market accounted for $0.8 billion in 2019 and is expected to reach $3.77 billion by 2027, growing at a CAGR of 21.4% during the forecast period.Some of the key factors propelling the growth of the market are increasing demand for high-speed broadband services, deployment of 5G technologies in developing nations, and growing demand for CMOS-integrated silicon photonics technology. However, the risk of thermal effect is the restraining factor for the growth of the market.Silicon photonic devices contain optical systems that use silicon as the optical medium. Since silicon is used as a substrate for most ICs, it is easily possible to manufacture hybrid devices in which electronic as well as the optic components are integrated on a single microchip. They are increasingly used in data transfer between microchips, through optical rays. Moreover, they are capable of carrying a large amount of data in a short time as compared to the electrical conductors.By application, the IT and telecommunication segment is expected to grow at a significant market share during the forecast period because of the growing demand for smartphone products and the need for maximizing the performance of existing fixed and mobile infrastructures. Based on geography, Asia-Pacific is anticipated to hold considerable market share during the forecast period owing to the strong growth in the data centres, long haul & transport networks, and presence of consumer electronics manufacturers.Some of the key players in Silicon Photonics Market include Intel, Cisco, IBM, Globalfoundries, STMicroelectronics, Rockley Photonics, Inphi, Mellanox, Ranovus, Neophotonics, Lumentum, broadcom, Ii-Vi Incorporated, Macom, and Sicoya.What the report offers: Market share assessments for the regional and country-level segments Strategic recommendations for the new entrants Covers Market data for the years 2018, 2019, 2020, 2024 and 2027 Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations) Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc. Strategic recommendations in key business segments based on the market estimations Competitive landscaping mapping the key common trends Company profiling with detailed strategies, financials, and recent developments Supply chain trends mapping the latest technological advancements Key Topics Covered: 1 Executive Summary2 Preface2.1 Abstract2.2 Stake Holders2.3 Research Scope2.4 Research Methodology2.5 Research Sources3 Market Trend Analysis3.1 Introduction3.2 Drivers3.3 Restraints3.4 Opportunities3.5 Threats3.6 Product Analysis3.7 Application Analysis3.8 Technology Analysis3.9 Emerging Markets3.10 Impact of COVID-194 Porters Five Forces Analysis4.1 Bargaining Power of Suppliers4.2 Bargaining Power of Buyers4.3 Threat of Substitutes4.4 Threat of New Entrants4.5 Competitive Rivalry5 Global Silicon Photonics Market, By Product5.1 Introduction5.2 Switches5.3 Sensors5.4 Optical Multiplexers5.5 Cables5.6 Optical Transceivers5.6.1 Parallel Channel5.6.2 Single Channel5.7 Photovoltaic Cells/Solar Cells5.8 Light Emitting Diode5.9 Microring Laser5.10 Photonic Integrated Circuit5.11 Variable Optical Attenuators5.12 Distributed Feedback Integrated Laser5.13 Optical Interconnects5.13.1 Intrachip Interconnects5.13.2 Backplane Interconnects5.13.3 Interchip Interconnects5.14 Other Products5.14.1 Optical Engines5.14.2 Radio Frequency Circuits6 Global Silicon Photonics Market, By Material6.1 Introduction6.2 Photonic Integrated Circuits (ICs) Materials6.2.1 Gallium Arsenide6.2.2 Lithium Niobate6.2.3 Indium Phosphide6.2.4 Silicon on Insulator6.2.5 Silica on Silicon6.3 Silicon Photonics Materials6.3.1 Silicon6.3.2 Silicon-Germanium Alloys6.3.3 Indium-Phosphide (InP) Based Alloys6.3.4 Other III-V Alloys7 Global Silicon Photonics Market, By Range7.1 Introduction7.2 400-1,500 nm7.3 1,310-1,550 nm7.4 900-7,000 nm8 Global Silicon Photonics Market, By Component8.1 Introduction8.2 Active Components8.2.1 Micro-Optics8.2.1.1 Micro Lens8.2.1.2 Micromirror8.2.1.3 Light Diffuser8.2.1.4 Beam Shapers8.2.2 Splitters8.2.3 Waveguide8.2.3.1 Optical Waveguide8.2.3.2 Planar Waveguides8.2.3.3 Strip Waveguides8.2.3.4 Rib Waveguides8.2.3.5 Fiber Waveguides8.2.5 Laser8.3 Passive Components8.3.1 Photo Detectors8.3.2 Optical Modulator8.3.2.1 Refractive Modulators8.3.2.1.1 Polarization Changes in Liquid Crystals8.3.2.1.2 Electro-optic Effect8.3.2.1.3 Thermo-optic Effect8.3.2.1.4 Magneto-optic Effect8.3.2.2 Absorptive Modulators8.3.2.2.1 Franz-Keldysh8.3.2.2.2 Plasma Dispersion8.3.2.2.3 Quantum-confined Stark8.3.3 Optical Receptacles8.3.4 AWG Terminals8.3.5 Optical Isolators8.3.6 Mux/Demux Modules8.3.7 Silicon Lens8.3.7.1 Hemispherical8.3.7.2 Plano-Convex8.3.8 Filters8.3.8.1 Wavelength Division Multiplexing (WDM) Filters8.3.8.2 Micro-Optical Filters9 Global Silicon Photonics Market, By Application9.1 Introduction9.2 IT and Telecommunication9.2.1 Fiber to the Home (FTTH)9.2.2 Metro and Long Haul Applications9.2.3 Optical Switching9.2.4 High Speed Modulation9.2.5 Signal Routers9.2.6 Free Space Applications9.2.7 Point to Point (PTP)9.2.8 Optical Fiber Communication9.2.9 Information Processing9.2.10 Optical Down Converter to Microwave9.2.11 Active Optical Cables (AOCs)9.3 Data Center and High-Performance Computing9.3.1 Embedded Optical Modules9.3.2 Aggregate Bandwidth9.3.3 Parallel Optic Transceivers9.4 Military, Defense, and Aerospace9.5 Consumer Electronics & Display9.5.1 Connecting PCs with HDTVs9.5.2 Desktop PC Devices9.6 Commercial9.7 Metrology9.7.1 Time & Frequency Measurement9.7.2 Range Finding9.8 Medical and Life Science9.9 Sensing and Instruments9.9.1 Automotive Lidar9.9.2 Silicon Photonic Thermometer9.10 Research and Development9.11 Holography9.12 Spectroscopy9.13 Data Communication9.14 Media & Advertising10 Global Silicon Photonics Market, By Technology10.1 Introduction10.2 Complementary Metal Oxide Semiconductor (CMOS)10.3 Micro-Electro-Mechanical Systems (MEMS)10.4 3D Stacking11 Global Silicon Photonics Market, By Geography12 Key Developments12.1 Agreements, Partnerships, Collaborations and Joint Ventures12.2 Acquisitions & Mergers12.3 New Product Launches12.4 Expansions12.5 Other Key Strategies13 Company Profiling13.1 Intel13.2 Cisco13.3 IBM13.4 Globalfoundries13.5 STMicroelectronics13.6 Rockley Photonics13.7 Inphi13.8 Mellanox13.9 Ranovus13.10 Neophotonics13.11 Lumentum13.12 Broadcom13.13 Ii-Vi Incorporated13.14 Macom13.15 SicoyaFor more information about this report visit https://www.researchandmarkets.com/r/1xf19b Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com

edtsum7792

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, Aug. 12, 2020 /PRNewswire/ --Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed againstVelocity Financial, Inc.f/k/a Velocity Financial, LLC("Velocity" or "the Company") (NYSE:VEL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Velocity common stock pursuant and/or traceable to the Registration Statement and Prospectus (the "Offering Materials") issued in connection with Velocity's January 2020 initial public offering ("IPO").Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/vel. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933. The Complaint alleges that defendants failed to disclose that, at the time of the IPO, the Company's non-performing loans had dramatically increased in size from the figures provided in the offering materials, as measured by both the amount of unpaid principal balance and as a percentage of the Company's overall loan portfolio. In addition, defendants failed to provide any information to investors regarding the potential impact of the novel coronavirus on Velocity's business and operations, despite the fact that the international spread of the virus had already been confirmed at the time of the IPO. The failure to disclose the substantial and growing proportion of the Company's loans that were non-performing and/or on non-accrual status as of the IPO rendered the statements contained in the Offering Materials regarding the quality of the Company's loan portfolio and underwriting practices materially misleading. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/velor you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Velocityyou have until September 28, 2020 to request that the Court appoint you as co-lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz 212-697-6484 | [emailprotected] SOURCE Bronstein, Gewirtz & Grossman, LLC Related Links https://www.bgandg.com/ Answer:

VEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Velocity Financial, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm

NEW YORK, Aug. 12, 2020 /PRNewswire/ --Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed againstVelocity Financial, Inc.f/k/a Velocity Financial, LLC("Velocity" or "the Company") (NYSE:VEL) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Velocity common stock pursuant and/or traceable to the Registration Statement and Prospectus (the "Offering Materials") issued in connection with Velocity's January 2020 initial public offering ("IPO").Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/vel. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933. The Complaint alleges that defendants failed to disclose that, at the time of the IPO, the Company's non-performing loans had dramatically increased in size from the figures provided in the offering materials, as measured by both the amount of unpaid principal balance and as a percentage of the Company's overall loan portfolio. In addition, defendants failed to provide any information to investors regarding the potential impact of the novel coronavirus on Velocity's business and operations, despite the fact that the international spread of the virus had already been confirmed at the time of the IPO. The failure to disclose the substantial and growing proportion of the Company's loans that were non-performing and/or on non-accrual status as of the IPO rendered the statements contained in the Offering Materials regarding the quality of the Company's loan portfolio and underwriting practices materially misleading. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/velor you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Velocityyou have until September 28, 2020 to request that the Court appoint you as co-lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes. Contact:Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz 212-697-6484 | [emailprotected] SOURCE Bronstein, Gewirtz & Grossman, LLC Related Links https://www.bgandg.com/

edtsum7793

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: MONROE, La., July 27, 2020 /PRNewswire/ --This summer, PPM Consultants was again awarded for their exceptional growth over the past three years. The company experienced the strongest financial performance of its 25-year history in 2019, and has been recognized as a leader among architecture, engineering, and consulting (AEC) firms by the Zweig Group. PPM Consultants was recognized as number 69 out of the Top 100 AEC firms with a Fast Growth distinction. This honor is granted to firms within the AEC industry that achieve a growth rate of 20% or higher, a rate that significantly outpaces the industry. Co-founder and Principal L. Todd Perry said, "Receiving recognition from the folks who measure our industry is satisfying, but the real fun is working every day with the professionals at PPM who serve our clients with incredible solutions." One of the hallmark characteristics of the firm is its employee retention; 48 percent of the PPM team has been with the company ten years or more. Founded primarily as a firm specializing in soil and groundwater assessment and remediation for the petroleum marketing industry, PPM's services have expanded over the years to include a full range of air, water, and waste compliance consulting, due diligence and other related environmental services. PPM serves the petroleum marketing, industrial, commercial real estate, legal, and oil and gas sectors, as well as local, state, and federal government. PPM Consultants is an environmental engineering and consulting firm with over 25 years of experience serving enterprises small and large. Multi-year Inc. 500 award winner, Zweig White Hot Firm and Engineering News-Record (ENR) Top 200 firm, PPM has completed over 30,000 environmental projects in 26 states. With seven office locations across the Gulf South and over 30 service centers across the nation, PPM provides timely, expert environmental services to simplify the complexities of environmental compliance. Contact: Gretchen DuffMarketing Coordinator PPM Consultants[emailprotected]Office: (318) 812-3441Mobile: (318) 376-7270 SOURCE PPM Consultants Related Links www.ppmco.com Answer:

PPM Consultants Honored with Zweig Hot Firm Award

MONROE, La., July 27, 2020 /PRNewswire/ --This summer, PPM Consultants was again awarded for their exceptional growth over the past three years. The company experienced the strongest financial performance of its 25-year history in 2019, and has been recognized as a leader among architecture, engineering, and consulting (AEC) firms by the Zweig Group. PPM Consultants was recognized as number 69 out of the Top 100 AEC firms with a Fast Growth distinction. This honor is granted to firms within the AEC industry that achieve a growth rate of 20% or higher, a rate that significantly outpaces the industry. Co-founder and Principal L. Todd Perry said, "Receiving recognition from the folks who measure our industry is satisfying, but the real fun is working every day with the professionals at PPM who serve our clients with incredible solutions." One of the hallmark characteristics of the firm is its employee retention; 48 percent of the PPM team has been with the company ten years or more. Founded primarily as a firm specializing in soil and groundwater assessment and remediation for the petroleum marketing industry, PPM's services have expanded over the years to include a full range of air, water, and waste compliance consulting, due diligence and other related environmental services. PPM serves the petroleum marketing, industrial, commercial real estate, legal, and oil and gas sectors, as well as local, state, and federal government. PPM Consultants is an environmental engineering and consulting firm with over 25 years of experience serving enterprises small and large. Multi-year Inc. 500 award winner, Zweig White Hot Firm and Engineering News-Record (ENR) Top 200 firm, PPM has completed over 30,000 environmental projects in 26 states. With seven office locations across the Gulf South and over 30 service centers across the nation, PPM provides timely, expert environmental services to simplify the complexities of environmental compliance. Contact: Gretchen DuffMarketing Coordinator PPM Consultants[emailprotected]Office: (318) 812-3441Mobile: (318) 376-7270 SOURCE PPM Consultants Related Links www.ppmco.com

edtsum7794

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: HOBOKEN, N.J.--(BUSINESS WIRE)--Navigating todays Always On environment with zero compromise requires powerful innovation and smart, strategic decisioning. With this in mind, NICE Actimize, a NICE (NASDAQ: NICE) business today announced ENGAGE LIVE, the financial crime industrys largest virtual customer event of the year. To be held on October 14-15, 2020, this free event will provide unprecedented insights to guide business decisions at the worlds leading financial institutions. Global financial services organizations will attend the event, featuring more than 35 sessions and six tracks dedicated to financial crime solutions and services. Focused on the Always On environment reflected within the rapidly-changing financial crime industry, the event highlights innovation fueled by Digital Acceleration, Cloud Transformation, Always on AI and Actionable Data. Spotlighted at the interactive Solutions Showcase, event attendees can view the latest technologies in action from NICE Actimize and its X-Sight Marketplace partners. The Showcase will also feature strategic partners, including Infosys, a global leader in next-generation digital services and consulting. Online Pods will be staffed for live chat and networking opportunities. Featuring content to suit every role and interest across anti-money laundering, enterprise fraud, financial markets compliance, and case management, this global event offers a wealth of informative sessions, including visionary keynotes from Craig Costigan, NICE Actimize CEO; Chad Hetherington, NICE Actimize VP, Global Head of Product; and Yossi Levin, NICE Actimize VP, Global Head of Engineering. Danica Patrick, Robert Herjavec Headline Celebrity Keynotes On October 14, Danica Patrick, former world-renowned racing driver, will also deliver a keynote to kick off the event. As a professional racecar driver, Patrick broke barriers and set records with her impressive on-track performance. Attendees will have the exclusive opportunity to hear her story and unique perspective on how to stay ahead with speed and agility. And entrepreneur and leading Shark featured on ABCs Shark Tank, Robert Herjavec, will join ENGAGE LIVE on October 15. Born in Eastern Europe, and escaping Communism with his parents from the former Yugoslavia, Herjavec rose to launch his own computer company from his basement. In 2003, he founded the Herjavec Group, and it quickly became one of Americas fastest growing technology companies. His motivational business advice has received millions of impressions through TV, print, radio and digital media. Additional guest speakers include Frank McKenna, Chief Fraud Strategist of Point Predictive, and author of the well-known industry blog FrankonFraud. McKenna is an advocate for fraud managers and data scientists, who has dedicated his career to fighting fraud across the world. He has worked with over 200 banks, lenders, and finance companies, to solve fraud issues that impact customers. Organizations that accelerate digital transformation will become tomorrows leaders, said Craig Costigan, NICE Actimize CEO who will deliver the opening keynote. Balancing risk and customer experience is an imperative to transitioning successfully. To help our customers perfect that balancing act, weve introduced several innovations fuelled by the Power of our Always On AI strategy which is built on the solid foundation of our cloud platforms, Xceed and X-Sight, which provide ease and flexibility for organizations of all sizes. To register for ENGAGE LIVE, go to our registration link by clicking here. To view the complete ENGAGE LIVE Agenda, please click here. Additional NICE Actimize ENGAGE LIVE resources: About NICE Actimize NICE Actimize is the largest and broadest provider of financial crime, risk and compliance solutions for regional and global financial institutions, as well as government regulators. Consistently ranked as number one in the space, NICE Actimize experts apply innovative technology to protect institutions and safeguard consumers and investors assets by identifying financial crime, preventing fraud and providing regulatory compliance. The company provides real-time, cross-channel fraud prevention, anti-money laundering detection, and trading surveillance solutions that address such concerns as payment fraud, cybercrime, sanctions monitoring, market abuse, customer due diligence and insider trading. Find us at www.niceactimize.com, @NICE_Actimize or Nasdaq: NICE. About NICE NICE (Nasdaq: NICE) is the worlds leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com. Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICEs marks, please see: www.nice.com/nice-trademarks. Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Costigan, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the Company). In some cases, such forward-looking statements can be identified by terms such as believe, expect, seek, may, will, intend, should, project, anticipate, plan, estimate, or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Companys growth strategy; success and growth of the Companys cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company's products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Companys dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the SEC). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company's reports filed from time to time with the SEC, including the Companys Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law. Answer:

NICE Actimize Announces ENGAGE LIVE, The Largest Virtual Financial Crime Risk Management Customer Event of the Year, Focused on the Power of Always On AI Over 1000 attendees from leading Global financial services organizations will attend the conference featuring 35+ sessions dedicated to financial crime solutions and services

HOBOKEN, N.J.--(BUSINESS WIRE)--Navigating todays Always On environment with zero compromise requires powerful innovation and smart, strategic decisioning. With this in mind, NICE Actimize, a NICE (NASDAQ: NICE) business today announced ENGAGE LIVE, the financial crime industrys largest virtual customer event of the year. To be held on October 14-15, 2020, this free event will provide unprecedented insights to guide business decisions at the worlds leading financial institutions. Global financial services organizations will attend the event, featuring more than 35 sessions and six tracks dedicated to financial crime solutions and services. Focused on the Always On environment reflected within the rapidly-changing financial crime industry, the event highlights innovation fueled by Digital Acceleration, Cloud Transformation, Always on AI and Actionable Data. Spotlighted at the interactive Solutions Showcase, event attendees can view the latest technologies in action from NICE Actimize and its X-Sight Marketplace partners. The Showcase will also feature strategic partners, including Infosys, a global leader in next-generation digital services and consulting. Online Pods will be staffed for live chat and networking opportunities. Featuring content to suit every role and interest across anti-money laundering, enterprise fraud, financial markets compliance, and case management, this global event offers a wealth of informative sessions, including visionary keynotes from Craig Costigan, NICE Actimize CEO; Chad Hetherington, NICE Actimize VP, Global Head of Product; and Yossi Levin, NICE Actimize VP, Global Head of Engineering. Danica Patrick, Robert Herjavec Headline Celebrity Keynotes On October 14, Danica Patrick, former world-renowned racing driver, will also deliver a keynote to kick off the event. As a professional racecar driver, Patrick broke barriers and set records with her impressive on-track performance. Attendees will have the exclusive opportunity to hear her story and unique perspective on how to stay ahead with speed and agility. And entrepreneur and leading Shark featured on ABCs Shark Tank, Robert Herjavec, will join ENGAGE LIVE on October 15. Born in Eastern Europe, and escaping Communism with his parents from the former Yugoslavia, Herjavec rose to launch his own computer company from his basement. In 2003, he founded the Herjavec Group, and it quickly became one of Americas fastest growing technology companies. His motivational business advice has received millions of impressions through TV, print, radio and digital media. Additional guest speakers include Frank McKenna, Chief Fraud Strategist of Point Predictive, and author of the well-known industry blog FrankonFraud. McKenna is an advocate for fraud managers and data scientists, who has dedicated his career to fighting fraud across the world. He has worked with over 200 banks, lenders, and finance companies, to solve fraud issues that impact customers. Organizations that accelerate digital transformation will become tomorrows leaders, said Craig Costigan, NICE Actimize CEO who will deliver the opening keynote. Balancing risk and customer experience is an imperative to transitioning successfully. To help our customers perfect that balancing act, weve introduced several innovations fuelled by the Power of our Always On AI strategy which is built on the solid foundation of our cloud platforms, Xceed and X-Sight, which provide ease and flexibility for organizations of all sizes. To register for ENGAGE LIVE, go to our registration link by clicking here. To view the complete ENGAGE LIVE Agenda, please click here. Additional NICE Actimize ENGAGE LIVE resources: About NICE Actimize NICE Actimize is the largest and broadest provider of financial crime, risk and compliance solutions for regional and global financial institutions, as well as government regulators. Consistently ranked as number one in the space, NICE Actimize experts apply innovative technology to protect institutions and safeguard consumers and investors assets by identifying financial crime, preventing fraud and providing regulatory compliance. The company provides real-time, cross-channel fraud prevention, anti-money laundering detection, and trading surveillance solutions that address such concerns as payment fraud, cybercrime, sanctions monitoring, market abuse, customer due diligence and insider trading. Find us at www.niceactimize.com, @NICE_Actimize or Nasdaq: NICE. About NICE NICE (Nasdaq: NICE) is the worlds leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com. Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICEs marks, please see: www.nice.com/nice-trademarks. Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Costigan, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the Company). In some cases, such forward-looking statements can be identified by terms such as believe, expect, seek, may, will, intend, should, project, anticipate, plan, estimate, or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Companys growth strategy; success and growth of the Companys cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company's products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Companys dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the SEC). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company's reports filed from time to time with the SEC, including the Companys Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.

edtsum7795

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, March 13, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), formerly known as Spherix Incorporated, today announced that the record date and distribution date have changed for the previously announced distribution to AIkido stockholders of 70,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by AIkido. Each AIkido stockholder will be entitled to receive one (1) share of Hoth common stock for every seventy (70) shares of AIkido common stock held as of 5 p.m. Eastern Time on March 16, 2020, the new record date. The distribution date of the dividend distribution is anticipated to occur on or around April 30, 2020; however, this date is subject to change based upon the filing date of a registration statement by Hoth. About AIkido AIkido was initially formed in 1967 and is currently a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law. Contact: Investor Relations: Hayden IR Brett Maas, Managing Partner Phone: (646) 536-7331 Email: [emailprotected] www.haydenir.com AIkido: Phone: 212-745-1373 Email: [emailprotected] www.AIkido.com SOURCE AIkido Pharma Inc. Related Links https://spherix.com Answer:

AIkido Pharma Inc. Announces Change in the Record Date and Anticipated Distribution Date for Dividend Distribution

NEW YORK, March 13, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company"), formerly known as Spherix Incorporated, today announced that the record date and distribution date have changed for the previously announced distribution to AIkido stockholders of 70,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by AIkido. Each AIkido stockholder will be entitled to receive one (1) share of Hoth common stock for every seventy (70) shares of AIkido common stock held as of 5 p.m. Eastern Time on March 16, 2020, the new record date. The distribution date of the dividend distribution is anticipated to occur on or around April 30, 2020; however, this date is subject to change based upon the filing date of a registration statement by Hoth. About AIkido AIkido was initially formed in 1967 and is currently a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law. Contact: Investor Relations: Hayden IR Brett Maas, Managing Partner Phone: (646) 536-7331 Email: [emailprotected] www.haydenir.com AIkido: Phone: 212-745-1373 Email: [emailprotected] www.AIkido.com SOURCE AIkido Pharma Inc. Related Links https://spherix.com

edtsum7796

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE:BFA) (NYSE:BFB)will release its financial results for the third quarter fiscal 2021 on March 3, 2021 by 8:00 a.m. (EST), followed by a conference call to discuss the results at 10:00 a.m. (EST). A live audio broadcast of the conference call will be available via Brown-Formans Internet website, www.brown-forman.com, through a link to "Investors/Events & Presentations." A digital audio recording of the conference call will be available on the website approximately two hours after the conclusion of the conference call. The replay will be available for at least 30 days following the conference call. Interested parties in the U.S. are also invited to join the conference call by dialing 833-962-1472 and asking for the Brown-Forman call. International callers should dial 442-268-1255. The company suggests that participants dial in approximately ten minutes in advance of the 10:00 a.m. (EST) start. For over 150 years, Brown-Forman Corporation has enriched the experience of life by responsibly building fine quality beverage alcohol brands, including Jack Daniels Tennessee Whiskey, Jack Daniels Tennessee RTDs, Jack Daniels Tennessee Honey, Jack Daniels Tennessee Apple, Jack Daniels Tennessee Fire, Gentleman Jack, Jack Daniels Single Barrel, Finlandia, Korbel, el Jimador, Woodford Reserve, Old Forester, Coopers Craft, Herradura, New Mix, Sonoma-Cutrer, Chambord, Benriach, GlenDronach, Glenglassaugh, Slane, and Fords Gin. Brown-Formans brands are supported by approximately 4,800 employees and sold in more than 170 countries worldwide. For more information about the company, please visit http://www.brown-forman.com/. Answer:

Brown-Forman Third Quarter Earnings Release and Conference Call Scheduled for March 3, 2021

LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE:BFA) (NYSE:BFB)will release its financial results for the third quarter fiscal 2021 on March 3, 2021 by 8:00 a.m. (EST), followed by a conference call to discuss the results at 10:00 a.m. (EST). A live audio broadcast of the conference call will be available via Brown-Formans Internet website, www.brown-forman.com, through a link to "Investors/Events & Presentations." A digital audio recording of the conference call will be available on the website approximately two hours after the conclusion of the conference call. The replay will be available for at least 30 days following the conference call. Interested parties in the U.S. are also invited to join the conference call by dialing 833-962-1472 and asking for the Brown-Forman call. International callers should dial 442-268-1255. The company suggests that participants dial in approximately ten minutes in advance of the 10:00 a.m. (EST) start. For over 150 years, Brown-Forman Corporation has enriched the experience of life by responsibly building fine quality beverage alcohol brands, including Jack Daniels Tennessee Whiskey, Jack Daniels Tennessee RTDs, Jack Daniels Tennessee Honey, Jack Daniels Tennessee Apple, Jack Daniels Tennessee Fire, Gentleman Jack, Jack Daniels Single Barrel, Finlandia, Korbel, el Jimador, Woodford Reserve, Old Forester, Coopers Craft, Herradura, New Mix, Sonoma-Cutrer, Chambord, Benriach, GlenDronach, Glenglassaugh, Slane, and Fords Gin. Brown-Formans brands are supported by approximately 4,800 employees and sold in more than 170 countries worldwide. For more information about the company, please visit http://www.brown-forman.com/.

edtsum7797

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: NEW YORK, March 21, 2020 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Norwegian Cruise Line Holdings Ltd. between February 20, 2020 and March 12, 2020, inclusive (the "Class Period") of the important May 11, 2020 lead plaintiff deadline in securities class action commenced by the firm. The lawsuit seeks to recover damages for Norwegian investors under the federal securities laws. To join the Norwegian class action, go to http://www.rosenlegal.com/cases-register-1806.htmlor call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected]or [emailprotected]for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Norwegian was employing sales tactics of providing customers with unproven and/or blatantly false statements about COVID-19 to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members; and (2) as a result, defendants' statements regarding Norwegian's business and operations were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 11, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1806.htmlor to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [emailprotected] or [emailprotected]. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [emailprotected] [emailprotected] [emailprotected] www.rosenlegal.com SOURCE Rosen Law Firm, P.A. Related Links http://www.rosenlegal.com/ Answer:

ROSEN, A TOP RANKED LAW FIRM, Reminds Norwegian Cruise Line Holdings Ltd. Investors of Important Deadline in Securities Class Action Commenced by the Firm

NEW YORK, March 21, 2020 /PRNewswire/ --Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Norwegian Cruise Line Holdings Ltd. between February 20, 2020 and March 12, 2020, inclusive (the "Class Period") of the important May 11, 2020 lead plaintiff deadline in securities class action commenced by the firm. The lawsuit seeks to recover damages for Norwegian investors under the federal securities laws. To join the Norwegian class action, go to http://www.rosenlegal.com/cases-register-1806.htmlor call Phillip Kim, Esq. toll-free at 866-767-3653 or email [emailprotected]or [emailprotected]for information on the class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Norwegian was employing sales tactics of providing customers with unproven and/or blatantly false statements about COVID-19 to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members; and (2) as a result, defendants' statements regarding Norwegian's business and operations were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 11, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1806.htmlor to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [emailprotected] or [emailprotected]. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [emailprotected] [emailprotected] [emailprotected] www.rosenlegal.com SOURCE Rosen Law Firm, P.A. Related Links http://www.rosenlegal.com/

edtsum7798

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the third quarter ended September 30, 2020. This quarter we drove strong performance through the continued growth of new prescribers with more patients benefitting from NUPLAZID treatment for their Parkinsons disease psychosis and remain on-track with our supplemental NDA for the treatment of dementia-related psychosis with a PDUFA date of April 3, 2021, said Steve Davis, Acadias Chief Executive Officer. We continue to advance our late-stage programs and invest in new opportunities through business development, highlighted by our recent acquisition of CerSci Therapeutics which expands our clinical pipeline with an innovative first-in-class, non-opioid, acute and chronic pain program. Company Updates Financial Results Revenue Net sales of NUPLAZID (pimavanserin) were $120.6 million for the three months ended September 30, 2020, an increase of 27% as compared to $94.6 million reported for the three months ended September 30, 2019. For the nine months ended September 30, 2020 and 2019, Acadia reported net product sales of $320.7 million and $240.8 million, respectively. Research and Development Research and development expenses for the three months ended September 30, 2020 were $120.1 million, compared to $62.6 million for the same period of 2019. This increase was primarily due to $52.8 million in upfront consideration and transaction expenses related to the acquisition of CerSci Therapeutics. For the nine months ended September 30, 2020 and 2019, research and development expenses were $257.0 million and $182.9 million, respectively. This increase was primarily due to the acquisition of CerSci Therapeutics and the upfront payment to Vanderbilt University for the M1 PAM program. Selling, General and Administrative Selling, general and administrative expenses for the three months ended September 30, 2020 were $81.6 million, compared to $72.7 million for the same period of 2019. For the nine months ended September 30, 2020 and 2019, selling, general and administrative expenses were $267.9 million and $233.8 million, respectively. This increase was primarily due to increased advertising and promotional costs as well as an increase in personnel and related costs. Net Loss For the three months ended September 30, 2020, Acadia reported a net loss of $84.7 million, or $0.54 per common share, compared to a net loss of $42.0 million, or $0.29 per common share, for the same period in 2019. The net losses for the three months ended September 30, 2020 and 2019 included $21.4 million and $22.0 million, respectively, of non-cash stock-based compensation expense. For the nine months ended September 30, 2020, Acadia reported a net loss of $214.8 million, or $1.37 per common share, compared to a net loss of $182.2 million, or $1.26 per common share, for the same period in 2019. The net losses for the nine months ended September 30, 2020 and 2019 included $63.2 million and $62.5 million, respectively, of non-cash stock-based compensation expense. Cash and Investments At September 30, 2020, Acadias cash, cash equivalents, and investment securities totaled $644.4 million, compared to $697.4 million at December 31, 2019. 2020 Financial Guidance Conference Call and Webcast Information Acadia management will review its third quarter financial results and operations via conference call and webcast today at 4:30 p.m. Eastern Time. The conference call may be accessed by dialing 855-638-4820 for participants in the United States or Canada and 443-877-4067 for international callers (reference passcode 6266016). A telephone replay of the conference call may be accessed through November 18, 2020 by dialing 855-859-2056 for callers in the United States or Canada and 404-537-3406 for international callers (reference passcode 6266016). The conference call also will be webcast live on Acadias website, www.acadia-pharm.com, under the investors section and will be archived there until December 2, 2020. About NUPLAZID (pimavanserin) NUPLAZID is the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinsons disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting 5-HT2A receptors that are thought to play an important role in Parkinsons disease psychosis. NUPLAZID is an oral medicine taken once a day with a recommended dose of 34 mg. NUPLAZID is not FDA-approved for any other neuropsychiatric disorders. Acadia discovered and developed this new chemical entity and holds worldwide rights to develop and commercialize NUPLAZID. About Trofinetide Trofinetide is an investigational drug. It is a novel synthetic analog of the amino-terminal tripeptide of IGF-1 designed to treat the core symptoms of Rett syndrome by potentially reducing neuroinflammation and supporting synaptic function. In the central nervous system, IGF-1 is produced by both of the major types of brain cells neurons and glia. IGF-1 in the brain is critical for both normal development and for response to injury and disease. Trofinetide has been granted Fast Track Status and Orphan Drug Designation in the U.S. and Orphan Drug Designation in Europe for both Rett syndrome and Fragile X syndrome. About Acadia Pharmaceuticals Acadia is trailblazing breakthroughs in neuroscience to elevate life through science. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinsons disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn. Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, statements related to: the potential opportunity for future growth in sales of NUPLAZID; the timing of ongoing and future clinical studies for pimavanserin; the development and commercialization of trofinetide, ACP-044 and the M1 PAM program; unanticipated impacts of COVID-19 on Acadias business, including its commercial sales operations, current and planned clinical trials, supply chain, and guidance for full-year 2020 NUPLAZID net sales and certain expense line items. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the uncertainty of future commercial sales and related items that would impact net sales during 2020, the risks and uncertainties inherent in drug development, approval and commercialization, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to Acadias annual report on Form 10-K for the year ended December 31, 2019 as well as Acadias subsequent filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are qualified in their entirety by this cautionary statement and Acadia undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law. Copyright 2020 by Tiburon Sunrise, LLC ACADIA PHARMACEUTICALS INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Revenues Product sales, net $ 120,577 $ 94,586 $ 320,748 $ 240,750 Total revenues 120,577 94,586 320,748 240,750 Operating expenses Cost of product sales, license fees and royalties (1) 4,801 4,689 15,249 14,264 Research and development (1) 120,083 62,622 257,014 182,865 Selling, general and administrative (1) 81,592 72,696 267,909 233,767 Total operating expenses 206,476 140,007 540,172 430,896 Loss from operations (85,899 ) (45,421 ) (219,424 ) (190,146 ) Interest income, net 1,242 2,432 6,056 7,893 Other (expense) income (202 ) 747 (1,262 ) 506 Loss before income taxes (84,859 ) (42,242 ) (214,630 ) (181,747 ) Income tax expense (199 ) (264 ) 194 476 Net loss $ (84,660 ) $ (41,978 ) $ (214,824 ) $ (182,223 ) Net loss per common share, basic and diluted $ (0.54 ) $ (0.29 ) $ (1.37 ) $ (1.26 ) Weighted average common shares outstanding, basic and diluted 158,129 145,906 156,683 144,741 (1) Includes the following stock-based compensation expense Cost of product sales, license fees and royalties $ 495 $ 372 $ 2,087 $ 2,344 Research and development $ 7,953 $ 8,680 $ 23,645 $ 24,461 Selling, general and administrative $ 12,924 $ 12,971 $ 37,495 $ 35,697 ACADIA PHARMACEUTICALS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) September 30, 2020 December 31, 2019 (unaudited) Assets Cash, cash equivalents and investment securities $ 644,441 $ 697,429 Accounts receivable, net 46,344 35,781 Interest and other receivables 1,440 2,093 Inventory 7,979 6,341 Prepaid expenses 30,009 18,606 Total current assets 730,213 760,250 Property and equipment, net 8,427 3,180 Operating lease right-of-use assets 48,232 9,524 Intangible assets, net 1,477 2,585 Restricted cash 5,770 4,787 Other assets 1,545 2,857 Total assets $ 795,664 $ 783,183 Liabilities and stockholders equity Accounts payable $ 3,471 $ 7,222 Accrued liabilities 88,385 67,604 Total current liabilities 91,856 74,826 Operating lease liabilities 45,343 6,361 Other long-term liabilities 3,598 2,861 Total liabilities 140,797 84,048 Total stockholders equity 654,867 699,135 Total liabilities and stockholders equity $ 795,664 $ 783,183 Answer:

Acadia Pharmaceuticals Reports Third Quarter 2020 Financial Results - 3Q20 Net Sales of $120.6 Million, a 27% Increase Over 3Q19

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its financial results for the third quarter ended September 30, 2020. This quarter we drove strong performance through the continued growth of new prescribers with more patients benefitting from NUPLAZID treatment for their Parkinsons disease psychosis and remain on-track with our supplemental NDA for the treatment of dementia-related psychosis with a PDUFA date of April 3, 2021, said Steve Davis, Acadias Chief Executive Officer. We continue to advance our late-stage programs and invest in new opportunities through business development, highlighted by our recent acquisition of CerSci Therapeutics which expands our clinical pipeline with an innovative first-in-class, non-opioid, acute and chronic pain program. Company Updates Financial Results Revenue Net sales of NUPLAZID (pimavanserin) were $120.6 million for the three months ended September 30, 2020, an increase of 27% as compared to $94.6 million reported for the three months ended September 30, 2019. For the nine months ended September 30, 2020 and 2019, Acadia reported net product sales of $320.7 million and $240.8 million, respectively. Research and Development Research and development expenses for the three months ended September 30, 2020 were $120.1 million, compared to $62.6 million for the same period of 2019. This increase was primarily due to $52.8 million in upfront consideration and transaction expenses related to the acquisition of CerSci Therapeutics. For the nine months ended September 30, 2020 and 2019, research and development expenses were $257.0 million and $182.9 million, respectively. This increase was primarily due to the acquisition of CerSci Therapeutics and the upfront payment to Vanderbilt University for the M1 PAM program. Selling, General and Administrative Selling, general and administrative expenses for the three months ended September 30, 2020 were $81.6 million, compared to $72.7 million for the same period of 2019. For the nine months ended September 30, 2020 and 2019, selling, general and administrative expenses were $267.9 million and $233.8 million, respectively. This increase was primarily due to increased advertising and promotional costs as well as an increase in personnel and related costs. Net Loss For the three months ended September 30, 2020, Acadia reported a net loss of $84.7 million, or $0.54 per common share, compared to a net loss of $42.0 million, or $0.29 per common share, for the same period in 2019. The net losses for the three months ended September 30, 2020 and 2019 included $21.4 million and $22.0 million, respectively, of non-cash stock-based compensation expense. For the nine months ended September 30, 2020, Acadia reported a net loss of $214.8 million, or $1.37 per common share, compared to a net loss of $182.2 million, or $1.26 per common share, for the same period in 2019. The net losses for the nine months ended September 30, 2020 and 2019 included $63.2 million and $62.5 million, respectively, of non-cash stock-based compensation expense. Cash and Investments At September 30, 2020, Acadias cash, cash equivalents, and investment securities totaled $644.4 million, compared to $697.4 million at December 31, 2019. 2020 Financial Guidance Conference Call and Webcast Information Acadia management will review its third quarter financial results and operations via conference call and webcast today at 4:30 p.m. Eastern Time. The conference call may be accessed by dialing 855-638-4820 for participants in the United States or Canada and 443-877-4067 for international callers (reference passcode 6266016). A telephone replay of the conference call may be accessed through November 18, 2020 by dialing 855-859-2056 for callers in the United States or Canada and 404-537-3406 for international callers (reference passcode 6266016). The conference call also will be webcast live on Acadias website, www.acadia-pharm.com, under the investors section and will be archived there until December 2, 2020. About NUPLAZID (pimavanserin) NUPLAZID is the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinsons disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting 5-HT2A receptors that are thought to play an important role in Parkinsons disease psychosis. NUPLAZID is an oral medicine taken once a day with a recommended dose of 34 mg. NUPLAZID is not FDA-approved for any other neuropsychiatric disorders. Acadia discovered and developed this new chemical entity and holds worldwide rights to develop and commercialize NUPLAZID. About Trofinetide Trofinetide is an investigational drug. It is a novel synthetic analog of the amino-terminal tripeptide of IGF-1 designed to treat the core symptoms of Rett syndrome by potentially reducing neuroinflammation and supporting synaptic function. In the central nervous system, IGF-1 is produced by both of the major types of brain cells neurons and glia. IGF-1 in the brain is critical for both normal development and for response to injury and disease. Trofinetide has been granted Fast Track Status and Orphan Drug Designation in the U.S. and Orphan Drug Designation in Europe for both Rett syndrome and Fragile X syndrome. About Acadia Pharmaceuticals Acadia is trailblazing breakthroughs in neuroscience to elevate life through science. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinsons disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia-pharm.com and follow us on LinkedIn. Forward-Looking Statements Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, statements related to: the potential opportunity for future growth in sales of NUPLAZID; the timing of ongoing and future clinical studies for pimavanserin; the development and commercialization of trofinetide, ACP-044 and the M1 PAM program; unanticipated impacts of COVID-19 on Acadias business, including its commercial sales operations, current and planned clinical trials, supply chain, and guidance for full-year 2020 NUPLAZID net sales and certain expense line items. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties. Actual events or results may differ materially from those projected in any of such statements due to various factors, including the uncertainty of future commercial sales and related items that would impact net sales during 2020, the risks and uncertainties inherent in drug development, approval and commercialization, and the fact that past results of clinical trials may not be indicative of future trial results. For a discussion of these and other factors, please refer to Acadias annual report on Form 10-K for the year ended December 31, 2019 as well as Acadias subsequent filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are qualified in their entirety by this cautionary statement and Acadia undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law. Copyright 2020 by Tiburon Sunrise, LLC ACADIA PHARMACEUTICALS INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Revenues Product sales, net $ 120,577 $ 94,586 $ 320,748 $ 240,750 Total revenues 120,577 94,586 320,748 240,750 Operating expenses Cost of product sales, license fees and royalties (1) 4,801 4,689 15,249 14,264 Research and development (1) 120,083 62,622 257,014 182,865 Selling, general and administrative (1) 81,592 72,696 267,909 233,767 Total operating expenses 206,476 140,007 540,172 430,896 Loss from operations (85,899 ) (45,421 ) (219,424 ) (190,146 ) Interest income, net 1,242 2,432 6,056 7,893 Other (expense) income (202 ) 747 (1,262 ) 506 Loss before income taxes (84,859 ) (42,242 ) (214,630 ) (181,747 ) Income tax expense (199 ) (264 ) 194 476 Net loss $ (84,660 ) $ (41,978 ) $ (214,824 ) $ (182,223 ) Net loss per common share, basic and diluted $ (0.54 ) $ (0.29 ) $ (1.37 ) $ (1.26 ) Weighted average common shares outstanding, basic and diluted 158,129 145,906 156,683 144,741 (1) Includes the following stock-based compensation expense Cost of product sales, license fees and royalties $ 495 $ 372 $ 2,087 $ 2,344 Research and development $ 7,953 $ 8,680 $ 23,645 $ 24,461 Selling, general and administrative $ 12,924 $ 12,971 $ 37,495 $ 35,697 ACADIA PHARMACEUTICALS INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) September 30, 2020 December 31, 2019 (unaudited) Assets Cash, cash equivalents and investment securities $ 644,441 $ 697,429 Accounts receivable, net 46,344 35,781 Interest and other receivables 1,440 2,093 Inventory 7,979 6,341 Prepaid expenses 30,009 18,606 Total current assets 730,213 760,250 Property and equipment, net 8,427 3,180 Operating lease right-of-use assets 48,232 9,524 Intangible assets, net 1,477 2,585 Restricted cash 5,770 4,787 Other assets 1,545 2,857 Total assets $ 795,664 $ 783,183 Liabilities and stockholders equity Accounts payable $ 3,471 $ 7,222 Accrued liabilities 88,385 67,604 Total current liabilities 91,856 74,826 Operating lease liabilities 45,343 6,361 Other long-term liabilities 3,598 2,861 Total liabilities 140,797 84,048 Total stockholders equity 654,867 699,135 Total liabilities and stockholders equity $ 795,664 $ 783,183

edtsum7799

You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. Text: RALEIGH, N.C., March 10, 2021 /PRNewswire/ --FYX Gaming, the Raleigh-based esports infrastructure and technology provider specializing in the development of blockchain-based solutions, today announces that it has entered into a partnership with leading esports betting operator Unikrn.The deal will see the two leading esports companies collaborate to deliver next-generation iGaming products and technology. Headlining the partnership is the inclusion of CryptoFights a skill-based strategic fighting game and the flagship title for the FYX platform on Unikrn Virtual, a proprietary gaming product offered by Unikrn that uses historical esports match data to power a non-stop stream of content coupled with live betting markets. Unikrn Virtual will utilize the in-game data created during real-life CryptoFights matches, all of which is recorded in real-time to the Bitcoin SV blockchain through the FYX platform, as the basis for a selection of new streams and markets on its platform. The inclusion of CryptoFights on Unikrn Virtual is the first of several planned collaborations between FYX and Unikrn; the infrastructure established between these two entities integrates the unique blockchain-based data products from FYX with Unikrn and can be leveraged for future games and esports offerings on the FYX platform. Game developers that integrate with Unikrn through the FYX platform receive a percentage of all net revenues generated from their games instantly unlocking a new method of monetization for game developers throughout the entire lifespan of their product. Set for public release later in 2021, FYX leverages the unique characteristics of blockchain technology to power a competitive esports experience like no other, with native cash matches and tournaments, verifiable game integrity, as well as new methods of monetization for game developers. It has been built to be game engine-agnostic, with a range of integration options through an SDK and API available to developers of all sizes from AAA studios right through to small indie developers with no up-front implementation costs. Powering the FYX platform is the Bitcoin SV (BSV) blockchain, which provides a massively scaled network capable of handling huge volumes of payment and data transaction throughput at a predictably low cost required by enterprise-grade blockchain applications. Its distributed data ledger is public and used to permanently store individual match data in real-time offering auditable game integrity and enabling a host of new competitive, monetized features for players and developers alike. To find out more and register your interest, visit fyxgaming.com Speaking on today's announcement, FYX CEO Adam Kling, commented: "Today's agreement between FYX and Unikrn is a huge first step towards shifting the business and monetization models that underpin the gaming industry. The partnership immediately creates an all-new revenue stream for game developers, with the foundation laid for future games on FYX to follow the CryptoFights template and integrate with Unikrn another unique feature enabled through our innovative blockchain-based esports platform." About FYX FYXis an esports infrastructure and technology provider, specializing in the development and implementation of blockchain technologies. The company offers a full suite of specialized esports products and services, with innovative solutions spanning game monetization, integrity, data and analytics. In 2020, FYX was admitted as a member of the esports Integrity Commission (ESIC). About Unikrn Established in 2014, Unikrn is one of the world's leading esports companies, with operations spanning betting, gaming and esports. Unikrn was recognized as the Esports Operator of the Year in consecutive years at EGR's 2019 & 2020 awards. As the leading bookmaker in the esports space, Unikrn has patent-pending technologies and unique award-winning gaming experiences alongside best-in-class traditional betting options including an online casino and sports betting. SOURCE FYX Gaming Answer:

Blockchain esports platform FYX partners with leading esports betting operator Unikrn to deliver next-generation iGaming products

RALEIGH, N.C., March 10, 2021 /PRNewswire/ --FYX Gaming, the Raleigh-based esports infrastructure and technology provider specializing in the development of blockchain-based solutions, today announces that it has entered into a partnership with leading esports betting operator Unikrn.The deal will see the two leading esports companies collaborate to deliver next-generation iGaming products and technology. Headlining the partnership is the inclusion of CryptoFights a skill-based strategic fighting game and the flagship title for the FYX platform on Unikrn Virtual, a proprietary gaming product offered by Unikrn that uses historical esports match data to power a non-stop stream of content coupled with live betting markets. Unikrn Virtual will utilize the in-game data created during real-life CryptoFights matches, all of which is recorded in real-time to the Bitcoin SV blockchain through the FYX platform, as the basis for a selection of new streams and markets on its platform. The inclusion of CryptoFights on Unikrn Virtual is the first of several planned collaborations between FYX and Unikrn; the infrastructure established between these two entities integrates the unique blockchain-based data products from FYX with Unikrn and can be leveraged for future games and esports offerings on the FYX platform. Game developers that integrate with Unikrn through the FYX platform receive a percentage of all net revenues generated from their games instantly unlocking a new method of monetization for game developers throughout the entire lifespan of their product. Set for public release later in 2021, FYX leverages the unique characteristics of blockchain technology to power a competitive esports experience like no other, with native cash matches and tournaments, verifiable game integrity, as well as new methods of monetization for game developers. It has been built to be game engine-agnostic, with a range of integration options through an SDK and API available to developers of all sizes from AAA studios right through to small indie developers with no up-front implementation costs. Powering the FYX platform is the Bitcoin SV (BSV) blockchain, which provides a massively scaled network capable of handling huge volumes of payment and data transaction throughput at a predictably low cost required by enterprise-grade blockchain applications. Its distributed data ledger is public and used to permanently store individual match data in real-time offering auditable game integrity and enabling a host of new competitive, monetized features for players and developers alike. To find out more and register your interest, visit fyxgaming.com Speaking on today's announcement, FYX CEO Adam Kling, commented: "Today's agreement between FYX and Unikrn is a huge first step towards shifting the business and monetization models that underpin the gaming industry. The partnership immediately creates an all-new revenue stream for game developers, with the foundation laid for future games on FYX to follow the CryptoFights template and integrate with Unikrn another unique feature enabled through our innovative blockchain-based esports platform." About FYX FYXis an esports infrastructure and technology provider, specializing in the development and implementation of blockchain technologies. The company offers a full suite of specialized esports products and services, with innovative solutions spanning game monetization, integrity, data and analytics. In 2020, FYX was admitted as a member of the esports Integrity Commission (ESIC). About Unikrn Established in 2014, Unikrn is one of the world's leading esports companies, with operations spanning betting, gaming and esports. Unikrn was recognized as the Esports Operator of the Year in consecutive years at EGR's 2019 & 2020 awards. As the leading bookmaker in the esports space, Unikrn has patent-pending technologies and unique award-winning gaming experiences alongside best-in-class traditional betting options including an online casino and sports betting. SOURCE FYX Gaming